Abstract is: Juvenile idiopathic arthritis (JIA) is the most common, chronic rheumatic disease of childhood, affecting approximately one per 1,000 children. Juvenile, in this context, refers to disease onset before 16 years of age, while idiopathic refers to a condition with no defined cause, and arthritis is inflammation within the joint. JIA is an autoimmune, noninfective, inflammatory joint disease, the cause of which remains poorly understood. It is characterised by chronic joint inflammation. JIA is a subset of childhood arthritis, but unlike other, more transient forms of childhood arthritis, JIA persists for at least six weeks, and in some children is a lifelong condition. It differs significantly from forms of arthritis commonly seen in adults (osteoarthritis, rheumatoid arthritis), in terms of cause, disease associations, and prognosis. The prognosis for children with JIA has improved dramatically over recent decades, particularly with the introduction of biological therapies and a shift towards more aggressive treatment strategies. JIA treatment aims for normal physical and psychosocial functioning, which is an achievable goal for some children with this condition.
| arthropathy | Q708176 |
| class of disease | Q112193867 |
| disease | Q12136 |
| rheumatoid arthritis | Q187255 |
| childhood arthritis | Q1029413 |
| polyarthritis | Q1274464 |
| P2176 | drug or therapy used for treatment | ibuprofen | Q186969 |
| Diclofenac | Q244408 | ||
| etanercept | Q415343 | ||
| sulfasalazine | Q420035 | ||
| methotrexate | Q422232 | ||
| naproxen | Q1215575 | ||
| oxaprozin | Q1749609 | ||
| tolmetin | Q3992411 | ||
| aurothioglucose | Q4072449 | ||
| P2293 | genetic association | VTCN1 | Q18046261 |
| REEP3 | Q18053462 | ||
| JMJD1C | Q18053463 | ||
| P1995 | health specialty | rheumatology | Q327657 |
| P5008 | on focus list of Wikimedia project | WikiProject Medicine | Q4099686 |
| Q55788665 | enthesitis-related juvenile idiopathic arthritis |
| Q55788661 | oligoarticular juvenile idiopathic arthritis |
| Q56014153 | polyarticular juvenile idiopathic arthritis |
| Q55788663 | psoriasis-related juvenile idiopathic arthritis |
| Q55788660 | rheumatoid factor-negative juvenile idiopathic arthritis |
| Q17148432 | systemic-onset juvenile idiopathic arthritis |
| Q3624447 | undifferentiated juvenile idiopathic arthritis |
| Q89504322 | "Asking Too Much?": Randomized N-of-1 Trial Exploring Patient Preferences and Measurement Reactivity to Frequent Use of Remote Multidimensional Pain Assessments in Children and Young People With Juvenile Idiopathic Arthritis |
| Q57154148 | "I just want to get better": experiences of children and youth with juvenile idiopathic arthritis in a home-based exercise intervention |
| Q90981836 | "Reluctant to Assess Pain": A Qualitative Study of Health Care Professionals' Beliefs About the Role of Pain in Juvenile Idiopathic Arthritis |
| Q39975012 | 'It might hurt, but you have to push through the pain': Perspectives on physical activity from children with juvenile idiopathic arthritis and their parents |
| Q53947637 | 'The eyes have it!' The need to improve awareness and access to early ophthalmological screening for juvenile idiopathic arthritis associated uveitis. |
| Q59350681 | (528) Development and usability testing of an iPad and desktop psycho-educational game for children with Juvenile Idiopathic Arthritis and their parents |
| Q45752110 | 12A. The Gut-Joint Connection: Treating Juvenile Idiopathic Arthritis and Intestinal Hyperpermeability With Acupuncture, Natural Products, and Diet. |
| Q45746320 | 14.3 Early cardiovascular risk assessment in patients with juvenile idiopathic arthritis |
| Q45746326 | 14.4 Oligoarticular Juvenile Idiopathic Arthritis (JIA): can extension be predicted? |
| Q45746331 | 14.5 Rheumatoid Arthritis susceptibility loci; STAT4, TRAF1/C5 and 6q23 region, are also associated with Juvenile Idiopathic Arthritis. |
| Q46679309 | 19S IgM Forssman-type heterophile antibodies in juvenile rheumatoid arthritis |
| Q68911185 | 19S IgM rheumatoid factor plaque forming cells in a five-year-old patient with juvenile rheumatoid arthritis |
| Q70310354 | 19S IgM rheumatoid factor-7S IgG rheumatoid factor immune complexes isolated in sera of patients with juvenile rheumatoid arthritis |
| Q74281247 | 2 classification of juvenile idiopathic arthritis |
| Q59268775 | 2-year outcome of juvenile idiopathic arthritis in current daily practice: what can we tell our patients? |
| Q45746164 | 2.1 Long-term safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis (JIA). |
| Q45746238 | 2.2 A phase II trial with canakinumab, a new IL-1beta blocking monoclonal antibody (ACZ885), to evaluate preliminary dosing, safety and efficacy profile in children with systemic Juvenile Idiopathic arthritis (sJIA). |
| Q45746313 | 2.3 Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular course juvenile rheumatoid arthritis (JRA): Findings from an open-label treatment extension. |
| Q45746349 | 2.4 Magnetic resonance imaging, ultrasonography and conventional radiography in the assessment of bone erosions in juvenile idiopathic arthritis |
| Q35567870 | 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features |
| Q33613293 | 2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis [...] |
| Q86446863 | 2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening a |
| Q38575277 | 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Coll |
| Q38729149 | 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Coll |
| Q51369462 | 2016 update of the Portuguese recommendations for the use of biological therapies in children and adolescents with Juvenile Idiopathic Arthritis. |
| Q90301719 | 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis |
| Q90301763 | 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis |
| Q95469391 | 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis |
| Q94071067 | 22. Systemic onset juvenile idiopathic arthritis with multi-organ failure in a teenager |
| Q68013420 | 25-Hydroxyvitamin D therapy in children with active juvenile rheumatoid arthritis: short-term effects on serum osteocalcin levels and bone mineral density |
| Q35878750 | 25-hydroxyvitamin D levels and juvenile idiopathic arthritis: is there an association with disease activity? |
| Q45746365 | 3.4 Physical activity in adolescents with juvenile idiopathic arthritis |
| Q45746371 | 3.5 Comparison of functional ability in juvenile idiopathic arthritis, juvenile dermatomyositis, juvenile systemic lupus erythematosus and healthy controls. An analysis of the PRINTO database |
| Q94551956 | 3. Transient acute coronary syndrome: delayed reaction to infliximab in an adolescent with juvenile idiopathic arthritis |
| Q94102903 | 3019 Metabolomic Markers of Methotrexate Response in Juvenile Idiopathic Arthritis |
| Q53259377 | 3D analysis of facial asymmetry in subjects with juvenile idiopathic arthritis. |
| Q45746379 | 4.4 Different phenotype of anaemia in systemic juvenile idiopathic arthritis (s-JIA) compared to anaemia in other subtypes of JIA. |
| Q45746383 | 4.5 Defective phosphorylation of the interleukin 18 receptor beta-chain causes impaired NK cell function in systemic onset Juvenile Idiopathic Arthritis |
| Q62513281 | 5-Aminoimidazole-4-carboxamide ribonucleotide-transformylase and inosine-triphosphate-pyrophosphatase genes variants predict remission rate during methotrexate therapy in patients with juvenile idiopathic arthritis |
| Q46861391 | 5-aminoimidazole-4-carboxamide ribonucleotide-transformylase and inosine-triphosphate-pyrophosphatase genes variants predict remission rate during methotrexate therapy in patients with juvenile idiopathic arthritis |
| Q54282588 | 50 Years Ago in The Journal of Pediatrics: Monarticular Juvenile Rheumatoid Arthritis. |
| Q88496817 | 50 Years Ago in The Journal of Pediatrics: Rash Associated with Juvenile Rheumatoid Arthritis |
| Q98621193 | 50 Years Ago in The Journal of Pediatrics: Revolutionary Changes in the Management of Juvenile Idiopathic Arthritis |
| Q96683691 | 50 Years Ago in The Journal of Pediatrics: The Clinical Significance of Serologic Testing for Juvenile Idiopathic Arthritis: Then and Now |
| Q97873604 | 50 Years Ago in TheJournalofPediatrics: The Liver in Juvenile Idiopathic Arthritis and the Evolution of Liver Function Tests |
| Q44845942 | 50 years ago in the Journal of Pediatrics: clinical and serologic observations in patients with juvenile rheumatoid arthritis and their relatives |
| Q61307946 | 50. The development and evaluation of an interactive health communication application to promote self-management in young people diagnosed with juvenile idiopathic arthritis: a pilot study |
| Q94552339 | 6. A case of complex juvenile idiopathic arthritis in childhood, adolescence and adulthood |
| Q42994494 | 677TT genotype is associated with elevated risk of methotrexate (MTX) toxicity in juvenile idiopathic arthritis: treatment outcome, erythrocyte concentrations of MTX and folates, and MTHFR polymorphisms. |
| Q74281277 | 7 juvenile idiopathic arthritis |
| Q45746200 | 7.4 Improvements in individual disease components are sustained with long-term adalimumab therapy for polyarticular Juvenile Idiopathic Arthritis |
| Q45746205 | 7.5 Safety data from over 1,200 patients-years of methotrexate and/or etanercept treatment in children with polyarticular or systemic juvenile rheumatoid arthritis |
| Q47383021 | 90K immunostimulatory glycoprotein in children with juvenile idiopathic arthritis. |
| Q99611893 | ; LIVER LESION IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS WITH DIFFERENT DURATION OF METHOTREXATE TREATMENT |
| Q84400268 | A 14-year-old girl with Smith-McCort dysplasia misdiagnosed as seronegative juvenile idiopathic arthritis |
| Q81226352 | A 2 year followup study of enhanced magnetic resonance imaging and clinical examination of the temporomandibular joint in children with juvenile idiopathic arthritis |
| Q42231947 | A 21-year-old man with systemic-onset juvenile rheumatoid arthritis, cough and progressive dyspnea. |
| Q55492457 | A 6-month, multicenter, open-label study of fixed dose naproxen/esomeprazole in adolescent patients with juvenile idiopathic arthritis. |
| Q91886979 | A Bullseye for Children With Systemic Juvenile Idiopathic Arthritis |
| Q24609382 | A CLEC16A variant confers risk for juvenile idiopathic arthritis and anti-cyclic citrullinated peptide antibody negative rheumatoid arthritis |
| Q101455509 | A Case of Stimulator of Interferon Genes-associated Vasculopathy with an Onset in Infancy Diagnosed after the Development of Atypical Pulmonary Lesions During Treatment as Juvenile Idiopathic Arthritis |
| Q91895089 | A Common Functional Ability Score for Young People with Juvenile Idiopathic Arthritis |
| Q41360790 | A Comparative Study of Joint Pain in Adult and Juvenile Rheumatoid Arthritis |
| Q93160646 | A Comparison of Radiographic Joint Space Width Measurements Versus Ultrasonographic Assessment of Cartilage Thickness in Children with Juvenile Idiopathic Arthritis |
| Q58694039 | A Granulocyte-Specific Protein S100A12 as a Potential Prognostic Factor Affecting Aggressiveness of Therapy in Patients with Juvenile Idiopathic Arthritis |
| Q38691413 | A Meta-Analysis to Estimate the Placebo Effect in Randomized Controlled Trials in Juvenile Idiopathic Arthritis. |
| Q42370688 | A Novel Method for Pathway Identification Based on Attractor and Crosstalk in Polyarticular Juvenile Idiopathic Arthritis. |
| Q90905694 | A Novel STK4 Mutation Presenting with Juvenile Idiopathic Arthritis and Epidermodysplasia Verruciformis |
| Q36403381 | A Patient-Specific Foot Model for the Estimate of Ankle Joint Forces in Patients with Juvenile Idiopathic Arthritis |
| Q92134296 | A Rare Case of Juvenile Idiopathic Arthritis following a Ruptured Baker's Cyst in a Toddler |
| Q86678180 | A Rare Skin Disorder Misdiagnosed as Juvenile Idiopathic Arthritis |
| Q35769120 | A Systematic Critical Appraisal of Clinical Practice Guidelines in Juvenile Idiopathic Arthritis Using the Appraisal of Guidelines for Research and Evaluation II (AGREE II) Instrument |
| Q42291818 | A Systemic-Onset Juvenile Idiopathic Arthritis Patient with Reduced Anakinra Treatment Admitted with an Attack |
| Q92457859 | A UK study: vocational experiences of young adults with juvenile idiopathic arthritis |
| Q39066421 | A better understanding of juvenile idiopathic arthritis with classification criteria |
| Q45942181 | A biopsychosocial approach to parents of children with juvenile idiopathic arthritis. |
| Q40744152 | A case of Fahr's disease associated with juvenile rheumatoid arthritis |
| Q91814632 | A case of acute lymphoblastic leukemia mimicking juvenile idiopathic arthritis |
| Q81106302 | A case of adult-onset Felty syndrome in juvenile rheumatoid arthritis |
| Q42368348 | A case of choroidal neovascular membrane in 6-year-old boy with juvenile idiopathic arthritis |
| Q83436225 | A case of juvenile idiopathic arthritis exhibiting repair of systemic bone erosion in response to continuation of MTX therapy after achievement of clinical remission |
| Q68082587 | A case of juvenile rheumatoid arthritis with panuveitis |
| Q41763321 | A case of juvenile rheumatoid arthritis with sclerodactylia and calcinosis |
| Q40066811 | A case of juvenile rheumatoid arthritis with ventricular septal defect. (Report of a case with a brief review of the literature) |
| Q91929306 | A case of life-threatening valvulitis mimicking infective endocarditis in systemic juvenile idiopathic arthritis |
| Q69261783 | A case of lymphoproliferative disease presenting as juvenile rheumatoid arthritis. Diagnosis by synovial fluid examination |
| Q33499992 | A case of macrophage activation syndrome developed with systemic juvenile rheumatoid arthritis |
| Q46968839 | A case of macrophage activation syndrome in a child with systemic juvenile idiopathic arthritis |
| Q90207911 | A case of moderate haemophilia A with inhibitor, carrying the p.R1800H mutation, complicated with juvenile idiopathic arthritis |
| Q46814965 | A case of panuveitis with optic disc neovascularization associated with juvenile idiopathic arthritis which progressed during a clinical trial of etanercept |
| Q70478590 | A case of persistent pulmonary functional abnormalities in systemic-onset juvenile chronic polyarthritis |
| Q51715223 | A case of planned pregnancy with an interruption in infliximab administration in a 27-year-old female patient with rheumatoid-factor-positive polyarthritis juvenile idiopathic arthritis which improved after restarting infliximab and methotrexate. |
| Q40340174 | A case of pseudomembranous colitis in a juvenile rheumatoid arthritis patient taking methotrexate |
| Q40201902 | A case of severe systemic juvenile idiopathic arthritis introduced tocilizumab in early phase of the disease |
| Q55208895 | A case of systemic juvenile idiopathic arthritis with pulmonary hemosiderosis secondary to recurrent macrophage activation syndrome or a new autoinflammatory syndrome? |
| Q40391968 | A case report of successful treatment with plasma exchange for hemophagocytic syndrome associated with severe systemic juvenile idiopathic arthritis in an infant girl |
| Q40607523 | A case with juvenile rheumatoid arthritis who developed cerebral vasculitis and venovascular hypertension |
| Q48510677 | A case-control sleep study in children with polyarticular juvenile rheumatoid arthritis. |
| Q38449777 | A child with interstitial granulomatous dermatitis and juvenile idiopathic arthritis |
| Q74409637 | A child with spina bifida, cerebral palsy and juvenile rheumatoid arthritis: rehabilitation challenge |
| Q104066748 | A clinical prediction model for estimating the risk of developing uveitis in patients with juvenile idiopathic arthritis |
| Q87808144 | A cohort study of patients with juvenile idiopathic arthritis and arthritis of the temporomandibular joint: outcome of arthrocentesis with and without the use of steroids |
| Q28360076 | A combination of etanercept and methotrexate for the treatment of refractory juvenile idiopathic arthritis: a pilot study |
| Q31064321 | A commentary on TREAT: the trial of early aggressive drug therapy in juvenile idiopathic arthritis |
| Q45744101 | A comparison of clinical vs ultrasound determined synovitis in juvenile idiopathic arthritis (JIA). |
| Q45779682 | A comparison of immunoglobulin G-containing high-molecular-weight complexes isolated from children with juvenile rheumatoid arthritis and congenital human immunodeficiency virus infection |
| Q83216496 | A comparison of response criteria to evaluate therapeutic response in patients with juvenile idiopathic arthritis treated with methotrexate and/or anti-tumor necrosis factor alpha agents |
| Q37627929 | A comparison of three treatment strategies in recent onset non-systemic Juvenile Idiopathic Arthritis: initial 3-months results of the BeSt for Kids-study |
| Q61775115 | A complete deficiency of Hyaluronoglucosaminidase 1 (HYAL1) presenting as familial juvenile idiopathic arthritis |
| Q41526254 | A complication of juvenile rheumatoid arthritis--spontaneous biceps tendon rupture |
| Q37364217 | A comprehensive candidate gene study on bronchial asthma and juvenile idiopathic arthritis |
| Q36836577 | A comprehensive review of the genetics of juvenile idiopathic arthritis |
| Q78685869 | A controlled longitudinal study of the social functioning of children with juvenile rheumatoid arthritis |
| Q46861364 | A controlled trial of intra-articular corticosteroids with or without methotrexate in oligoarticular juvenile idiopathic arthritis |
| Q97637727 | A controversial topic in juvenile idiopathic arthritis: Association between biologic agents and malignancy |
| Q36428112 | A critical appraisal of radiographic scoring systems for assessment of juvenile idiopathic arthritis |
| Q39885101 | A critical reappraisal of juvenile rheumatoid arthritis |
| Q41737134 | A cross sectional study on juvenile idiopathic arthritis in paediatric population |
| Q72840636 | A decrease in the estimated frequency of the extended HLA haplotype B18 CF130 DR3 DQw2 is common to non-insulin-dependent diabetes, juvenile rheumatoid arthritis, and Berger's disease |
| Q38070036 | A descriptive analysis of 14 cases of progressive-psuedorheumatoid-arthropathy of childhood from south India: review of literature in comparison with juvenile idiopathic arthritis |
| Q72184098 | A descriptive study of foot problems in children with juvenile rheumatoid arthritis (JRA) |
| Q48279687 | A distinct HLA-DRw8 haplotype characterizes patients with juvenile rheumatoid arthritis |
| Q54956166 | A family carrying a homozygous LACC1 truncated mutation expands the clinical phenotype of this disease beyond systemic-onset juvenile idiopathic arthritis. |
| Q46967897 | A family case of early onset juvenile idiopathic arthritis with uveitis: lessons of the past and the present |
| Q33568056 | A family with a high incidence of juvenile rheumatoid arthritis |
| Q47379400 | A fatal case of tuberculous meningitis in a child with juvenile idiopathic arthritis: a diagnostic challenge |
| Q46403608 | A feasibility study of the effect of intra-articular corticosteroid injection on isokinetic muscle strength in children with juvenile idiopathic arthritis |
| Q72215977 | A five year prospective study of rheumatoid factor tests in juvenile rheumatoid arthritis |
| Q78486828 | A follow-up study of juvenile rheumatoid arthritis into adulthood |
| Q83126605 | A follow-up study of patients with juvenile idiopathic arthritis who discontinued etanercept due to disease remission |
| Q74054010 | A follow-up study of systemic-onset juvenile rheumatoid arthritis in children |
| Q92312721 | A fresh look at angiogenesis in juvenile idiopathic arthritis |
| Q69559900 | A functional assessment for juvenile rheumatoid arthritis |
| Q40555458 | A functional promoter haplotype of macrophage migration inhibitory factor is linked and associated with juvenile idiopathic arthritis. |
| Q46508918 | A gene in the telomeric HLA complex distinct from HLA-A is involved in predisposition to juvenile idiopathic arthritis (JIA). |
| Q50760921 | A gene in the telomeric HLA complex distinct from HLA-A is involved in predisposition to juvenile idiopathic arthritis. |
| Q59697449 | A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1α polymorphism |
| Q80806180 | A genome-wide scan for juvenile rheumatoid arthritis in affected sibpair families provides evidence of linkage |
| Q92020796 | A global perspective on juvenile idiopathic arthritis |
| Q47398869 | A high proportion of the V delta 1+ synovial fluid gamma delta T cells in juvenile rheumatoid arthritis patients express the very early activation marker CD69, but carry the high molecular weight isoform of the leucocyte common antigen (CD45RA). |
| Q46033539 | A hospital based registry of juvenile idiopathic arthritis in Norway. |
| Q45745774 | A juvenile idiopathic arthritis biobank at the Royal Children's Hospital, Melbourne, Australia. |
| Q48488503 | A life-threatening central nervous system-tuberculosis inflammatory reaction nonresponsive to corticosteroids and successfully controlled by infliximab in a young patient with a variant of juvenile idiopathic arthritis. |
| Q81508875 | A longitudinal analysis of physical functional disability over the course of juvenile idiopathic arthritis |
| Q41923106 | A longterm prospective real-life experience with leflunomide in juvenile idiopathic arthritis. |
| Q67956413 | A low-frequency alternating magnetic field and its combination with radon baths in juvenile rheumatoid arthritis |
| Q47098780 | A meta-analysis to estimate the “real” placebo effect in juvenile idiopathic arthritis (JIA) trials |
| Q81330839 | A method of treating the patient with postpubescent juvenile rheumatoid arthritis |
| Q74214003 | A mixed Th1/Th2 cell cytokine response predominates in systemic onset juvenile rheumatoid arthritis: immunoregulatory IL-10 function |
| Q83206200 | A modified juvenile arthritis damage index to improve articular damage assessment in juvenile idiopathic arthritis--enthesitis-related arthritis (JIA-ERA) |
| Q36465136 | A multicenter case-control study on predictive factors distinguishing childhood leukemia from juvenile rheumatoid arthritis |
| Q36347465 | A multicenter study of patients with adult-onset Still's disease compared with systemic juvenile idiopathic arthritis |
| Q34758768 | A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial) |
| Q43615149 | A multidimensional blood stimulation assay reveals immune alterations underlying systemic juvenile idiopathic arthritis |
| Q53047736 | A new approach to clinical care of juvenile idiopathic arthritis: the Juvenile Arthritis Multidimensional Assessment Report. |
| Q59268762 | A new approach to defining inactive disease, minimal disease activity and parent- and child-acceptable symptom state in juvenile idiopathic arthritis |
| Q88990369 | A new biopsychosocial and clinical questionnaire to assess juvenile idiopathic arthritis: JAB-Q |
| Q85734437 | A new era in the treatment of systemic juvenile idiopathic arthritis |
| Q68541105 | A new method for the detection of hidden IgM rheumatoid factor in patients with juvenile rheumatoid arthritis |
| Q48853317 | A new short and simple health-related quality of life measurement for paediatric rheumatic diseases: initial validation in juvenile idiopathic arthritis. |
| Q55101824 | A nine-year-old patient affected by chromosomal aberration with the suspicion of juvenile idiopathic arthritis. |
| Q74384525 | A novel 5'-flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic-onset juvenile idiopathic arthritis |
| Q91091283 | A novel NFKBIA variant substituting serine 36 of IκBα causes immunodeficiency with warts, bronchiectasis and juvenile rheumatoid arthritis in the absence of ectodermal dysplasia |
| Q72576119 | A novel autoantibody to the putative oncoprotein DEK in pauciarticular onset juvenile rheumatoid arthritis |
| Q55109632 | A novel juvenile idiopathic arthritis (JIA) susceptibility gene in HLA class I region marked by microsatellite D6S265. |
| Q46289734 | A novel method for eliciting foot care preferences in juvenile idiopathic arthritis: a discrete choice experiment |
| Q91936259 | A novel mutation in NCF2 resulting in very-early-onset colitis and juvenile idiopathic arthritis in a patient with chronic granulomatous disease |
| Q57173408 | A novel radiographic scoring system for growth abnormalities and structural change in children with juvenile idiopathic arthritis of the hip |
| Q35902952 | A novel reactive epitope-based antigen targeted by serum autoantibodies in oligoarticular and polyarticular juvenile idiopathic arthritis and development of an electrochemical biosensor. |
| Q35392560 | A nutritional screening test for use in children and adolescents with juvenile rheumatoid arthritis |
| Q51655531 | A patient diagnosed with pauciarticular juvenile rheumatoid arthritis after a mechanical prosthetic valve replacement due to aortic regurgitation. |
| Q34632661 | A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features. |
| Q46100346 | A pilot study for genome wide association study (GWAS) in patients with juvenile idiopathic arthritis (JIA) and their parents |
| Q71077861 | A pilot trial of oral type II collagen in the treatment of juvenile rheumatoid arthritis |
| Q35637074 | A polymorphic variant inside the osteopontin gene shows association with disease course in oligoarticular juvenile idiopathic arthritis |
| Q74618376 | A population-based study on uveitis in juvenile rheumatoid arthritis |
| Q92180511 | A prediction rule for lack of achievement of inactive disease with methotrexate as the sole disease-modifying antirheumatic therapy in juvenile idiopathic arthritis |
| Q72865758 | A prognostic study of juvenile rheumatoid arthritis. Analysis of 544 cases |
| Q34897164 | A promoter haplotype of the interleukin-18 gene is associated with juvenile idiopathic arthritis in the Japanese population |
| Q34881449 | A prospective study comparing celecoxib with naproxen in children with juvenile rheumatoid arthritis |
| Q35152199 | A prospective study comparing infection risk and disease activity in children with juvenile idiopathic arthritis treated with and without tumor necrosis factor-alpha inhibitors |
| Q81656082 | A prospective study of magnetic resonance and radiographic imaging in relation to symptoms and clinical findings of the temporomandibular joint in children with juvenile idiopathic arthritis |
| Q40524609 | A pruritic linear urticarial rash, fever, and systemic inflammatory disease in five adolescents: adult-onset still disease or systemic juvenile idiopathic arthritis sine arthritis? |
| Q64089950 | A qualitative study examining the validity and comprehensibility of physical activity items: developed and tested in children with juvenile idiopathic arthritis |
| Q84908854 | A qualitative study of fitness instructors' experiences leading an exercise program for children with juvenile idiopathic arthritis |
| Q37479820 | A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial). |
| Q33241559 | A randomized clinical trial of dietary calcium to improve bone accretion in children with juvenile rheumatoid arthritis |
| Q33248033 | A randomized controlled trial of calcium supplementation to increase bone mineral density in children with juvenile rheumatoid arthritis |
| Q80330583 | A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate |
| Q45251908 | A randomized, double-blind clinical trial of two doses of meloxicam compared with naproxen in children with juvenile idiopathic arthritis: short- and long-term efficacy and safety results |
| Q58069337 | A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis |
| Q81371522 | A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis |
| Q89273062 | A rare case of myelofibrosis secondary to juvenile idiopathic arthritis |
| Q37791622 | A reappraisal of intra-articular corticosteroid therapy in juvenile idiopathic arthritis. |
| Q36668136 | A recurring rollercoaster ride: a qualitative study of the emotional experiences of parents of children with juvenile idiopathic arthritis |
| Q40385383 | A relapse of systemic type juvenile idiopathic arthritis after a rubella vaccination in a patient during a long-term remission period |
| Q40734906 | A retrospective study on 158 Thai patients with juvenile idiopathic arthritis followed in a single center over a 15-year period |
| Q38118330 | A review guide to oligoarticular and polyarticular juvenile idiopathic arthritis |
| Q37919810 | A review of current concepts on the pathogenesis of juvenile rheumatoid arthritis |
| Q80387752 | A role for US screening in juvenile idiopathic arthritis |
| Q38633441 | A safety evaluation of canakinumab for the treatment of systemic onset juvenile idiopathic arthritis |
| Q45767724 | A search for persistent rubella virus infection in persons with chronic symptoms after rubella and rubella immunization and in patients with juvenile rheumatoid arthritis |
| Q44267311 | A selective COX-2 inhibitor, meloxicam, as a treatment option in patients with juvenile idiopathic arthritis and gastrointestinal side effects from naproxen |
| Q54130278 | A six-month open safety assessment of a naproxen suspension formulation in the therapy of juvenile rheumatoid arthritis. |
| Q48669970 | A social support intervention for parents of children with juvenile rheumatoid arthritis: results of a randomized trial. |
| Q70970390 | A soft tissue lesion related to salicylate treatment of juvenile rheumatoid arthritis: clinical report |
| Q24601796 | A specific HLA-DP beta allele is associated with pauciarticular juvenile rheumatoid arthritis but not adult rheumatoid arthritis |
| Q68795043 | A study of classification criteria for a diagnosis of juvenile rheumatoid arthritis |
| Q40788066 | A study of prognosis in 52 cases with juvenile rheumatoid arthritis. |
| Q70747456 | A study of rheumatoid factors in juvenile rheumatoid arthritis (chronic polyarthritis) by the photometric latex test |
| Q45768411 | A study of school adjustment, self-concept, self-esteem, general wellbeing and parent child relationship in Juvenile Idiopathic Arthritis |
| Q40642029 | A study of specificities of antinuclear antibodies in juvenile rheumatoid arthritis |
| Q72113965 | A study of the relationship of alpha 1-antitrypsin phenotype to the occurrence and severity of juvenile rheumatoid arthritis |
| Q37714740 | A study on the physical fitness of children with juvenile rheumatoid arthritis |
| Q46823418 | A subgroup of juvenile idiopathic arthritis patients who respond well to methotrexate are identified by the serum biomarker MRP8/14 protein. |
| Q37296422 | A successful treatment of juvenile idiopathic arthritis with rituximab: A report of two cases |
| Q39852968 | A survey of foot problems in juvenile idiopathic arthritis |
| Q33576975 | A survey of national and multi-national registries and cohort studies in juvenile idiopathic arthritis: challenges and opportunities |
| Q34862833 | A systematic review of effectiveness and economic evaluation of new drug treatments for juvenile idiopathic arthritis: etanercept |
| Q31147114 | A systematic review of the effectiveness of strategies for reducing fracture risk in children with juvenile idiopathic arthritis with additional data on long-term risk of fracture and cost of disease management |
| Q46363500 | A three minute- screening tool for temporomandibular joint involvement in children with juvenile idiopathic arthritis |
| Q33212615 | A two-year prospective controlled study of bone mass and bone turnover in children with early juvenile idiopathic arthritis |
| Q69518393 | A unique presentation of juvenile rheumatoid arthritis: proximal interphalangeal joint synovitis |
| Q67988865 | A viral aetiology for juvenile rheumatoid arthritis? |
| Q57805126 | A wearable activity tracker intervention for promoting physical activity in adolescents with juvenile idiopathic arthritis: a pilot study |
| Q42137360 | A130: Is the CCR5-delta32 Mutation Protective Against Systemic-Onset Juvenile Idiopathic Arthritis? |
| Q59160678 | A13: The Research in Arthritis in Canadian Children Emphasizing Outcomes (ReACCh Out) Cohort: Prospective Determination of the Incidence of New Onset Uveitis in Juvenile Idiopathic Arthritis |
| Q60998441 | A21: Physical Activity in Children with Juvenile Idiopathic Arthritis (JIA): The LEAP (Linking Exercise, Activity, and Pathophysiology in Childhood Arthritis) Study |
| Q60998444 | A67: Factors That Contribute to Classification of Children as Having Undifferentiated Juvenile Idiopathic Arthritis |
| Q60998445 | A96: The Roller Coaster of Juvenile Idiopathic Arthritis: A Qualitative Examination of Parents' Emotional Responses to the Disease and Its Management |
| Q34715073 | AA amyloidosis associated with systemic-onset juvenile idiopathic arthritis |
| Q61882700 | AB0677 How do parents of children with juvenile idiopathic arthritis (jia) perceive their therapies? |
| Q61882701 | AB0678 Enuresis in moroccan children with juvenile idiopathic arthritis |
| Q61882704 | AB0691 Ultrasonography signs in metacarpophalangeal and metatarsophalangeal joints in children suffering from juvenile idiopathic arthritis in morocco : comparison of clinical evaluation |
| Q61882706 | AB0698 Sleep and its relationship to pain, dysfunction, and disease activity in juvenile rheumatoid arthritis |
| Q61882708 | AB0699 Discordance between physician’S and parent’s global assessments in juvenile idiopathic arthritis |
| Q61882652 | AB0882 To Determine the Factors Influencing the Lean Body Mass in Patients with Juvenile Idiopathic Arthritis |
| Q61882653 | AB0883 The Factors Affecting the FAT Body Mass in Patients with Juvenile Idiopathic Arthritis |
| Q61882654 | AB0884 The Factors Affecting Bone Mineral Content in Patients with Juvenile Idiopathic Arthritis |
| Q61882658 | AB0908 Evaluation of the Activity of Juvenile Idiopathic Arthritis by Jadas: Jadas ESR versus Jadas3 |
| Q61882661 | AB0909 The Jadas in Assessing the Activity of Juvenile Idiopathic Arthritis: Jadas ESR versus Crp |
| Q61882665 | AB0912 Effect of Corticosteroids on Bone Mineral Density and Body Composition in Patients with Juvenile Idiopathic Arthritis |
| Q61882667 | AB0913 Influence of Gender on Disease Activity, Body Composition and Bone Mineral Density in Patients with Juvenile Idiopathic Arthritis |
| Q57926922 | AB0976 Association of Vitamin D Receptor Polymorphisms with Juvenile Idiopathic Arthritis (JIA) |
| Q61882718 | AB1151 Bone profile in moroccan children with juvenile idiopathic arthritis |
| Q61882725 | AB1155 Growth and sexual maturity in moroccan children with juvenile idiopathic arthritis |
| Q42716671 | ABCB1 and ABCC3 gene polymorphisms are associated with first-year response to methotrexate in juvenile idiopathic arthritis |
| Q51041973 | ACTH in the treatment of juvenile rheumatoid arthritis. |
| Q48351581 | ADJUVITE: a double-blind, randomised, placebo-controlled trial of adalimumab in early onset, chronic, juvenile idiopathic arthritis-associated anterior uveitis. |
| Q46072563 | ANA positivity in juvenile idiopathic arthritis: make a difference in a Colombian children population? |
| Q61831260 | ANCA-Associated Glomerulonephritis in Systemic-Onset Juvenile Idiopathic Arthritis |
| Q53069360 | APL-2, an altered peptide ligand derived from heat-shock protein 60, induces interleukin-10 in peripheral blood mononuclear cell derived from juvenile idiopathic arthritis patients and downregulates the inflammatory response in collagen-induced arth |
| Q46374622 | Abatacept for refractory juvenile idiopathic arthritis-associated uveitis- a case report |
| Q85125635 | Abatacept for refractory juvenile idiopathic arthritis-associated uveitis: two new cases. Comment on the article by Zulian et al |
| Q83074635 | Abatacept for severe anti-tumor necrosis factor alpha refractory juvenile idiopathic arthritis-related uveitis |
| Q48351375 | Abatacept improves health-related quality of life, pain, sleep quality, and daily participation in subjects with juvenile idiopathic arthritis. |
| Q34594335 | Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial |
| Q37307846 | Abatacept in difficult-to-treat juvenile idiopathic arthritis. |
| Q51060566 | Abatacept in the treatment of severe, longstanding, and refractory uveitis associated with juvenile idiopathic arthritis. |
| Q45746051 | Abatacept treatment improves health-related quality of life, pain, and sleep quality in juvenile idiopathic arthritis patients |
| Q100493292 | Abatacept: A Review of the Treatment of Polyarticular-Course Juvenile Idiopathic Arthritis |
| Q37797940 | Abatacept: a potential therapy in refractory cases of juvenile idiopathic arthritis-associated uveitis. |
| Q68449828 | Abnormal T suppressor cell function in juvenile rheumatoid arthritis |
| Q38514116 | Abnormal expression of the genes involved in cytokine networks and mitochondrial function in systemic juvenile idiopathic arthritis identified by DNA microarray analysis |
| Q79525921 | Abnormal kappa:lambda light chain ratio in circulating immune complexes as a marker for B cell activity in juvenile idiopathic arthritis |
| Q64914600 | Abnormal regulation of interleukin 6 in systemic juvenile idiopathic arthritis. |
| Q41587368 | Abnormalities in skeletal growth in children with juvenile rheumatoid arthritis |
| Q34509309 | Abnormalities in the Distribution of Serum Immunoglobulin Concentrations in Juvenile Rheumatoid Arthritis |
| Q69531428 | Abnormalities of immunoregulation in juvenile rheumatoid arthritis |
| Q69810443 | Abnormalities of respiratory gases in synovial fluid of patients with juvenile rheumatoid arthritis |
| Q35552549 | Abrupt condylar destruction of the mandibula in juvenile idiopathic arthritis |
| Q33436343 | Abrupt temperature change triggers arthralgia in patients with juvenile rheumatoid arthritis. |
| Q67677486 | Absence of reverse transcriptase activity in cultured peripheral blood mononuclear cells from patients with systemic-onset juvenile rheumatoid arthritis |
| Q84966179 | Accelerated carpal bone maturation in juvenile idiopathic arthritis: pitfall for bone age measurement |
| Q41930955 | Accelerated nodulosis during methotrexate therapy for juvenile rheumatoid arthritis |
| Q39679364 | Accelerometer-assessed daily physical activity in relation to pain cognition in juvenile idiopathic arthritis. |
| Q40509680 | Accelerometry-based monitoring of daily physical activity in children with juvenile idiopathic arthritis |
| Q60701302 | Access to Biologic Therapies in Canada for Children with Juvenile Idiopathic Arthritis |
| Q99560585 | Access to paediatric rheumatology care in juvenile idiopathic arthritis: what do we know? A systematic review |
| Q82263211 | Access to pediatric rheumatology care -- a major challenge to improving outcome in juvenile idiopathic arthritis |
| Q33697136 | Access to pediatric rheumatology care for Juvenile Idiopathic Arthritis in the United Arab Emirates. |
| Q51634827 | Accuracy of Wallace criteria for clinical remission in juvenile idiopathic arthritis: a cohort study of 761 consecutive cases. |
| Q99249721 | Acetabula Osteoid Osteoma Mimicking Juvenile Idiopathic Arthritis and Chronic Recurrent Multifocal Osteomyelitis |
| Q69911830 | Acetylsalicylic acid and juvenile rheumatoid Arthritis. Effect of dosage interval on the serum salicylic acid level |
| Q62741443 | Achievement of a State of Inactive Disease at Least Once in the First 5 Years Predicts Better Outcome of Patients with Polyarticular Juvenile Idiopathic Arthritis |
| Q51055393 | Achievement of clinical remission in patients with juvenile idiopathic arthritis under a 2-10-year Etanercept exposure. |
| Q92129321 | Achromobacter xylosoxidans Sepsis Unveiling X-linked Agammaglobulinemia Masquerading as Systemic-onset Juvenile Idiopathic Arthritis |
| Q71500358 | Acid phosphatase activity in the synovial fluid of children with juvenile rheumatoid arthritis |
| Q71307507 | Acquired Brown's syndrome in children with juvenile rheumatoid arthritis |
| Q43640731 | Acquired Brown's syndrome with juvenile idiopathic arthritis: resolution with early steroid treatment. |
| Q87418902 | Acquired Madelung's deformity in rheumatoid factor-positive polyarticular juvenile idiopathic arthritis |
| Q40637825 | Acquired factor VIII inhibitor in juvenile rheumatoid arthritis |
| Q45744843 | Activated CD27+ and CD27- memory B cells accumulate in the joints of patients with juvenile idiopathic arthritis |
| Q50998439 | Activated memory B cells may function as antigen-presenting cells in the joints of children with juvenile idiopathic arthritis. |
| Q70037738 | Activation of OKT4 suppressor cells in the autologous mixed lymphocyte reaction of patients with juvenile rheumatoid arthritis |
| Q77742422 | Activation of the haemostatic system in children with juvenile rheumatoid arthritis correlates with disease activity |
| Q74021929 | Activation-induced cell death and Fas-induced apoptosis in patients with systemic or pauciarticular juvenile idiopathic arthritis |
| Q97649154 | Acute acalculous cholecystitis in child with systemic juvenile idiopathic arthritis, unreported manifestation |
| Q72852177 | Acute airway obstruction due to arytenoiditis in a child with juvenile rheumatoid arthritis |
| Q40861550 | Acute febrile juvenile rheumatoid arthritis in adults: cause of polyarthritis and fever. |
| Q70075203 | Acute hemorrhagic, hepatic, and neurologic manifestations in juvenile rheumatoid arthritis: possible relationship to drugs or infection |
| Q40924663 | Acute hepatic dysfunction in juvenile rheumatoid arthritis |
| Q33587308 | Acute hepatitis in three patients with systemic juvenile idiopathic arthritis taking interleukin-1 receptor antagonist |
| Q45250549 | Acute hypoxic respiratory failure as the first manifestation of systemic-onset juvenile rheumatoid arthritis in a child |
| Q44234182 | Acute iridocyclitis in antinuclear antibody-positive pauciarticular juvenile rheumatoid arthritis detected a decade earlier. |
| Q57158555 | Acute lethal encephalopathy in systemic juvenile rheumatoid arthritis |
| Q71628216 | Acute leucemia in a patient with juvenile rheumatoid arthritis displaying cystic osseous lesions |
| Q82327995 | Acute liver failure in young children with systemic-onset juvenile idiopathic arthritis without macrophage activation syndrome: report of two cases |
| Q40380892 | Acute lymphoblastic leukemia masquerading as juvenile rheumatoid arthritis: diagnostic pitfall and association with survival. |
| Q83005655 | Acute lymphoblastic leukemia masquerading as juvenile rheumatoid arthritis: no association with survival |
| Q46011730 | Acute lymphoblastic leukemia masquerading as juvenile rheumatoid arthritis: response. |
| Q69017231 | Acute lymphoid leukemia and juvenile rheumatoid arthritis. Differential diagnosis. Considerationes on a case |
| Q72421387 | Acute monoblastic leukaemia in child receiving chlorambucil for juvenile rheumatoid arthritis |
| Q72605737 | Acute posterior multifocal placoid pigment epitheliopathy in a patient with systemic-onset juvenile rheumatoid arthritis: treatment with cyclosporin A and prednisone |
| Q43050300 | Acute, non-obstructive, sterile cholecystitis associated with etanercept and infliximab for the treatment of juvenile polyarticular rheumatoid arthritis |
| Q44336292 | Acute-onset opioid-induced hyperalgesia in a child with juvenile idiopathic arthritis |
| Q45745981 | Adalimumab and severe uveitis in juvenile idiopathic arthritis (JIA) therapy |
| Q47912343 | Adalimumab for Uveitis in Juvenile Idiopathic Arthritis |
| Q48625167 | Adalimumab for juvenile idiopathic arthritis-associated uveitis. |
| Q92764718 | Adalimumab in Juvenile Idiopathic Arthritis-Associated Uveitis: 5-Year Follow-up of the Bristol Participants of the SYCAMORE Trial |
| Q64092580 | Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT |
| Q48685987 | Adalimumab in juvenile idiopathic arthritis-associated chronic anterior uveitis. |
| Q82816441 | Adalimumab in juvenile rheumatoid arthritis |
| Q94834382 | Adalimumab in juvenile rheumatoid arthritis |
| Q84238277 | Adalimumab in juvenile rheumatoid arthritis/juvenile idiopathic arthritis |
| Q51033785 | Adalimumab in the Treatment of Uveitis in Juvenile Idiopathic Arthritis. |
| Q48527924 | Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis. |
| Q59268628 | Adalimumab treatment in Juvenile Idiopathic Arthritis (JIA) patients with special focus on Uveitis |
| Q58570696 | Adalimumab versus adalimumab and methotrexate for the treatment of juvenile idiopathic arthritis: long-term data from the German BIKER registry |
| Q33361908 | Adalimumab with or without methotrexate in juvenile rheumatoid arthritis |
| Q46068495 | Adalimumab-Induced Cutaneous Lupus Erythematosus in a 16-Year-Old Girl with Juvenile Idiopathic Arthritis |
| Q36677345 | Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease |
| Q38119017 | Adaptation of the methotrexate in rheumatoid arthritis knowledge questionnaire (MiRAK) for use with parents of children with juvenile idiopathic arthritis: a qualitative study |
| Q80974142 | Adapted versions of the Sharp/van der Heijde score are reliable and valid for assessment of radiographic progression in juvenile idiopathic arthritis |
| Q87650988 | Adding canakinumab to the Childhood Arthritis and Rheumatology Research Alliance consensus treatment plans for systemic juvenile idiopathic arthritis: Comment on the article by DeWitt et al |
| Q88337789 | Adding patient-reported outcomes to a multisite registry to quantify quality of life and experiences of disease and treatment for youth with juvenile idiopathic arthritis |
| Q91211748 | Adenosine deaminase 2 as a biomarker of macrophage activation syndrome in systemic juvenile idiopathic arthritis |
| Q43842153 | Adenosine deaminase activity and its isoenzyme pattern in patients with juvenile rheumatoid arthritis and systemic lupus erythematosus |
| Q83233960 | Adherence to methotrexate in juvenile idiopathic arthritis |
| Q89916654 | Adherence to ophthalmological screening recommendations and course of uveitis in children with juvenile idiopathic arthritis: data from the Inception Cohort of Newly diagnosed patients with JIA (ICON-JIA) study |
| Q91671615 | Adjunctive vitamin D for the treatment of active juvenile idiopathic arthritis: An open-label, prospective, randomized controlled trial |
| Q46974162 | Administration of adalimumab in paediatric patients with juvenile idiopathic arthritis in South Ural region |
| Q46590222 | Administration of routine preventative vaccinations in children with polyarticular juvenile idiopathic arthritis receiving adalimumab |
| Q44582840 | Adolescents with juvenile idiopathic arthritis: who cares after the age of 16? |
| Q97527512 | Adolescents' social needs living with juvenile idiopathic arthritis and their views about digital resources |
| Q78809038 | Adrenal cortex hormones in combination with pyrazolone derivatives in the treatment of juvenile rheumatoid arthritis, rheumatoid arthritis and spondylitis ankylopoetica |
| Q54612013 | Adrenocortical function in children with juvenile rheumatoid arthritis and other connective tissue disorders. |
| Q67580503 | Adult JRA (juvenile rheumatoid arthritis) and RA (rheumatoid arthritis) |
| Q40319993 | Adult and juvenile rheumatoid arthritis: current epidemiologic concepts |
| Q40908803 | Adult onset juvenile rheumatoid arthritis |
| Q91995360 | Adult outcome of juvenile idiopathic arthritis: A nationwide population-based retrospective cohort study in Taiwan |
| Q43485082 | Adult outcomes of patients with juvenile idiopathic arthritis |
| Q47617922 | Adult patients with uveitis associated with juvenile idiopathic arthritis: a retrospective review |
| Q67600955 | Adult sexuality and juvenile rheumatoid arthritis |
| Q45804312 | Advanced bone age in the affected side predicts worse radiographic progression in patients with juvenile idiopathic arthritis and unilateral wrist disease |
| Q46290002 | Advanced dental maturity in children with juvenile rheumatoid arthritis |
| Q38336957 | Advanced drug therapy for juvenile rheumatoid arthritis |
| Q68758437 | Advanced drug therapy in juvenile rheumatoid arthritis |
| Q37997306 | Advances and challenges in imaging in juvenile idiopathic arthritis. |
| Q51189191 | Advances from clinical trials in juvenile idiopathic arthritis. |
| Q33838872 | Advances in the medical treatment of juvenile rheumatoid arthritis. |
| Q38161412 | Advances in the pathogenesis and treatment of systemic juvenile idiopathic arthritis. |
| Q27001017 | Advances in the treatment of polyarticular juvenile idiopathic arthritis |
| Q91307757 | Adverse effects of TNF inhibitor in a patient with DiGeorge syndrome and juvenile idiopathic arthritis |
| Q45745654 | Adverse events during anti-TNF therapy in 269 patients with juvenile idiopathic arthritis |
| Q57538180 | Aerobic and anaerobic capacity in Juvenile Idiopathic Arthritis: evaluation of the cardiorespiratory response |
| Q80707163 | Aerobic and anaerobic exercise capacity in adolescents with juvenile idiopathic arthritis |
| Q80707172 | Aerobic and anaerobic exercise capacity in children with juvenile idiopathic arthritis |
| Q42378594 | Aerobic capacity and disease activity in children, adolescents and young adults with juvenile idiopathic arthritis (JIA). |
| Q42918622 | Aerobic capacity and disease activity in children, adolescents and young adults with juvenile idiopathic arthritis (JIA). |
| Q73463833 | Aerobic capacity in juvenile rheumatoid arthritis patients and healthy children |
| Q35016521 | Aerobic fitness in children with juvenile idiopathic arthritis: a systematic review |
| Q47936043 | Age at menarche in juvenile rheumatoid arthritis |
| Q73065122 | Age-specific effects of juvenile rheumatoid arthritis-associated HLA alleles |
| Q50242889 | Aggrecanase cleavage in juvenile idiopathic arthritis patients is minimally detected in the aggrecan interglobular domain but robust at the aggrecan C-terminus. |
| Q41932642 | Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): a multicentre randomised open-label clinical trial |
| Q87319256 | Agreement among musculoskeletal pediatric specialists in the assessment of radiographic joint damage in juvenile idiopathic arthritis |
| Q45837159 | Agreement between objective and subjective definitions of inactive disease, remission and minimal disease activity in juvenile idiopathic arthritis |
| Q68043174 | Agreement between parents and physicians regarding clinical evaluation of patients with juvenile rheumatoid arthritis |
| Q36431906 | Agreement between physicians and parents in rating functional ability of children with juvenile idiopathic arthritis |
| Q35456471 | Agreement between proxy and adolescent assessment of disability, pain, and well-being in juvenile idiopathic arthritis |
| Q45187874 | Albuminuria and tubular markers in juvenile idiopathic arthritis |
| Q36462746 | Algorithm development for corticosteroid management in systemic juvenile idiopathic arthritis trial using consensus methodology. |
| Q79886396 | Allelic frequency of the MCP-1 promoter -2518 polymorphism in the Turkish population and in Turkish patients with juvenile rheumatoid arthritis |
| Q39820320 | Allergen testing in juvenile rheumatoid arthritis |
| Q57094411 | Allogeneic hematopoietic stem cell transplantation for severe, refractory juvenile idiopathic arthritis |
| Q96427879 | Alloplastic Temporomandibular Joint Reconstruction for Patients With Juvenile Idiopathic Arthritis |
| Q28821054 | Alteration of Fecal Microbiota Profiles in Juvenile Idiopathic Arthritis. Associations with HLA-B27 Allele and Disease Status |
| Q67327405 | Alterations in macroscopically intact skin of children with juvenile rheumatoid arthritis |
| Q71502927 | Altered body water distribution in subjects with juvenile rheumatoid arthritis and its effects on the measurement of water compartments from bioelectric impedance |
| Q54285108 | Altered expression of intestinal human leucocyte antigen D-related and immune signalling molecules in juvenile idiopathic arthritis. |
| Q66962947 | Altered responsiveness to mitogens in subgroups of patients with juvenile rheumatoid arthritis |
| Q36578742 | Altered signaling in systemic juvenile idiopathic arthritis monocytes |
| Q35784755 | Alternative activation in systemic juvenile idiopathic arthritis monocytes |
| Q35858811 | Alumina-on-alumina THA in patients with juvenile idiopathic arthritis: a 5-year followup study |
| Q72845488 | American Academy of Pediatrics Section on Rheumatology and Section on Ophthalmology: Guidelines for ophthalmologic examinations in children with juvenile rheumatoid arthritis |
| Q53150640 | American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis. |
| Q51916954 | Amitriptyline to relieve pain in juvenile idiopathic arthritis: a pilot study using Bayesian metaanalysis of multiple N-of-1 clinical trials. |
| Q52851656 | Amplified ambivalence: having a sibling with juvenile idiopathic arthritis. |
| Q79306444 | Amyloid goiter in juvenile onset rheumatoid arthritis |
| Q72438942 | Amyloidosis and juvenile rheumatoid arthritis |
| Q93842652 | Amyloidosis and juvenile rheumatoid arthritis |
| Q40847811 | Amyloidosis associated with juvenile rheumatoid arthritis. |
| Q40519111 | Amyloidosis in juvenile rheumatoid arthritis |
| Q44562257 | Amyloidosis in juvenile rheumatoid arthritis |
| Q67389229 | Amyloidosis in juvenile rheumatoid arthritis |
| Q40689290 | Amyloidosis of the small intestine secondary to rheumatoid arthritis and juvenile rheumatoid arthritis: report of two cases |
| Q68987417 | Amyloidosis secondary to juvenile rheumatoid arthritis: a case report from Saudi Arabia |
| Q92455987 | An Algorithm for Management of Dentofacial Deformity Resulting From Juvenile Idiopathic Arthritis: Results of a Multinational Consensus Conference |
| Q44928289 | An Eco RI polymorphic site in the human complement C4 gene distinguishes juvenile rheumatoid arthritis (JRA) susceptibility-bearing haplotypes |
| Q108591597 | An Integrative Transcriptomic Analysis of Systemic Juvenile Idiopathic Arthritis for Identifying Potential Genetic Markers and Drug Candidates |
| Q28181400 | An additional susceptibility gene for juvenile idiopathic arthritis in the HLA class I region on several DR-DQ haplotypes |
| Q40859810 | An adult form of juvenile rheumatoid arthritis |
| Q59268637 | An alternative analgesic agent for intra-articular corticosteroid injections (IAI) in juvenile idiopathic arthritis (JIA) – a fentanyl lollipop |
| Q52808342 | An amino acid motif in HLA-DRβ1 distinguishes patients with uveitis in juvenile idiopathic arthritis. |
| Q83324329 | An analysis of the costs and treatment success of etanercept in juvenile idiopathic arthritis: results from the Dutch Arthritis and Biologicals in Children register |
| Q72121328 | An association between HLA-A2 and juvenile rheumatoid arthritis in girls |
| Q24797623 | An association between the acute phase response and patterns of antigen induced T cell proliferation in juvenile idiopathic arthritis |
| Q72184092 | An educational needs assessment of children with juvenile rheumatoid arthritis |
| Q77489901 | An eleven-year-old female Turkish patient with progressive pseudorheumatoid dysplasia mimicking juvenile idiopathic arthritis |
| Q35534327 | An evaluation of a juvenile idiopathic arthritis retreat for families |
| Q34500967 | An evaluation of baseline risk factors predicting severity in juvenile idiopathic arthritis associated uveitis and other chronic anterior uveitis in early childhood |
| Q37257760 | An evaluation of dry eye symptoms and signs in a cohort of children with juvenile idiopathic arthritis. |
| Q33813403 | An evaluation of the utility of routine laboratory monitoring of juvenile idiopathic arthritis (JIA) patients using non-steroidal anti-inflammatory drugs (NSAIDs): a retrospective review |
| Q59268667 | An experience of sequental use of three biologics and recombinant growth hormone in a patient with juvenile idiopathic arthritis associated with unsuccessful outcome of hip damage |
| Q37593194 | An exploration of parents' preferences for foot care in juvenile idiopathic arthritis: a possible role for the discrete choice experiment |
| Q91295621 | An image-based kinematic model of the tibiotalar and subtalar joints and its application to gait analysis in children with Juvenile Idiopathic Arthritis |
| Q33410259 | An important complication of a child with juvenile idiopathic arthritis: macrophage activation syndrome |
| Q46074030 | An improved high-performance liquid chromatography method for quantification of methotrexate polyglutamates in red blood cells of children with juvenile idiopathic arthritis. |
| Q45744616 | An in-depth analysis of young people's experience of their juvenile idiopathic arthritis (JIA) once receiving Etanercept |
| Q37834144 | An international consensus survey of diagnostic criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis. |
| Q33574864 | An intra-articular ganglion cyst in a patient with juvenile idiopathic arthritis |
| Q69057944 | An investigation of the dental occlusion in children with juvenile rheumatoid arthritis |
| Q44388106 | An open label study to establish dosing recommendations for nabumetone in juvenile rheumatoid arthritis |
| Q47960742 | An unequal crossover between the RCCX modules of the human MHC leading to the presence of a CYP21B gene and a tenascin TNXB/TNXA-RP2 recombinant between C4A and C4B genes in a patient with juvenile rheumatoid arthritis |
| Q35123928 | An unusual case of epidermolysis bullosa complicated by persistent oligoarticular juvenile idiopathic arthritis; lessons to be learned |
| Q40674425 | An unusual pattern of growth disturbance of the hip in juvenile rheumatoid arthritis. |
| Q64279069 | An unusual presentation of purine nucleoside phosphorylase deficiency mimicking systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome |
| Q86381108 | An urge for change: transitional care for young adults with juvenile idiopathic arthritis |
| Q83944811 | Anaerobic-to-aerobic power ratio in children with juvenile idiopathic arthritis |
| Q90049900 | Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still Disease |
| Q40335671 | Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series |
| Q37369987 | Anakinra for myocarditis in juvenile idiopathic arthritis |
| Q55396600 | Anakinra for systemic onset juvenile idiopathic arthritis: experience as a second versus first line treatment. |
| Q61911597 | Anakinra in Systemic Juvenile Idiopathic Arthritis: A Single-center Experience |
| Q45745616 | Anakinra in systemic juvenile idiopathic arthritis (soJIA) non responsive to antiTNF. |
| Q53530845 | Anakinra in the treatment of polyarticular-course juvenile rheumatoid arthritis: safety and preliminary efficacy results of a randomized multicenter study. |
| Q34895303 | Anakinra pharmacokinetics in children and adolescents with systemic-onset juvenile idiopathic arthritis and autoinflammatory syndromes. |
| Q40335706 | Anakinra therapy in a child with systemic-onset juvenile rheumatoid arthritis after human herpesvirus 6 encephalitis |
| Q80751210 | Anakinra treatment for systemic juvenile idiopathic arthritis and adult onset Still disease |
| Q80824585 | Anakinra treatment for systemic onset juvenile idiopathic arthritis (SOJIA) |
| Q82505644 | Anakinra: a safe and effective first-line treatment in systemic onset juvenile idiopathic arthritis (SoJIA) |
| Q46014753 | Analysis of MHC region genetics in Finnish patients with juvenile idiopathic arthritis: evidence for different locus-specific effects in polyarticular vs pauciarticular subsets and a shared DRB1 epitope. |
| Q102131020 | Analysis of arthritis flares after achievement of inactive disease with methotrexate monotherapy in juvenile idiopathic arthritis |
| Q45744156 | Analysis of ceiling effect and score distribution of outcome measures in juvenile idiopathic arthritis (JIA). |
| Q36202308 | Analysis of childhood reactive arthritis and comparison with juvenile idiopathic arthritis. |
| Q83563761 | Analysis of disease activity, functional disability and articular damage in patients with juvenile idiopathic arthritis: a prospective outcome study |
| Q37233437 | Analysis of health care claims during the peri-transfer stage of transition from pediatric to adult care among juvenile idiopathic arthritis patients |
| Q37700346 | Analysis of intracellular methotrexate polyglutamates in patients with juvenile idiopathic arthritis: effect of route of administration on variability in intracellular methotrexate polyglutamate concentrations |
| Q80211392 | Analysis of juvenile idiopathic arthritis associated uveitis in India over the last 16 years |
| Q42094369 | Analysis of low-molecular substances in the urine of patients with diagnosed juvenile rheumatoid arthritis |
| Q46453686 | Analysis of quantitative ultrasound graphic trace and derived variables assessed at proximal phalanges of the hand in healthy subjects and in patients with cerebral palsy or juvenile idiopathic arthritis. A pilot study. |
| Q72891559 | Analysis of the HLA-DR gene frequencies in Japanese cases of juveniles rheumatoid arthritis and rheumatoid arthritis by oligonucleotide DNA typing |
| Q84290435 | Analysis of the classical, alternative, and mannose binding lectin pathway of the complement system in the pathogenesis of oligoarticular juvenile idiopathic arthritis |
| Q38362173 | Anaphylaxis to anakinra in a pediatric patient with systemic juvenile idiopathic arthritis successfully treated with canakinumab: a case-based review |
| Q38091957 | Anaphylaxis to etanercept in two children with juvenile idiopathic arthritis |
| Q43679593 | Anemia in patients with juvenile rheumatoid arthritis |
| Q42063553 | Anesthesia for intra-articular corticosteroid injections in juvenile idiopathic arthritis: A survey of pediatric rheumatologists |
| Q51866453 | Anesthetic management of a parturient with severe juvenile rheumatoid arthritis. |
| Q47269368 | Angiotensin converting enzyme gene insertion-deletion polymorphism is associated with juvenile rheumatoid arthritis. |
| Q42588618 | Animal model of human disease. Juvenile rheumatoid arthritis. Animal model: rheumatoid arthritis in the dog |
| Q40693972 | Ankle arthritis predicts polyarticular disease course and unfavourable outcome in children with juvenile idiopathic arthritis |
| Q46862261 | Ankle arthritis predicts worse outcome in children with juvenile idiopathic arthritis |
| Q53509962 | Ankle disease in juvenile idiopathic arthritis: ultrasound findings in clinically swollen ankles. |
| Q39032872 | Ankylosis of the Temporomandibular Joint and Reconstruction With a Costochondral Graft in a Patient With Juvenile Idiopathic Arthritis |
| Q68927109 | Ankylosis of the cervical spine in the adult age as a manifestation of juvenile rheumatoid arthritis |
| Q44881647 | Another patient with chromosome 18 deletion syndrome and juvenile rheumatoid arthritis. |
| Q40659176 | Anterior Uveitis in Juvenile Rheumatoid Arthritis |
| Q67560633 | Anterior uveitis and juvenile rheumatoid arthritis |
| Q41553328 | Anterior-pituitary adrenal function of gold-treated patients with juvenile rheumatoid arthritis |
| Q80788064 | Anti-BiP antibody levels in juvenile idiopathic arthritis (JIA) |
| Q43886421 | Anti-CCP antibodies in Brazilian children and adults with juvenile idiopathic arthritis |
| Q54539022 | Anti-IgG and Antinuclear Antibodies in Juvenile Rheumatoid Arthritis |
| Q70211966 | Anti-IgG antibodies in juvenile rheumatoid arthritis |
| Q33435733 | Anti-Interleukin-6 Receptor Tocilizumab for Severe Juvenile Idiopathic Arthritis-Associated Uveitis Refractory to Anti-Tumor Necrosis Factor Therapy: A Multicenter Study of Twenty-Five Patients |
| Q51617034 | Anti-MCV and anti-CCP antibodies-diagnostic and prognostic value in children with juvenile idiopathic arthritis (JIA). |
| Q70326241 | Anti-T cell antibody in juvenile rheumatoid arthritis |
| Q52672719 | Anti-adalimumab antibodies in a cohort of patients with juvenile idiopathic arthritis: incidence and clinical correlations. |
| Q47214327 | Anti-adalimumab antibodies in juvenile idiopathic arthritis-related uveitis |
| Q87309364 | Anti-adalimumab antibodies in juvenile idiopathic arthritis: frequent association with loss of response |
| Q91212362 | Anti-adalimumab antibodies kinetics: an early guide for juvenile idiopathic arthritis (JIA) switching |
| Q44388104 | Anti-cyclic citrullinated peptide (anti-CCP) antibodies in children with juvenile idiopathic arthritis. |
| Q46239627 | Anti-cyclic citrullinated peptide (anti-CCP) antibody in juvenile idiopathic arthritis (JIA): correlations with disease activity and severity of joint damage (a multicenter trial). |
| Q45896536 | Anti-cyclic citrullinated peptide antibodies in adult patients with juvenile idiopathic arthritis |
| Q37358171 | Anti-cyclic citrullinated peptide antibodies in children with Juvenile Idiopathic Arthritis |
| Q43172107 | Anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis |
| Q39039199 | Anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis |
| Q44302951 | Anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis |
| Q81370033 | Anti-cyclic citrullinated peptide: diagnostic and prognostic values in juvenile idiopathic arthritis and rheumatoid arthritis in a Chinese population |
| Q45745862 | Anti-cyclic citrullinated peptide: its prevalence and clinical significance in a South African cohort with juvenile idiopathic arthritis |
| Q53583145 | Anti-endothelial cell antibodies are prevalent in juvenile idiopathic arthritis: implications for clinical disease course and pathogenesis. |
| Q46822043 | Anti-inflammatory effect by exclusive enteral nutrition (EEN) in a patient with juvenile idiopathic arthritis (JIA): brief report |
| Q36068915 | Anti-inflammatory effect of exclusive enteral nutrition in patients with juvenile idiopathic arthritis |
| Q46509636 | Anti-keratin and anti-cyclic citrullinated peptide autoantibodies in patients with juvenile idiopathic arthritis. |
| Q46511934 | Anti-keratin antibodies in juvenile idiopathic arthritis. |
| Q61755143 | Anti-keratin antibodies in patients with juvenile idiopathic arthritis |
| Q46512295 | Anti-skin anti-intercellular antibodies in juvenile idiopathic arthritis. |
| Q47784443 | Anti-tumor necrosis factor alpha switching in rheumatoid arthritis and juvenile chronic arthritis |
| Q47684684 | Anti-tumor necrosis factor α targets protein kinase B/c-Akt-induced resistance of effector cells to suppression in juvenile idiopathic arthritis |
| Q45745664 | Anti-tumour necrosis factor (anti-TNF) in the treatment of juvenile idiopathic arthritis-associated uveitis |
| Q81690776 | Anti-tumour necrosis factor-alpha treatment of juvenile idiopathic arthritis in a patient with common variable immunodeficiency |
| Q46036042 | Anti-type II collagen antibodies detection and avidity in patients with oligoarticular and polyarticular forms of juvenile idiopathic arthritis. |
| Q33770863 | Anti-type II collagen antibodies, anti-CCP, IgA RF and IgM RF are associated with joint damage, assessed eight years after onset of juvenile idiopathic arthritis (JIA). |
| Q33203327 | Antiagalactosyl IgG antibodies in juvenile idiopathic arthritis, juvenile onset Sjögren's syndrome, and healthy children. |
| Q35701575 | Antibiotic Exposure and Juvenile Idiopathic Arthritis: A Case-Control Study |
| Q39526831 | Antibodies against M. Bovis 65 KDa Heat Shock Protein and Its P180-188 Epitope in Sera of Patients with Juvenile Idiopathic Arthritis |
| Q73802353 | Antibodies against a peptide sequence located in the linker region of the HMG-1/2 box domains in sera from patients with juvenile rheumatoid arthritis |
| Q81248173 | Antibodies against cyclic citrullinated peptide are associated with HLA-DR4 in simplex and multiplex polyarticular-onset juvenile rheumatoid arthritis |
| Q44023550 | Antibodies from patients with rheumatoid arthritis and juvenile chronic arthritis analyzed with core histone synthetic peptides. |
| Q51070244 | Antibodies to Cyclic Citrullinated Peptides in Patients With Juvenile Idiopathic Arthritis and Patients With Rheumatoid Arthritis: Shared Expression of the Inherently Autoreactive 9G4 Idiotype. |
| Q69018284 | Antibodies to basement membrane proteins nidogen and laminin in sera from streptococcal-related diseases and juvenile rheumatoid arthritis patients |
| Q67348645 | Antibodies to dna in patients with rheumatoid arthritis and juvenile rheumatoid arthritis |
| Q69741777 | Antibodies to histones H1 and H5 in sera of patients with juvenile rheumatoid arthritis |
| Q69555534 | Antibodies to iris and retina detected in sera from patients with juvenile rheumatoid arthritis with iridocyclitis by indirect immunofluorescence studies on human eye tissue |
| Q67908644 | Antibodies to lipid A in pauciarticular juvenile arthritis: clinical studies |
| Q43258265 | Antibodies to mutated citrullinated vimentin and antibodies to cyclic citrullinated peptides in juvenile idiopathic arthritis. |
| Q28305228 | Antibodies to the 45 kDa DEK nuclear antigen in pauciarticular onset juvenile rheumatoid arthritis and iridocyclitis: selective association with MHC gene |
| Q40770995 | Antibody levels to enteric bacteria in juvenile rheumatoid arthritis |
| Q30462109 | Antibody to ribonucleoprotein in pauciarticular juvenile rheumatoid arthritis |
| Q69386925 | Antibody to streptococcal cell wall peptidoglycan-polysaccharide polymers in sera of patients with juvenile rheumatoid arthritis but absent in isolated immune complexes |
| Q43775754 | Antibody-Dependent Cytotoxicity Mediated by Cells Eluted from Synovial Tissues of Patients with Rheumatoid Arthritis and Juvenile Rheumatoid Arthritis |
| Q47965354 | Anticarbamylated protein (anti-CarP) antibodies are present in sera of juvenile idiopathic arthritis (JIA) patients |
| Q83552470 | Anticitrullinated protein antibodies and radiological progression in juvenile idiopathic arthritis |
| Q61693543 | Anticyclic Citrullinated Peptide Antibody: A Predictor of Juvenile Idiopathic Arthritis Progression Toward Rheumatoid Arthritis |
| Q36682034 | Anticyclic citrullinated peptide antibodies in juvenile idiopathic arthritis |
| Q39357759 | Antigammaglobulins in normal individuals and in patients with adult and juvenile rheumatoid arthritis and osteoarthritis |
| Q104138914 | Antigen-driven PD-1+TOX+BHLHE40+ and PD-1+TOX+EOMES+ T lymphocytes regulate juvenile idiopathic arthritis in situ |
| Q40762771 | Antiglobulins in juvenile rheumatoid arthritis |
| Q40829793 | Antilymphocyte antibodies in the sera of children with juvenile rheumatoid arthritis and rheumatic fever |
| Q88509537 | Antinuclear Antibody-Positive Juvenile Idiopathic Arthritis Despite IRAK-4 Deficiency |
| Q40682720 | Antinuclear antibodies and juvenile rheumatoid arthritis |
| Q69531433 | Antinuclear antibody in juvenile rheumatoid arthritis sera reacts with 50-40 kDa antigen(s) found in HeLa nuclear extracts |
| Q67921641 | Antinuclear antibody profile in juvenile rheumatoid arthritis |
| Q87334294 | Antinuclear antibody screening by ELISA and IF techniques: discrepant results in juvenile idiopathic arthritis but consistency in childhood systemic lupus erythematous |
| Q49048178 | Antinuclear antibody-positive cohort constitutes homogeneous entity in juvenile idiopathic arthritis. |
| Q62741431 | Antinuclear antibody-positive patients should be grouped as a separate category in the classification of juvenile idiopathic arthritis |
| Q44046473 | Antioxidant enzymes levels in children with juvenile rheumatoid arthritis |
| Q38881728 | Antioxidant status in children with juvenile rheumatoid arthritis (JRA) living in Cairo, Egypt |
| Q77222447 | Antiperinuclear factor and antibodies to the stratum corneum of rat esophagus in juvenile idiopathic arthritis |
| Q41245876 | Antiperinuclear factor in juvenile rheumatoid arthritis |
| Q46269738 | Antiperinuclear factor in the diagnosis of juvenile rheumatoid arthritis |
| Q50225439 | Antisalmonella agglutinins in juvenile rheumatoid arthritis presenting with jaundice |
| Q92749917 | Anxiety associates with pain and disability but not increased measures of inflammation for adolescent patients with juvenile idiopathic arthritis |
| Q39634341 | Aortic valve insufficiency and coronary artery narrowing in a child with polyarticular juvenile rheumatoid arthritis |
| Q35552923 | Apoptosis of peripheral blood lymphocytes in patients with juvenile idiopathic arthritis |
| Q37134126 | Application of Rasch analysis to the parent adherence report questionnaire in juvenile idiopathic arthritis |
| Q55474748 | Application of a novel multi-segment foot model to assess foot function in children and adolescents with juvenile idiopathic arthritis. |
| Q104612104 | Application of the OMERACT synovitis ultrasound scoring system in juvenile idiopathic arthritis: a multicenter reliability exercise |
| Q36552413 | Application of the Yamaguchi criteria for classification of "suspected" systemic juvenile idiopathic arthritis (sJIA). |
| Q48164132 | Application of the international league against rheumatism classification criteria for systemic juvenile idiopathic arthritis as a prognostic factor in patients with adults-onset Still's disease |
| Q72214831 | Apropos of 2 cases of juvenile rheumatoid arthritis (A.R.J) |
| Q40918101 | Apropos of the H. Bloch Michel and P. Waltzing paper. Rheumatoid rosette test in juvenile rheumatoid arthritis. Preliminary results in 50 cases |
| Q73587999 | Aquatic fitness training for children with juvenile idiopathic arthritis |
| Q48192436 | Are We Right to Consider Mesenchymal Stem Cells to Be a New Perspective for Patients with Juvenile Idiopathic Arthritis? |
| Q39208034 | Are panoramic radiographs predictive of temporomandibular joint synovitis in children with juvenile idiopathic arthritis? |
| Q45744639 | Are parents' views about their child's treatment for juvenile idiopathic arthritis (JIA) related to evaluations of their child's quality of life (QoL)? – SPARKS CHARM study |
| Q53555804 | Are temporomandibular joint signs and symptoms associated with magnetic resonance imaging findings in juvenile idiopathic arthritis patients? A longitudinal study. |
| Q73924843 | Are the number of joints involved or the presence of psoriasis still useful tools to identify homogeneous disease entities in juvenile idiopathic arthritis? |
| Q80349894 | Are there common human leucocyte antigen associations in juvenile idiopathic arthritis and periodontitis? |
| Q91519586 | Are there new targets for juvenile idiopathic arthritis? |
| Q42376296 | Are we closer to personalized therapy in juvenile idiopathic arthritis? |
| Q44733067 | Arterial haemodynamics and coronary artery calcification in adult patients with juvenile idiopathic arthritis |
| Q60926645 | Arterial properties in adults with long-lasting active juvenile idiopathic arthritis compared to healthy controls |
| Q68007471 | Arthritis complicating acute pancreatitis--a rare but important condition to be distinguished from juvenile rheumatoid arthritis |
| Q40531580 | Arthritis in children: comparison of clinical and biological characteristics of septic arthritis and juvenile idiopathic arthritis. |
| Q86952813 | Arthritis mutilans in a patient with juvenile idiopathic arthritis |
| Q36899724 | Arthroplasty of the hip and knee in juvenile rheumatoid arthritis |
| Q42613059 | Arthroscopic and radiographic examination of patients with juvenile rheumatoid arthritis before and after open synovectomy of the knee joint. A prospective study with a 5-year follow-up |
| Q51720665 | Arthroscopic synovectomy in the treatment of patients with juvenile rheumatoid arthritis |
| Q47879881 | Arthroscopy of the Temporomandibular Joint in Patients With Juvenile Idiopathic Arthritis |
| Q43050617 | Arthrosonography of hip and knee joints in the follow up of juvenile rheumatoid arthritis |
| Q55101170 | Articular Doppler ultrasonography in juvenile idiopathic arthritis in remission: a prospective study. |
| Q82288460 | Articular damage in adults with juvenile idiopathic arthritis |
| Q43537257 | Aseptic necrosis in juvenile rheumatoid arthritis |
| Q70497192 | Aspiration and achievement. A study of one hundred patients with juvenile rheumatoid arthritis |
| Q54421184 | Aspirin and fenoprofen (Nalfon) in the treatment of juvenile rheumatoid arthritis results of the double blind-trial. A segment II study. |
| Q93603703 | Aspirin in juvenile rheumatoid arthritis |
| Q67582342 | Aspirin-induced hepatotoxicity and its effect on juvenile rheumatoid arthritis |
| Q66965719 | Aspirin-induced hepatotoxicity in juvenile rheumatoid arthritis a prospective study |
| Q40471293 | Assays of complement in polyarticular juvenile rheumatoid arthritis |
| Q88537710 | Assessing Barriers to Therapeutic Regimens for Young People with Juvenile Idiopathic Arthritis |
| Q91525893 | Assessing Barriers to Uveitis Screening in Patients with Juvenile Idiopathic Arthritis Through Semi-Structured Interviews |
| Q34695300 | Assessing and enhancing adherence to medical regimens for juvenile rheumatoid arthritis |
| Q56783328 | Assessing current outcomes of juvenile idiopathic arthritis: a cross-sectional study in a tertiary center sample |
| Q85324693 | Assessing the likelihood of new-onset inflammatory bowel disease following tumor necrosis factor-alpha inhibitor therapy for rheumatoid arthritis and juvenile rheumatoid arthritis |
| Q95652741 | Assessing the reporting quality of physical activity programs in randomized controlled trials for the management of juvenile idiopathic arthritis using three standardized assessment tools |
| Q38068191 | Assessment and management of pain in juvenile idiopathic arthritis |
| Q85833588 | Assessment and management of pain in juvenile idiopathic arthritis |
| Q70606465 | Assessment methods of disease activity in juvenile rheumatoid arthritis--evaluated in a prednisolone/placebo double-blind study |
| Q93164380 | Assessment of anti-HBs antibody concentration in children with juvenile idiopathic arthritis treated with biological drugs, vaccinated against viral type B hepatitis in infancy |
| Q46450428 | Assessment of cardiac and pulmonary function in children with juvenile idiopathic arthritis |
| Q55005209 | Assessment of dentofacial growth deviation in juvenile idiopathic arthritis: Reliability and validity of three-dimensional morphometric measures. |
| Q37428914 | Assessment of disease activity by patients with juvenile idiopathic arthritis and the parents compared to the assessment by pediatric rheumatologists |
| Q47268739 | Assessment of disease activity in juvenile idiopathic arthritis. The number and the size of joints matter. |
| Q81602790 | Assessment of inflammatory response in a study of uveitis associated with juvenile idiopathic arthritis: comment on the article by Smith et al |
| Q37436281 | Assessment of left atrial mechanical functions and atrial electromechanical delay in Juvenile idiopathic arthritis by tissue Doppler echocardiography |
| Q81209386 | Assessment of left ventricular systolic and diastolic function in juvenile rheumatoid arthritis |
| Q33564369 | Assessment of pain in patients with juvenile rheumatoid arthritis: relation between pain intensity and degree of joint inflammation |
| Q69283671 | Assessment of protein-energy malnutrition in children and adolescents with juvenile rheumatoid arthritis |
| Q33312730 | Assessment of spine bone mineral density in juvenile idiopathic arthritis: impact of scan projection |
| Q26741501 | Assessment of the Therapeutic Effect of Total Glucosides of Peony for Juvenile Idiopathic Arthritis: A Systematic Review and Meta-Analysis |
| Q35206701 | Assessment of the body composition and parameters of the cardiovascular risk in juvenile idiopathic arthritis. |
| Q35637026 | Assessment of the clinical significance of gelatinase activity in patients with juvenile idiopathic arthritis using quantitative protein substrate zymography |
| Q47857902 | Assessment of the outcome of ophthalmological screening for uveitis in a cohort of Swedish children with juvenile idiopathic arthritis |
| Q48827909 | Assessment of vascular function in systemic onset juvenile idiopathic arthritis. |
| Q38856421 | Associates of school impairment in Egyptian patients with juvenile idiopathic arthritis: Sharkia Governorate |
| Q46368513 | Association analysis of the 1858C>T polymorphism in the PTPN22 gene in juvenile idiopathic arthritis and other autoimmune diseases |
| Q45744393 | Association between IL2RA and juvenile idiopathic arthritis (JIA) disease severity at first presentation to paediatric rheumatology: results from the Childhood Arthritis Prospective Study (CAPS). |
| Q90941032 | Association between STAT4 polymorphisms and the risk of juvenile idiopathic arthritis in Han Chinese populations |
| Q41738574 | Association between cannabinoid receptor type 2 Q63R variant and oligo/polyarticular juvenile idiopathic arthritis. |
| Q36538046 | Association between drug intake and incidence of malignancies in patients with Juvenile Idiopathic Arthritis: a nested case-control study. |
| Q45745852 | Association between inflammatory status and intima-media-thickness in children with juvenile idiopathic arthritis: preliminary data |
| Q91138210 | Association between interleukin-1, interleukin-6, and tumor necrosis factor-alpha polymorphisms and juvenile idiopathic arthritis: a meta-analysis |
| Q95361180 | Association between interleukin-10 polymorphisms and juvenile idiopathic arthritis: a meta-analysis |
| Q26827416 | Association between juvenile idiopathic arthritis and osteogenesis imperfecta: case report |
| Q42601805 | Association between perceived treatment adherence and health-related quality of life in children with juvenile idiopathic arthritis: perspectives of both parents and children. |
| Q77944601 | Association between serum inflammatory cytokines and disease activity in juvenile idiopathic arthritis |
| Q46525978 | Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population: further support that PTPN22 is an autoimmunity gene |
| Q86704407 | Association between the ultrasonographic and clinical findings in the hips of patients with juvenile idiopathic arthritis |
| Q86200083 | Association between vitamin D deficiency and disease activity in juvenile idiopathic arthritis |
| Q89682640 | Association of Circulating COMP and YKL-40 as Markers of Metabolic Changes of Cartilage with Adipocytokines in Juvenile Idiopathic Arthritis |
| Q83932996 | Association of HLA DRB1 alleles with juvenile idiopathic arthritis in Mexicans |
| Q83000708 | Association of HLA-A*02:06 and HLA-DRB1*04:05 with clinical subtypes of juvenile idiopathic arthritis |
| Q43647643 | Association of HLA-B39 with HLA-B27-negative ankylosing spondylitis and pauciarticular juvenile rheumatoid arthritis in Japanese patients. Evidence for a role of the peptide-anchoring B pocket |
| Q31032836 | Association of HLA-DRB1*13 with susceptibility to uveitis in juvenile idiopathic arthritis in two independent data sets |
| Q42316804 | Association of IL-10 gene polymorphisms and susceptibility to Juvenile Idiopathic Arthritis in Egyptian children and adolescents: a case-control study |
| Q51551716 | Association of IRF5 polymorphisms with susceptibility to macrophage activation syndrome in patients with juvenile idiopathic arthritis. |
| Q58090802 | Association of Increased Sun Exposure Over the Life-Course with a Reduced Risk of Juvenile Idiopathic Arthritis |
| Q40730241 | Association of Interleukin-2, but not Interferon-Gamma, single nucleotide polymorphisms with juvenile idiopathic arthritis |
| Q57578973 | Association of Interleukin-6 Single Nucleotide Polymorphisms with Juvenile Idiopathic Arthritis |
| Q38167854 | Association of NLRP3 and CARD8 genetic polymorphisms with juvenile idiopathic arthritis in a Taiwanese population. |
| Q40509418 | Association of PTPN22 Gene Polymorphisms with Susceptibility to Juvenile Idiopathic Arthritis in Iranian Population |
| Q54488633 | Association of RANTES promoter polymorphism with juvenile rheumatoid arthritis. |
| Q42644623 | Association of SLC11A1 (NRAMP1) with persistent oligoarticular and polyarticular rheumatoid factor-negative juvenile idiopathic arthritis in Finnish patients: haplotype analysis in Finnish families |
| Q91503365 | Association of SLCO1B1 *14 Allele with Poor Response to Methotrexate in Juvenile Idiopathic Arthritis Patients |
| Q40670963 | Association of TRAF1-C5 with risk of uveitis in juvenile idiopathic arthritis. |
| Q85309904 | Association of a mutation in LACC1 with a monogenic form of systemic juvenile idiopathic arthritis |
| Q45842182 | Association of disease activity and anti-rheumatic treatment in juvenile idiopathic arthritis with serum lipid profiles: a prospective study |
| Q91106761 | Association of hand grip strength with disease activity, disability and quality of life in children and adolescents with Juvenile Idiopathic Arthritis |
| Q50103820 | Association of interferon regulatory factor 5 (IRF5) gene polymorphisms with juvenile idiopathic arthritis. |
| Q40513342 | Association of interleukin-1 family gene polymorphisms with juvenile idiopathic arthritis in Iranian population |
| Q40534937 | Association of interleukin-6 single nucleotide polymorphisms with juvenile idiopathic arthritis |
| Q43080262 | Association of juvenile idiopathic arthritis and digeorge syndrome; a case report |
| Q91985660 | Association of juvenile idiopathic arthritis and morphea: a case series |
| Q36828983 | Association of juvenile idiopathic arthritis with PTPN22 rs2476601 is specific to females in a Greek population. |
| Q44176122 | Association of low bone mass with vitamin d receptor gene and calcitonin receptor gene polymorphisms in juvenile idiopathic arthritis |
| Q43730158 | Association of macrophage migration inhibitory factor gene -173 G/C polymorphism with prognosis in Turkish children with juvenile rheumatoid arthritis |
| Q72774695 | Association of methotrexate treatment with a decrease of double negative (CD4-CD8-) and gamma/delta T cell levels in patients with juvenile rheumatoid arthritis |
| Q87650920 | Association of microRNA-146a and its target gene IRAK1 polymorphism with enthesitis related arthritis category of juvenile idiopathic arthritis |
| Q55527792 | Association of microRNA-146a and their target gene IRAK-1 polymorphism with enthesitis related arthritis category of juvenile idiopathic arthritis. |
| Q46867050 | Association of neopterin as a marker of immune system activation and juvenile rheumatoid arthritis activity. |
| Q104756104 | Association of novel rare coding variants with juvenile idiopathic arthritis |
| Q59234323 | Association of single nucleotide polymorphisms within cytokine genes to juvenile idiopathic arthritis in Czech children |
| Q47410706 | Association of single nucleotide polymorphisms within cytokine genes with juvenile idiopathic arthritis in the Czech population. |
| Q40291329 | Association of systemic-onset juvenile idiopathic arthritis and celiac disease - a case report |
| Q35082782 | Association of the 5-aminoimidazole-4-carboxamide ribonucleotide transformylase gene with response to methotrexate in juvenile idiopathic arthritis |
| Q39796826 | Association of the AFF3 gene and IL2/IL21 gene region with juvenile idiopathic arthritis |
| Q34282309 | Association of the CCR5 gene with juvenile idiopathic arthritis |
| Q45795981 | Association of the CCR5Δ32 variant with juvenile idiopathic arthritis in a meta-analysis. |
| Q55421940 | Association of the CD226 (DNAM-1) Gly307Ser polymorphism with juvenile idiopathic arthritis. |
| Q44838586 | Association of the HLA-G 14-bp insertion/deletion polymorphism with juvenile idiopathic arthritis and rheumatoid arthritis |
| Q34456454 | Association of the IL-10 gene family locus on chromosome 1 with juvenile idiopathic arthritis (JIA). |
| Q34235185 | Association of the IL2RA/CD25 gene with juvenile idiopathic arthritis |
| Q81514459 | Association of the TRAF1-C5 locus on chromosome 9 with juvenile idiopathic arthritis |
| Q45919174 | Association of the autoimmunity locus 4q27 with juvenile idiopathic arthritis. |
| Q74456133 | Association of the inflammatory state in active juvenile rheumatoid arthritis with hypo-high-density lipoproteinemia and reduced lipoprotein-associated platelet-activating factor acetylhydrolase activity |
| Q55129062 | Association of the polymorphisms P53 gene with juvenile idiopathic arthritis in children Russian Federation. |
| Q39278641 | Association of tumour necrosis factor-alpha G/A -238 and G/A -308 single nucleotide polymorphisms with juvenile idiopathic arthritis |
| Q34082362 | Association of two functional polymorphisms in the CCR5 gene with juvenile rheumatoid arthritis |
| Q47257120 | Association study of polymorphisms within interleukin-18 in juvenile idiopathic arthritis and bronchial asthma |
| Q44621266 | Association study of the IL13 variant Arg110Gln in atopic diseases and juvenile idiopathic arthritis |
| Q88198637 | Associations between gene polymorphisms and treatment outcomes of methotrexate in patients with juvenile idiopathic arthritis |
| Q54215085 | Associations between interleukin-10 polymorphisms and susceptibility to juvenile idiopathic arthritis: a systematic review and meta-analysis. |
| Q93157971 | Associations of clinical and inflammatory biomarker clusters with juvenile idiopathic arthritis categories |
| Q40373886 | Ataxia Telangiectasia and Juvenile Idiopathic Arthritis |
| Q27010113 | Atherosclerosis in juvenile idiopathic arthritis |
| Q84926768 | Atlanto-axial joint involvement as exclusive manifestation of juvenile idiopathic arthritis (JIA) |
| Q81980682 | Atlanto-axial subluxation in a patient with polyarticular juvenile idiopathic arthritis: clinical and radiological response to infliximab |
| Q51155090 | Atopy in children with systemic onset juvenile idiopathic arthritis (SoJIA) is associated with a worse outcome. |
| Q87232429 | Atopy in children with the enthesitis-related arthritis (ERA) subtype of juvenile idiopathic arthritis is associated with a worse outcome |
| Q43051579 | Atrophoderma and juvenile idiopathic arthritis. |
| Q47177876 | Attained adult height in juvenile rheumatoid arthritis with or without corticosteroid treatment. |
| Q37133996 | Attainment of inactive disease status following initiation of TNF-α inhibitor therapy for juvenile idiopathic arthritis: enthesitis-related arthritis predicts persistent active disease |
| Q83951815 | Attenuated type I mucopolysaccharidosis in the differential diagnosis of juvenile idiopathic arthritis: a series of 13 patients with Scheie syndrome |
| Q40945306 | Atypical Cutaneous Blastomycosis in a Child With Juvenile Idiopathic Arthritis on Infliximab |
| Q98289459 | Atypical clinical presentation of systemic juvenile idiopathic arthritis or Still's disease: a report of two cases |
| Q46611341 | Atypical debut manifestations in juvenile idiopathic arthritis |
| Q37586565 | Atypical monoarthritis presentation in children with oligoarticular juvenile idiopathic arthritis: a case series |
| Q48612118 | Audiovestibular function in patients with juvenile idiopathic arthritis (JIA). |
| Q72761019 | Augmented numbers of HLA-DR-positive T lymphocytes in the synovial fluid and synovial tissue of patients with rheumatoid arthritis and juvenile rheumatoid arthritis: in vivo-activated T lymphocytes are potent stimulators in the mixed lymphocyte reac |
| Q70493229 | Auranofin in juvenile rheumatoid arthritis. An open label, non-controlled study |
| Q70424217 | Auranofin in the treatment of juvenile rheumatoid arthritis |
| Q64989844 | Auranofin in the treatment of juvenile rheumatoid arthritis. Results of the USA-USSR double-blind, placebo-controlled trial. The USA Pediatric Rheumatology Collaborative Study Group. The USSR Cooperative Children's Study Group. |
| Q54075496 | Auranofin therapy for juvenile rheumatoid arthritis: results of the five-year open label extension trial. |
| Q68765945 | Auranofin therapy in juvenile rheumatoid arthritis: a 48-week phase II study |
| Q87658812 | Australian Paediatric Rheumatology Group standards of care for the management of juvenile idiopathic arthritis |
| Q43049895 | Autoantibodies against glucose-6-phosphate isomerase are not a diagnostic marker for juvenile idiopathic arthritis. |
| Q47199174 | Autoantibodies and gastrointestinal symptoms in colombian children with juvenile idiopathic arthritis. |
| Q45004739 | Autoantibodies in juvenile idiopathic arthritis: glucose-6-phosphate isomerase is not a specific target. |
| Q61448747 | Autoantibodies in the Pathogenesis, Diagnosis, and Prognosis of Juvenile Idiopathic Arthritis |
| Q46720760 | Autoantibodies to DNA topoisomerase II in juvenile rheumatoid arthritis |
| Q46902941 | Autoantibodies to chromatin components in juvenile rheumatoid arthritis |
| Q80429721 | Autoantibodies to chromatin: prevalence and clinical significance in juvenile rheumatoid arthritis |
| Q68925217 | Autoantibodies to nonhistone chromosomal proteins HMG-1 and HMG-2 in sera of patients with juvenile rheumatoid arthritis |
| Q68099294 | Autoantibodies to the chromosomal protein HMG-17 in juvenile rheumatoid arthritis |
| Q40902579 | Autoantibody studies in juvenile rheumatoid arthritis |
| Q36996580 | Autoantibody to an immunoregulatory inducer population in patients with juvenile rheumatoid arthritis |
| Q83752132 | Autoantibody to heterogeneous nuclear ribonucleoprotein-A2 (RA33) in juvenile idiopathic arthritis: clinical significance |
| Q41097173 | Autoimmune Thrombotic Thrombocytopenic Purpura: Two Rare Cases Associated with Juvenile Idiopathic Arthritis and Multiple Sclerosis. |
| Q84238016 | Autoimmune diseases in children with juvenile idiopathic arthritis |
| Q40257553 | Autoimmune endocrine disorders and coeliac disease in children and adolescents with juvenile idiopathic arthritis and rheumatic fever |
| Q59268735 | Autoimmune response following influenza H1N1 vaccination in patients with juvenile idiopathic arthritis |
| Q36669011 | Autoimmune response to transthyretin in juvenile idiopathic arthritis |
| Q36435446 | Autoinflammation and autoimmunity in systemic juvenile idiopathic arthritis |
| Q36753558 | Autoinflammatory gene polymorphisms and susceptibility to UK juvenile idiopathic arthritis |
| Q37208079 | Autoinflammatory genes and susceptibility to psoriatic juvenile idiopathic arthritis |
| Q72770658 | Autologous Mixed Lymphocyte Reactions in Patients with Rheumatoid Arthritis and Juvenile Rheumatoid Arthritis: Both Non-T Cells and in-Vivo-Activated T Cells Can Act as Stimulator Cells |
| Q43409587 | Autologous T cell depleted haematopoietic stem cell transplantation in children with severe juvenile idiopathic arthritis in the UK (2000-2007). |
| Q28764481 | Autologous haematopoietic stem cell transplantation in juvenile idiopathic arthritis |
| Q44712374 | Autologous hematopoietic stem cell transplantation for 3 patients with severe juvenile rheumatoid arthritis |
| Q93629356 | Autologous stem cell transplantation for juvenile idiopathic arthritis |
| Q35553325 | Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidity |
| Q80544807 | Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a prospective clinical trial |
| Q34941818 | Automated determination of bone age and bone mineral density in patients with juvenile idiopathic arthritis: a feasibility study |
| Q41155232 | Autoreactivity to human heat-shock protein 60 predicts disease remission in oligoarticular juvenile rheumatoid arthritis. |
| Q83394245 | Average craniofacial development from 6 to 35 years of age in a mixed group of patients with juvenile idiopathic arthritis |
| Q51556892 | Azathioprine as a treatment option for uveitis in patients with juvenile idiopathic arthritis. |
| Q68873467 | Azathioprine versus placebo in patients with juvenile rheumatoid arthritis: a single center double blind comparative study |
| Q40670077 | B Cell Alloantigens in Juvenile Rheumatoid Arthritis |
| Q54456786 | B lymphocyte stimulator expression in pediatric systemic lupus erythematosus and juvenile idiopathic arthritis patients. |
| Q35429503 | B-cell pathology in juvenile idiopathic arthritis |
| Q36844927 | BOLD MRI at 1.5 Tesla in juvenile idiopathic arthritis: preliminary experience |
| Q82983807 | BSPAR Standards of Care for children and young people with juvenile idiopathic arthritis |
| Q85080625 | BTK gene mutation in two non-identical twins with X-linked agammaglobulinemia associated with polyarticular juvenile idiopathic arthritis |
| Q40853893 | Bactericidal system of leukocytes and natural resistance in children with juvenile rheumatoid arthritis |
| Q79381560 | Band-shaped keratitis in juvenile rheumatoid arthritis |
| Q50118736 | Barriers to Adherence in Juvenile Idiopathic Arthritis: A Multicenter Collaborative Experience and Preliminary Results. |
| Q73287717 | Bartonella infection associated with systemic juvenile rheumatoid arthritis |
| Q40750916 | Basal ganglia mass lesions in juvenile rheumatoid arthritis |
| Q50044430 | Baseline ultrasound examination as possible predictor of relapse in patients affected by juvenile idiopathic arthritis (JIA). |
| Q59293506 | Basic and clinical immunology – 3034. Peculiarities of parameters immune system in juvenile rheumatoid arthritis |
| Q64046070 | Bayesian comparative effectiveness study of four consensus treatment plans for initial management of systemic juvenile idiopathic arthritis: FiRst-Line Options for Systemic juvenile idiopathic arthritis Treatment (FROST) |
| Q38818751 | Behavioral Problems in Juvenile Idiopathic Arthritis: A Controlled Study to Examine the Risk of Psychopathology in a Chronic Pediatric Disorder. |
| Q49392160 | Benefit of Temporomandibular Joint Lavage With Intra-Articular Steroids Versus Lavage Alone in the Management of Temporomandibular Joint Involvement in Juvenile Idiopathic Arthritis. |
| Q80164730 | Benefit of fluoroscopically guided intraarticular, long-acting corticosteroid injection for subtalar arthritis in juvenile idiopathic arthritis |
| Q36596538 | Benefit of intraarticular corticosteroid injection under fluoroscopic guidance for subtalar arthritis in juvenile idiopathic arthritis. |
| Q91855324 | Benign transient hyperphosphatasemia in Juvenile Idiopathic Arthritis: a case report |
| Q39244866 | Benorylate in the treatment of children with juvenile rheumatoid arthritis |
| Q89148789 | Beware of the Uric Acid: Severe Azathioprine Myelosuppression in a Patient With Juvenile Idiopathic Arthritis and Hereditary Xanthinuria |
| Q69786404 | Bf polymorphism and juvenile rheumatoid arthritis |
| Q64095856 | Biallelic loss-of-function LACC1/FAMIN Mutations Presenting as Rheumatoid Factor-Negative Polyarticular Juvenile Idiopathic Arthritis |
| Q53514456 | Bicipital synovial cyst associated with systemic juvenile idiopathic arthritis: new insights obtained from unique pathological findings. |
| Q83908583 | Bicipital synovial cyst in systemic-onset juvenile idiopathic arthritis |
| Q71965493 | Bicipital synovial cysts in juvenile rheumatoid arthritis: clinical description and sonographic correlation |
| Q64055945 | Bilateral Destructive Hip Disease from Untreated Juvenile Idiopathic Arthritis |
| Q88318706 | Bilateral absence of the cruciate ligaments with meniscal dysplasia: Unexpected diagnosis in a child with juvenile idiopathic arthritis |
| Q93068996 | Bilateral brachial synovial cysts in systemic juvenile idiopathic arthritis: Case report and literature review |
| Q70058889 | Bilateral symmetrical march fractures simulating juvenile rheumatoid arthritis |
| Q44389329 | Bilateral total hip replacement in juvenile rheumatoid arthritis |
| Q67585163 | Biochemical analysis of leukocytes in juvenile rheumatoid arthritis |
| Q57159406 | Biochemical definition of distinct HLA haplotypes associated with juvenile rheumatoid arthritis |
| Q37070967 | Biochemical markers of bone turnover associated with calcium supplementation in children with juvenile rheumatoid arthritis: results of a double-blind, placebo-controlled intervention trial |
| Q58056473 | Biologic Drug Access and Juvenile Idiopathic Arthritis in Canada: Improving Collaboration Between Clinician Experts and Funders |
| Q99550952 | Biologic Switching among Non-Systemic Juvenile Idiopathic Arthritis Patients: A Cohort Study in the Childhood Arthritis and Rheumatology Research Alliance Registry |
| Q92681333 | Biologic Therapies in Polyarticular Juvenile Idiopathic Arthritis. Comparison of Long-Term Safety Data from the German BIKER Registry |
| Q33203294 | Biologic agents for the treatment of juvenile rheumatoid arthritis: current status |
| Q33815056 | Biologic predictors of extension of oligoarticular juvenile idiopathic arthritis as determined from synovial fluid cellular composition and gene expression. |
| Q40444162 | Biologic response modifiers for juvenile idiopathic arthritis |
| Q34476320 | Biologic similarities based on age at onset in oligoarticular and polyarticular subtypes of juvenile idiopathic arthritis |
| Q36798451 | Biologic therapies in juvenile idiopathic arthritis: why and for whom? |
| Q39302854 | Biologic therapy modifies clinical and laboratory features of macrophage activation syndrome associated with systemic juvenile idiopathic arthritis. |
| Q37177593 | Biologic treatment response among adults with juvenile idiopathic arthritis: results from the British Society for Rheumatology Biologics Register |
| Q39091095 | Biological agents in polyarticular juvenile idiopathic arthritis: A meta-analysis of randomized withdrawal trials |
| Q89799357 | Biological disease-modifying antirheumatic drugs in juvenile idiopathic arthritis of polyarticular course, enthesitis-related arthritis, and psoriatic arthritis: a consensus statement |
| Q37290665 | Biological therapies for the treatment of juvenile idiopathic arthritis: Lessons from the adult and pediatric experiences |
| Q36183846 | Biological treatment in systemic juvenile idiopathic arthritis: achievement of inactive disease or clinical remission on a first, second or third biological agent |
| Q55348928 | Biologicals acting against interleukin 1 may reduce corticosteroid dependence in systemic onset juvenile idiopathic arthritis. |
| Q40735220 | Biologicals in Juvenile Idiopathic Arthritis |
| Q88776281 | Biologics for the Treatment of Juvenile Idiopathic Arthritis |
| Q36849754 | Biologics for the treatment of juvenile idiopathic arthritis: a systematic review and critical analysis of the evidence |
| Q39446782 | Biologics in juvenile idiopathic arthritis: a narrative review |
| Q44503376 | Biologics register JuMBO. Long-term safety of biologic therapy of juvenile idiopathic arthritis |
| Q28647737 | Biomarkers in systemic juvenile idiopathic arthritis: a comparison with biomarkers in cryopyrin-associated periodic syndromes |
| Q84148279 | Biomarkers of chronic uveitis in juvenile idiopathic arthritis: predictive value of antihistone antibodies and antinuclear antibodies |
| Q45936940 | Bipolar hemiarthroplasty in juvenile rheumatoid arthritis: long-term survivorship and outcomes. |
| Q38913405 | Birth Outcomes in Women with a History of Juvenile Idiopathic Arthritis |
| Q51821191 | Bivalent HPV vaccine safety depending on subtypes of juvenile idiopathic arthritis. |
| Q70445657 | Blood and serum concentrations of gold after a single dose of auranofin in children with juvenile rheumatoid arthritis |
| Q35953233 | Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study. |
| Q99402981 | Blood calprotectin in children with juvenile idiopathic arthritis: relationship to flare development after discontinuation of treatment |
| Q33622723 | Blood gene expression profiling in pediatric systemic lupus erythematosus and systemic juvenile idiopathic arthritis: from bench to bedside |
| Q33555294 | Blood gold concentrations in children with juvenile rheumatoid arthritis undergoing long-term oral gold therapy |
| Q36229664 | Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockade |
| Q57063431 | Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockade |
| Q54236334 | Blood mucoids in juvenile rheumatoid arthritis. |
| Q41641912 | Bloodstream infections among children with juvenile idiopathic arthritis: a prospective study from the onset of disease. |
| Q40947172 | Blueberry Improves the Therapeutic Effect of Etanercept on Patients with Juvenile Idiopathic Arthritis: Phase III Study |
| Q35757991 | Body composition and adipokines in patients with juvenile idiopathic arthritis and systemic glucocorticoids |
| Q60932089 | Body composition and phase angle as an indicator of nutritional status in children with juvenile idiopathic arthritis |
| Q35687613 | Body composition in children with juvenile idiopathic arthritis: effect of dietary intake of macronutrient: results from a cross sectional study |
| Q48302807 | Body experiences, emotional competence, and psychosocial functioning in juvenile idiopathic arthritis. |
| Q69084344 | Body-image disturbances ensuing from juvenile rheumatoid arthritis, a preliminary study |
| Q46964044 | Bodycomposition, bone mineral density and serum adipokines in juvenile idiopathic arthritis with previous glucocorticoid therapy |
| Q73824693 | Bone and joint diseases around the world. France: rheumatoid polyarthritis, chronic juvenile idiopathic arthritis, and ankylosing spondylitis. A public health priority |
| Q24653333 | Bone density, structure, and strength in juvenile idiopathic arthritis: importance of disease severity and muscle deficits |
| Q67246265 | Bone evaluation by microdensitometry in patients with juvenile rheumatoid arthritis |
| Q38463919 | Bone health and growth in glucocorticoid-treated patients with juvenile idiopathic arthritis |
| Q46861799 | Bone health assessment of patients with juvenile idiopathic arthritis: a comparison between DXA and bonexpert |
| Q47580595 | Bone health in adult men and women with a history of juvenile idiopathic arthritis |
| Q34216120 | Bone health in children and adolescents with juvenile idiopathic arthritis and the influence of short-term physical exercise. |
| Q38990869 | Bone health of patients with juvenile idiopathic arthritis: a comparison between dual-energy X-ray absorptiometry and digital X-ray radiogrammetry |
| Q71233693 | Bone marrow damage following immunosuppressive therapy with azathioprine of juvenile rheumatoid arthritis and the Still syndrome |
| Q81831566 | Bone marrow findings in juvenile idiopathic arthritis |
| Q70674771 | Bone marrow findings in juvenile rheumatoid arthritis |
| Q33766649 | Bone mass and quality in patients with juvenile idiopathic arthritis: longitudinal evaluation of bone-mass determinants by using dual-energy x-ray absorptiometry, peripheral quantitative computed tomography, and quantitative ultrasonography |
| Q73030139 | Bone mass change during methotrexate treatment in patients with juvenile rheumatoid arthritis |
| Q30764317 | Bone mass development and bone metabolism in juvenile idiopathic arthritis: treatment with growth hormone for 4 years |
| Q80181377 | Bone mass in adolescents with early-onset juvenile idiopathic arthritis: comment on the article by Lien et al |
| Q45745894 | Bone mass predictors in a large cohort of children with juvenile idiopathic arthritis (JIA). |
| Q68809254 | Bone metabolism in juvenile rheumatoid arthritis |
| Q82442846 | Bone mineral content in young adults with active or inactive juvenile idiopathic arthritis and in controls |
| Q33241716 | Bone mineral density and turnover in non-corticosteroid treated African American children with juvenile rheumatoid arthritis |
| Q45746102 | Bone mineral density improvement after one year of treatment with etanercept in patients with juvenile idiopathic arthritis |
| Q64974822 | Bone mineral density in children wth systemic lupus erythematosus and juvenile rheumatoid arthritis. |
| Q45746015 | Bone mineral density in patients with Juvenile Rheumatoid Arthritis |
| Q33504745 | Bone mineral density in patients with juvenile idiopathic arthritis |
| Q33327072 | Bone mineral metabolism in children with juvenile idiopathic arthritis--preliminary report. |
| Q40417080 | Bone mineral metabolism in children with juvenile rheumatoid arthritis. |
| Q33899925 | Bone mineral status in juvenile rheumatoid arthritis |
| Q36799964 | Bone mineralization and bone mineral metabolism in children with juvenile rheumatoid arthritis |
| Q86032830 | Bone status in adults with early-onset juvenile idiopathic arthritis following 1-year anti-TNFα therapy and discontinuation of glucocorticoids |
| Q57927850 | Bone status over 1 yr of etanercept treatment in juvenile idiopathic arthritis |
| Q47952831 | Bone turnover is reduced in children with juvenile rheumatoid arthritis |
| Q91876166 | Bone-marrow derived mesenchymal stromal cells infusion in therapy refractory juvenile idiopathic arthritis patients |
| Q76434361 | Bony ankylosis of the temporomandibular joints due to juvenile rheumatoid arthritis |
| Q68090768 | Both HLA class II and class III DNA polymorphisms are linked to juvenile rheumatoid arthritis susceptibility |
| Q72057423 | Breast feeding and the development of juvenile rheumatoid arthritis |
| Q73350071 | Brief Report: Child-Rearing Practices of Caregivers With and Without a Child With Juvenile Rheumatoid Arthritis: Perspectives of Caregivers and Professionals |
| Q57801058 | Brief Report: Innate lymphoid cells and T-cells contribute to the IL-17A signature detected in the synovial fluid of patients with Juvenile Idiopathic Arthritis |
| Q50095442 | Brief Report: The Genetic Profile of Rheumatoid Factor-Positive Polyarticular Juvenile Idiopathic Arthritis Resembles That of Adult Rheumatoid Arthritis. |
| Q73529906 | Brief report: adjustment to juvenile rheumatoid arthritis: a family systems perspective |
| Q87177426 | Brief report: etanercept inhibits the tumor necrosis factor α-driven shift of Th17 lymphocytes toward a nonclassic Th1 phenotype in juvenile idiopathic arthritis |
| Q36794584 | Brief report: incidence of selected opportunistic infections among children with juvenile idiopathic arthritis |
| Q44406211 | Brief report: use of complementary and alternative medicine and psychological functioning in Latino children with juvenile idiopathic arthritis or arthralgia |
| Q39840219 | British isles survey of methotrexate monitoring practice during treatment of juvenile idiopathic arthritis |
| Q98169836 | Broadening our understanding of the genetics of Juvenile Idiopathic Arthritis (JIA): Interrogation of three dimensional chromatin structures and genetic regulatory elements within JIA-associated risk loci |
| Q43886473 | Bronchiolitis obliterans in a case of juvenile rheumatoid arthritis presented with pneumomediastinum |
| Q73957163 | Bucillamine-induced nephropathy in a child with juvenile rheumatoid arthritis and Kartagener's syndrome |
| Q35554270 | Burden and cost of illness in patients with juvenile idiopathic arthritis |
| Q44607104 | C-reactive protein and delayed hypersensitivity in juvenile rheumatoid arthritis |
| Q73814318 | C-reactive protein as measured by a sensitive enzyme-linked immunosorbent assay in patients with juvenile idiopathic arthritis |
| Q69092558 | C-reactive protein in the assessment of disease activity in juvenile rheumatoid arthritis and juvenile spondyloarthritis |
| Q73050633 | C1q-containing immune complexes purified from sera of juvenile rheumatoid arthritis patients mediate IL-8 production by human synoviocytes: role of C1q receptors |
| Q93054156 | CAPTURE-JIA: a consensus-derived core dataset to improve clinical care for children and young people with juvenile idiopathic arthritis |
| Q57538285 | CD226(DNAM-1) is associated with susceptibility to juvenile idiopathic arthritis |
| Q61048602 | CD3+4−8−WT31− (T cell receptor γ+) cells and other unusual phenotypes are frequently detected among spontaneously interleukin 2-responsive T lymphocytes present in the joint fluid in juvenile rheumatoid arthritis. A clonal analysis |
| Q40394728 | CD3+CD56+ natural killer T cell activity in children with different forms of juvenile idiopathic arthritis and the influence of etanercept treatment on polyarticular subgroup |
| Q47643874 | CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. |
| Q67536924 | CD5+ B lymphocytes and T-cell subsets in a case of juvenile rheumatoid arthritis |
| Q46504798 | CLARITY: ChiLdhood Arthritis Risk Factor Identification STudY. Investigating the role of aberrant DNA methylation in juvenile idiopathic arthritis. |
| Q76505091 | CLINICAL ASPECTS OF JUVENILE RHEUMATOID ARTHRITIS. OBSERVATION OF 25 CASES |
| Q94298955 | CLINICAL ASPECTS OF JUVENILE RHEUMATOID ARTHRITIS. OBSERVATION OF 25 CASES |
| Q24803773 | CXCR3/CXCL10 expression in the synovium of children with juvenile idiopathic arthritis |
| Q43478970 | CXCR6-CXCL16 interaction in the pathogenesis of Juvenile Idiopathic Arthritis. |
| Q72922698 | Calcium absorption and metabolism in children with juvenile rheumatoid arthritis assessed using stable isotopes |
| Q86569933 | Camptodactyly-arthropathy-coxa vara-pericarditis (CACP) syndrome: a mimicker of juvenile idiopathic arthritis |
| Q37188423 | Camptodactyly-arthropathy-coxa vara-pericarditis syndrome: important differential for juvenile idiopathic arthritis |
| Q67885980 | Campylobacter pylori gastroduodenitis in children with juvenile rheumatoid arthritis |
| Q36661427 | Can Seeding in the Clinic Reach a Wide Audience? A Proof of Concept Study on Spreading a Health Message About Juvenile Idiopathic Arthritis Using a Shareable Online Video. |
| Q36823510 | Can exercise influence low bone mineral density in children with juvenile rheumatoid arthritis? |
| Q40811402 | Can genetic markers contribute to the classification of juvenile rheumatoid arthritis? |
| Q45070955 | Can peak work rate predict peak oxygen uptake in children with juvenile idiopathic arthritis? |
| Q91380829 | Can quantitative MRI be used in the clinical setting to quantify the impact of intra-articular glucocorticoid injection on synovial disease activity in juvenile idiopathic arthritis? |
| Q92380574 | Can ultrasound-detected subclinical synovitis be an indicator of flare recurrence in juvenile idiopathic arthritis remission patients on tapered TNFi? |
| Q95409797 | Canakinumab (Ilaris) for systemic juvenile idiopathic arthritis |
| Q89424968 | Canakinumab for first line steroid-free treatment in a child with systemic-onset juvenile idiopathic arthritis |
| Q38883228 | Canakinumab for the treatment of active systemic juvenile idiopathic arthritis |
| Q38255582 | Canakinumab for the treatment of systemic juvenile idiopathic arthritis |
| Q91886002 | Canakinumab in patients with systemic juvenile idiopathic arthritis and active systemic features: results from the 5-year long-term extension of the phase III pivotal trials |
| Q46863469 | Canakinumab treatment shows maintained efficacy in systemic juvenile idiopathic arthritis patients |
| Q38395697 | Canakinumab: a review of its use in the management of systemic juvenile idiopathic arthritis |
| Q80231472 | Candidate early predictors for progression to joint damage in systemic juvenile idiopathic arthritis |
| Q38509881 | Caravaggio's "Il Amore Dormiente": a sleeping cupid with juvenile rheumatoid arthritis |
| Q85603424 | Cardiac Function in Adult Patients with Juvenile Idiopathic Arthritis |
| Q38897190 | Cardiac involvement in juvenile idiopathic arthritis. |
| Q68832590 | Cardiac involvement in juvenile rheumatoid arthritis |
| Q71815036 | Cardiac involvement in juvenile rheumatoid arthritis. A follow-up study |
| Q84040835 | Cardiac tamponade in a child with systemic-onset juvenile idiopathic arthritis: dramatic improvement after interleukin-1 blockade by anakinra |
| Q68062417 | Cardiac tamponade in juvenile rheumatoid arthritis |
| Q73831655 | Cardiac tamponade in juvenile rheumatoid arthritis |
| Q45836824 | Cardiac tamponade in juvenile rheumatoid arthritis. |
| Q40827999 | Cardiac tamponade in systemic juvenile rheumatoid arthritis requiring emergency pericardiectomy |
| Q80510048 | Cardiopulmonary exercise testing in juvenile idiopathic arthritis |
| Q91736291 | Cardiovascular disease in Juvenile Idiopathic Arthritis |
| Q38090373 | Cardiovascular risk in juvenile idiopathic arthritis |
| Q36438907 | Care of the adult with juvenile rheumatoid arthritis |
| Q79850326 | Caregiver recall of treatment recommendations in juvenile idiopathic arthritis |
| Q87297156 | Carotid Atherosclerosis in Adult Patients with Persistently Active Juvenile Idiopathic Arthritis Compared with Healthy Controls |
| Q69409363 | Carpal alterations in adult-onset Still disease, juvenile chronic arthritis, and adult-onset rheumatoid arthritis: comparative study |
| Q71429751 | Carpal ankylosis in juvenile rheumatoid arthritis |
| Q53408619 | Carpal erosions in children with juvenile idiopathic arthritis: repeatability of a newly devised MR-scoring system. |
| Q44950042 | Carpo-metacarpal growth disturbance and the assessment of carpal narrowing in children with juvenile rheumatoid arthritis |
| Q57420655 | Cartilage Oligomeric Matrix Protein in Patients with Juvenile Idiopathic Arthritis: Relation to Growth and Disease Activity |
| Q80498889 | Cartilage proteoglycan aggrecan as a predictor of joint damage in juvenile rheumatoid arthritis |
| Q86300784 | Cartilage thickness of the knee joint in juvenile idiopathic arthritis: comparative assessment by ultrasonography and magnetic resonance imaging |
| Q40835672 | Case of juvenile rheumatoid arthritis presenting as fever of unknown origin and positive diagnosis established after reaching adulthood |
| Q33395590 | Case of systemic-onset juvenile idiopathic arthritis complicated with sepsis --usefulness of cytokine profile for the differentiation between macrophage activation syndrome and sepsis |
| Q72146414 | Case report: immunoglobulin A deficiency in patients with juvenile rheumatoid arthritis treated with aspirin |
| Q49367837 | Case-control Association Study of Autoimmunity Associated Variants in PDCD1 and Juvenile Idiopathic Arthritis. |
| Q90572943 | Cataract Risk and Topical Corticosteroids among Children with Juvenile Idiopathic Arthritis-Related Uveitis |
| Q30423057 | Cataract development and cataract surgery in patients with juvenile rheumatoid arthritis-associated iridocyclitis |
| Q43794607 | Cataract management in juvenile idiopathic arthritis: simultaneous versus secondary intraocular lens implantation |
| Q81282910 | Cataract surgery and intraocular lens implantation in children with juvenile rheumatoid arthritis associated uveitis |
| Q37143809 | Cataract surgery in children with juvenile idiopathic arthritis associated uveitis |
| Q86280282 | Catch-up growth during tocilizumab therapy for systemic juvenile idiopathic arthritis: results from a phase III trial |
| Q53984133 | Cathechol-O-methyltransferase Val158Met polymorphism is associated with nocebo effects, but not with methotrexate intolerance in patients with juvenile idiopathic arthritis. |
| Q67601743 | Causes of reduced visual acuity on long-term follow-up after cataract extraction in patients with uveitis and juvenile rheumatoid arthritis |
| Q70705001 | Causes of reduced visual acuity on long-term follow-up after cataract extraction in patients with uveitis and juvenile rheumatoid arthritis |
| Q70749251 | Causes of reduced visual acuity on long-term follow-up after cataract extraction in patients with uveitis and juvenile rheumatoid arthritis |
| Q30279058 | Causes of uveitis in children without juvenile idiopathic arthritis |
| Q72600969 | Cefadroxil reduces the production of IgE in a 3 year old asthmatic with juvenile rheumatoid arthritis |
| Q44314566 | Celiac disease and juvenile idiopathic arthritis: a still enigmatic crossover |
| Q51348038 | Celiac disease autoantibodies in juvenile idiopathic arthritis. |
| Q72821173 | Cellular defense mechanisms in rheumatoid arthritis and juvenile rheumatoid arthritis |
| Q68922322 | Cellular immunity in patients with systemic juvenile rheumatoid arthritis |
| Q83748938 | Cellular interactions of synovial fluid γδ T cells in juvenile idiopathic arthritis |
| Q51512855 | Cemented total knee arthroplasty in patients with juvenile rheumatoid arthritis. |
| Q51433523 | Cementless hip arthroplasty in juvenile idiopathic arthritis. |
| Q70541520 | Cementless total knee arthroplasty in juvenile onset rheumatoid arthritis |
| Q43489373 | Cerebral Vasculitis Visualized by Angiography in Juvenile Rheumatoid Arthritis Simulating Brain Tumor |
| Q39957727 | Cerebral complications in juvenile rheumatoid arthritis |
| Q69468933 | Cerebral complications in juvenile rheumatoid arthritis |
| Q93754031 | Cerebral complications in juvenile rheumatoid arthritis |
| Q67978643 | Cerebral infarction in juvenile rheumatoid arthritis |
| Q48710202 | Cerebral involvement in juvenile rheumatoid arthritis |
| Q74819680 | Cerebral vasculitis in an adolescent with juvenile rheumatoid arthritis |
| Q72762761 | Cervical instability in Down's syndrome and juvenile rheumatoid arthritis |
| Q37684982 | Cervical spine involvement in patients with juvenile idiopathic arthritis - MRI follow-up study |
| Q85737244 | Cervical vertebral fracture in a patient with juvenile idiopathic arthritis and osteopoikilosis |
| Q83408254 | Challenge for timely diagnosis of juvenile idiopathic arthritis in children |
| Q37303219 | Challenges in the management of juvenile idiopathic arthritis with etanercept |
| Q82298121 | Change in condylar and mandibular morphology in juvenile idiopathic arthritis: Cone Beam volumetric imaging |
| Q46139440 | Change in condylar and mandibular morphology in juvenile idiopathic arthritis: cone beam volumetric imaging |
| Q38167735 | Changes in body mass index in children with juvenile idiopathic arthritis treated with tumor necrosis factor inhibitors. |
| Q35972166 | Changes in fecal microbiota and metabolomics in a child with juvenile idiopathic arthritis (JIA) responding to two treatment periods with exclusive enteral nutrition (EEN). |
| Q42499635 | Changes in growth hormone receptor gene expression during therapy in children with juvenile idiopathic arthritis. |
| Q79218996 | Changes in periodontal and rheumatological conditions after 2 years in patients with juvenile idiopathic arthritis |
| Q44047958 | Changes in the cervical spine in juvenile rheumatoid arthritis |
| Q39899502 | Changes in the cervical spine in juvenile rheumatoid arthritis (author's transl) |
| Q83283763 | Changes in the cervical spine of children with juvenile idiopathic arthritis evaluated with lateral cephalometric radiographs: a case control study |
| Q74395426 | Changes in the incidence of juvenile rheumatoid arthritis in Finland |
| Q45036905 | Changes in the production of IgM in response to pokeweed mitogen in juvenile rheumatoid arthritis. Correlations with disease activity |
| Q88143169 | Changes in thiol/disulfide homeostasis in juvenile idiopathic arthritis |
| Q84923265 | Changes in vascular function and structure in juvenile idiopathic arthritis |
| Q37182199 | Changes of Platelet Indices in Juvenile Idiopathic Arthritis in Acute Phase and After Two Months Treatment |
| Q40080398 | Characteristic elevation of soluble TNF receptor II : I ratio in macrophage activation syndrome with systemic juvenile idiopathic arthritis. |
| Q38828474 | Characteristics and Course of Enthesitis in a Juvenile Idiopathic Arthritis Inception Cohort |
| Q36417240 | Characteristics and relationship of periodontal disease with juvenile idiopathic and rheumatoid arthritis |
| Q48940870 | Characteristics of FDG-PET findings in the diagnosis of systemic juvenile idiopathic arthritis. |
| Q35669508 | Characteristics of a cohort of children with Juvenile Idiopathic Arthritis and JIA-associated Uveitis |
| Q58804676 | Characteristics of bone marrow cells in 107 patients with juvenile idiopathic arthritis: A retrospective study |
| Q41931977 | Characteristics of juvenile rheumatoid arthritis: its medical and orthopedic management |
| Q41912600 | Characteristics of responders and nonresponders to slow-acting antirheumatic drugs in juvenile rheumatoid arthritis |
| Q46378718 | Characterization of active joint count trajectories in juvenile idiopathic arthritis. |
| Q90734999 | Characterization of microbiota in systemic-onset juvenile idiopathic arthritis with different disease severities |
| Q36827894 | Characterization of the Inflammatory Properties of Actively Released HMGB1 in Juvenile Idiopathic Arthritis |
| Q80228762 | Charnley low-frictional torque arthroplasty in young rheumatoid and juvenile rheumatoid arthritis: 292 hips followed for an average of 15 years |
| Q73896294 | Chemokine receptor CCR4 on CD4+ T cells in juvenile rheumatoid arthritis synovial fluid defines a subset of cells with increased IL-4:IFN-gamma mRNA ratios |
| Q44238650 | Chemotaxis of leukocytes from peripheral blood of patients with juvenile rheumatoid arthritis (JRA). |
| Q52077266 | Cherubism, gingival fibromatosis, epilepsy, and mental deficiency (Ramon syndrome) with juvenile rheumatoid arthritis. |
| Q91367683 | Child and Family Adaptation to Juvenile Idiopathic Arthritis-A Systematic Review of the Role of Resilience Resources and Mechanisms |
| Q88881190 | Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans for Juvenile Idiopathic Arthritis-Associated and Idiopathic Chronic Anterior Uveitis |
| Q35743755 | Childhood Arthritis and Rheumatology Research Alliance consensus treatment plans for new-onset polyarticular juvenile idiopathic arthritis |
| Q37590342 | Childhood leukaemia masquerading as juvenile idiopathic arthritis |
| Q33488480 | Childhood leukemia mimicking juvenile rheumatoid arthritis. |
| Q53791138 | Childhood sarcoidosis manifesting as juvenile rheumatoid arthritis. |
| Q102075522 | Childhood uveitis not associated with juvenile idiopathic arthritis: a national survey of incidence, management and visual outcomes |
| Q44573461 | Children suffering from juvenile rheumatoid arthritis need their national clinic |
| Q40574878 | Children with fever peaks and bone and joint pain: systemic juvenile idiopathic arthritis or acute lymphoblastic leukemia after all? |
| Q46654036 | Children with juvenile idiopathic arthritis currently followed in a tertiary care setting have a better psychosocial well-being than healthy peers |
| Q48544610 | Children with juvenile idiopathic arthritis frequently experience interruptions to their medical therapy. |
| Q48432040 | Children with juvenile idiopathic arthritis: are health outcomes better for those diagnosed younger? |
| Q69779138 | Children with juvenile rheumatoid arthritis at school. Functional problems, participation in physical education. The implementation of Public Law 94-142 |
| Q68222248 | Children with juvenile rheumatoid arthritis treated with salicylates for 15 days, with daily serum salicylate determinations |
| Q37881351 | Children with oligoarticular juvenile idiopathic arthritis are at considerable risk for growth retardation |
| Q98393742 | Children with oligoarticular juvenile idiopathic arthritis have skewed synovial monocyte polarization pattern with functional impairment-a distinct inflammatory pattern for oligoarticular juvenile arthritis |
| Q38002779 | Children's experiences of living with juvenile idiopathic arthritis: a thematic synthesis of qualitative studies |
| Q42372237 | Chitinase 3-like-1 is produced by human Th17 cells and correlates with the level of inflammation in juvenile idiopathic arthritis patients |
| Q46715737 | Chitotriosidase activity in juvenile idiopathic arthritis |
| Q33567854 | Chlorambucil in the management of juvenile chronic polyarthritis complicated by amyloidosis |
| Q70660888 | Chlorambucil in the treatment of iridocyclitis in juvenile rheumatoid arthritis |
| Q71234740 | Chlorambucil in the treatment of iridocyclitis in juvenile rheumatoid arthritis |
| Q77403415 | Chlorambucil therapy in juvenile chronic arthritis (juvenile idiopathic arthritis) |
| Q41933488 | Chloroquine and hydroxychloroquine dosage in juvenile rheumatoid arthritis |
| Q43584560 | Chloroquine-induced vitiligo in a patient with juvenile onset rheumatoid arthritis |
| Q54573196 | Choice of biologic drug among children with juvenile idiopathic arthritis. |
| Q43902507 | Chorioretinitis as a complication of pauciarticular juvenile rheumatoid arthritis. |
| Q37697949 | Chromatin landscapes and genetic risk for juvenile idiopathic arthritis |
| Q40781984 | Chronic Non-infectious Uveitis in Patients with Juvenile Idiopathic Arthritis |
| Q71000579 | Chronic arthritis in children. Juvenile rheumatoid arthritis |
| Q48852935 | Chronic childhood arthritis: 100 years after the intuition of G. F. Still. |
| Q46966475 | Chronic granulomatous disease associated with systemic lupus erythematosus and systemic onset juvenile idiopathic arthritis |
| Q71139782 | Chronic iridocyclitis in juvenile rheumatoid arthritis |
| Q45981451 | Chronic musculoskeletal pain and functional status in juvenile rheumatoid arthritis: an empirical model. |
| Q39512008 | Chronic pain and the child with juvenile rheumatoid arthritis |
| Q34335755 | Chronic recurrent multifocal osteomyelitis is a differential diagnosis of juvenile idiopathic arthritis |
| Q42105293 | Chronic recurrent multifocal osteomyelitis with concomitant features of juvenile idiopathic arthritis |
| Q67421959 | Chronic salicylate administration in juvenile rheumatoid arthritis: aspirin "hepatitis" and its clinical significance |
| Q33455692 | Chronic salicylism in a patient with juvenile rheumatoid arthritis |
| Q51702127 | Chronic uveitis in children with and without juvenile idiopathic arthritis: differences in patient characteristics and clinical course. |
| Q69637410 | Circulating autoantibodies against articular tissues in juvenile rheumatoid arthritis (author's transl) |
| Q40623037 | Circulating cartilage oligomeric matrix protein in juvenile idiopathic arthritis |
| Q37343947 | Circulating complexes between tumour necrosis factor-alpha and etanercept predict long-term efficacy of etanercept in juvenile idiopathic arthritis. |
| Q40661641 | Circulating immune complexes and antinuclear antibodies in juvenile rheumatoid arthritis |
| Q40820725 | Circulating immune complexes in children suffering from rheumatic fever and juvenile rheumatoid arthritis |
| Q87651023 | Circulating keratan sulfate as a marker of metabolic changes of cartilage proteoglycan in juvenile idiopathic arthritis; influence of growth factors as well as proteolytic and prooxidative agents on aggrecan alterations |
| Q35554687 | Circulating leptin levels in juvenile idiopathic arthritis: a marker of nutritional status? |
| Q74319740 | Circulating levels of soluble E-selectin, P-selectin and intercellular adhesion molecule-1 in patients with juvenile idiopathic arthritis |
| Q58326258 | Circulating levels of the adipokines vaspin and omentin in patients with juvenile idiopathic arthritis, and relation to disease activity |
| Q81483167 | Circulating survivin indicates severe course of juvenile idiopathic arthritis |
| Q73608627 | Classification of chronic arthritides of childhood (juvenile idiopathic arthritis): criticisms and suggestions to improve the efficacy of the Santiago-Durban criteria |
| Q73798842 | Classification of juvenile idiopathic arthritis: should family history be included in the criteria? |
| Q72371985 | Classification of juvenile rheumatoid arthritis |
| Q72371986 | Classification of juvenile rheumatoid arthritis. Author's reply |
| Q44456906 | Classification of temporomandibular joint erosion, arthritis, and inflammation in patients with juvenile idiopathic arthritis |
| Q99619231 | Clinical Features in 305 Patients with Juvenile Idiopathic Arthritis: A Single Center Turkish Study |
| Q73363996 | Clinical Images: Hip joint remodeling in systemic-onset juvenile rheumatoid arthritis |
| Q50016485 | Clinical Juvenile Arthritis Disease Activity Score proves to be a useful tool in treat-to-target therapy in juvenile idiopathic arthritis. |
| Q40105064 | Clinical Observation of Employment of Umbilical Cord Derived Mesenchymal Stem Cell for Juvenile Idiopathic Arthritis Therapy. |
| Q38770165 | Clinical Orofacial Examination in Juvenile Idiopathic Arthritis: International Consensus-based Recommendations for Monitoring Patients in Clinical Practice and Research Studies |
| Q57168320 | Clinical Practice Guidance for Juvenile Idiopathic Arthritis (JIA) 2018 |
| Q38671265 | Clinical Trial Design in Juvenile Idiopathic Arthritis |
| Q40253872 | Clinical analysis in 202 children with juvenile idiopathic arthritis |
| Q53600421 | Clinical analysis of 570 cases with juvenile rheumatoid arthritis: results of a nationwide retrospective survey in Japan. |
| Q33692269 | Clinical and MRI outcome of cervical spine lesions in children with juvenile idiopathic arthritis treated with anti-TNFα drugs early in disease course. |
| Q45745996 | Clinical and articular presentation of juvenile idiopathic arthritis |
| Q92528348 | Clinical and associated inflammatory biomarker features predictive of short-term outcomes in non-systemic juvenile idiopathic arthritis |
| Q40199387 | Clinical and biochemical characteristics of children with juvenile idiopathic arthritis |
| Q39568508 | Clinical and genetic features of juvenile rheumatoid arthritis |
| Q66863058 | Clinical and immunological study of anterior uveitis in juvenile chronic polyarthritis |
| Q72247225 | Clinical and radiographic evaluation of juvenile rheumatoid arthritis: report of a case |
| Q79687168 | Clinical and serologic observations in patients with juvenile rheumatoid arthritis and their relatives |
| Q46977105 | Clinical and ultrasound assessment of the knee in children with juvenile rheumatoid arthritis |
| Q40646264 | Clinical aspects of juvenile rheumatoid arthritis |
| Q79421906 | Clinical assessment and core outcome variables are poor predictors of hip arthritis diagnosed by MRI in juvenile idiopathic arthritis |
| Q67890143 | Clinical assessment of a group of children with juvenile rheumatoid arthritis receiving long-term treatment with oral gold salt |
| Q40271226 | Clinical characteristics of influenza virus infection in juvenile idiopathic arthritis patients treated with tocilizumab |
| Q38751508 | Clinical characteristics of juvenile idiopathic arthritis in an area of central Italy: a population-based study |
| Q74630183 | Clinical characteristics of juvenile rheumatoid arthritis in Taiwan |
| Q35194098 | Clinical comparison of early-onset psoriatic and non-psoriatic oligoarticular juvenile idiopathic arthritis. |
| Q92447457 | Clinical correlates of HLA-B*27 and its subtypes in enthesitis-related arthritis variant of juvenile idiopathic arthritis in south Indian Tamil patients |
| Q69287651 | Clinical correlates of antinuclear antibodies in juvenile rheumatoid arthritis |
| Q67858243 | Clinical course and prognosis of juvenile rheumatoid arthritis (juvenile chronic polyarthritis) and its special forms (proceedings) |
| Q67873942 | Clinical course and prognosis of juvenile rheumatoid arthritis (juvenile chronic polyarthritis) and its variations |
| Q45817499 | Clinical course and prognostic value of disease activity in the first two years in different subtypes of juvenile idiopathic arthritis. |
| Q46966846 | Clinical depiction, treatment and long term follow up characterization of a group of enthesitis related arthritis - juvenile idiopathic arthritis patients from a spanish pediatric tertiary hospital |
| Q39221868 | Clinical efficacy of mycophenolate mofetil in the treatment of systemic-onset juvenile idiopathic arthritis |
| Q64056604 | Clinical features and characteristics of uveitis associated with juvenile idiopathic arthritis in Japan: first report of the pediatric rheumatology association of Japan (PRAJ) |
| Q50863902 | Clinical features and perforin A91V gene analysis in 31 patients with macrophage activation syndrome and systemic juvenile idiopathic arthritis in China. |
| Q68354898 | Clinical features and serologic abnormalities in juvenile rheumatoid arthritis |
| Q54243353 | Clinical features of children with enthesitis-related juvenile idiopathic arthritis / juvenile spondyloarthritis followed in a French tertiary care pediatric rheumatology centre. |
| Q47585405 | Clinical features of children with juvenile idiopathic arthritis using the ILAR classification criteria: a community-based cohort study in Taiwan |
| Q45069120 | Clinical features of juvenile rheumatoid arthritis with onset before 5 years of age |
| Q40198507 | Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients. |
| Q38345902 | Clinical management algorithm of uveitis associated with juvenile idiopathic arthritis: interdisciplinary panel consensus |
| Q43793513 | Clinical observations on juvenile rheumatoid arthritis |
| Q86940837 | Clinical oral and salivary parameters of children with juvenile idiopathic arthritis |
| Q26752701 | Clinical outcome measures in juvenile idiopathic arthritis |
| Q37894016 | Clinical outcomes after withdrawal of anti-tumor necrosis factor α therapy in patients with juvenile idiopathic arthritis: a twelve-year experience |
| Q40740757 | Clinical patterns of chronic iridocyclitis in children with juvenile rheumatoid arthritis |
| Q37359611 | Clinical patterns of juvenile idiopathic arthritis in Zambia |
| Q38907789 | Clinical pharmacology of tocilizumab for the treatment of polyarticular-course juvenile idiopathic arthritis |
| Q38087694 | Clinical pharmacology of tocilizumab for the treatment of systemic juvenile idiopathic arthritis |
| Q40736247 | Clinical pictures of juvenile rheumatoid arthritis |
| Q38680818 | Clinical predictors of temporomandibular joint arthritis in juvenile idiopathic arthritis: A systematic literature review |
| Q39679049 | Clinical profile and juvenile arthritis damage index in children with juvenile idiopathic arthritis: A study from a tertiary care center in south India |
| Q73393135 | Clinical relevance of IgA rheumatoid factor (RF) in children with juvenile rheumatoid arthritis |
| Q37196432 | Clinical remission in juvenile idiopathic arthritis after termination of etanercept |
| Q47818655 | Clinical remission in patients with systemic juvenile idiopathic arthritis treated with anti-tumor necrosis factor agents. |
| Q46965190 | Clinical remission off medication in greek adults with juvenile idiopathic arthritis during a 17 year follow-up period |
| Q73608520 | Clinical response to etanercept in polyarticular course juvenile rheumatoid arthritis |
| Q81602800 | Clinical responsiveness of self-report functional assessment measures for children with juvenile idiopathic arthritis undergoing intraarticular corticosteroid injections |
| Q45745965 | Clinical significance of anti-cyclic citrullinated peptide antibodies in patients with juvenile rheumatoid arthritis |
| Q33329498 | Clinical significance of anticardiolipin antibodies in juvenile idiopathic arthritis. |
| Q83230879 | Clinical significance of decreased serum concentration of cartilage oligomeric matrix protein in systemic juvenile idiopathic arthritis |
| Q102129884 | Clinical significance of interleukin-18 for the diagnosis and prediction of disease course in systemic juvenile idiopathic arthritis |
| Q92880576 | Clinical significance of serum CXCL9 levels as a biomarker for systemic juvenile idiopathic arthritis associated macrophage activation syndrome |
| Q68138435 | Clinical study of systemic juvenile rheumatoid arthritis (Still) |
| Q36243970 | Clinical study of tocilizumab in children with systemic-onset juvenile idiopathic arthritis |
| Q86300058 | Clinical trial of etanercept tapering in juvenile idiopathic arthritis during remission |
| Q40734240 | Clinical trials for the treatment of systemic onset juvenile rheumatoid arthritis-juvenile idiopathic arthritis |
| Q41976428 | Clinical, laboratory, and ultrasound assessment of the knee in juvenile rheumatoid arthritis |
| Q81574960 | Clinically diagnosed fatal cerebral vasculitis in long-standing juvenile rheumatoid arthritis |
| Q73128402 | Clinically important change in treatment trials for juvenile rheumatoid arthritis |
| Q42658114 | Clinically inactive disease in a cohort of children with new-onset polyarticular juvenile idiopathic arthritis treated with early aggressive therapy: time to achievement, total duration, and predictors |
| Q72057415 | Clinically significant gastropathy associated with nonsteroidal antiinflammatory drug use in children with juvenile rheumatoid arthritis |
| Q40668536 | Clinico-immunological profile in juvenile rheumatoid arthritis--an Indian experience |
| Q73572659 | Clinico-immunological profile of juvenile rheumatoid arthritis at Chandigarh |
| Q84307085 | Clinico-serological profile of juvenile idiopathic arthritis |
| Q44828505 | Clonal analysis of joint fluid T lymphocytes in patients with juvenile rheumatoid arthritis |
| Q71405419 | Clq binding in serum in juvenile rheumatoid arthritis |
| Q43733248 | Co-existent sickle cell disease and juvenile rheumatoid arthritis. Two cases with delayed diagnosis and severe destructive arthropathy. |
| Q80839912 | Coeliac disease in 108 patients with juvenile idiopathic arthritis: a 13-year follow-up study |
| Q99205706 | Coexistence of a novel WISP3 pathogenic variant and an MEFV mutation in an Arabic family with progressive pseudorheumatoid dysplasia mimicking polyarticular juvenile idiopathic arthritis |
| Q37709062 | Coexistence of familial Mediterranean fever and juvenile idiopathic arthritis with osteoporosis successfully treated with etanercept |
| Q44103583 | Coexistent sickle cell disease and juvenile rheumatoid arthritis: 2 cases with delayed diagnosis and severe destructive arthropathy |
| Q84523407 | Coexpression of chemokine receptors CCR5, CXCR3, and CCR4 and ligands for P- and E-selectin on T lymphocytes of patients with juvenile idiopathic arthritis |
| Q35986757 | Cognitive behavioral group intervention for pain and well-being in children with juvenile idiopathic arthritis: a study of feasibility and preliminary efficacy |
| Q68137555 | Cognitive-behavioral pain management in children with juvenile rheumatoid arthritis |
| Q41188188 | Coincidence of Tracheobronchomegaly (Mounier-Kuhn Syndrome) and Juvenile Idiopathic Arthritis. |
| Q45745970 | Collaboration in long term follow-up of juvenile idiopathic arthritis |
| Q68330783 | Collagen antibodies in juvenile arthritis and adult rheumatoid arthritis: differences in levels and type-specificity |
| Q40821803 | Colonic Diverticulitis in a 19-Year-Old Boy With Juvenile Idiopathic Arthritis: Surgical Implications of Chronic Immunosuppression |
| Q83084990 | Combination therapy of abatacept and anakinra in children with refractory systemic juvenile idiopathic arthritis: a retrospective case series |
| Q41936057 | Combination therapy of juvenile rheumatoid arthritis with hydroxychloroquine-gold-methotrexate: a pilot study |
| Q44099596 | Combination therapy with methotrexate and cyclosporine A in juvenile idiopathic arthritis |
| Q101236885 | Combined genetic analysis of juvenile idiopathic arthritis clinical subtypes identifies novel risk loci, target genes and key regulatory mechanisms |
| Q84514189 | Combined pre-injection wrist and ankle MRI protocol and steroid joint injections in juvenile idiopathic arthritis |
| Q91462730 | Combined three-dimensional gait and plantar pressure analyses detecting significant functional deficits in children with juvenile idiopathic arthritis |
| Q44018694 | Combining cyclosporine with prevailing antirheumatic drug therapy in the treatment of juvenile idiopathic arthritis. |
| Q41597812 | Comics as an educational tool for children with juvenile idiopathic arthritis |
| Q82624546 | Comment on failure to distinguish systemic-onset juvenile idiopathic arthritis from incomplete Kawasaki disease in an infant |
| Q84586431 | Comment on: Developing standards of care for patients with juvenile idiopathic arthritis |
| Q90583758 | Commentary on "Effects of Structured Exercise Training in Individuals With Juvenile Idiopathic Arthritis" |
| Q52953691 | Commentary on "Inter- and intrareader variability in the interpretation of two radiographic classification systems for juvenile rheumatoid arthritis". |
| Q39400807 | Commentary on "Physical Exercise and Physical Activity for Children and Adolescents With Juvenile Idiopathic Arthritis: A Literature Review". |
| Q57751376 | Commentary: Juvenile idiopathic arthritis—issues of definition and causation |
| Q72560770 | Comments on juvenile rheumatoid arthritis |
| Q93593330 | Commparison of Differential Agglutination Titre (D.A.T.) in Juvenile and Adult Rheumatoid Arthritis |
| Q47301200 | Comorbidity of Type 1 Diabetes Mellitus in Patients with Juvenile Idiopathic Arthritis. |
| Q41496547 | Comorbidity of type 1 diabetes and juvenile idiopathic arthritis |
| Q44748003 | Comorbidity profiles among adult patients with juvenile idiopathic arthritis: results of a biologic register |
| Q39384420 | Comparable Efficacy of Abatacept Used as First-line or Second-line Biological Agent for Severe Juvenile Idiopathic Arthritis-related Uveitis. |
| Q61831507 | Comparative Tolerability of Treatments for Juvenile Idiopathic Arthritis |
| Q91162379 | Comparative analysis of the etanercept efficacy in children with juvenile idiopathic arthritis under the age of 4 years and children of older age groups using the propensity score matching method |
| Q47121394 | Comparative characteristic of quality of life with patients suffering from juvenile idiopathic arthritis (JIA), attending school and taught at home |
| Q104585155 | Comparative effectiveness and persistence of TNFi and non-TNFi in juvenile idiopathic arthritis: a large pediatric rheumatology center in US |
| Q41937304 | Comparative efficacy and safety of advanced drug therapy in children with juvenile rheumatoid arthritis |
| Q67444171 | Comparative results of synovectomy (synovocapsulectomy) of the knee joint in the early and late stage of juvenile rheumatoid arthritis |
| Q41722906 | Comparative sequence analysis of the human T cell receptor beta chain in juvenile rheumatoid arthritis and juvenile spondylarthropathies: evidence for antigenic selection of T cells in the synovium |
| Q64086464 | Comparative study of Interleukin-18 (IL-18) serum levels in adult onset Still's disease (AOSD) and systemic onset juvenile idiopathic arthritis (sJIA) and its use as a biomarker for diagnosis and evaluation of disease activity |
| Q41941902 | Comparative study of the pharmacokinetics of MTX in juvenile idiopathic arthritis patients receiving long-term MTX monotherapy or MTX plus chloroquine |
| Q37031639 | Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in juvenile rheumatoid arthritis. |
| Q102216576 | Comparing Clinical and Radiological Manifestations of Adolescent Idiopathic Condylar Resorption and Juvenile Idiopathic Arthritis in the Temporomandibular Joint |
| Q92390080 | Comparing Proxy, Adolescent, and Adult Assessments of Functional Ability in Adolescents With Juvenile Idiopathic Arthritis |
| Q39265528 | Comparing parental distress, family functioning, and the role of social support for caregivers with and without a child with juvenile rheumatoid arthritis |
| Q45880043 | Comparing the Quality of Life of Patients With Hemophilia and Juvenile Idiopathic Arthritis in Which Chronic Arthropathy Is a Common Complication |
| Q47269375 | Comparing the self-reported referral and management preferences of pediatricians and family physicians for children with juvenile rheumatoid arthritis. |
| Q53245368 | Comparison between Children with Juvenile Idiopathic Arthritis (JIA) and their parents concerning perceived Quality of Life. |
| Q70930086 | Comparison between Three Radiographic Techniques for Examination of the Temporomandibular Joints in Juvenile Rheumatoid Arthritis |
| Q57234563 | Comparison between children with juvenile idiopathic arthritis and their parents concerning perceived treatment adherence |
| Q93256653 | Comparison between clinical and ultrasound assessment of the ankle region in juvenile idiopathic arthritis |
| Q88753042 | Comparison of Adults With Polyarticular Juvenile Idiopathic Arthritis to Adults With Rheumatoid Arthritis: A Cross-sectional Analysis of Clinical Features and Medication Use |
| Q93093904 | Comparison of Different Diagnostic Guidelines for the Diagnosis of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: Single Centre Experience |
| Q41355511 | Comparison of Differential Agglutination Titre (D.A.T.) in Juvenile and Adult Rheumatoid Arthritis |
| Q92784304 | Comparison of adverse events of biologicals for treatment of juvenile idiopathic arthritis: a systematic review |
| Q40143547 | Comparison of biomarkers for systemic juvenile idiopathic arthritis |
| Q50942618 | Comparison of blood and synovial fluid th17 and novel peptidase inhibitor 16 Treg cell subsets in juvenile idiopathic arthritis. |
| Q57927151 | Comparison of bone mass and quality determinants in adolescents and young adults with juvenile systemic lupus erythematosus (JSLE) and juvenile idiopathic arthritis (JIA) |
| Q44676350 | Comparison of bone mass and quality determinants in adolescents and young adults with juvenile systemic lupus erythematosus (JSLE) and juvenile idiopathic arthritis (JIA). |
| Q82704767 | Comparison of clinical and laboratory variables in familial versus sporadic systemic onset juvenile idiopathic arthritis |
| Q83539208 | Comparison of clinical and ultrasonographic evaluations for peripheral synovitis in juvenile idiopathic arthritis |
| Q57786256 | Comparison of clinical versus ultrasound-determined synovitis in juvenile idiopathic arthritis |
| Q55502678 | Comparison of cortisone and aspirin in treatment of juvenile rheumatoid arthritis. |
| Q90789790 | Comparison of familial Mediterranean fever and juvenile idiopathic arthritis patients according to family origin |
| Q44480932 | Comparison of intra-articular triamcinolone hexacetonide and triamcinolone acetonide in oligoarticular juvenile idiopathic arthritis |
| Q97552453 | Comparison of paediatric and adult classification criteria in juvenile idiopathic arthritis during the transition from paediatric to adult care |
| Q84334316 | Comparison of patients with juvenile psoriatic arthritis and nonpsoriatic juvenile idiopathic arthritis: how different are they? |
| Q70481153 | Comparison of peak isometric knee extensor torque in children with and without juvenile rheumatoid arthritis |
| Q45744205 | Comparison of physician's, parent's and patient's global ratings made on linear or 21-circle visual analogue scales (VAS) in juvenile idiopathic arthritis (JIA). |
| Q92870145 | Comparison of serum biomarkers for the diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis |
| Q90408611 | Comparison of serum biomarkers for the diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis during tocilizumab therapy |
| Q44639495 | Comparison of serum nitric oxide levels in active juvenile rheumatoid arthritis with those of patients in remission |
| Q24674649 | Comparison of soluble adhesion molecules in juvenile idiopathic arthritis between the active and remission stages |
| Q68166053 | Comparison of synovectomy and no synovectomy in patients with juvenile rheumatoid arthritis. A 24-month controlled study |
| Q45744191 | Comparison of the accuracy of different definitions of clinical remission (CR) and minimal disease activity (MDA) in juvenile idiopathic arthritis (JIA). |
| Q102064458 | Comparison of the efficacy and safety of biological agents in patients with systemic juvenile idiopathic arthritis: A Bayesian network meta-analysis of randomized controlled trials |
| Q35966882 | Comparison of the intraarticular effectiveness of triamcinolone hexacetonide and triamcinolone acetonide in treatment of juvenile rheumatoid arthritis. |
| Q71139526 | Comparison of three serological tests in adult rheumatoid arthritis and Still's disease (juvenile rheumatoid arthritis) |
| Q40812120 | Comparison of tolmetin sodium and aspirin in the treatment of juvenile rheumatoid arthritis |
| Q37436386 | Comparison of treatment response, remission rate and drug adherence in polyarticular juvenile idiopathic arthritis patients treated with etanercept, adalimumab or tocilizumab |
| Q80210168 | Comparison of treatment-response criteria for juvenile idiopathic arthritis |
| Q36716852 | Comparison of ultrasonography with Doppler and MRI for assessment of disease activity in juvenile idiopathic arthritis: a pilot study |
| Q90453876 | Comparison of uveitis in the course of juvenile idiopathic arthritis with isolated uveitis in children - own experiences |
| Q40502733 | Comparisons of the outcomes between early and late tocilizumab treatment in systemic juvenile idiopathic arthritis. |
| Q84342316 | Compensated inflammation in systemic juvenile idiopathic arthritis: role of alternatively activated macrophages |
| Q70039459 | Complement C3b receptors on erythrocytes in patients with juvenile rheumatoid arthritis |
| Q72731723 | Complement activation and immune complexes in children with polyarticular juvenile rheumatoid arthritis: a longitudinal study |
| Q70579988 | Complement activation and immune complexes in juvenile rheumatoid arthritis |
| Q69657961 | Complement activation in synovial fluid and tissue from patients with juvenile rheumatoid arthritis |
| Q46862241 | Complement analysis reveals new biomarkers in patients with juvenile idiopathic arthritis |
| Q89998078 | Complement lectin pathway protein levels reflect disease activity in juvenile idiopathic arthritis: a longitudinal study of the Nordic JIA cohort |
| Q41298115 | Complement-fixing ability of antinuclear factors. Studies in adult and juvenile rheumatoid arthritis and systemic lupus erythematosus |
| Q41898123 | Complement-fixing hidden rheumatoid factor in juvenile rheumatoid arthritis |
| Q33913947 | Complementary and alternative medicine use in adolescents with inflammatory bowel disease and juvenile idiopathic arthritis |
| Q80327516 | Complementary therapies in juvenile idiopathic arthritis |
| Q91842363 | Complete Avulsion of Quadriceps Tendon in a Child with Juvenile Idiopathic Arthritis: A Case Report |
| Q89272079 | Complete clinical remission with tocilizumab in two infants with systemic juvenile idiopathic arthritis: a case series |
| Q44848488 | Complete control of disease activity and remission induced by treatment with etanercept in juvenile idiopathic arthritis |
| Q24798945 | Complex genetic predisposition in adult and juvenile rheumatoid arthritis |
| Q54547444 | Complexes of IgG and IgG Rheumatoid Factor in Synovial Tissues of Juvenile Rheumatoid Arthritis |
| Q36974508 | Complexity and Specificity of the Neutrophil Transcriptomes in Juvenile Idiopathic Arthritis |
| Q70782164 | Compliance With Salicylate Therapy in Adolescents With Juvenile Rheumatoid Arthritis |
| Q92848145 | Complication and prognosis of juvenile idiopathic arthritis associated uveitis in the era of modern immunomodulatory treatment |
| Q38406386 | Complications of systemic juvenile idiopathic arthritis: risk factors and management recommendations |
| Q72295363 | Composition and biological behaviour of immune complexes isolated from synovial fluid of patients with juvenile rheumatoid arthritis (JRA) |
| Q89761929 | Comprehensive Assessment of Orofacial Health and Disease Related Parameters in Adolescents with Juvenile Idiopathic Arthritis-A Cross-Sectional Study |
| Q69147410 | Comprehensive assessment of pain in juvenile rheumatoid arthritis: an empirical model |
| Q40421570 | Comprehensive association study of genetic variants in the IL-1 gene family in systemic juvenile idiopathic arthritis |
| Q70889015 | Comprehensive management of juvenile rheumatoid arthritis |
| Q70559098 | Con A-induced suppressor cell activity and T-lymphocyte subpopulations in peripheral blood lymphocytes of patients with rheumatoid arthritis and juvenile rheumatoid arthritis |
| Q72773034 | Concanavalin-A-activated suppressor cells in patients with juvenile rheumatoid arthritis |
| Q52851322 | Concealed concern: fathers' experiences of having a child with juvenile idiopathic arthritis. |
| Q52227184 | Conceptions of illness by children with juvenile rheumatoid arthritis: a cognitive developmental approach. |
| Q48196713 | Concomitant administration of methotrexate does not improve efficacy of intra-articular joint injections in patients with oligoarticular juvenile idiopathic arthritis |
| Q36169335 | Concurrence of juvenile idiopathic arthritis and multiple sclerosis |
| Q57298162 | Concurrence of juvenile idiopathic arthritis and primary demyelinating disease in a young child |
| Q47152424 | Concurrent one-stage total knee and hip arthroplasty due to sequel of juvenile rheumatoid arthritis: A case report |
| Q89799716 | Condylar alterations and facial growth in children with juvenile idiopathic arthritis |
| Q63350575 | Condylar asymmetry in children with juvenile idiopathic arthritis assessed by cone-beam computed tomography |
| Q59490120 | Condylar asymmetry in patients with juvenile idiopathic arthritis: Could it be a sign of a possible temporomandibular joints involvement? |
| Q82913036 | Congestive heart failure: an uncommon presentation of systemic onset juvenile idiopathic arthritis (SOJIA) |
| Q47603509 | Congruence between polysomnography obstructive sleep apnea and the pediatric sleep questionnaire: fatigue and health-related quality of life in juvenile idiopathic arthritis. |
| Q24610145 | Consensus treatment plans for new-onset systemic juvenile idiopathic arthritis |
| Q57171464 | Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative |
| Q39979340 | Considerations About the Role of the CCR5 Gene in Juvenile Idiopathic Arthritis - Look at the Whole or Put All Parts Together? |
| Q43049137 | Conspicuous synovial lymphatic capillaries in juvenile idiopathic arthritis synovitis with rice bodies |
| Q77411956 | Construct validity of ILAR and EULAR criteria in juvenile idiopathic arthritis: a population based incidence study from the Nordic countries. International League of Associations for Rheumatology. European League Against Rheumatism |
| Q41994850 | Construct validity of pixel-by-pixel DCE-MRI: Correlation with conventional MRI scores in juvenile idiopathic arthritis |
| Q45053731 | Consultation with an arthritis specialist for children with suspected juvenile rheumatoid arthritis: a population-based study |
| Q71106773 | Consumption coagulopathy associated with systemic juvenile rheumatoid arthritis |
| Q51196341 | Contrast-enhanced MRI compared with the physical examination in the evaluation of disease activity in juvenile idiopathic arthritis. |
| Q36128034 | Contrast-enhanced MRI features in the early diagnosis of Juvenile Idiopathic Arthritis |
| Q46093618 | Contrast-enhanced MRI of the knee in asymptomatic pediatric controls compared to juvenile idiopathic arthritis patients to validate synovitis scores |
| Q36651293 | Contrast-enhanced MRI of the knee in children unaffected by clinical arthritis compared to clinically active juvenile idiopathic arthritis patients |
| Q50460408 | Contrast-enhanced MRI of the temporomandibular joint: findings in children without juvenile idiopathic arthritis. |
| Q47794710 | Contrasting cytokine profiles in the synovium of different forms of juvenile rheumatoid arthritis and juvenile spondyloarthropathy: prominence of interleukin 4 in restricted disease. |
| Q56582884 | Contribution of the use of basic telemedicine tools to the care of children and adolescents with juvenile idiopathic arthritis at the Puerto Montt Hospital, Chile |
| Q34742968 | Controversies in juvenile idiopathic arthritis-associated uveitis |
| Q52628959 | Conventional radiography in juvenile idiopathic arthritis: Joint recommendations from the French societies for rheumatology, radiology and paediatric rheumatology. |
| Q93041476 | Coping strategies and anxiety in association with methotrexate-induced nausea in juvenile idiopathic arthritis |
| Q73446321 | Copper and zinc intake and serum levels in patients with juvenile rheumatoid arthritis |
| Q42216780 | Coronary artery abnormalities in children with systemic-onset juvenile idiopathic arthritis |
| Q40507131 | Coronary artery dilation among patients presenting with systemic-onset juvenile idiopathic arthritis |
| Q90101842 | Correction to: Diffusion-weighted imaging for assessment of synovial inflammation in juvenile idiopathic arthritis: a promising imaging biomarker as an alternative to gadolinium-based contrast agents |
| Q58721268 | Correction to: Health-related quality of life in girls and boys with juvenile idiopathic arthritis: self- and parental reports in a cross-sectional study |
| Q57454418 | Correction to: Inter- and intra-observer reliability of contrast-enhanced magnetic resonance imaging parameters in children with suspected juvenile idiopathic arthritis of the hip |
| Q91660110 | Correction to: Trends towards more active introduction of drug therapy, emphasizing methotrexate and biologic agents, for juvenile idiopathic arthritis |
| Q42358399 | Correction: Mental health and adjustment to juvenile idiopathic arthritis: Level of agreement between parent and adolescent reports according to Strengths and Difficulties Questionnaire and Adolescent Outcomes Questionnaire |
| Q34455674 | Correlation analyses of clinical and molecular findings identify candidate biological pathways in systemic juvenile idiopathic arthritis |
| Q77953073 | Correlation between clinical and ultrasound assessment of the knee in children with mono-articular or pauci-articular juvenile rheumatoid arthritis |
| Q55438027 | Correlation between clinical indices and findings of joint ultrasonography in juvenile idiopathic arthritis with adalimumab therapy. |
| Q87749578 | Correlation between disease severity and presence of ocular autoantibodies in juvenile idiopathic arthritis-associated uveitis |
| Q79398048 | Correlation between juvenile idiopathic arthritis activity and damage measures in early, advanced, and longstanding disease |
| Q37257326 | Correlation of low CD73 expression on synovial lymphocytes with reduced adenosine generation and higher disease severity in juvenile idiopathic arthritis. |
| Q41666122 | Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis |
| Q90367602 | Correlation of temporomandibular joint clinical signs with cone beam computed tomography radiologic features in juvenile idiopathic arthritis patients |
| Q91507693 | Correlation of ultrasonography synovitis with disease activity and clinical response to etanercept treatment in juvenile idiopathic arthritis patients |
| Q90150209 | Correlations between serum interleukin 6, serum soluble interleukin 6 receptor, and disease activity in systemic juvenile idiopathic arthritis patients treated with or without tocilizumab |
| Q67437546 | Correlations between transaminase concentrations and serum salicylate concentration in juvenile rheumatoid arthritis |
| Q87741989 | Corrigendum to "MiR-146a modulates macrophage polarization in systemic juvenile idiopathic arthritis by targeting INHBA" [Mol. Immunol. 77 (2016) 205-212] |
| Q58761165 | Corrigendum to "Single Bout Exercise in Children with Juvenile Idiopathic Arthritis: Impact on Inflammatory Markers" |
| Q67435149 | Corticosteroid treatment of juvenile chronic polyarthritis over 22 years |
| Q70807023 | Corticosteroids causing severe growth suppression in juvenile rheumatoid arthritis |
| Q40471309 | Corticosteroids in juvenile rheumatoid arthritis |
| Q69175360 | Corticosteroids-salicylate interaction in a case of juvenile rheumatoid arthritis |
| Q35149220 | Corticotrophin therapy in juvenile chronic polyarthritis (Still's disease) and effect on growth |
| Q41045484 | Cortisone and corticotropin in rheumatic fever and juvenile rheumatoid arthritis. |
| Q39432090 | Cost of biologics in the treatment of juvenile idiopathic arthritis: a factor not to be overlooked |
| Q51759532 | Cost-Effectiveness Analysis of First-Line Treatment With Biologic Agents in Polyarticular Juvenile Idiopathic Arthritis. |
| Q58565522 | Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with Juvenile Idiopathic Arthritis |
| Q99550737 | Cost-utility and budget impact analysis of tocilizumab for the treatment of refractory systemic juvenile idiopathic arthritis in Thailand |
| Q36725341 | Costing juvenile idiopathic arthritis: examining patient-based costs during the first year after diagnosis. |
| Q102990636 | Costs of medication use among patients with juvenile idiopathic arthritis in the Dutch healthcare system |
| Q43420432 | Cost‐effectiveness of biologics in polyarticular‐course juvenile idiopathic arthritis patients unresponsive to disease‐modifying antirheumatic drugs |
| Q79947148 | Could hormones make a difference in the treatment of juvenile rheumatoid arthritis? |
| Q50932296 | Countermeasures against methotrexate intolerance in juvenile idiopathic arthritis instituted by parents show no effect. |
| Q81162772 | Course of joint disease in patients with antinuclear antibody-positive juvenile idiopathic arthritis |
| Q83121083 | Course of juvenile rheumatoid arthritis: social life is less affected than school functioning, physical activity, and well-being during a follow-up of 1.5-13 years |
| Q40321128 | Course, Outcome and Complications in Children with Systemic Onset Juvenile Idiopathic Arthritis. |
| Q46863384 | Course, outcome and complications in a single centre cohort of 53 indian children with systemic onset juvenile idiopathic arthritis with a minimum follow up of 3 years. |
| Q40220325 | Cow's Milk Allergy in Infancy and Later Development of Juvenile Idiopathic Arthritis: A Register-Based Case-Control Study |
| Q39986195 | Coxsackievirus and adenovirus infection. Association with acute febrile and juvenile rheumatoid arthritis |
| Q89184294 | Cranial structure and condylar asymmetry of patients with juvenile idiopathic arthritis: a risky growth pattern |
| Q68055253 | Craniofacial characteristics of children affected with juvenile rheumatoid arthritis |
| Q53286102 | Craniofacial growth disturbance is related to temporomandibular joint abnormality in patients with juvenile idiopathic arthritis, but normal facial profile was also found at the 27-year follow-up. |
| Q43834100 | Craniofacial growth in children affected by juvenile idiopathic arthritis involving the temporomandibular joint: functional therapy management. |
| Q48400117 | Craniofacial surgical management of a patient with systematic juvenile idiopathic arthritis and Crohn's disease. |
| Q67543181 | Cricoarytenoid arthritis and airway obstruction in juvenile rheumatoid arthritis |
| Q69239601 | Criteria for the classification of juvenile rheumatoid arthritis |
| Q38266706 | Critical appraisal of studies measuring quality of life in juvenile idiopathic arthritis |
| Q37511803 | Crohn's disease during etanercept therapy in juvenile idiopathic arthritis: a case report and review of the literature |
| Q44295250 | Crohn's disease in a patient with juvenile idiopathic arthritis after starting etanercept therapy - causal link or only temporal coincidence? |
| Q38985228 | Cross cultural adaptation and validation of the Arabic version of the Childhood Health Assessment Questionnaire for measuring functional status in children with juvenile idiopathic arthritis |
| Q38646728 | Cross sectional, qualitative thematic analysis of patient perspectives of disease impact in juvenile idiopathic arthritis-associated uveitis |
| Q47207166 | Cross-cultural adaptation, reliability, and validity of the Turkish version of PedsQL 3.0 Arthritis Module: a quality-of-life measure for patients with juvenile idiopathic arthritis in Turkey |
| Q69077853 | Cross-reactive antiidiotypic antibodies against human rheumatoid factors from patients with juvenile rheumatoid arthritis |
| Q43048429 | Cross-sectional and longitudinal evaluation of bone mass in children and young adults with juvenile idiopathic arthritis: the role of bone mass determinants in a large cohort of patients |
| Q81581097 | Crusted scabies in a patient being treated with infliximab for juvenile rheumatoid arthritis |
| Q93024413 | Cumulative Incidence of Orofacial Manifestations in Early Juvenile Idiopathic Arthritis: A Regional, Three Year Cohort Study |
| Q98950459 | Cumulative damage in juvenile idiopathic arthritis: A multi-center study from the Pediatric Rheumatology Arab Group (PRAG) |
| Q38483834 | Current Status of Efforts on Standardizing Magnetic Resonance Imaging of Juvenile Idiopathic Arthritis: Report from the OMERACT MRI in JIA Working Group and Health-e-Child. |
| Q89962261 | Current and emerging biologics for the treatment of juvenile idiopathic arthritis |
| Q91248962 | Current and future perspectives in the management of juvenile idiopathic arthritis |
| Q46860711 | Current evidence for the medical treatments of systemic juvenile idiopathic arthritis |
| Q39667674 | Current knowledge of the etiology and pathogenesis of chronic uveitis accompanying juvenile rheumatoid arthritis. |
| Q36424768 | Current management of juvenile idiopathic arthritis |
| Q92031973 | Current management of juvenile idiopathic arthritis affecting the craniovertebral junction |
| Q35294398 | Current medical treatments for juvenile idiopathic arthritis |
| Q40279406 | Current medication choices in juvenile rheumatoid arthritis II--update of a survey performed in 1993. |
| Q83131385 | Current perspectives of autologous stem cell transplantation for severe Juvenile Idiopathic Arthritis |
| Q104101309 | Current status of MR imaging of juvenile idiopathic arthritis |
| Q36899694 | Current status of the medical treatment of children with juvenile rheumatoid arthritis |
| Q88687457 | Current status of wrist imaging in juvenile idiopathic arthritis |
| Q99563384 | Current therapeutic options for the treatment of juvenile idiopathic arthritis |
| Q34482495 | Current treatment of juvenile rheumatoid arthritis. |
| Q42852676 | Current treatments for juvenile idiopathic arthritis |
| Q38468185 | Current understanding of the pathophysiology of systemic juvenile idiopathic arthritis (sJIA) and target-directed therapeutic approaches |
| Q42838277 | Cyclophosphamide therapy for secondary amyloidosis in a patient with juvenile idiopathic arthritis unresponsive to tumor necrosis factor α inhibitor therapy |
| Q71852028 | Cyclophosphamide therapy for severe juvenile rheumatoid arthritis |
| Q68060907 | Cyclosporin treatment of a patient with severe systemic juvenile rheumatoid arthritis |
| Q42607043 | Cyclosporine A in juvenile idiopathic arthritis. Results of the PRCSG/PRINTO phase IV post marketing surveillance study. |
| Q92466987 | Cyclosporine for Systemic Onset Juvenile Idiopathic Arthritis: Current Stand and Future Directions |
| Q53555760 | Cystoid macular edema associated with juvenile idiopathic arthritis resolved by a dexamethasone intravitreal implant. |
| Q88004797 | Cytokine Biomarkers of Disease Activity and Therapeutic Response after Initiating Methotrexate Therapy in Patients with Juvenile Idiopathic Arthritis |
| Q38221835 | Cytokine balance and cytokine-driven natural killer cell dysfunction in systemic juvenile idiopathic arthritis. |
| Q80829232 | Cytokine flexibility of early and differentiated memory T helper cells in juvenile idiopathic arthritis |
| Q38301613 | Cytokine gene polymorphisms and susceptibility to juvenile idiopathic arthritis. British Paediatric Rheumatology Study Group |
| Q59314389 | Cytokine genotypes correlate with pain and radiologically defined joint damage in patients with juvenile rheumatoid arthritis |
| Q72117242 | Cytokine levels in serum and synovial fluid of patients with juvenile rheumatoid arthritis |
| Q52066903 | Cytokine levels in serum of patients with juvenile rheumatoid arthritis. |
| Q74661832 | Cytokine production by peripheral blood mononuclear cells from patients with juvenile idiopathic arthritis |
| Q51719511 | Cytokine profile in adult-onset Still's disease: Comparison with systemic juvenile idiopathic arthritis. |
| Q81582521 | Cytokine profiles in peripheral blood and whole blood cell cultures associated with aggressive periodontitis, juvenile idiopathic arthritis, and rheumatoid arthritis |
| Q53547995 | Cytokine profiling and in vitro studies of murine bone growth using biological fluids from children with juvenile idiopathic arthritis. |
| Q59986644 | Cytokine profiling at disease onset: support for classification of young antinuclear antibody-positive patients as a separate category of juvenile idiopathic arthritis |
| Q78503272 | Cytokines and juvenile idiopathic arthritis |
| Q40854280 | Cytokines in juvenile rheumatoid arthritis (JRA). |
| Q41601085 | Cytokines in juvenile rheumatoid arthritis. |
| Q61831206 | Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-γ |
| Q72266907 | Cytology of the synovial fluid in the juvenile form of rheumatoid arthritis |
| Q57997167 | Cytotoxic anti-t cell antibodies in children with juvenile rheumatoid arthritis |
| Q58592944 | Czech Dysplasia Masquerading as Juvenile Idiopathic Arthritis |
| Q38252693 | D-penicillamine-induced elastosis perforans serpiginosa in a child with juvenile rheumatoid arthritis. Report of a case and review of the literature |
| Q35051109 | DEK in the synovium of patients with juvenile idiopathic arthritis: characterization of DEK antibodies and posttranslational modification of the DEK autoantigen |
| Q46967963 | DIssociation of T lymphocyte subpopulations in patients with juvenile idiopathic arthritis |
| Q95412914 | DMARDs for Juvenile Idiopathic Arthritis: A Review of the Research for Parents and Caregivers |
| Q68332813 | DNA analysis of HLA-DR, DQ and DP genes in pauciarticular juvenile rheumatoid arthritis |
| Q67888323 | DNA analysis of HLA-DR, DQ, and DP alleles in children with polyarticular juvenile rheumatoid arthritis |
| Q36156306 | DNA methylation at IL32 in juvenile idiopathic arthritis. |
| Q44445066 | DNA polymorphism of HLA class II genes in pauciarticular juvenile rheumatoid arthritis |
| Q43563599 | DNA typing for HLA-DPB1*02 and -DPB1*04 in multiple sclerosis and juvenile rheumatoid arthritis. |
| Q40823229 | DR, C4, and Bf allotypes in juvenile rheumatoid arthritis |
| Q42910896 | DRESS-syndrome on sulfasalazine and naproxen treatment for juvenile idiopathic arthritis and reactivation of human herpevirus 6 in an 11-year-old Caucasian boy. |
| Q92276043 | Dacryoadenitis Associated With Juvenile Idiopathic Arthritis |
| Q37228166 | Daily Sleep Patterns, Sleep Quality, and Sleep Hygiene Among Parent-Child Dyads of Young Children Newly Diagnosed With Juvenile Idiopathic Arthritis and Typically Developing Children. |
| Q91859329 | Damage quantification of mandibular condyle in juvenile idiopathic arthritis: 3D morphological study by cone beam computed tomography |
| Q40333739 | De novo 19q13.42 duplications involving NLRP gene cluster in a patient with systemic-onset juvenile idiopathic arthritis |
| Q80222211 | Dealing with the effects of juvenile rheumatoid arthritis in growing children |
| Q70261724 | Declines in the range of motion and malalignment in hands of patients with juvenile rheumatoid arthritis studied over 6 years |
| Q77941123 | Decrease in synovial cellularity and cytokine expression after autologous stem cell transplantation in patients with juvenile idiopathic arthritis |
| Q72922700 | Decrease in the number of deaths from secondary amyloidosis in patients with juvenile rheumatoid arthritis |
| Q88245425 | Decreased PD-1 expression on circulating CD4+T cell and PD-L1 expression on myeloid dendritic cell correlate with clinical manifestations in systemic juvenile idiopathic arthritis |
| Q87032029 | Decreased cartilage thickness in juvenile idiopathic arthritis assessed by ultrasonography |
| Q45260419 | Decreased expression of nicotinamide phosphoribosyltransferase in patients with juvenile idiopathic arthritis receiving methotrexate |
| Q98569467 | Decreased frequency of allergy in juvenile idiopathic arthritis: results of a case-control study |
| Q35188363 | Decreased high-density lipoprotein cholesterol levels in polyarticular juvenile idiopathic arthritis. |
| Q46002926 | Decreased osteoblastogenesis from synovial fluid progenitors as a marker of systemic inflammatory process in juvenile idiopathic arthritis. |
| Q40108770 | Decreased pain threshold in juvenile idiopathic arthritis: a cross-sectional study |
| Q63551257 | Decreased physical function in juvenile rheumatoid arthritis |
| Q93553625 | Decreased plating efficiency, proliferation and osteogenic differentiation of synovial fluid mesenchymal progenitors as a marker of severity of juvenile idiopathic arthritis |
| Q51054089 | Decreased recent thymus emigrant number in rheumatoid factor-negative polyarticular juvenile idiopathic arthritis. |
| Q37930506 | Decreased use of non-steroidal anti-inflammatory drugs for the treatment of juvenile idiopathic arthritis in the era of modern aggressive treatment |
| Q91303387 | Decreasing trend in the incidence of serious pneumonias in Finnish children with juvenile idiopathic arthritis |
| Q41882301 | Defect of suppressor cell induction in patients with juvenile rheumatoid arthritis. |
| Q54723923 | Defective phosphorylation of interleukin-18 receptor beta causes impaired natural killer cell function in systemic-onset juvenile idiopathic arthritis. |
| Q93635351 | Defects in pokeweed mitogen (PWM) induced immunoglobulin (Ig) synthesis by lymphocytes of patients with juvenile rheumatoid arthritis |
| Q86895370 | Defining criteria for disease activity states in juvenile idiopathic arthritis |
| Q88187233 | Defining criteria for disease activity states in nonsystemic juvenile idiopathic arthritis based on a three-variable juvenile arthritis disease activity score |
| Q43484603 | Defining criteria for high disease activity in juvenile idiopathic arthritis based on the juvenile arthritis disease activity score. |
| Q37965666 | Defining juvenile idiopathic arthritis remission and optimum time for disease-modifying anti-rheumatic drug withdrawal: why we need a consensus |
| Q92737263 | Defining new clinically derived criteria for high disease activity in non-systemic juvenile idiopathic arthritis: a Finnish multicentre study |
| Q91804757 | Defining outcome measures in juvenile idiopathic arthritis associated uveitis by a systematic review analysis: do we need a consensus? |
| Q49263679 | Defining the normal appearance of the temporomandibular joints by magnetic resonance imaging with contrast: a comparative study of children with and without juvenile idiopathic arthritis. |
| Q44513624 | Definition of improvement in juvenile idiopathic arthritis using the juvenile arthritis disease activity score. |
| Q46458697 | Definitive differences in laboratory and radiological characteristics between two subtypes of juvenile idiopathic arthritis: systemic arthritis and polyarthritis |
| Q68522624 | Degradation in vivo of articular cartilage in rheumatoid arthritis and juvenile chronic arthritis by cathepsin G and elastase from polymorphonuclear leukocytes |
| Q80707209 | Delay in access to appropriate care for children presenting with musculoskeletal symptoms and ultimately diagnosed with juvenile idiopathic arthritis |
| Q52294181 | Delay in motor development as a presentation of juvenile rheumatoid arthritis |
| Q51591055 | Delayed clinical response in patients with juvenile idiopathic arthritis treated with etanercept. |
| Q74097196 | Delayed diagnosis of juvenile rheumatoid arthritis in a girl with Turner's syndrome |
| Q47717022 | Delayed maculopapular, urticarial rash due to infliximab in two children with systemic onset juvenile idiopathic arthritis |
| Q44605887 | Delayed repair of DNA damage by ionizing radiation in cells from patients with juvenile systemic lupus erythematosus and rheumatoid arthritis. |
| Q53193870 | Delineating the Application of Ultrasound in Detecting Synovial Abnormalities of the Subtalar Joint in Juvenile Idiopathic Arthritis. |
| Q45348883 | Delineating the role of multiple intraarticular corticosteroid injections in the management of juvenile idiopathic arthritis in the biologic era. |
| Q70617224 | Demonstration of antibodies to denatured type I and type II collagen in juvenile rheumatoid arthritis, Still's syndrome and controls by 14C collagen radioimmunoassay |
| Q67239166 | Demonstration of antibodies to denatured type I and type II collagen in juvenile rheumatoid arthritis, Still's syndrome and controls by [14C] collagen radioimmunoassay |
| Q30416148 | Dense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritis. |
| Q98611779 | Dental age estimation in children affected by juvenile rheumatoid arthritis |
| Q80402993 | Dental and facial characteristics of patients with juvenile idiopathic arthritis |
| Q67907553 | Dental considerations for the patient with juvenile rheumatoid arthritis |
| Q48104431 | Dental surgery and anesthetic precautions of a patient with Down syndrome and juvenile rheumatoid arthritis: a case report. |
| Q49723461 | Dentoalveolar characteristics in children with juvenile idiopathic arthritis. |
| Q48538771 | Dentoskeletal morphology in children with juvenile idiopathic arthritis compared with healthy children. |
| Q91738454 | Depression And Anxiety In Patients With Juvenile Idiopathic Arthritis: Current Insights And Impact On Quality Of Life, A Systematic Review |
| Q46527204 | Depression, anxiety and pain in children with juvenile idiopathic arthritis (JIA). |
| Q45744720 | Depression, anxiety and pain in juvenile idiopathic arthritis |
| Q52561537 | Depressive symptoms, pain and disability for adolescent patients with juvenile idiopathic arthritis: results from the Childhood Arthritis Prospective Study. |
| Q45832272 | Dermatomyositis induced by anti-tumor necrosis factor in a patient with juvenile idiopathic arthritis |
| Q45808304 | Description of active joint count trajectories in juvenile idiopathic arthritis |
| Q30658657 | Design and acceptance of Rheumates@Work, a combined internet-based and in person instruction model, an interactive, educational, and cognitive behavioral program for children with juvenile idiopathic arthritis |
| Q33768257 | Design and implementation of a decision aid for juvenile idiopathic arthritis medication choices |
| Q79505428 | Design and validation of a new scale to assess the functional ability in children with juvenile idiopathic arthritis (JIA) |
| Q71276129 | Destructive arthritis of the hip in juvenile rheumatoid arthritis |
| Q45783606 | Detection of Epstein-Barr virus and cytomegalovirus genome in white blood cells from patients with juvenile rheumatoid arthritis and childhood systemic lupus erythematosus |
| Q67936068 | Detection of IgM rheumatoid factors by enzyme-linked immunosorbent assay in children with juvenile rheumatoid arthritis: correlation with articular disease and laboratory abnormalities |
| Q72761017 | Detection of T-lymphocyte subpopulation in the peripheral blood and the synovium of patients with rheumatoid arthritis and juvenile rheumatoid arthritis using monoclonal antibodies |
| Q84949547 | Detection of active disease in juvenile idiopathic arthritis: sensitivity and specificity of the physical examination vs ultrasound |
| Q95590683 | Detection of synovitis by ultrasonography in clinically inactive juvenile idiopathic arthritis on and off medication |
| Q68040274 | Detection of the major rheumatoid factor cross-reactive idiotype precedes human IgG binding activity in a patient with polyarticular juvenile rheumatoid arthritis |
| Q38856428 | Determinants of health-related quality of life impairment in Egyptian children and adolescents with juvenile idiopathic arthritis: Sharkia Governorate |
| Q37605006 | Determinants of health-related quality of life in children newly diagnosed with juvenile idiopathic arthritis |
| Q50847593 | Determinants of vitamin D levels in children, adolescents, and young adults with juvenile idiopathic arthritis. |
| Q34344556 | Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis |
| Q69059808 | Determination of ketoprofen by high-performance liquid chromatography from serum and urine: clinical application in children with juvenile rheumatoid arthritis |
| Q40498818 | Developing a disease activity tool for systemic-onset juvenile idiopathic arthritis by international consensus using the Delphi approach |
| Q79108015 | Developing a programme of transitional care for adolescents with juvenile idiopathic arthritis: results of a postal survey |
| Q38642052 | Developing and Evaluating JIApp: Acceptability and Usability of a Smartphone App System to Improve Self-Management in Young People With Juvenile Idiopathic Arthritis |
| Q82983801 | Developing standards of care for patients with juvenile idiopathic arthritis |
| Q100505302 | Development and Acceptability of a Patient Decision Aid for Pain Management in Juvenile Idiopathic Arthritis: The JIA Option Map |
| Q74714756 | Development and evaluation of a single value score to assess global range of motion in juvenile idiopathic arthritis |
| Q98630961 | Development and initial validation of a composite disease activity score for systemic juvenile idiopathic arthritis |
| Q53063302 | Development and initial validation of a radiographic scoring system for the hip in juvenile idiopathic arthritis. |
| Q48662070 | Development and initial validation of composite parent- and child-centered disease assessment indices for juvenile idiopathic arthritis. |
| Q91806789 | Development and initial validation of the MS score for diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis |
| Q45744232 | Development and initial validation of the parent acceptable symptom state in juvenile idiopathic arthritis (JIA). |
| Q53077117 | Development and preliminary validation of a paediatric-targeted MRI scoring system for the assessment of disease activity and damage in juvenile idiopathic arthritis. |
| Q79319435 | Development and preliminary validation of a self-efficacy measure for use among parents of children with juvenile idiopathic arthritis |
| Q80511773 | Development and preliminary validation of the 'Mind the Gap' scale to assess satisfaction with transitional health care among adolescents with juvenile idiopathic arthritis |
| Q83327207 | Development and testing of reduced joint counts in juvenile idiopathic arthritis |
| Q36178472 | Development and validation of a clinical index for assessment of long-term damage in juvenile idiopathic arthritis. |
| Q46030916 | Development and validation of a composite disease activity score for juvenile idiopathic arthritis. |
| Q80707190 | Development and validation of a new short and simple measure of physical function for juvenile idiopathic arthritis |
| Q40064593 | Development and validation of a preliminary definition of minimal disease activity in patients with juvenile idiopathic arthritis. |
| Q92640069 | Development and validation of the CAREGIVERS questionnaire: multi-assessing the impact of juvenile idiopathic arthritis on caregivers |
| Q80371247 | Development of Crohn disease during anti-TNF-alpha therapy in a child with juvenile idiopathic arthritis |
| Q44876546 | Development of a disability measurement tool for juvenile rheumatoid arthritis. The Juvenile Arthritis Functional Assessment Report for Children and their Parents |
| Q69804171 | Development of a disability measurement tool for juvenile rheumatoid arthritis. The Juvenile Arthritis Functional Assessment Scale |
| Q47410777 | Development of a national audit tool for juvenile idiopathic arthritis: a BSPAR project funded by the Health Care Quality Improvement Partnership |
| Q72002990 | Development of a self-report functional status index for juvenile rheumatoid arthritis |
| Q46687334 | Development of a standardized method of assessment of radiographs and radiographic change in juvenile idiopathic arthritis: introduction of the Dijkstra composite score |
| Q35204680 | Development of a vision-related quality of life instrument for children ages 8-18 years for use in juvenile idiopathic arthritis-associated uveitis. |
| Q45744519 | Development of a web-based register for the Dutch national study on biologicals in juvenile idiopathic arthritis:. |
| Q60701432 | Development of an observation method for assessing pain behaviors in children with juvenile rheumatoid arthritis |
| Q82115373 | Development of autoimmune hepatitis in a child with systemic-onset juvenile idiopathic arthritis during therapy with etanercept |
| Q46378666 | Development of consensus best treatment plans for new-onset systemic juvenile idiopathic arthritis |
| Q91864739 | Development of crohn's disease following treatment for juvenile idiopathic arthritis in a nigerian child: Case report and review of literature |
| Q73202471 | Development of diabetes mellitus during etanercept therapy in a child with systemic-onset juvenile rheumatoid arthritis |
| Q82449988 | Development of germinoma during the treatment of systemic-onset juvenile idiopathic arthritis with infliximab |
| Q67296341 | Development of hypothyroidism due to chronic thyroiditis and diabetic coma during the clinical course of juvenile rheumatoid arthritis--a case study |
| Q34628130 | Development of inflammatory bowel disease in patients with juvenile idiopathic arthritis treated with etanercept |
| Q87070301 | Development of macular edema and impact on visual acuity in uveitis associated with juvenile idiopathic arthritis |
| Q45840736 | Development of new classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. |
| Q34023067 | Development of positive antinuclear antibodies and rheumatoid factor in systemic juvenile idiopathic arthritis points toward an autoimmune phenotype later in the disease course |
| Q84713761 | Development of pylomatrixoma after the subcutaneous injection of methotrexate for the treatment of juvenile idiopathic arthritis |
| Q34219644 | Developmental pharmacogenetics in pediatric rheumatology: utilizing a new paradigm to effectively treat patients with juvenile idiopathic arthritis with methotrexate |
| Q71847420 | Diabetes mellitus, Hashimoto's thyroiditis, and juvenile rheumatoid arthritis |
| Q43649269 | Diabetes, coeliac disease, multiple sclerosis and chronic arthritis in first-degree relatives of patients with juvenile idiopathic arthritis |
| Q57093959 | Diagnosing a possible case of juvenile idiopathic arthritis: A palaeopathology study from the Ishkeenickh River Cave Site |
| Q88076070 | Diagnosis and Treatment of Systemic Juvenile Idiopathic Arthritis |
| Q38181672 | Diagnosis and classification of juvenile idiopathic arthritis |
| Q37816008 | Diagnosis and management of juvenile idiopathic arthritis |
| Q77061436 | Diagnosis and management of juvenile idiopathic arthritis: current status |
| Q68730592 | Diagnosis and management of juvenile rheumatoid arthritis with TMJ involvement |
| Q35582800 | Diagnosis and treatment of juvenile idiopathic arthritis-associated uveitis |
| Q40924841 | Diagnosis of juvenile rheumatoid arthritis |
| Q46071339 | Diagnosis of juvenile rheumatoid arthritis. |
| Q38378094 | Diagnosis of systemic-onset juvenile idiopathic arthritis after treatment for presumed Kawasaki disease |
| Q35553662 | Diagnostic accuracy of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. |
| Q45164812 | Diagnostic criteria for juvenile chronic rheumatoid arthritis |
| Q44836462 | Diagnostic criteria for juvenile rheumatoid arthritis |
| Q40691626 | Diagnostic performance of anti-citrullinated protein/peptide antibodies in juvenile idiopathic arthritis |
| Q44353520 | Diagnostic significance of antibody to native deoxyribonucleic acid in children with juvenile rheumatoid arthritis and other connective tissue diseases |
| Q74517063 | Diagnostic significance of increased serum hyaluronic acid in juvenile rheumatoid arthritis |
| Q71563955 | Dialysis treatment in children with amyloidosis due to juvenile rheumatoid arthritis |
| Q93714659 | Diaphragmatic weakness and myositis associated with systemic juvenile rheumatoid arthritis [correction] |
| Q42777899 | Diaphragmatic weakness and myositis associated with systemic juvenile rheumatoid arthritis. |
| Q69154012 | Dietary deficiencies in children with juvenile rheumatoid arthritis |
| Q83889822 | Differences in disease outcomes between medicaid and privately insured children: possible health disparities in juvenile rheumatoid arthritis |
| Q73521085 | Differences in synovial fluid cytokine levels between juvenile and adult rheumatoid arthritis |
| Q74141288 | Differences in the profiles of circulating levels of soluble tumor necrosis factor receptors and interleukin 1 receptor antagonist reflect the heterogeneity of the subgroups of juvenile rheumatoid arthritis |
| Q37035014 | Different HLA-D associations in adult and juvenile rheumatoid arthritis |
| Q74249570 | Different circulating lymphocyte profiles in patients with different subtypes of juvenile idiopathic arthritis |
| Q80168047 | Different familial association patterns of autoimmune diseases between juvenile-onset systemic lupus erythematosus and juvenile rheumatoid arthritis |
| Q90859872 | Different phenotypes of the same XIAP mutation in a family: A case of XIAP deficiency with juvenile idiopathic arthritis |
| Q98735553 | Differential Accumulation and Activation of Monocyte and Dendritic Cell Subsets in Inflamed Synovial Fluid Discriminates Between Juvenile Idiopathic Arthritis and Septic Arthritis |
| Q33570753 | Differential Agglutination Titre (D.A.T.) in Juvenile Rheumatoid Arthritis |
| Q54551423 | Differential CCR5Delta32 allelic frequencies in juvenile idiopathic arthritis subtypes: evidence for different regulatory roles of CCR5 in rheumatological diseases. |
| Q45844162 | Differential cytokine profiles in juvenile idiopathic arthritis subtypes revealed by cluster analysis |
| Q40910052 | Differential diagnosis of juvenile rheumatoid arthritis |
| Q71235214 | Differential diagnostic problems in various forms of juvenile rheumatoid arthritis |
| Q41855175 | Differential expression patterns of recombination-activating genes in individual mature B cells in juvenile idiopathic arthritis |
| Q46863207 | Differential monocyte microrna expression profiles in children with active systemic juvenile idiopathic arthritis |
| Q85332809 | Differential plasma microRNAs expression in juvenile idiopathic arthritis |
| Q54442285 | Differential recognition of heat-shock protein dnaJ-derived epitopes by effector and Treg cells leads to modulation of inflammation in juvenile idiopathic arthritis. |
| Q44929941 | Differentiating arthritic from myofascial pain in children with juvenile idiopathic arthritis: preliminary report |
| Q43500394 | Differentiating macrophage activation syndrome in systemic juvenile idiopathic arthritis from other forms of hemophagocytic lymphohistiocytosis |
| Q70637469 | Differentiation of systemic juvenile rheumatoid arthritis from acute leukemia near the onset of disease |
| Q38759376 | Difficult-To-Treat Juvenile Idiopathic Arthritis: Current and Future Options |
| Q84905807 | Difficulties in defining antinuclear antibody-positive patients as a separate category in the classification of juvenile idiopathic arthritis: comment on the article by Ravelli et al |
| Q48280393 | Difficulty in the diagnosis of bone and joint pain associated with pediatric acute leukemia; comparison with juvenile idiopathic arthritis |
| Q40174823 | Diffusion-weighted imaging for assessment of synovial inflammation in juvenile idiopathic arthritis: a promising imaging biomarker as an alternative to gadolinium-based contrast agents |
| Q35937455 | Digital artery thrombosis and vasculitis in juvenile rheumatoid arthritis |
| Q99578916 | Direct Healthcare Costs Associated with Oligoarticular Juvenile Idiopathic Arthritis at a Single Center |
| Q57064315 | Disability and health-related quality of life are associated with restricted social participation in young adults with juvenile idiopathic arthritis |
| Q51895357 | Disability impact on quality of life in Mexican adults with juvenile idiopathic arthritis and juvenile ankylosing spondylitis. |
| Q68967107 | Discoid meniscus presenting as juvenile rheumatoid arthritis |
| Q89731152 | Discontinuation of Canakinumab following Clinical Disease Remission Is Feasible in Patients with Systemic Juvenile Idiopathic Arthritis |
| Q46382871 | Discontinuation of etanercept after clinical remission in patients with juvenile idiopathic arthritis. |
| Q84973425 | Discontinuation of etanercept after successful treatment in patients with juvenile idiopathic arthritis |
| Q39336335 | Discontinuation of long-term adalimumab treatment in patients with juvenile idiopathic arthritis-associated uveitis |
| Q41646822 | Discontinuation of methotrexate treatment in juvenile rheumatoid arthritis |
| Q79747970 | Discordance between physician's and parent's global assessments in juvenile idiopathic arthritis |
| Q74395418 | Discordance between proxy-reported and observed assessment of functional ability of children with juvenile idiopathic arthritis |
| Q87792166 | Discrepancy between clinical and radiological responses to tocilizumab treatment in patients with systemic-onset juvenile idiopathic arthritis |
| Q33397722 | Discrimination of acute lymphoblastic leukemia from systemic-onset juvenile idiopathic arthritis at disease onset |
| Q47340476 | Disease Activity of Juvenile Idiopathic Arthritis during and after Pregnancy: A Prospective Multicenter Study |
| Q67766623 | Disease Experience and Psychosocial Adjustment in Children with Juvenile Rheumatoid Arthritis: Children's Versus Mothers' Reports |
| Q91735497 | Disease activity and damage in juvenile idiopathic arthritis: methotrexate era versus biologic era |
| Q37462544 | Disease activity and disability in children with juvenile idiopathic arthritis one year following presentation to paediatric rheumatology. Results from the Childhood Arthritis Prospective Study |
| Q50026914 | Disease activity and dropout in young persons with juvenile idiopathic arthritis in transition of care: a longitudinal observational study. |
| Q33982847 | Disease activity and fatigue in juvenile idiopathic arthritis |
| Q86409959 | Disease activity score in 28 joints at 3 months after the initiation of biologic agent can be a predictive target for switching to the second biologic agent in patients with polyarticular juvenile idiopathic arthritis |
| Q95512103 | Disease activity, overweight, physical activity and screen time in a cohort of patients with juvenile idiopathic arthritis |
| Q93382967 | Disease activity, treatment and long-term prognosis of adult juvenile idiopathic arthritis patients compared with rheumatoid arthritis patients |
| Q77445714 | Disease and family contributors to adaptation in juvenile rheumatoid arthritis and juvenile diabetes |
| Q46380857 | Disease characteristics and medication use in a multicenter cohort of children with juvenile idiopathic arthritis (JIA): preliminary analyses from the CARRAnet registry |
| Q37621496 | Disease control and health-related quality of life in juvenile idiopathic arthritis |
| Q99568021 | Disease course and obstetric outcomes of pregnancies in juvenile idiopathic arthritis: are there any differences among disease subtypes? A single-centre retrospective study of prospectively followed pregnancies in a dedicated pregnancy clinic |
| Q53417067 | Disease course and outcome of juvenile rheumatoid arthritis in a multicenter cohort. |
| Q53283674 | Disease flare after 7 year-remission of systemic type juvenile idiopathic arthritis: is growth hormone therapy a culprit or innocent bystander? |
| Q38150905 | Disease of the year: juvenile idiopathic arthritis--differential diagnosis |
| Q38177314 | Disease of the year: juvenile idiopathic arthritis-associated uveitis--classification and diagnostic approach |
| Q85895565 | Disease progression into adulthood and predictors of long-term active disease in juvenile idiopathic arthritis |
| Q37518319 | Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept |
| Q35797997 | Disease-Associated Single-Nucleotide Polymorphisms From Noncoding Regions in Juvenile Idiopathic Arthritis Are Located Within or Adjacent to Functional Genomic Elements of Human Neutrophils and CD4+ T Cells |
| Q95412900 | Disease-Modifying Antirheumatic Drugs in Children With Juvenile Idiopathic Arthritis |
| Q37147226 | Disease-modifying antirheumatic drug use in the treatment of juvenile idiopathic arthritis: a cross-sectional analysis of the CARRA Registry |
| Q55513036 | Disease-specific regulation of gene expression in a comparative analysis of juvenile idiopathic arthritis and inflammatory bowel disease. |
| Q86858564 | Disk abnormality coexists with any degree of synovial and osseous abnormality in the temporomandibular joints of children with juvenile idiopathic arthritis |
| Q67360985 | Disorders of sexual development in boys with juvenile rheumatoid arthritis |
| Q40776578 | Disorders of the system of hemostasis in patients with juvenile rheumatoid arthritis and rheumatic fever |
| Q40892182 | Disruption of vascular endothelial homeostasis in systemic juvenile idiopathic arthritis-associated macrophage activation syndrome: The dynamic roles of angiopoietin-1 and -2. |
| Q43666116 | Dissecting popliteal cyst in a child with juvenile rheumatoid arthritis |
| Q41068374 | Dissecting the heterogeneity of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis |
| Q33564375 | Disseminated intravascular coagulation with renal and liver damage as the predominant manifestations of recurrent relapses in systemic juvenile rheumatoid arthritis |
| Q43464840 | Distal interphalangeal joint abnormalities in children with polyarticular juvenile rheumatoid arthritis |
| Q40536133 | Distensibility and pulse wave velocity of the thoracic aorta in patients with juvenile idiopathic arthritis: an MRI study |
| Q43062304 | Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis |
| Q34885098 | Distinct effects of methotrexate and etanercept on the B cell compartment in patients with juvenile idiopathic arthritis |
| Q53589830 | Distinct expression pattern of IFN-alpha and TNF-alpha in juvenile idiopathic arthritis synovial tissue. |
| Q85816760 | Distinct subsets of patients with systemic juvenile idiopathic arthritis based on their cytokine profiles |
| Q49078668 | Distinct synovial immunopathologic characteristics of juvenile-onset spondylarthritis and other forms of juvenile idiopathic arthritis. |
| Q81508879 | Distribution and clinical significance of blood dendritic cells in children with juvenile idiopathic arthritis |
| Q34651122 | Distribution of Borrelia burgdorferi specific antibody among patients with juvenile rheumatoid arthritis in Korea |
| Q33569918 | Distribution of HLA-B27 in patients with juvenile rheumatoid arthritis |
| Q67678880 | Distribution of HLA-B27 in patients with juvenile rheumatoid arthritis |
| Q33636807 | Distribution of circulating cells in systemic juvenile idiopathic arthritis across disease activity states |
| Q87737604 | Distribution pattern of MRI abnormalities within the knee and wrist of juvenile idiopathic arthritis patients: signature of disease activity |
| Q37610438 | Do B cells play a role in the pathogenesis of juvenile idiopathic arthritis? |
| Q50051693 | Do infections trigger juvenile idiopathic arthritis? |
| Q45744118 | Do parent's global rating of well-being and disease activity of children with juvenile idiopathic arthritis yield different information? |
| Q35431243 | Do patients with juvenile idiopathic arthritis in clinical remission have evidence of persistent inflammation on 3T magnetic resonance imaging? |
| Q86914076 | Do patients with juvenile idiopathic arthritis in remission exhibit active synovitis on joint ultrasound? |
| Q50048365 | Do pedometers with or without education on exercise increase functional walking capacity and physical activity level in adolescents with juvenile idiopathic arthritis? |
| Q91206049 | Do we need a new classification of juvenile idiopathic arthritis? |
| Q77567716 | Does breast feeding prevent the development of juvenile rheumatoid arthritis? |
| Q59268816 | Does childhood health assessment questionnaire can predict outcome of patients with juvenile idiopathic arthritis? |
| Q83426574 | Does continued treatment with methotrexate in juvenile idiopathic arthritis in remission prevent flare? |
| Q46584805 | Does early sulfasalazine treatment provide long-term benefits to patients with juvenile idiopathic arthritis? |
| Q45744150 | Does incorporation of aids/devices and help, make a difference in the childhood health assessment questionnaire disability index? Analysis from the printo juvenile idiopathic arthritis database |
| Q46864251 | Does red-man reaction stimulate macrophage activation syndrome in children with systemic juvenile idiopathic arthritis? |
| Q44081178 | Does sport negatively influence joint scores in patients with juvenile rheumatoid arthritis. An 8-year prospective study |
| Q30350880 | Does systemic-onset juvenile idiopathic arthritis belong under juvenile idiopathic arthritis? |
| Q46966610 | Does ultrasound agree with parent's perception of joint disease in juvenile idiopathic arthritis? |
| Q45745843 | Does unity of Familial Mediterranean fever with juvenile idiopathic arthritis affect the outcome? |
| Q36690327 | Dominant T-cell-receptor beta chain variable region V beta 14+ clones in juvenile rheumatoid arthritis |
| Q83494056 | Dominant vertebral artery injury during posterior atlantoaxial transarticular screw fixation in a juvenile rheumatoid arthritis patient with atlantoaxial subluxation |
| Q41933594 | Dosage of Antimalarial Drugs for Children with Juvenile Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Clinical Study with Determination of Serum Concentrations of Chloroquine and Hydroxychloroquine |
| Q67344885 | Dosage of Salicylates for Children with Juvenile Rheumatoid Arthritis:A Preliminary Report |
| Q41043186 | Dosage of salicylates for children with juvenile rheumatoid arthritis. A prospective clinical trial with three different preparations of acetylsalicylic acid |
| Q41765516 | Dosage of salicylates in juvenile rheumatoid arthritis |
| Q44962941 | Dosing celecoxib in pediatric patients with juvenile rheumatoid arthritis |
| Q45908598 | Dosing of biologics in juvenile idiopathic arthritis: is the sky the limit? |
| Q38015291 | Dosing regimen determination for juvenile idiopathic arthritis: a review of studies during drug development |
| Q41914638 | Double-blind evaluation of the therapeutic efficacy of D-penicillamine and hydroxychloroquine in juvenile rheumatoid arthritis |
| Q70387110 | Doubts about Sandro Botticelli's depiction of juvenile rheumatoid arthritis |
| Q59268772 | Down regulation of anti-inflammatory cytokines in ileal mucosa associates with active disease in juvenile idiopathic arthritis |
| Q91899400 | Drug Costs, Effectiveness, and Kids in the Crossfire: Adalimumab in Juvenile Idiopathic Arthritis-Associated Uveitis |
| Q60916566 | Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis |
| Q90348966 | Drug monitoring in long-term treatment with adalimumab for juvenile idiopathic arthritis-associated uveitis |
| Q44063100 | Drug survival and reasons for discontinuation of the first course of biological therapy in 301 juvenile idiopathic arthritis patients. |
| Q81243526 | Drug survival of the first and second course of anti-tumour necrosis factor agents in juvenile idiopathic arthritis |
| Q40903936 | Drug therapy in juvenile rheumatoid arthritis. Experiences with azathioprine |
| Q41926779 | Drug therapy of juvenile chronic polyarthritis |
| Q40417103 | Drug treatment in children with juvenile rheumatoid arthritis. Past, present, and future. |
| Q70365888 | Drug treatment of patients with juvenile rheumatoid arthritis (a review of the literature) |
| Q92319699 | Drug-free inactive disease in juvenile idiopathic arthritis can be achieved for 40% of patients |
| Q73395410 | Drug-induced systemic lupus erythematosus associated with etanercept therapy in a child with juvenile idiopathic arthritis |
| Q46378505 | Durability of response to intra-articular corticosteroid injections with triamcinolone hexacetonide in juvenile idiopathic arthritis. |
| Q45193352 | Duration of etanercept treatment and reasons for discontinuation in a cohort of juvenile idiopathic arthritis patients. |
| Q43053476 | Duration of methotrexate treatment until partial and total remission of refractory juvenile rheumatoid arthritis |
| Q57156953 | Dutch juvenile idiopathic arthritis patients, carers and clinicians create a research agenda together following the James Lind Alliance method: a study protocol |
| Q40336265 | Dynamic contrast-enhanced magnetic resonance imaging can play a role in predicting flare in juvenile idiopathic arthritis |
| Q53062883 | Dynamic contrast-enhanced magnetic resonance imaging in the assessment of disease activity in patients with juvenile idiopathic arthritis. |
| Q37596773 | Dynamic contrast-enhanced magnetic resonance imaging of the wrist in children with juvenile idiopathic arthritis |
| Q35232922 | Dynamic knee joint function in children with juvenile idiopathic arthritis (JIA). |
| Q36203332 | Dynamic tracking of functional gene modules in treated juvenile idiopathic arthritis |
| Q84826668 | Dynamics of body composition and bone in patients with juvenile idiopathic arthritis treated with growth hormone |
| Q92457727 | Dynamics of concomitant therapy in children with juvenile idiopathic arthritis treated with etanercept and methotrexate |
| Q69601426 | Dyslipoproteinemia in juvenile rheumatoid arthritis |
| Q69661077 | Dysphagia and micrognathia in a patient with juvenile rheumatoid arthritis |
| Q72364595 | Dysplasia Epiphysealis Hemimelica: An Unusual Case Combined with Juvenile Rheumatoid Arthritis |
| Q48557360 | EEG findings in juvenile rheumatoid arthritis and other connective tissue diseases in children. |
| Q26798354 | EULAR-PReS points to consider for the use of imaging in the diagnosis and management of juvenile idiopathic arthritis in clinical practice |
| Q98734374 | Early Prediction of Clinical Response to Etanercept Treatment in Juvenile Idiopathic Arthritis Using Machine Learning |
| Q90585226 | Early Self-Reported Pain in Juvenile Idiopathic Arthritis as Related to Long-Term Outcomes: Results From the Nordic Juvenile Idiopathic Arthritis Cohort Study |
| Q64119945 | Early Treatment of Systemic Juvenile Idiopathic Arthritis with Canakinumab and Complete Remission After 2 Years of Treatment Suspension: Case Report of an Adolescent Girl |
| Q52767190 | Early activation of cutaneous vessels and epithelial cells is characteristic of acute systemic onset juvenile idiopathic arthritis. |
| Q86118743 | Early aggressive therapy for patients with juvenile idiopathic arthritis: are we there yet? |
| Q90930679 | Early and Accurate Prediction of Clinical Response to Methotrexate Treatment in Juvenile Idiopathic Arthritis Using Machine Learning |
| Q37602644 | Early changes in gene expression and inflammatory proteins in systemic juvenile idiopathic arthritis patients on canakinumab therapy |
| Q90232769 | Early detection of high disease activity in juvenile idiopathic arthritis by sequential monitoring of patients' health-related quality of life scores |
| Q85219244 | Early detection of temporomandibular joint arthritis in children with juvenile idiopathic arthritis - the role of contrast-enhanced MRI |
| Q84392851 | Early diagnosis for polyarthritis of juvenile idiopathic arthritis using systemic gallium scintigraphy |
| Q37190014 | Early diagnosis of temporomandibular joint involvement in juvenile idiopathic arthritis: a pilot study comparing clinical examination and ultrasound to magnetic resonance imaging. |
| Q81821466 | Early disease course and predictors of disability in juvenile rheumatoid arthritis and juvenile spondyloarthropathy: a 3 year prospective study |
| Q70461334 | Early experiences with auranofin in juvenile rheumatoid arthritis |
| Q33733641 | Early feeding and risk of Juvenile idiopathic arthritis: a case control study in a prospective birth cohort |
| Q84484420 | Early intervention is key in juvenile idiopathic arthritis |
| Q96016465 | Early joint replacement in juvenile idiopathic arthritis (JIA): trend over time and factors influencing implant survival |
| Q38028105 | Early juvenile idiopathic arthritis |
| Q68850222 | Early occurrence of aortic valve regurgitation in a youth with systemic-onset juvenile rheumatoid arthritis |
| Q45171638 | Early onset bilateral anterior uveitis preceding a late manifestation of juvenile idiopathic arthritis: a case report. |
| Q74112036 | Early onset of pulmonary parenchymal disease associated with juvenile rheumatoid arthritis |
| Q35769077 | Early onset pauciarticular arthritis is the major risk factor for naproxen-induced pseudoporphyria in juvenile idiopathic arthritis |
| Q40613096 | Early onset sarcoidosis masquerading as juvenile rheumatoid arthritis |
| Q43099980 | Early outcomes and improvement of patients with juvenile idiopathic arthritis enrolled in a Canadian multicenter inception cohort |
| Q52732724 | Early prediction for over two years efficacy of the first biologic agent for polyarticular juvenile idiopathic arthritis: A multi-institutional study in Japan. |
| Q42695582 | Early predictors of longterm outcome in patients with juvenile rheumatoid arthritis: subset-specific correlations |
| Q35669614 | Early predictors of outcome in juvenile idiopathic arthritis. |
| Q40611992 | Early predictors of poor functional outcome in systemic-onset juvenile rheumatoid arthritis: a multicenter cohort study |
| Q46861783 | Early predictors of prognosis in juvenile idiopathic arthritis patients: a systematic literature review. |
| Q38223059 | Early predictors of prognosis in juvenile idiopathic arthritis: a systematic literature review |
| Q78472114 | Early predictors of severe course of uveitis in oligoarticular juvenile idiopathic arthritis |
| Q46279983 | Early recombinant human growth hormone treatment in glucocorticoid-treated children with juvenile idiopathic arthritis: a 3-year randomized study |
| Q89060251 | Early reduction of serum interleukin-6 levels as a predictor of clinical remission in systemic juvenile idiopathic arthritis |
| Q70947556 | Early synovectomy in juvenile rheumatoid arthritis |
| Q67881137 | Early synovectomy in the treatment of juvenile rheumatoid arthritis |
| Q50199192 | Early treatment with infliximab in patients with juvenile idiopathic arthritis. |
| Q45744238 | Early untreated juvenile idiopathic arthritis: predictors of outcome |
| Q37027911 | Early-onset pauciarticular juvenile rheumatoid arthritis associated with human leukocyte antigen-DRw5, iritis, and antinuclear antibody |
| Q70267529 | Early-onset pauciarticular juvenile rheumatoid arthritis. A histopathologic study |
| Q98781094 | Early-onset subclinical cardiovascular damage assessed by non-invasive methods in children with Juvenile Idiopathic Arthritis: analytical cross-sectional study |
| Q71281679 | Echocardiographic detection of early cardiac involvement in juvenile rheumatoid arthritis |
| Q100506508 | Economic Burden of Juvenile Idiopathic Arthritis in India |
| Q36056815 | Economic impact of juvenile idiopathic arthritis and familial Mediterranean fever |
| Q50179312 | Economic impact of juvenile idiopathic arthritis. |
| Q88470868 | Editorial: Caught in the Act: Dissecting Natural Killer Cell Function in Systemic Juvenile Idiopathic Arthritis |
| Q68935970 | Editorial: Corticosteroids in juvenile rheumatoid arthritis (Still's disease) |
| Q88144330 | Editorial: Toward Personalized Treatment for Systemic Juvenile Idiopathic Arthritis |
| Q42924167 | Editorial: interferon-γ: friend or foe in systemic juvenile idiopathic arthritis and adult-onset Still's Disease? |
| Q33716815 | Education and employment in patients with juvenile idiopathic arthritis - a standardized comparison to the German general population |
| Q68388123 | Educational and behavioral strategies for improving medication compliance in juvenile rheumatoid arthritis |
| Q60706085 | Educational and occupational outcomes among young adults with juvenile idiopathic arthritis |
| Q53763871 | Effect of Electromyographic Biofeedback Training on Pain, Quadriceps Muscle Strength, and Functional Ability in Juvenile Rheumatoid Arthritis. |
| Q74631174 | Effect of IL-6 on IGF binding protein-3: a study in IL-6 transgenic mice and in patients with systemic juvenile idiopathic arthritis |
| Q53489687 | Effect of Intraarticular Corticosteroid Foot Injections on Walking Function in Children With Juvenile Idiopathic Arthritis. |
| Q91579707 | Effect of Janus Kinase Inhibitor Treatment on Anterior Uveitis and Associated Macular Edema in an Adult Patient with Juvenile Idiopathic Arthritis |
| Q49104112 | Effect of age on prevalence of anticitrullinated protein/peptide antibodies in polyarticular juvenile idiopathic arthritis. |
| Q40827471 | Effect of aspirin on renal and hepatic function in children suffering from juvenile rheumatoid arthritis and rheumatic fever |
| Q43758730 | Effect of biologic treatments on growth in children with juvenile idiopathic arthritis. |
| Q33991868 | Effect of body composition on bone mineral density in Moroccan patients with juvenile idiopathic arthritis |
| Q40166046 | Effect of etanercept on refractory systemic-onset juvenile idiopathic arthritis |
| Q36411261 | Effect of inflammatory activity and glucocorticoid [corrected] use on nutritional variables in patients with juvenile idiopathic arthritis. |
| Q97586848 | Effect of intra-articular corticosteroid injections on pain and mouth opening in juvenile idiopathic arthritis with temporomandibular involvement: A systematic review and meta-analysis |
| Q45013269 | Effect of joint injections in children with juvenile idiopathic arthritis: evaluation by 3D-gait analysis |
| Q73994146 | Effect of methotrexate on the temporomandibular joint and facial morphology in juvenile rheumatoid arthritis patients |
| Q36953886 | Effect of miR-19a and miR-21 on the JAK/STAT signaling pathway in the peripheral blood mononuclear cells of patients with systemic juvenile idiopathic arthritis |
| Q53106094 | Effect of musculoskeletal pain on sexuality of male adolescents and adults with juvenile idiopathic arthritis. |
| Q49250110 | Effect of nationwide selenium supplementation in Finland on selenium status in children with juvenile rheumatoid arthritis. A ten-year follow-up study. |
| Q33569808 | Effect of penicillamine treatment on immune complexes in two cases of seropositive juvenile rheumatoid arthritis |
| Q46510745 | Effect of physical therapy on static postural balance, lower extremity muscle strength and funtional status in children with juvenile idiopathic arthritis |
| Q33468052 | Effect of probiotics on clinical and immune parameters in enthesitis-related arthritis category of juvenile idiopathic arthritis |
| Q42844555 | Effect of recombinant human tumor necrosis factor receptor type II-Fc fusion protein antibody on cytokines and bone metabolism in patients with juvenile idiopathic arthritis |
| Q86981764 | Effect of strengthening versus balance-proprioceptive exercises on lower extremity function in patients with juvenile idiopathic arthritis: a randomized, single-blind clinical trial |
| Q90965619 | Effect of the Inclusion of the Metacarpophalangeal Joints on the Wrist Magnetic Resonance Imaging Scoring System in Juvenile Idiopathic Arthritis |
| Q54571820 | Effect of tocilizumab on growth impairment in systemic juvenile idiopathic arthritis with long-term corticosteroid therapy. |
| Q45241043 | Effect of wrist involvement on median nerve electrophysiology in juvenile idiopathic arthritis |
| Q74796221 | Effect on lung function of methotrexate and non-steroid anti-inflammatory drugs in children with juvenile rheumatoid arthritis |
| Q30421442 | Effective seroconversion and safety following the pandemic influenza vaccination (anti-H1N1) in patients with juvenile idiopathic arthritis |
| Q40524401 | Effective use of the recombinant interleukin 1 receptor antagonist anakinra in therapy resistant systemic onset juvenile rheumatoid arthritis. |
| Q31032345 | Effectiveness and long-term retention of anti-tumour necrosis factor treatment in juvenile and adult patients with juvenile idiopathic arthritis: data from Reuma.pt. |
| Q37356217 | Effectiveness and safety of TNF inhibitors in adults with juvenile idiopathic arthritis |
| Q47580938 | Effectiveness and safety of a second and third biological agent after failing etanercept in juvenile idiopathic arthritis: results from the Dutch National ABC Register |
| Q43699310 | Effectiveness and side-effects of long-term treatment with glucocorticoids in patients with juvenile rheumatoid arthritis |
| Q33946842 | Effectiveness and toxicity of methotrexate in juvenile idiopathic arthritis: comparison of 2 initial dosing regimens. |
| Q42410308 | Effectiveness of a once weekly double dose of etanercept in patients with juvenile idiopathic arthritis: a clinical study |
| Q46861203 | Effectiveness of adalimumab in the treatment of juvenile idiopathic arthritis associated with uveitis |
| Q35476683 | Effectiveness of dexamethasone iontophoresis for temporomandibular joint involvement in juvenile idiopathic arthritis. |
| Q51740150 | Effectiveness of first-line treatment with recombinant interleukin-1 receptor antagonist in steroid-naive patients with new-onset systemic juvenile idiopathic arthritis: results of a prospective cohort study. |
| Q37753591 | Effectiveness of leflunomide in patients with juvenile idiopathic arthritis in clinical practice |
| Q88324024 | Effectiveness of preformed foot orthoses in reducing lower limb pain, swollen and tender joints and in improving quality of life and gait parameters in children with juvenile idiopathic arthritis: a randomised controlled trial (Protocol) |
| Q40601096 | Effectiveness of systemic immunoglobulins in the treatment of the systemic variants of juvenile rheumatoid arthritis |
| Q46974259 | Effectiveness of tnf inhibitors therapy in children with juvenile idiopathic arthritis aged 2 to 5 years |
| Q46364772 | Effects of Combined Resistive Underwater Exercises and Interferential Current Therapy in Patients with Juvenile Idiopathic Arthritis: A Randomized Controlled Trial |
| Q39395514 | Effects of Pilates exercises on health-related quality of life in individuals with juvenile idiopathic arthritis |
| Q90583755 | Effects of Structured Exercise Training in Children and Adolescents With Juvenile Idiopathic Arthritis |
| Q92594437 | Effects of Structured Exercise Training in Children and Adolescents With Juvenile Idiopathic Arthritis: Erratum |
| Q57175739 | Effects of Video Games-Based Task-Oriented Activity Training (Xbox 360 KinectTM) on Activity Performance and Participation in Patients with Juvenile Idiopathic Arthritis: A Randomized Clinical Trial |
| Q36157101 | Effects of acute exercise on circulating endothelial and progenitor cells in children and adolescents with juvenile idiopathic arthritis and healthy controls: a pilot study |
| Q80707203 | Effects of adherence to treatment on short-term outcomes in children with juvenile idiopathic arthritis |
| Q42967348 | Effects of anti-TNF therapy on glucose metabolism in patients with ankylosing spondylitis, psoriatic arthritis or juvenile idiopathic arthritis |
| Q46863310 | Effects of antirheumatic treatment with tocilizumab on longitudinal growth in children with juvenile idiopathic arthritis |
| Q37639030 | Effects of growth hormone treatment in juvenile idiopathic arthritis: bone and body composition |
| Q37639028 | Effects of growth hormone treatment on growth in children with juvenile idiopathic arthritis |
| Q80686453 | Effects of infliximab on cytokines, myeloperoxidase, and soluble adhesion molecules in patients with juvenile idiopathic arthritis |
| Q39413365 | Effects of intranasal salmon calcitonin in juvenile idiopathic arthritis: an observational study |
| Q34127601 | Effects of juvenile idiopathic arthritis on kinematics and kinetics of the lower extremities call for consequences in physical activities recommendations |
| Q84613546 | Effects of long-term etanercept treatment on growth in children with selected categories of juvenile idiopathic arthritis |
| Q72547353 | Effects of methotrexate on radiologic progression in juvenile rheumatoid arthritis |
| Q104569937 | Effects of motion correction, sampling rate and parametric modelling in dynamic contrast enhanced MRI of the temporomandibular joint in children affected with juvenile idiopathic arthritis |
| Q71608951 | Effects of polyarticular and pauciarticular onset juvenile rheumatoid arthritis on facial and mandibular growth |
| Q40022166 | Effects of serial casting in the treatment of flexion contractures of proximal interphalangeal joints in patients with rheumatoid arthritis and juvenile idiopathic arthritis: A retrospective study |
| Q51005074 | Effects of systemic onset juvenile rheumatoid arthritis on facial morphology and temporomandibular joint form and function. |
| Q38449764 | Effects of the live attenuated measles-mumps-rubella booster vaccination on disease activity in patients with juvenile idiopathic arthritis: a randomized trial |
| Q39170493 | Effects of the use of growth hormone in children and adolescents with juvenile idiopathic arthritis: a systematic review |
| Q53963792 | Effects of the use of growth hormone in children and adolescents with juvenile idiopathic arthritis: a systematic review. |
| Q44694450 | Effects on growth and body composition of growth hormone treatment in children with juvenile idiopathic arthritis requiring steroid therapy. |
| Q93184213 | Effects on the Facial Growth of Rapid Palatal Expansion in Growing Patients Affected by Juvenile Idiopathic Arthritis with Monolateral Involvement of the Temporomandibular Joints: A Case-Control Study on Posteroanterior and Lateral Cephalograms |
| Q99576761 | Efficacy and Safety of Tocilizumab for Polyarticular-Course Juvenile Idiopathic Arthritis in the Open-Label 2-Year Extension of a Phase 3 Trial |
| Q64072177 | Efficacy and cost savings with the use of a minimal sedation / anxiolysis protocol for intra-articular corticosteroid injections in children with juvenile idiopathic arthritis: a retrospective review of prospectively collected data |
| Q46272864 | Efficacy and safety of Etanercept therapy in juvenile idiopathic arthritis |
| Q38236298 | Efficacy and safety of TNF-alpha antagonists in children with juvenile idiopathic arthritis who started treatment under 4 years of age. |
| Q46974137 | Efficacy and safety of TNF-alpha antagonists in children with juvenile idiopathic arthritis who started treatment under 4 years of age. |
| Q88106792 | Efficacy and safety of adalimumab as the first and second biologic agent in juvenile idiopathic arthritis: the German Biologics JIA Registry |
| Q26775512 | Efficacy and safety of biological agents for systemic juvenile idiopathic arthritis: a systematic review and meta-analysis of randomized trials |
| Q52658156 | Efficacy and safety of canakinumab in patients with Still's disease: exposure-response analysis of pooled systemic juvenile idiopathic arthritis data by age groups. |
| Q96582504 | Efficacy and safety of canakinumab in systemic juvenile idiopathic arthritis: 48-week results from an open-label Phase III study in Japanese patients |
| Q59270117 | Efficacy and safety of canakinumab, a long acting fully human anti-Interleukin-1β antibody, in systemic juvenile idiopathic arthritis with active systemic features: results from a phase III study |
| Q41311218 | Efficacy and safety of etanercept in patients with the enthesitis-related arthritis category of juvenile idiopathic arthritis: results from a phase III randomized, double-blind study |
| Q100393520 | Efficacy and safety of intraarticular corticosteroid injections in adolescents with juvenile idiopathic arthritis in the temporomandibular joint: a Norwegian 2-year prospective multicenter pilot study |
| Q74255236 | Efficacy and safety of methotrexate therapy for juvenile rheumatoid arthritis |
| Q33659233 | Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER study |
| Q40038082 | Efficacy and safety of oral and parenteral methotrexate therapy in children with juvenile idiopathic arthritis: an observational study with patients from the German Methotrexate Registry |
| Q83559383 | Efficacy and safety of repeat courses of rituximab treatment in patients with severe refractory juvenile idiopathic arthritis |
| Q55076209 | Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (SJIA): tender 52-week data. |
| Q46378819 | Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (sJIA): TENDER 52-week data. |
| Q92268032 | Efficacy and safety of tocilizumab in a real-life observational cohort of patients with polyarticular juvenile idiopathic arthritis |
| Q46869092 | Efficacy and safety of tocilizumab in european children with systemic onset juvenile idiopathic arthritis |
| Q35605487 | Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial |
| Q34764081 | Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial |
| Q70514573 | Efficacy of Synovectomy in Juvenile Rheumatoid Arthritis |
| Q48379640 | Efficacy of a land-based home exercise programme for patients with juvenile idiopathic arthritis: a randomized, controlled, single-blind study. |
| Q45745730 | Efficacy of a second TNF blocker, when the first one failed, in patients with juvenile idiopathic arthritis (JIA). |
| Q59268728 | Efficacy of abatacept in juvenile idiopathic arthritis related uveitis |
| Q59268683 | Efficacy of adalimumab in refractory juvenile idiopathic arthritis related uveitis: report of 6 cases |
| Q33712570 | Efficacy of adalimumab in young children with juvenile idiopathic arthritis and chronic uveitis: a case series |
| Q30240218 | Efficacy of biologic therapy across individual juvenile idiopathic arthritis subtypes: A systematic review |
| Q38061615 | Efficacy of biological agents in juvenile idiopathic arthritis: a systematic review using indirect comparisons |
| Q46118856 | Efficacy of custom foot orthotics in improving pain and functional status in children with juvenile idiopathic arthritis: a randomized trial. |
| Q44912283 | Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type |
| Q73140806 | Efficacy of folinic acid in reducing methotrexate toxicity in juvenile idiopathic arthritis |
| Q88297363 | Efficacy of high-dose methylprednisolone pulses in a child with noninfectious persistent pleuropericarditis revealing systemic juvenile idiopathic arthritis |
| Q51960019 | Efficacy of measles, mumps and rubella revaccination in children with juvenile idiopathic arthritis treated with methotrexate and etanercept. |
| Q46381208 | Efficacy of non-steroidal anti-inflammatory drug monotherapy in children with systemic juvenile idiopathic arthritis |
| Q45746002 | Efficacy of oral versus subcutaneous methotrexate in children with juvenile idiopathic arthritis |
| Q45282294 | Efficacy of rapamycin in patient with juvenile rheumatoid arthritis |
| Q48714958 | Efficacy of recombinant human growth hormone in children with juvenile rheumatoid arthritis and growth failure. |
| Q81364804 | Efficacy of repeated intravenous infusions of an anti-tumor necrosis factor alpha monoclonal antibody, infliximab, in persistently active, refractory juvenile idiopathic arthritis: results of an open-label prospective study |
| Q80812264 | Efficacy of thalidomide in systemic onset juvenile rheumatoid arthritis |
| Q36420780 | Efficacy, pharmacokinetics, and safety of adalimumab in pediatric patients with juvenile idiopathic arthritis in Japan. |
| Q45745534 | Efficacy, safety and effect on gene expression profiling of anakinra in systemic-onset juvenile idiopathic arthritis: final results of a randomised, double-blind, placebo-controlled trial (ANAJIS). |
| Q34646212 | Efficacy, safety and tolerability of tocilizumab in patients with systemic juvenile idiopathic arthritis |
| Q55461419 | Eight years of experience with biological treatment in juvenile idiopathic arthritis. |
| Q43200876 | Eisenmenger syndrome and juvenile rheumatoid arthritis--a case of double diagnosis. |
| Q67873215 | Elaboration of diagnostic criteria for juvenile rheumatoid arthritis |
| Q66983402 | Elaboration of the criteria for the early diagnosis of juvenile rheumatoid arthritis (JRA) |
| Q51322120 | Elbow monoarthritis: an atypical onset of juvenile idiopathic arthritis. |
| Q39393144 | Elbow synovectomy on patients with juvenile rheumatoid arthritis |
| Q72898966 | Electrocardiographic findings in juvenile rheumatoid arthritis. A study of 116 cases |
| Q51306529 | Electronically monitored adherence to medications by newly diagnosed patients with juvenile rheumatoid arthritis. |
| Q40669876 | Electrophoretic Mobility of Lymphocyte Populations in Juvenile Rheumatoid Arthritis |
| Q46511708 | Elevated BAFF (BLyS) and APRIL in Juvenile idiopathic arthritis patients: relation to clinical manifestations and disease activity. |
| Q35209487 | Elevated IgG autoantibody production in oligoarticular juvenile idiopathic arthritis may predict a refractory course |
| Q40255552 | Elevated S100A8/A9 and S100A12 Serum Levels Reflect Intraocular Inflammation in Juvenile Idiopathic Arthritis-Associated Uveitis: Results From a Pilot Study |
| Q71514159 | Elevated circulating interleukin-7 levels in patients with systemic juvenile rheumatoid arthritis |
| Q51705351 | Elevated circulating levels of interferon-γ and interferon-γ-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. |
| Q81922694 | Elevated concentrations of monocyte derived cytokines in synovial fluid of children with enthesitis related arthritis and polyarticular types of juvenile idiopathic arthritis |
| Q54289137 | Elevated intraocular pressure in uveitis associated with juvenile idiopathic arthritis-associated uveitis, often detected after achieving inactivity. |
| Q33903368 | Elevated laser flare values correlate with complicated course of anterior uveitis in patients with juvenile idiopathic arthritis |
| Q82055314 | Elevated production of galectin-3 is correlated with juvenile idiopathic arthritis disease activity, severity, and progression |
| Q36726316 | Elevated serum levels of soluble CD154 in children with juvenile idiopathic arthritis |
| Q71514156 | Elevated serum prolactin levels in children with juvenile rheumatoid arthritis and antinuclear antibody seropositivity |
| Q80805406 | Elevated serum receptor activator of NFkappaB ligand (RANKL), osteoprotegerin (OPG), matrix metalloproteinase (MMP)3, and ProMMP1 in patients with juvenile idiopathic arthritis |
| Q46149920 | Elevated serum resistin in juvenile idiopathic arthritis: relation to categories and disease activity. |
| Q70766600 | Elevated soluble CD8 antigen and soluble interleukin-2 receptors in the sera of patients with juvenile rheumatoid arthritis |
| Q73437503 | Elevated vitreous concentration of monoclonal immunoglobulin manifesting as schlieren in juvenile rheumatoid arthritis-associated uveitis |
| Q85157923 | Emergence of Crohn's disease in juvenile idiopathic arthritis during treatment with etanercept: a causal link or a mere coincidence? |
| Q37870209 | Emerging drugs to treat juvenile idiopathic arthritis |
| Q46379204 | Emotion regulation predicts pain and functioning in children with juvenile idiopathic arthritis |
| Q35687902 | Emotion regulation predicts pain and functioning in children with juvenile idiopathic arthritis: an electronic diary study |
| Q64112486 | Empowering Young People Living With Juvenile Idiopathic Arthritis to Better Communicate With Families and Care Teams: Content Analysis of Semistructured Interviews |
| Q67016138 | Endogenous uveitis in juvenile rheumatoid arthritis |
| Q68267981 | Endomyocardial fibrosis in a white girl with sero-positive juvenile rheumatoid arthritis |
| Q80983998 | Endonasal endoscopic resection of the odontoid process in a nonachondroplastic dwarf with juvenile rheumatoid arthritis: feasibility of the approach and utility of the intraoperative Iso-C three-dimensional navigation. Case report |
| Q95559007 | Endothelial function, arterial wall mechanics and intima media thickness in juvenile idiopathic arthritis |
| Q35108691 | Endothelial progenitor cell levels in juvenile idiopathic arthritis patients: effects of anti-inflammatory therapies. |
| Q72296630 | Enhanced synthesis of cysteinyl leukotrienes in juvenile rheumatoid arthritis |
| Q90214811 | Enrollment Completed for Largest New Onset Cohort Study in Juvenile Idiopathic Arthritis (JIA) History |
| Q35176849 | Enthesitis as a component of dactylitis in psoriatic juvenile idiopathic arthritis: histology of an established clinical entity |
| Q91674456 | Enthesitis-Related Juvenile Idiopathic Arthritis |
| Q36442308 | Enthesitis-related arthritis is associated with higher pain intensity and poorer health status in comparison with other categories of juvenile idiopathic arthritis: the Childhood Arthritis and Rheumatology Research Alliance Registry |
| Q92827646 | Enthesitis-related arthritis is the most common category of juvenile idiopathic arthritis in Taiwan and presents persistent active disease |
| Q40261974 | Environmental Risk Factors and Early-Life Exposures in Juvenile Idiopathic Arthritis: A Case-Control Study |
| Q37637303 | Environmental factors and the geoepidemiology of juvenile idiopathic arthritis |
| Q68294590 | Enzyme linked (ELISA) immunoabsorbent assay for the detection of hidden 19S IgM rheumatoid factors in juvenile rheumatoid arthritis |
| Q33569436 | Eosinophil-specific and other granulocyte-specific antinuclear antibodies in juvenile chronic polyarthritis and adult rheumatoid arthritis |
| Q36675632 | Epidemiology and risk of juvenile idiopathic arthritis among children with allergic diseases: a nationwide population-based study |
| Q53253199 | Epidemiology of juvenile idiopathic arthritis in Alsace, France. |
| Q35908108 | Epidemiology of juvenile idiopathic arthritis in Oman |
| Q45105080 | Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort: ethnicity as a risk factor |
| Q50597461 | Epidemiology of juvenile rheumatoid arthritis in Manitoba, Canada, 1975-92: cycles in incidence. |
| Q83931115 | Epidemiology of juvenile rheumatoid arthritis in the Americas: an update |
| Q50794887 | Epidemiology of rheumatoid arthritis, juvenile idiopathic arthritis and gout in two regions of the Czech Republic in a descriptive population-based survey in 2002-2003. |
| Q44927484 | Epidemiology of uveitis in juvenile idiopathic arthritis from a national paediatric rheumatologic and ophthalmologic database |
| Q41742958 | Epistasis amongst PTPN2 and genes of the vitamin D pathway contributes to risk of juvenile idiopathic arthritis |
| Q45411736 | Epstein-Barr virus associated Hodgkin lymphoma in a 9-year-old girl receiving long-term methotrexate therapy for juvenile idiopathic arthritis |
| Q45744244 | Epstein-Barr virus-associated Hodgkin's lymphoma and legionella pneumophila infection complicating treatment of juvenile rheumatoid arthritis with methotrexate and cyclosporine A. |
| Q69091055 | Epurox in the treatment of juvenile rheumatoid arthritis |
| Q90146467 | Erratum - Salonen PH, Säilä H, Salonen JH, Linna M, Helminen M, Kauppi MJ: Pneumonia in children with juvenile idiopathic arthritis in Finland 1999-2014: a nationwide retrospective register linkage study". Clin Exp Rheumatol 2018; 36: 502-7 |
| Q50075777 | Erratum to "Effects of the use of growth hormone in children, adolescents with juvenile idiopathic arthritis: a systematic review" (Rev Bras Reumatol. 2017;57(2):100-106). |
| Q61911610 | Erratum to: MRI of the wrist in juvenile idiopathic arthritis: proposal of a paediatric synovitis score by a consensus of an international working group. Results of a multicentre reliability study |
| Q69587536 | Errors in diagnosis of juvenile rheumatoid arthritis |
| Q89617324 | Eruptive collagenomas associated with adalimumab treatment of juvenile rheumatoid arthritis |
| Q72793063 | Erythrocyte C3b Receptors in Juvenile Rheumatoid Arthritis |
| Q86104958 | Erythrocyte sedimentation rate as baseline predictor for the development of uveitis in children with juvenile idiopathic arthritis |
| Q67373887 | Erythroid aplasia in juvenile rheumatoid arthritis |
| Q91633732 | Establishing an Updated Core Domain Set for Studies in Juvenile Idiopathic Arthritis: A Report from the OMERACT 2018 JIA Workshop |
| Q40443767 | Establishing clinical meaning and defining important differences for Patient-Reported Outcomes Measurement Information System (PROMIS®) measures in juvenile idiopathic arthritis using standard setting with patients, parents, and providers. |
| Q41926521 | Estimates of the discriminant ability of definitions of improvement for juvenile rheumatoid arthritis. |
| Q77761545 | Estimation of anticardiolipin antibodies, anti-beta2 glycoprotein I antibodies and lupus anticoagulant in a prospective longitudinal study of children with juvenile idiopathic arthritis |
| Q68044877 | Estimation of bone mineral density in children with juvenile rheumatoid arthritis |
| Q38144094 | Etanercept (Enbrel) in the treatment of juvenile idiopathic arthritis |
| Q54040106 | Etanercept and urticaria in patients with juvenile idiopathic arthritis. |
| Q64978316 | Etanercept and uveitis in patients with juvenile idiopathic arthritis. |
| Q58554426 | Etanercept concentration and immunogenicity do not influence the response to Etanercept in patients with juvenile idiopathic arthritis |
| Q45746075 | Etanercept discontinuation in a cohort of juvenile idiopathic arthritis patients: etanercept inefficacy but not intolerance is associated with oral corticosteroid use. |
| Q80939248 | Etanercept does not essentially increase the total costs of the treatment of refractory juvenile idiopathic arthritis |
| Q73814236 | Etanercept improves active polyarticular juvenile rheumatoid arthritis |
| Q51699807 | Etanercept improves linear growth and bone mass acquisition in MTX-resistant polyarticular-course juvenile idiopathic arthritis. |
| Q86520150 | Etanercept improves lipid profile and oxidative stress measures in patients with juvenile idiopathic arthritis |
| Q73548256 | Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group |
| Q53977013 | Etanercept in four children with therapy-resistant systemic juvenile idiopathic arthritis. |
| Q59268718 | Etanercept in juvenile idiopathic arthritis: Who will benefit? |
| Q34219081 | Etanercept in juvenile rheumatoid arthritis |
| Q40571601 | Etanercept in systemic juvenile idiopathic arthritis |
| Q42596877 | Etanercept in the treatment of disease-modifying anti-rheumatic drug (DMARD)-refractory polyarticular course juvenile idiopathic arthritis: experience from Japanese clinical trials |
| Q54421616 | Etanercept reduces matrix metalloproteinase-9 level in children with polyarticular juvenile idiopathic arthritis and TNF-alpha-308GG genotype. |
| Q47676888 | Etanercept therapy in children with juvenile rheumatoid arthritis |
| Q40326459 | Etanercept treatment for children with refractory juvenile idiopathic arthritis. |
| Q64282281 | Etanercept treatment for extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis, or psoriatic arthritis: 6-year efficacy and safety data from an open-label trial |
| Q60746326 | Etanercept treatment improves longitudinal growth in prepubertal children with juvenile idiopathic arthritis |
| Q36771435 | Etanercept treatment in juvenile idiopathic arthritis: the Polish registry |
| Q46469878 | Etanercept treatment in patients with refractory systemic onset juvenile rheumatoid arthritis. |
| Q34991484 | Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis |
| Q67666738 | Etiopathogenesis, clinical aspects and diagnosis of juvenile rheumatoid arthritis |
| Q44576918 | Evaluation and management of pain in children with juvenile rheumatoid arthritis |
| Q84413776 | Evaluation of 21-numbered circle and 10-centimeter horizontal line visual analog scales for physician and parent subjective ratings in juvenile idiopathic arthritis |
| Q38654895 | Evaluation of Fitness and the Balance Levels of Children with a Diagnosis of Juvenile Idiopathic Arthritis: A Pilot Study. |
| Q77411951 | Evaluation of ILAR classification criteria for juvenile idiopathic arthritis in Spanish children |
| Q98772519 | Evaluation of Periarticular Soft Tissues in Patients With Juvenile Idiopathic Arthritis by Superb Microvascular Imaging and Shear Wave Elastography |
| Q57538152 | Evaluation of Static and Dynamic Postural Balance in Children With Juvenile Idiopathic Arthritis |
| Q67903155 | Evaluation of a psychological treatment package for treating pain in juvenile rheumatoid arthritis |
| Q46966768 | Evaluation of an nhs juvenile idiopathic arthritis (JIA) treatment pathway compared to published international recommendations |
| Q37152926 | Evaluation of anti-citrullinated type II collagen and anti-citrullinated vimentin antibodies in patients with juvenile idiopathic arthritis |
| Q87348778 | Evaluation of anti-cyclic citrullinated peptide antibodies may be beneficial in RF-negative juvenile idiopathic arthritis patients |
| Q51013205 | Evaluation of associations between breast feeding and subsequent development of juvenile rheumatoid arthritis. |
| Q40695826 | Evaluation of bone mass in children and young adults with juvenile idiopathic arthritis. |
| Q36071972 | Evaluation of children with juvenile idiopathic arthritis in southeastern Turkey: a single center experience. |
| Q101044289 | Evaluation of cognitive function in adult patients with juvenile idiopathic arthritis |
| Q71251506 | Evaluation of disease activity by laboratory tests in juvenile rheumatoid arthritis |
| Q90909900 | Evaluation of disease activity in a low-income juvenile idiopathic arthritis cohort |
| Q100522056 | Evaluation of enthesitis in patients with juvenile idiopathic arthritis by power color and spectral Doppler ultrasonography |
| Q44334734 | Evaluation of eutectic lidocaine/prilocaine cream (EMLA) for steroid joint injection in children with juvenile rheumatoid arthritis: a double blind, randomized, placebo controlled trial. |
| Q88505651 | Evaluation of facial asymmetry in patients with juvenile idiopathic arthritis: Correlation between hard tissue and soft tissue landmarks |
| Q72193845 | Evaluation of growth hormone secretion in children with juvenile rheumatoid arthritis and short stature |
| Q40325802 | Evaluation of immune response to hepatitis A vaccination and vaccine safety in juvenile idiopathic arthritis |
| Q36551787 | Evaluation of macrophage activation syndrome associated with systemic juvenile idiopathic arthritis: single center experience over a one-year period. |
| Q91747970 | Evaluation of ocular surface and meibomian glands in patients with uveitis related to oligoarticular juvenile idiopathic arthritis |
| Q91255035 | Evaluation of plasma microRNA expressions in patients with juvenile idiopathic arthritis |
| Q51718538 | Evaluation of psychological stress in primary caregivers of patients with juvenile idiopathic arthritis. |
| Q81463267 | Evaluation of revised International League of Associations for Rheumatology classification criteria for juvenile idiopathic arthritis in Spanish children (Edmonton 2001) |
| Q91846998 | Evaluation of screening for coeliac disease in children with juvenile idiopathic arthritis |
| Q46946151 | Evaluation of synovial inflammation in juvenile idiopathic arthritis by power color Doppler and Spectral Doppler ultrasonography. |
| Q77170157 | Evaluation of the ILAR criteria for juvenile idiopathic arthritis |
| Q57593517 | Evaluation of the Mean Platelet Volume in Children with Juvenile Idiopathic Arthritis |
| Q43498434 | Evaluation of the activity of juvenile rheumatoid arthritis (proceedings) |
| Q48246503 | Evaluation of the association between Hispanic ethnicity and disease activity and severity in a large cohort of patients with juvenile idiopathic arthritis. |
| Q95622256 | Evaluation of the benefits of sequential addition of leflunomide in patients with polyarticular course juvenile idiopathic arthritis failing standard dose methotrexate |
| Q83049542 | Evaluation of the comparative efficacy and tolerability of rofecoxib and naproxen in children and adolescents with juvenile rheumatoid arthritis: a 12-week randomized controlled clinical trial with a 52-week open-label extension |
| Q46963298 | Evaluation of the disease course of Italian children with juvenile idiopathic arthritis treated with etanercept: preliminary results in 772 patients |
| Q45745820 | Evaluation of the power of six clustering features in identifying a homogeneous disease subset in juvenile idiopathic arthritis (JIA). |
| Q31140276 | Evaluation of the presentation of systemic onset juvenile rheumatoid arthritis: data from the Pennsylvania Systemic Onset Juvenile Arthritis Registry (PASOJAR). |
| Q37966486 | Evidence and consensus based GKJR guidelines for the treatment of juvenile idiopathic arthritis |
| Q91413683 | Evidence for M2 macrophage activation in patients with enthesitis-related arthritis category of juvenile idiopathic arthritis |
| Q39384442 | Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic Arthritis |
| Q38623183 | Evidence for Updating the Core Domain Set of Outcome Measures for Juvenile Idiopathic Arthritis: Report from a Special Interest Group at OMERACT 2016. |
| Q73566316 | Evidence for activation of the alternate complement pathway in patients with juvenile rheumatoid arthritis |
| Q57538283 | Evidence for association of autoimmune genes with disabilty in juvenile idiopathic arthritis in a UK cohort |
| Q35605713 | Evidence for chronic, peripheral activation of neutrophils in polyarticular juvenile rheumatoid arthritis |
| Q70069444 | Evidence for intravascular coagulation in systemic onset, but not polyarticular, juvenile rheumatoid arthritis |
| Q39654023 | Evidence implicating infectious agents in rheumatoid arthritis and juvenile rheumatoid arthritis. |
| Q41431481 | Evidence of cellular immune response to outer membrane protein of Salmonella typhimurium in patients with enthesitis-related arthritis subtype of juvenile idiopathic arthritis |
| Q54291121 | Evidence of clonotypic pattern of T-cell repertoire in synovial fluid of children with juvenile rheumatoid arthritis at the onset of the disease. |
| Q21245434 | Evidence of fibrinogen as a target of citrullination in IgM rheumatoid factor-positive polyarticular juvenile idiopathic arthritis |
| Q46381058 | Evidence of fibrinogen as a target of citrullination in IgM rheumatoid factor-positive polyarticular juvenile idiopathic arthritis. |
| Q83549674 | Evidence of the transient nature of the Th17 phenotype of CD4+CD161+ T cells in the synovial fluid of patients with juvenile idiopathic arthritis |
| Q33432498 | Evidence-based outcomes of studies addressing diagnostic accuracy of MRI of juvenile idiopathic arthritis |
| Q37956187 | Evidence-based, interdisciplinary guidelines for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis |
| Q73521083 | Evolution of the T cell receptor beta repertoire from synovial fluid T cells of patients with juvenile onset rheumatoid arthritis |
| Q51163579 | Evolving spectrum of LRBA deficiency-associated chronic arthritis: is there a causative role in juvenile idiopathic arthritis? |
| Q73373344 | Ex vivo apoptosis, CD95 and CD28 expression in T cells of children with juvenile idiopathic arthritis |
| Q39025153 | Excellent balance skills despite active and inactive juvenile idiopathic arthritis - unexpected results of a cross-sectional study |
| Q38465129 | Excess of adiposity in female children and adolescents with juvenile idiopathic arthritis |
| Q68208100 | Exercise Response in Children with and without Juvenile Rheumatoid Arthritis: A Case-Comparison Study |
| Q38654117 | Exercise Therapy in Juvenile Idiopathic Arthritis: A Systematic Review and Meta-Analysis. |
| Q43050239 | Exercise in juvenile idiopathic arthritis: promise or passé. |
| Q24244054 | Exercise therapy for treating juvenile idiopathic arthritis |
| Q24242979 | Exercise therapy in juvenile idiopathic arthritis |
| Q37258184 | Exercise therapy in juvenile idiopathic arthritis: a Cochrane Review. |
| Q81544668 | Exercise tolerance in children with juvenile idiopathic arthritis after autologous SCT |
| Q33394404 | Exonic deletion of CASP10 in a patient presenting with systemic juvenile idiopathic arthritis, but not with autoimmune lymphoproliferative syndrome type IIa. |
| Q45745633 | Experience of one UK site presenting a closer examination of safety and efficacy of Anakinra (Kineret®) in systemic juvenile idiopathic arthritis |
| Q54941481 | Experience of the concentration of methotrexate evaluation in children with juvenile idiopathic arthritis. |
| Q47111826 | Experience with etanercept, tocilizumab and interleukin-1 inhibitors in systemic onset juvenile idiopathic arthritis patients from the BIKER registry. |
| Q51058847 | Experiences in the treatment of juvenile rheumatoid arthritis with ACTH. |
| Q54486804 | Experiences of employment among young people with juvenile idiopathic arthritis: a qualitative study. |
| Q92517588 | Experiences of living with juvenile idiopathic arthritis: a qualitative systematic review protocol |
| Q70742184 | Experiences with indomethacin in long-term therapy of juvenile rheumatoid arthritis |
| Q33836546 | Experiences with tumour necrosis factor-{alpha} inhibitors in patients with juvenile idiopathic arthritis: Hungarian data from the National Institute of Rheumatology and Physiotherapy Registry |
| Q91950867 | Experiences, perspectives and expectations of adolescents with juvenile idiopathic arthritis regarding future work participation; a qualitative study |
| Q30854595 | Experimental data concerning the elephantiasis developing in the course of a case of juvenile rheumatoid arthritis |
| Q36517235 | Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. |
| Q87128997 | Expert's comment concerning Grand Rounds case entitled "The surgical management of atlanto-axial subluxation in juvenile rheumatoid arthritis" (Khalid M. I. Salem et al. Eur Spine J; 2014, DOI 10.1007/s00586-014-3648-5) |
| Q46105016 | Explantation of intraocular lenses in children with juvenile idiopathic arthritis-associated uveitis |
| Q33559199 | Exposure to animals and risk of oligoarticular juvenile idiopathic arthritis: a multicenter case-control study |
| Q43674073 | Expression and significance of interleukin-6, interferon-inducible protein-10 and interleukin-17 in serum and synovial fluid of patients with juvenile idiopathic arthritis |
| Q54429320 | Expression of FLICE-inhibitory protein in synovial tissue and its association with synovial inflammation in juvenile idiopathic arthritis. |
| Q34151216 | Expression of Toll-like receptors 2 and 4 is increased in peripheral blood and synovial fluid monocytes of patients with enthesitis-related arthritis subtype of juvenile idiopathic arthritis |
| Q73792147 | Expression of angiogenic factors in juvenile rheumatoid arthritis: correlation with revascularization of human synovium engrafted into SCID mice |
| Q44186565 | Expression of cathepsin B, D and L protein in juvenile idiopathic arthritis |
| Q74385158 | Expression of galectins-1 and -3 correlates with defective mononuclear cell apoptosis in patients with juvenile idiopathic arthritis |
| Q54645460 | Expression of human endogenous retrovirus HERV-K18 superantigen is elevated in juvenile rheumatoid arthritis. |
| Q74267160 | Expression of macrophage markers by a population of T cells obtained from synovial fluid of a subgroup of patients with juvenile rheumatoid arthritis |
| Q46548291 | Expression of melanoma antigen gene by cells from inflamed joints in juvenile rheumatoid arthritis |
| Q73401314 | Expression of myeloid-related proteins 8 and 14 in systemic-onset juvenile rheumatoid arthritis |
| Q63859672 | Expression of the CD2 Activation Epitope T11-3 (CD2R) on T Cells in Rheumatoid Arthritis, Juvenile Rheumatoid Arthritis, Systemic Lupus Erythematosus, Ankylosing Spondylitis, and Lyme Disease: Phenotypic and Functional Analysis |
| Q34896763 | Expression of the inflammatory chemokines CCL5, CCL3 and CXCL10 in juvenile idiopathic arthritis, and demonstration of CCL5 production by an atypical subset of CD8+ T cells |
| Q69973876 | Expression of the major rheumatoid factor cross-reactive idiotype in juvenile rheumatoid arthritis |
| Q44686745 | Extension study of participants from the trial of early aggressive therapy in juvenile idiopathic arthritis |
| Q61041069 | Extensive Ichthyosiform Sarcoidosis in a Patient With Juvenile Rheumatoid Arthritis |
| Q41807165 | Extensive vascular calcification in association with juvenile rheumatoid arthritis and amyloidosis |
| Q71115601 | Extra-Articular Lesions in Juvenile Rheumatoid Arthritis: A Survey based upon a Study of 151 Cases |
| Q43936131 | Extra-articular manifestations in juvenile rheumatoid arthritis. Diagnostic difficulties. |
| Q70677912 | Extra-articular manifestations of juvenile rheumatoid arthritis |
| Q67574728 | Extraarticular manifestations in juvenile rheumatoid arthritis (author's transl) |
| Q92993826 | Extreme thrombocytosis in systemic juvenile idiopathic arthritis. A case report |
| Q40322015 | Extremely elevated IL-18 levels may help distinguish systemic-onset juvenile idiopathic arthritis from other febrile diseases |
| Q44083206 | Extremes in vitamin K status of bone are related to bone ultrasound properties in children with juvenile idiopathic arthritis |
| Q44315339 | Eye diseases in juvenile rheumatoid arthritis |
| Q69715289 | Eye lesions in juvenile rheumatoid arthritis |
| Q70674912 | Eye manifestations in juvenile rheumatoid arthritis |
| Q72296588 | FDA Arthritis Advisory Committee Meeting: juvenile rheumatoid arthritis drug evaluation guidelines; over-the-counter naproxen? |
| Q53686431 | FDA advisers endorse Celebrex for juvenile rheumatoid arthritis: lack of studies in children raises safety concerns. |
| Q87815055 | FDG-PET in macrophage activation syndrome associated with systemic juvenile idiopathic arthritis |
| Q40969973 | FEVER AND EXANTHEMA IN JUVENILE RHEUMATOID ARTHRITIS |
| Q45744315 | FOXP3 expression in peripheral blood and synovial cells of patients with juvenile idiopathic arthritis: relationship with IL-17 at cytokine and molecular level. |
| Q61882622 | FRI0517 Cross-Cultural Adaptation and Validation of the Screen for Child Anxiety Related Disorders Test (SCARED) in Juvenile Idiopathic Arthritis |
| Q68379460 | Facial deformity of juvenile rheumatoid arthritis |
| Q39235178 | Facial growth and oral function in a case of juvenile rheumatoid arthritis during an 8-year period |
| Q40348749 | Facial morphology in children and adolescents with juvenile idiopathic arthritis and moderate to severe temporomandibular joint involvement |
| Q92136110 | Facilitating patient-centered care: the development of illustrated multidimensional patient-reported outcome measures for children/adolescents with juvenile idiopathic arthritis |
| Q35637192 | Facioskeletal changes in children with juvenile idiopathic arthritis |
| Q46551325 | Factor XI deficiency, juvenile rheumatoid arthritis and systemic lupus erythematosus. Report of the first case |
| Q91077260 | Factors Associated With Preterm Delivery Among Women With Rheumatoid Arthritis and Women With Juvenile Idiopathic Arthritis |
| Q35932693 | Factors affecting clinical and therapeutic outcomes of patients with juvenile rheumatoid arthritis. |
| Q44336815 | Factors affecting the efficacy of intraarticular corticosteroid injection of knees in juvenile idiopathic arthritis |
| Q40351079 | Factors associated with a longer time to access pediatric rheumatologists in Canadian children with juvenile idiopathic arthritis |
| Q85592184 | Factors associated with achievement of inactive disease in children with juvenile idiopathic arthritis treated with etanercept |
| Q37195338 | Factors associated with choice of biologic among children with Juvenile Idiopathic Arthritis: results from two UK paediatric biologic registers |
| Q46445332 | Factors associated with choice of first biologic among children with juvenile idiopathic arthritis: a combined analysis from two UK paediatric biologic registers. |
| Q36795982 | Factors associated with improvement in disease activity following initiation of etanercept in children and young people with Juvenile Idiopathic Arthritis: results from the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort |
| Q80502314 | Factors associated with the use of complementary and alternative medicine in juvenile idiopathic arthritis |
| Q45779809 | Factors associated with treatment response to etanercept in juvenile idiopathic arthritis |
| Q36846774 | Factors influencing the efficacy of intra-articular steroid injections in patients with juvenile idiopathic arthritis |
| Q38997075 | Factors influencing the quality of life of Moroccan patients with juvenile idiopathic arthritis |
| Q44466477 | Factors related to severe uveitis at diagnosis in children with juvenile idiopathic arthritis in a screening program |
| Q69694343 | Factors relating to hip joint arthritis following three childhood diseases--juvenile rheumatoid arthritis, Perthes disease, and postreduction avascular necrosis in congenital hip dislocation |
| Q51562614 | Faecal Calprotectin in Treated and Untreated Children With Coeliac Disease and Juvenile Idiopathic Arthritis. |
| Q35882225 | Faecal microbiome in new-onset juvenile idiopathic arthritis |
| Q67741491 | Failure of multitarget detection of Borrelia burgdorferi-associated DNA sequences in synovial fluids of patients with juvenile rheumatoid arthritis: a cautionary note |
| Q81248384 | Failure to distinguish systemic-onset juvenile idiopathic arthritis from incomplete Kawasaki disease in an infant |
| Q103738155 | Fallen, But Not Forgotten: Atlantoaxial Dislocation in a Child With Polyarticular Juvenile Idiopathic Arthritis in the Era of Biologics |
| Q93711681 | False-positive tests for toxoplasmosis in juvenile rheumatoid arthritis |
| Q89500829 | Familial Juvenile Idiopathic Arthritis |
| Q36321862 | Familial Mediterranean fever and ankylosing spondylitis in a patient with juvenile idiopathic arthritis: A case report and review of the literature |
| Q81129112 | Familial aggregation of juvenile idiopathic arthritis |
| Q37001288 | Familial autoimmunity: maternal parent-of-origin effect in juvenile idiopathic arthritis |
| Q59268624 | Familial hypercholesterolemia misinterpreted as juvenile idiopathic arthritis |
| Q67356827 | Familial polyarticular osteochondritis dissecans masquerading as juvenile rheumatoid arthritis |
| Q70921418 | Familial predisposition in juvenile rheumatoid arthritis |
| Q72765168 | Familial rheumatoid arthritis: A kindred identified through a proband with seronegative juvenile arthritis includes members with seropositive, adult-onset disease |
| Q37021256 | Familial rheumatoid arthritis: linkage of HLA to disease susceptibility locus in four families where proband presented with juvenile rheumatoid arthritis |
| Q47614505 | Family functioning and hope in children with juvenile rheumatoid arthritis |
| Q51933525 | Family health and characteristics in chronic fatigue syndrome, juvenile rheumatoid arthritis, and emotional disorders of childhood. |
| Q43627688 | Family resilience and adaptive coping in children with juvenile idiopathic arthritis: protocol for a systematic review. |
| Q69754850 | Family variables and disease management in juvenile rheumatoid arthritis |
| Q73196183 | Family-level coping in juvenile rheumatoid arthritis: assessing the utility of a quantitative family interview |
| Q64050675 | Farber disease in infancy resembling juvenile idiopathic arthritis: identification of two new mutations and a good early response to allogeneic haematopoietic stem cell transplantation |
| Q91595378 | Farber disease: report of three cases with joint involvement mimicking juvenile idiopathic arthritis |
| Q43765904 | Farber lipogranulomatosis with predominant joint involvement mimicking juvenile idiopathic arthritis |
| Q70369262 | Fat embolism manifested in juvenile rheumatoid arthritis in a young patient |
| Q52709095 | Fatal Hepatic Necrosis After Halothane Anesthesia in a Boy with Juvenile Rheumatoid Arthritis |
| Q72002997 | Fatal bronchiolitis obliterans in a patient with juvenile rheumatoid arthritis receiving chrysotherapy |
| Q30460110 | Fatal multisystem disease with immune enteropathy heralded by juvenile rheumatoid arthritis. |
| Q41932714 | Fatal myocarditis in a child with systemic onset juvenile idiopathic arthritis during treatment with an interleukin 1 receptor antagonist |
| Q75406112 | Fatal occlusive vessel disease in a patient with systemic juvenile idiopathic arthritis |
| Q51003808 | Fathers' experience of parenting a child with juvenile rheumatoid arthritis. |
| Q48072923 | Fatigue in children with juvenile idiopathic arthritis: reliability of the "Pediatric Quality of Life Inventory-Multidimensional Fatigue Scale". |
| Q37476546 | Fatigue in patients with Juvenile Idiopathic Arthritis: relationship to perceived health, physical health, self-efficacy, and participation |
| Q38666022 | Fatigue in patients with juvenile idiopathic arthritis: A systematic review of the literature. |
| Q70656587 | Favorable effect of dimethyl sulfoxide on secondary amyloidosis in juvenile rheumatoid arthritis |
| Q40524407 | Favorable outcome in patients with renal involvement complicating macrophage activation syndrome in systemic onset juvenile rheumatoid arthritis. |
| Q33817468 | Favourable outcome after cataract surgery with IOL implantation in uveitis associated with juvenile idiopathic arthritis |
| Q81129184 | Feasibility and construct validity of the parent willingness-to-pay technique for children with juvenile idiopathic arthritis |
| Q46061111 | Feasibility and efficacy of intraarticular steroids (IAS) in juvenile idiopathic arthritis (JIA). |
| Q57805124 | Feasibility and safety of a 6-month exercise program to increase bone and muscle strength in children with juvenile idiopathic arthritis |
| Q36441325 | Feasibility of a Website and a Hospital-Based Online Portal for Young Adults With Juvenile Idiopathic Arthritis: Views and Experiences of Patients |
| Q59329589 | Feasibility of a musculoskeletal ultrasound intervention to improve adherence in juvenile idiopathic arthritis: a proof-of concept trial |
| Q36171687 | Feasibility of diffusion-weighted magnetic resonance imaging in patients with juvenile idiopathic arthritis on 1.0-T open-bore MRI |
| Q93380661 | Features distinguishing juvenile idiopathic arthritis among children with musculoskeletal complaints |
| Q89120962 | Fecal Calprotectin to Detect Inflammatory Bowel Disease in Juvenile Idiopathic Arthritis |
| Q36652430 | Fecal calprotectin in children with the enthesitis-related arthritis subtype of juvenile idiopathic arthritis |
| Q37618733 | Fecal calprotectin in juvenile idiopathic arthritis patients related to drug use. |
| Q103825923 | Fecal microbiota in untreated children with Juvenile Idiopathic Arthritis - a comparison with healthy children and healthy siblings |
| Q33504036 | Felty syndrome complicating juvenile rheumatoid arthritis |
| Q51134166 | Female sex and oligoarthritis category are not risk factors for uveitis in Italian children with juvenile idiopathic arthritis. |
| Q91503580 | Ferritin to Erythrocyte Sedimentation Rate Ratio: Simple Measure to Identify Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis |
| Q40811212 | Ferritinemia as an indicator of systemic disease activity in children with systemic juvenile rheumatoid arthritis |
| Q35647814 | Fever as an initial manifestation of enthesitis-related arthritis subtype of juvenile idiopathic arthritis: retrospective study |
| Q40955939 | Fever associated with juvenile rheumatoid arthritis |
| Q40519178 | Fever of unknown origin caused by adult juvenile rheumatoid arthritis: the diagnostic significance of double quotidian fevers and elevated serum ferritin levels |
| Q33402951 | Fever of unknown origin in a patient of systemic onset juvenile idiopathic arthritis |
| Q44123988 | Fibrin D-dimer as a marker of disease activity in systemic onset juvenile rheumatoid arthritis |
| Q89767434 | Filling the Gap: Toward a Disease Activity Tool for Systemic Juvenile Idiopathic Arthritis |
| Q45744212 | Final validation of a new composite disease activity score for juvenile idiopathic arthritis: the Juvenile Arthritis Disease Activity Score (JADAS). |
| Q26786198 | Finding specific 10-joint Juvenile Arthritis Disease Activity Score (JADAS10) and clinical JADAS10 cut-off values for disease activity levels in non-systemic juvenile idiopathic arthritis: a Finnish multicentre study |
| Q46964262 | Finding specific cut-off values of JADAS-10 and JADAS3-10 for disease activity levels in juvenile idiopathic arthritis: a finnish multicenter study |
| Q39080731 | Fine-mapping the MHC locus in juvenile idiopathic arthritis (JIA) reveals genetic heterogeneity corresponding to distinct adult inflammatory arthritic diseases |
| Q43049087 | Finger joint swellings in a teenager: juvenile rheumatoid arthritis or a psychiatric disorder? |
| Q44449408 | Finnish case-control and family studies support PTPN22 R620W polymorphism as a risk factor in rheumatoid arthritis, but suggest only minimal or no effect in juvenile idiopathic arthritis |
| Q46962664 | First episode of chronic anterior uveitis in patients with juvenile idiopathic arthritis and relationship with administrated treatments |
| Q47873184 | Flares after withdrawal of biologic therapies in juvenile idiopathic arthritis: Clinical and laboratory correlates of remission duration |
| Q88239779 | Flares of Disease in Children with Clinically Inactive Juvenile Idiopathic Arthritis Were Not Correlated with Ultrasound Findings |
| Q72086936 | Flow cytometry and cytoadherence studies of sera from children with juvenile rheumatoid arthritis and normal controls |
| Q88359193 | Fluocinolone acetonide intravitreal implant (Retisert® ) in the treatment of sight threatening macular oedema of juvenile idiopathic arthritis-related uveitis |
| Q42217638 | Flurbiprofen in the treatment of juvenile rheumatoid arthritis. |
| Q72003021 | Focal radiolucent hepatic lesions in a patient with juvenile rheumatoid arthritis |
| Q33377288 | Focus on adverse events of tumour necrosis factor alpha blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients |
| Q53246369 | Focus on juvenile idiopathic arthritis according to the 2001 Edmonton revised classification from the International League of Associations for Rheumatology: an Italian experience. |
| Q35223383 | Folate depletion and increased glutamation in juvenile idiopathic arthritis patients treated with methotrexate |
| Q44763585 | Folate usage in MTX-treated juvenile idiopathic arthritis (JIA) patients is inconsistent and highly variable |
| Q71707673 | Folinic acid supplementation in patients with juvenile rheumatoid arthritis treated with methotrexate |
| Q71906143 | Folinic acid to prevent side effects of methotrexate in juvenile rheumatoid arthritis |
| Q37451624 | Follistatin-like protein 1 and the ferritin/erythrocyte sedimentation rate ratio are potential biomarkers for dysregulated gene expression and macrophage activation syndrome in systemic juvenile idiopathic arthritis. |
| Q34063418 | Follistatin-like protein 1 is a mesenchyme-derived inflammatory protein and may represent a biomarker for systemic-onset juvenile rheumatoid arthritis |
| Q33568777 | Follow-up study of 100 cases of juvenile rheumatoid arthritis |
| Q33569002 | Follow-up study of juvenile chronic polyarthritis with particular reference to histocompatibility antigen W. 27. |
| Q36914542 | Foot function is well preserved in children and adolescents with juvenile idiopathic arthritis who are optimally managed |
| Q48082813 | Foot orthoses in children with juvenile idiopathic arthritis: a randomised controlled trial |
| Q55505295 | Foot related impairments and disability in juvenile idiopathic arthritis persist despite modern day treatment paradigms. |
| Q92667326 | Fostering the application of the MS score in systemic juvenile idiopathic arthritis. Response to: 'MS score in systemic juvenile idiopathic arthritis: suitable for routine use?' by Chi et al |
| Q35690424 | Foveal Serous Retinal Detachment in Juvenile Idiopathic Arthritis-associated Uveitis. |
| Q58586409 | Foxp3 Molecular Dynamics in Treg in Juvenile Idiopathic Arthritis |
| Q51472799 | Fraction of exhaled nitric oxide as a predictor in juvenile idiopathic arthritis progression. |
| Q45799790 | Frequencies of epstein-barr virus—inducible IgM anti-IgG B lymphocytes in normal children and children with juvenile rheumatoid arthritis |
| Q90692417 | Frequency and Identification of Risk Factors of Uveitis in Juvenile Idiopathic Arthritis: A Long-term Follow-up Study in a Cohort of Italian Children |
| Q39077036 | Frequency and Morbidity of Temporomandibular Joint Involvement in Adult Patients With a History of Juvenile Idiopathic Arthritis |
| Q37104691 | Frequency and phenotypic analysis of CD4+CD25+ regulatory T cells in children with juvenile idiopathic arthritis. |
| Q55651930 | Frequency of CD19+CD24hiCD38hi regulatory B cells is decreased in peripheral blood and synovial fluid of patients with juvenile idiopathic arthritis: a preliminary study. |
| Q44834336 | Frequency of HLA-Dw3 in juvenile rheumatoid arthritis |
| Q34957341 | Frequency of abnormal hand and wrist radiographs at time of diagnosis of polyarticular juvenile rheumatoid arthritis |
| Q61740085 | Frequency of anti-hsp60, -65 and -70 antibodies in sera of patients with juvenile idiopathic arthritis |
| Q50039342 | Frequency of auditory involvement and of associated factors in patients with juvenile idiopathic arthritis. |
| Q91845993 | Frequency of biologic switching and the outcomes of switching in children and young people with juvenile idiopathic arthritis: a national cohort study |
| Q45828001 | Frequency of joint involvement in juvenile idiopathic arthritis during a 5-year follow-up of newly diagnosed patients: implications for MR imaging as outcome measure |
| Q31152499 | Frequency of osteopenia in adolescents with early-onset juvenile idiopathic arthritis: a long-term outcome study of one hundred five patients |
| Q87319703 | Frequency of radiographic damage and progression in individual joints in children with juvenile idiopathic arthritis |
| Q40368302 | Frequency of relapse after discontinuation of methotrexate therapy for clinical remission in juvenile rheumatoid arthritis |
| Q74508420 | Frequency of uncommon diseases: is juvenile idiopathic arthritis underrecognized? |
| Q85042701 | Frequent discordance between clinical and musculoskeletal ultrasound examinations of foot disease in juvenile idiopathic arthritis |
| Q55505226 | Frequent discordance between clinical and musculoskeletal ultrasound examinations of foot disease in juvenile idiopathic arthritis observed in the multidisciplinary setting. |
| Q90160498 | From 'neurotic' to 'managing' mother: The 'medical career' experienced by mothers of a child diagnosed with Juvenile Idiopathic Arthritis |
| Q53201130 | From childhood to adult life with juvenile idiopathic arthritis (JIA): a pilot study. |
| Q92737245 | Fucosidosis mimicking juvenile idiopathic arthritis |
| Q97678303 | Functional Ability and Health-Related Quality of Life in Randomized Controlled Trials of Tocilizumab in Patients With Juvenile Idiopathic Arthritis |
| Q71941662 | Functional alpha 1-adrenergic receptors on leukocytes of patients with polyarticular juvenile rheumatoid arthritis |
| Q34196828 | Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis |
| Q43610438 | Functional changes following distraction osteogenesis treatment of asymmetric mandibular growth deviation in unilateral juvenile idiopathic arthritis: a prospective study with long-term follow-up |
| Q72216999 | Functional problems in juvenile rheumatoid arthritis |
| Q48473742 | Functional status in severe juvenile idiopathic arthritis in the biologic treatment era: an assessment in a French paediatric rheumatology referral centre. |
| Q53254425 | Functioning and preferences for improvement of health among patients with juvenile idiopathic arthritis in early adulthood using the WHO ICF model. |
| Q48066604 | Fundamental movement skills, physical fitness and physical activity among Australian children with juvenile idiopathic arthritis |
| Q34764497 | Fungal arthritis simulating juvenile rheumatoid arthritis |
| Q100510942 | Fused Omics Data Models Reveal Gut Microbiome Signatures Specific of Inactive Stage of Juvenile Idiopathic Arthritis in Pediatric Patients |
| Q46712572 | GSTT1, GSTM1 and GSTP1 polymorphisms and susceptibility to juvenile idiopathic arthritis |
| Q91781171 | Gait Adaptations In Youth With Juvenile Idiopathic Arthritis |
| Q69245408 | Gait deviations in patients with juvenile rheumatoid arthritis |
| Q69917731 | Galactosylation of IgG associated oligosaccharides: reduction in patients with adult and juvenile onset rheumatoid arthritis and relation to disease activity |
| Q83619650 | GammadeltaT cells in juvenile idiopathic arthritis: higher percentages of synovial Vdelta1+ and Vgamma9+ T cell subsets are associated with milder disease |
| Q45357622 | Gastric ulcer and gastroenteritis caused by Epstein-Barr virus during immunosuppressive therapy for a child with systemic juvenile idiopathic arthritis |
| Q77887448 | Gastroduodenal lesions in children with juvenile rheumatoid arthritis |
| Q44651135 | Gastrointestinal symptoms and permeability in patients with juvenile idiopathic arthritis |
| Q53265720 | Gastrointestinal symptoms and their association with health-related quality of life of children with juvenile rheumatoid arthritis: validation of a gastrointestinal symptom questionnaire. |
| Q36951513 | Gene Expression Deconvolution for Uncovering Molecular Signatures in Response to Therapy in Juvenile Idiopathic Arthritis |
| Q38701261 | Gene expression arrays in juvenile rheumatoid arthritis: will the blind men finally see the elephant? |
| Q41836488 | Gene expression profiling in neutrophils from children with polyarticular juvenile idiopathic arthritis |
| Q50672047 | Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndrome. |
| Q37340563 | Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets |
| Q33899945 | Gene therapy for juvenile rheumatoid arthritis? |
| Q36304070 | Gene-expression analysis of adult-onset Still's disease and systemic juvenile idiopathic arthritis is consistent with a continuum of a single disease entity |
| Q34235121 | Generation of novel pharmacogenomic candidates in response to methotrexate in juvenile idiopathic arthritis: correlation between gene expression and genotype. |
| Q31011687 | Genetic Predictors of Poor Prognosis in Portuguese Patients with Juvenile Idiopathic Arthritis: Data from Reuma.pt |
| Q37672375 | Genetic Screening of Mutations Associated with Fabry Disease in a Nationwide Cohort of Juvenile Idiopathic Arthritis Patients |
| Q36394375 | Genetic analysis of juvenile rheumatoid arthritis: approaches to complex traits |
| Q57304542 | Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications |
| Q92981793 | Genetic architecture study of rheumatoid arthritis and juvenile idiopathic arthritis |
| Q92800422 | Genetic aspects of idiopathic paediatric uveitis and juvenile idiopathic arthritis associated uveitis in Chinese Han |
| Q34319025 | Genetic association between juvenile rheumatoid arthritis and polymorphism in the SH2D2A gene |
| Q59394230 | Genetic association with articular damage in patients with juvenile idiopathic arthritis (JIA) |
| Q38189857 | Genetic background of juvenile idiopathic arthritis |
| Q27026473 | Genetic determinants for methotrexate response in juvenile idiopathic arthritis |
| Q46862101 | Genetic determinants of methotrexate treatment efficacy in patients with juvenile idiopathic arthritis |
| Q67060364 | Genetic dispostion in juvenile rheumatoid arthritis |
| Q55036040 | Genetic epidemiology of juvenile idiopathic arthritis. |
| Q33752910 | Genetic insights into juvenile idiopathic arthritis derived from deep whole genome sequencing |
| Q24652615 | Genetic loci contributing to hemophagocytic lymphohistiocytosis do not confer susceptibility to systemic-onset juvenile idiopathic arthritis |
| Q46090317 | Genetic markers in clinical subtypes of juvenile idiopathic arthritis. |
| Q59268705 | Genetic polymorphism of COL1A1 gene and bone mineralisation in juvenile idiopathic arthritis |
| Q36958163 | Genetic polymorphisms of collagen type I α1 chain (COL1A1) gene increase the frequency of low bone mineral density in the subgroup of children with juvenile idiopathic arthritis |
| Q59268642 | Genetic susceptibility to juvenile idiopathic arthritis in Iranian children |
| Q84704418 | Genetic susceptibility to juvenile idiopathic arthritis in Iranian children |
| Q85559228 | Genetic variants influencing response to methotrexate in juvenile idiopathic arthritis and rheumatoid arthritis |
| Q54389804 | Genetic variation in VTCN1 (B7-H4) is associated with course of disease in juvenile idiopathic arthritis. |
| Q38677730 | Genetics of Juvenile Idiopathic Arthritis |
| Q87515229 | Genetics of juvenile idiopathic arthritis |
| Q35864710 | Genetics of juvenile idiopathic arthritis: an update |
| Q35652611 | Genetics of juvenile idiopathic arthritis: new tools bring new approaches. |
| Q50526496 | Genome-Wide Association Meta-Analysis Reveals Novel Juvenile Idiopathic Arthritis Susceptibility Loci. |
| Q36507406 | Genome-scale case-control analysis of CD4+ T-cell DNA methylation in juvenile idiopathic arthritis reveals potential targets involved in disease. |
| Q28943486 | Genome-wide association analysis of juvenile idiopathic arthritis identifies a new susceptibility locus at chromosomal region 3q13 |
| Q30795448 | Genome-wide data reveal novel genes for methotrexate response in a large cohort of juvenile idiopathic arthritis cases |
| Q33775236 | Genomic characterization of remission in juvenile idiopathic arthritis |
| Q98951579 | Genomic risk scores for juvenile idiopathic arthritis and its subtypes |
| Q42467989 | Genotoxicity of anti-tumor necrosis factor therapy in patients with juvenile idiopathic arthritis. |
| Q46837607 | German evidence and consensus based guidelines 2010 for the treatment of juvenile idiopathic arthritis (JIA). |
| Q46378641 | German evidence- and consensus-based guidelines 2011 for the treatment of juvenile idiopathic arthritis (JIA). |
| Q39753039 | Ghrelin levels in patients with juvenile idiopathic arthritis: relation to anti-tumor necrosis factor treatment and disease activity |
| Q81045756 | Global damage in systemic juvenile idiopathic arthritis: preliminary early predictors |
| Q96346363 | Global prevalence estimates of three chronic musculoskeletal conditions: club foot, juvenile idiopathic arthritis and juvenile systemic lupus erythematosus |
| Q33792640 | Glucocorticoid receptor gene polymorphism and juvenile idiopathic arthritis |
| Q57062369 | Glucocorticoid treatment in juvenile idiopathic arthritis |
| Q87693297 | Glucocorticoids in juvenile idiopathic arthritis |
| Q38250159 | Glucocorticoids in juvenile idiopathic arthritis. |
| Q38118210 | Glucocorticoids in the management of systemic juvenile idiopathic arthritis. |
| Q70172517 | Glutathione and glutathione-metabolizing enzymes in the erythrocytes of healthy children and in children with insulin-dependent diabetes mellitus, juvenile rheumatoid arthritis, coeliac disease and acute lymphoblastic leukaemia |
| Q67991314 | Glycosaminoglycans in the synovial fluids of patients with juvenile rheumatoid arthritis |
| Q70579999 | Glycosylation of alpha 1-acid glycoprotein in systemic onset juvenile rheumatoid arthritis and acute bacterial infection: value in differential diagnosis |
| Q39643309 | Gold Nephropathy in Juvenile Rheumatoid Arthritis |
| Q39636845 | Gold Serum Levels in Children with Juvenile Rheumatoid Arthritis |
| Q66992686 | Gold nephropathy in rheumatoid arthritis and in juvenile chronic arthritis |
| Q71773575 | Gold salts in the therapy of juvenile rheumatoid arthritis |
| Q69976639 | Gold sodium thiomalate and D-penicillamine. A controlled, comparative study in patients with pauciarticular and polyarticular juvenile rheumatoid arthritis |
| Q67483339 | Gold therapy in juvenile rheumatoid arthritis |
| Q71499531 | Gold therapy in the management of juvenile rheumatoid arthritis |
| Q67357333 | Gold therapy in the therapeutic plan for juvenile rheumatoid arthritis |
| Q69351274 | Gold therapy of juvenile rheumatoid arthritis |
| Q41457227 | Golimumab for the treatment of refractory juvenile idiopathic arthritis-associated uveitis |
| Q50174467 | Golimumab in refractory uveitis associated to juvenile idiopathic arthritis: multicentre study of 7 cases and literature review. |
| Q98622894 | Gonioscopy-Assisted Transluminal Trabeculotomy in Uveitic Glaucoma Secondary to Juvenile Idiopathic Arthritis |
| Q78736870 | Good results from combining etanercept to prevailing DMARD therapy in refractory juvenile idiopathic arthritis |
| Q37493527 | Gout in a 15-year-old boy with juvenile idiopathic arthritis: a case study |
| Q73687218 | Gower's sign in children with juvenile idiopathic arthritis |
| Q45744182 | Grading of joint indices for severity reflects better the burden of joint disease and its impact on child's well-being in juvenile idiopathic arthritis (JIA). |
| Q66885408 | Granulocyte Reactive Antinuclear Factors in Juvenile Rheumatoid Arthritis |
| Q46840736 | Granulomatous inflammation in juvenile idiopathic arthritis-associated uveitis |
| Q84126621 | Graves' disease associated with juvenile idiopathic arthritis |
| Q73899254 | Growing pains: the ILAR classification of juvenile idiopathic arthritis |
| Q51232904 | Growing up and moving on in rheumatology: a multicentre cohort of adolescents with juvenile idiopathic arthritis. |
| Q82497048 | Growing up and moving on in rheumatology: development and preliminary evaluation of a transitional care programme for a multicentre cohort of adolescents with juvenile idiopathic arthritis |
| Q40337216 | Growing up and moving on in rheumatology: parents as proxies of adolescents with juvenile idiopathic arthritis |
| Q35636519 | Growing up and moving on. A multicentre UK audit of the transfer of adolescents with juvenile idiopathic arthritis from paediatric to adult centred care |
| Q85837467 | Growing up with juvenile idiopathic arthritis |
| Q72844492 | Growth Disturbance of the Mandible in Juvenile Rheumatoid Arthritis |
| Q89367929 | Growth During Tocilizumab Therapy for Polyarticular-course Juvenile Idiopathic Arthritis: 2-year Data from a Phase III Clinical Trial |
| Q89236743 | Growth Failure in Children with Systemic Juvenile Idiopathic Arthritis and Prolonged Inflammation despite Treatment with Biologicals: Late Normalization of Height by Combined Hormonal Therapies |
| Q47656914 | Growth Outcomes After GH Therapy of Patients Given Long-Term Corticosteroids for Juvenile Idiopathic Arthritis |
| Q37956807 | Growth abnormalities in children with juvenile rheumatoid arthritis. |
| Q91155942 | Growth and body mass index in a cohort of patients with juvenile idiopathic arthritis: effects of second line treatments |
| Q46277849 | Growth and bone mineralization in patients with juvenile idiopathic arthritis |
| Q84956630 | Growth and development abnormalities in children with juvenile idiopathic arthritis: treatment and prevention |
| Q68560427 | Growth and differentiation of B lymphocytes of patients with juvenile rheumatoid arthritis |
| Q82545034 | Growth and menarche during remission in children with juvenile idiopathic arthritis |
| Q41493415 | Growth and weight gain in children with juvenile idiopathic arthritis: results from the ReACCh-Out cohort |
| Q53591315 | Growth hormone changes bone geometry and body composition in patients with juvenile idiopathic arthritis requiring glucocorticoid treatment: a controlled study using peripheral quantitative computed tomography. |
| Q35684733 | Growth hormone deficiency, short stature, and juvenile rheumatoid arthritis in a patient with autoimmune polyglandular syndrome type 1: case report and brief review of the literature |
| Q30882636 | Growth hormone improves height in patients with juvenile idiopathic arthritis: 4-year data of a controlled study |
| Q31114096 | Growth hormone increases final height in patients with juvenile idiopathic arthritis: data from a randomized controlled study |
| Q41500676 | Growth in children and adolescents with juvenile idiopathic arthritis over 2 years of treatment with etanercept: results from the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study |
| Q37832553 | Growth in juvenile idiopathic arthritis: the role of inflammation. |
| Q43711537 | Growth of children with juvenile idiopathic arthritis. |
| Q47348764 | Growth patterns in early juvenile idiopathic arthritis: Results from the Childhood Arthritis Prospective Study (CAPS). |
| Q50733452 | Growth patterns in juvenile rheumatoid arthritis. |
| Q64377636 | Growth plate damage, a feature of juvenile idiopathic arthritis, can be induced by adenoviral gene transfer of oncostatin M: a comparative study in gene-deficient mice |
| Q75323164 | Growth reconstitution in juvenile idiopathic arthritis treated with etanercept |
| Q35755313 | Growth retardation and delayed puberty in children and adolescents with juvenile idiopathic arthritis. |
| Q40471165 | Growth retardation in juvenile rheumatoid arthritis (JRA) |
| Q73310705 | Growth retardation in non-steroid treated juvenile rheumatoid arthritis |
| Q45745785 | Growth retardation in patients with juvenile idiopathic arthritis and growth hormone therapy |
| Q82245587 | Growth velocity and interleukin 6 concentrations in juvenile idiopathic arthritis |
| Q83278525 | Guidance on the use of adalimumab for juvenile idiopathic arthritis in Japan |
| Q37877601 | Guidance on using tocilizumab for juvenile idiopathic arthritis. |
| Q45167254 | Guidelines for blood test monitoring of methotrexate toxicity in juvenile idiopathic arthritis. |
| Q37678277 | Guidelines on the use of etanercept for juvenile idiopathic arthritis in Japan. |
| Q44933421 | Guillain-Barré syndrome accompanied by central nervous system lupus in a patient with juvenile rheumatoid arthritis |
| Q91027285 | Gut microbiota in children and altered profiles in juvenile idiopathic arthritis |
| Q91704246 | Gut microbiota in children with juvenile idiopathic arthritis: characteristics, biomarker identification, and usefulness in clinical prediction |
| Q91829101 | Gut microbiota in chronic inflammatory disorders: A focus on pediatric inflammatory bowel diseases and juvenile idiopathic arthritis |
| Q26741980 | Gut microbiota-host interactions and juvenile idiopathic arthritis |
| Q37838731 | HDAC inhibition in rheumatoid arthritis and juvenile idiopathic arthritis |
| Q36516383 | HDL function and subclinical atherosclerosis in juvenile idiopathic arthritis |
| Q67328903 | HL-A W27 and Juvenile Rheumatoid Arthritis |
| Q66906183 | HL-A antigens in juvenile rheumatoid arthritis |
| Q68791395 | HL-A system and juvenile rheumatoid arthritis |
| Q36098863 | HLA Associations in a Cohort of Children With Juvenile Idiopathic Arthritis With and Without Uveitis |
| Q34244086 | HLA B27 allele types in homogeneous groups of juvenile idiopathic arthritis patients in Latvia |
| Q40653072 | HLA B27 typing in 511 children with juvenile idiopathic arthritis from India |
| Q36815392 | HLA II class alleles in juvenile idiopathic arthritis patients with and without temporomandibular joint arthritis. |
| Q46862068 | HLA II class alleles in juvenile idiopathic arthritis patients with temporomandibular joint involvement |
| Q45089775 | HLA and T cell receptor beta-chain DNA polymorphisms identify a distinct subset of patients with pauciarticular-onset juvenile rheumatoid arthritis |
| Q44946103 | HLA and T cell receptor polymorphisms in pauciarticular-onset juvenile rheumatoid arthritis |
| Q57740775 | HLA and altered sex ratios in juvenile rheumatoid arthritis sibships |
| Q73840919 | HLA and juvenile rheumatoid arthritis |
| Q34363693 | HLA and susceptibility to juvenile idiopathic arthritis: a study of affected sibpairs in an isolated Finnish population. |
| Q46472727 | HLA antigens in juvenile rheumatoid arthritis |
| Q73061753 | HLA class II genes in Latvian patients with juvenile rheumatoid arthritis |
| Q70057003 | HLA gene frequencies in children and adults with systemic onset juvenile rheumatoid arthritis |
| Q51125036 | HLA genotyping as first-line screening tool for coeliac disease in children with juvenile idiopathic arthritis. |
| Q37785740 | HLA susceptibility genes in rheumatoid factor positive juvenile rheumatoid arthritis |
| Q39856016 | HLA, juvenile rheumatoid arthritis and other disease associations |
| Q72112184 | HLA-B27 positive juvenile rheumatoid arthritis: altered lymphocyte responses to mitogens and low cytotoxic activity |
| Q86520162 | HLA-B27 predicts a more chronic disease course in an 8-year followup cohort of patients with juvenile idiopathic arthritis |
| Q45745834 | HLA-B27 predicts a more extended disease with increasing age at onset in boys with juvenile idiopathic arthritis |
| Q45940666 | HLA-B27 predicts a more extended disease with increasing age at onset in boys with juvenile idiopathic arthritis. |
| Q40599325 | HLA-B27 subtypes in enthesitis-related arthritis category of juvenile idiopathic arthritis and ankylosing spondylitis in northern India. |
| Q57740787 | HLA-DP antigens in patients with pauciarticular juvenile rheumatoid arthritis |
| Q68162939 | HLA-DP/DR interaction in children with juvenile rheumatoid arthritis |
| Q68316248 | HLA-DQA1*0101 haplotypes and disease outcome in early onset pauciarticular juvenile rheumatoid arthritis |
| Q69866536 | HLA-DR and MT associations with the clinical and serologic manifestations of pauciarticular onset juvenile rheumatoid arthritis |
| Q72706652 | HLA-DR beta, -DQ beta DNA polymorphisms in 9 juvenile rheumatoid arthritis affected Hungarian children |
| Q73433854 | HLA-DR expression in synovial membrane of juvenile rheumatoid arthritis (JRA) versus osteoarthritis (OA) |
| Q53093687 | HLA-DR typing in polyarticular juvenile idiopathic arthritis: a study from a tertiary care hospital in northern India. |
| Q55062253 | HLA-DR5 in juvenile rheumatoid arthritis confined to few joints |
| Q34317720 | HLA-DRB1 alleles and HLA-DRB1 shared epitopes are markers for juvenile rheumatoid arthritis subgroups in Colombian mestizos |
| Q50076758 | HLA-DRB1 alleles and juvenile idiopathic arthritis: Diagnostic clues emerging from a meta-analysis. |
| Q54261789 | HLA-DRB1 genotyping in patients with juvenile idiopathic arthritis in Taiwan. |
| Q36435134 | HLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis |
| Q57322527 | HLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis |
| Q46972523 | HLA-DRB1, TAP2/TAP1, and HLA-DPB1 haplotypes in Finnish juvenile idiopathic arthritis: more complexity within the MHC. |
| Q39842670 | HLA-Dw4 in adult and juvenile rheumatoid arthritis |
| Q83033960 | HLA-G and HLA-E in patients with juvenile idiopathic arthritis |
| Q44651195 | HMGB1 levels are increased in patients with juvenile idiopathic arthritis, correlate with early onset of disease, and are independent of disease duration |
| Q54323922 | HMOX1 promoter (GT)n polymorphim is associated with childhood-onset systemic lupus erythematosus but not with juvenile rheumatoid arthritis in a Mexican population. |
| Q46967596 | Hand function assessment in patients with juvenile idiopathic arthritis: usefulness of duruöz hand index |
| Q46310345 | Hand grip strength in juvenile idiopathic arthritis as predictor of disease activity and disability in clinical practice |
| Q50999558 | Handwriting difficulties in juvenile idiopathic arthritis: a pilot study. |
| Q36756166 | Haptoglobin Types in Patients with Juvenile Rheumatoid Arthritis |
| Q34266693 | Harlequin Ichthyosis in Association with Hypothyroidism and Juvenile Rheumatoid Arthritis |
| Q79375298 | Harlequin ichthyosis and juvenile idiopathic arthritis: a rare combination |
| Q29994491 | Harnessing interactive technologies to improve health outcomes in juvenile idiopathic arthritis |
| Q38194473 | Heading toward a modern imaging approach in juvenile idiopathic arthritis |
| Q94538797 | Health State Utility Values in Juvenile Idiopathic Arthritis: What is the Evidence? |
| Q48373687 | Health and identity: Self-positioning in adolescent chronic fatigue syndrome and juvenile idiopathic arthritis. |
| Q34035943 | Health related quality of life and parental perceptions of child vulnerability among parents of a child with juvenile idiopathic arthritis: results from a web-based survey |
| Q38873012 | Health related quality of life survey about children and adolescents with juvenile idiopathic arthritis. |
| Q35058734 | Health status of patients with juvenile rheumatoid arthritis at 1 and 5 years after diagnosis. |
| Q38839851 | Health-related quality of life among Swedish children with Juvenile Idiopathic Arthritis: parent-child discrepancies, gender differences and comparison with a European cohort. |
| Q45623795 | Health-related quality of life and emotional problems in juvenile idiopathic arthritis |
| Q92017205 | Health-related quality of life during early aggressive treatment in patients with polyarticular juvenile idiopathic arthritis: results from randomized controlled trial |
| Q83049255 | Health-related quality of life in adolescents with juvenile idiopathic arthritis |
| Q40284612 | Health-related quality of life in an inception cohort of children with Juvenile Idiopathic Arthritis: A longitudinal analysis. |
| Q92301715 | Health-related quality of life in children with early-stage juvenile idiopathic arthritis |
| Q37492207 | Health-related quality of life in children with juvenile idiopathic arthritis - child's and parent's point of view |
| Q36468685 | Health-related quality of life in girls and boys with juvenile idiopathic arthritis: self- and parental reports in a cross-sectional study |
| Q47193545 | Health-related quality of life of patients with juvenile idiopathic arthritis coming from 3 different geographic areas. The PRINTO multinational quality of life cohort study. |
| Q53106098 | Health-related quality of life, physical function, fatigue, and disease activity in children with established polyarticular juvenile idiopathic arthritis. |
| Q90711187 | Healthcare costs and outcomes in adult patients with juvenile idiopathic arthritis: a population-based study |
| Q50457674 | Hearing loss and middle ear involvement in patients with juvenile idiopathic arthritis. |
| Q37516558 | Heat shock protein 60 reactive T cells in juvenile idiopathic arthritis: what is new? |
| Q61740104 | Heat shock protein 70 membrane expression on fibroblast‐like synovial cells derived from synovial tissue of patients with rheumatoid and juvenile idiopathic arthritis |
| Q57126189 | Heat shock protein expression is low in intestinal mucosa in juvenile idiopathic arthritis: a defect in immunoregulation? |
| Q34994471 | Heat shock proteins in juvenile idiopathic arthritis: keys for understanding remitting arthritis and candidate antigens for immune therapy |
| Q91561316 | Heavy metals in fish and its association with autoimmunity in the development of juvenile idiopathic arthritis: a prospective birth cohort study |
| Q58556893 | Height and sexual maturation in girls with juvenile idiopathic arthritis |
| Q66994202 | Hemobilia from ruptured intrahepatic artery aneurysm in a patient with juvenile rheumatoid arthritis |
| Q83979151 | Hemophagocytosis during fludarabine-based SCT for systemic juvenile idiopathic arthritis |
| Q28335849 | Hepatic fibrosis with the use of methotrexate for juvenile rheumatoid arthritis |
| Q40931532 | Hepatic involvement in juvenile rheumatoid arthritis |
| Q40433253 | Hepatitis A-associated macrophage activation syndrome in children with systemic juvenile idiopathic arthritis: report of 2 cases |
| Q35554552 | Hepatitis B vaccination in children with juvenile idiopathic arthritis. |
| Q44688947 | Hepatitis B virus reactivation in a juvenile rheumatoid arthritis patient under treatment and its successful management: a complicated case |
| Q66877830 | Hepatotoxicity during treatment of juvenile rheumatoid arthritis and rheumatic diseases using salicylates |
| Q78472109 | Hepatotoxicity in patients with juvenile idiopathic arthritis receiving longterm methotrexate therapy |
| Q73924075 | Hereditary predisposition to low interleukin-10 production in children with extended oligoarticular juvenile idiopathic arthritis |
| Q40780138 | Herpes Virus Infections During Treatment With Etanercept in Juvenile Idiopathic Arthritis |
| Q84287364 | Heterogeneity in juvenile idiopathic arthritis: impact of molecular profiling based on DNA polymorphism and gene expression patterns |
| Q71289363 | Heterogeneity of HLA associations in systemic onset juvenile rheumatoid arthritis |
| Q91283919 | Heterogeneous Knee Effusions on Point-of-Care Ultrasound in a Toddler Diagnosed With Juvenile Idiopathic Arthritis |
| Q37865970 | Heterotopic ossification of the temporomandibular joint in juvenile idiopathic arthritis |
| Q33555862 | Hidden 19S IgM rheumatoid factor in adults with juvenile rheumatoid arthritis onset |
| Q71489799 | Hidden 19S IgM rheumatoid factor in juvenile rheumatoid arthritis |
| Q74151380 | Hidden 19S IgM rheumatoid factors in Turkish patients with juvenile rheumatoid arthritis |
| Q69905377 | Hidden and classical 19S IgM rheumatoid factor in a juvenile rheumatoid arthritis patient |
| Q68021294 | Hidden rheumatoid factor and Wa idiotype expression in juvenile rheumatoid arthritis |
| Q33568970 | Hidden rheumatoid factor in seronegative juvenile rheumatoid arthritis |
| Q59313338 | High Adiposity and Serum Leptin Accompanied by Altered Bone Turnover Markers in Severe Juvenile Idiopathic Arthritis |
| Q47245015 | High Levels of DEK Autoantibodies in Sera of Patients With Polyarticular Juvenile Idiopathic Arthritis and With Early Disease Flares Following Cessation of Anti-Tumor Necrosis Factor Therapy. |
| Q58535349 | High circulating levels of biologically inactive IL-6/SIL-6 receptor complexes in systemic juvenile idiopathic arthritis: evidence for serum factors interfering with the binding to gp130 |
| Q37472422 | High complication rate in revision total hip arthroplasty in juvenile idiopathic arthritis |
| Q43646709 | High dose methotrexate in the treatment of refractory juvenile rheumatoid arthritis. |
| Q34012312 | High dose, alternate day corticosteroids for systemic onset juvenile rheumatoid arthritis. |
| Q38129365 | High doses of infliximab in the management of juvenile idiopathic arthritis. |
| Q54892968 | High levels of DEK autoantibodies may predict early flare following cessation of anti-TNF therapy in juvenile idiopathic arthritis. |
| Q51378416 | High mobility group box protein 1-A prognostic marker for structural joint damage in 10-year follow-up of patients with juvenile idiopathic arthritis. |
| Q45967385 | High prevalence of IgA rheumatoid factor in severe polyarticular-onset juvenile rheumatoid arthritis, but not in systemic-onset or pauciarticular-onset disease. |
| Q50636496 | High prevalence of hand- and wrist-related symptoms, impairments, activity limitations and participation restrictions in children with juvenile idiopathic arthritis. |
| Q63865804 | High prevalence of methotrexate intolerance in juvenile idiopathic arthritis: Development and validation of a methotrexate intolerance severity score |
| Q37126302 | High prevalence of temporomandibular joint arthritis at disease onset in children with juvenile idiopathic arthritis, as detected by magnetic resonance imaging but not by ultrasound |
| Q59313470 | High prevalence of vertebral compression fractures in patients with juvenile idiopathic arthritis |
| Q41994113 | High rate of serious infection in juvenile idiopathic arthritis patients under biologic therapy in a real-life setting. |
| Q33645322 | High rates of unsuccessful transfer to adult care among young adults with juvenile idiopathic arthritis |
| Q44001419 | High response rate in the phase I/II study of meloxicam in juvenile rheumatoid arthritis |
| Q34070773 | High-dose daclizumab for the treatment of juvenile idiopathic arthritis-associated active anterior uveitis |
| Q38913955 | High-sensitive CRP as a predictive marker of long-term outcome in juvenile idiopathic arthritis |
| Q45945255 | High-throughput characterization of the functional impact of IgG Fc glycan aberrancy in juvenile idiopathic arthritis. |
| Q57752758 | Higher frequency of allele 2 of the interleukin-1 receptor antagonist gene in patients with juvenile idiopathic arthritis |
| Q78301243 | Highly elevated serum levels of interleukin-18 in systemic juvenile idiopathic arthritis but not in other juvenile idiopathic arthritis subtypes or in Kawasaki disease: comment on the article by Kawashima et al |
| Q53803052 | Hip arthroplasty by soft tissue interposition in juvenile rheumatoid arthritis. |
| Q33580170 | Hip disease in juvenile rheumatoid arthritis |
| Q74645221 | Hip disease in juvenile rheumatoid arthritis |
| Q82835081 | Hip disease in juvenile rheumatoid arthritis |
| Q33580241 | Hip involvement in juvenile chronic polyarthritis |
| Q39410600 | Hip involvement in juvenile idiopathic arthritis. |
| Q45835931 | Hip involvement in juvenile rheumatoid arthritis |
| Q67583293 | Hip joint restoration in juvenile rheumatoid arthritis |
| Q69804197 | Histocompatibility antigens in systemic-onset juvenile rheumatoid arthritis |
| Q39993268 | Histopathological features of gastrointestinal mucosal biopsies in children with juvenile idiopathic arthritis |
| Q59697456 | Hla class ii alleles and heterogeneity of juvenile rheumatoid arthritis.drb1*0101 may define a novel subset of the disease |
| Q74667176 | Hodgkin's disease in a patient with juvenile rheumatoid arthritis taking weekly low dose methotrexate |
| Q81727291 | Hodgkin's lymphoma and tumor necrosis factor inhibitors in juvenile idiopathic arthritis |
| Q81727294 | Hodgkin's lymphoma associated with anti-TNF use in juvenile idiopathic arthritis: supplemental case report |
| Q73789426 | Hodgkin's lymphoma in systemic onset juvenile rheumatoid arthritis after treatment with low dose methotrexate |
| Q35794642 | Homocysteine and lipid profile in children with Juvenile Idiopathic Arthritis. |
| Q78012747 | Hormones, sex ratios and juvenile rheumatoid arthritis |
| Q59330117 | Hospital clinical pathways for children affected by juvenile idiopathic arthritis |
| Q50864941 | How I treat juvenile idiopathic arthritis: A state of the art review. |
| Q39521686 | How accurate are diagnoses for rheumatoid arthritis and juvenile idiopathic arthritis in the general practice research database? |
| Q98898023 | How children and adolescents with juvenile idiopathic arthritis participate in their healthcare: health professionals' views |
| Q38847169 | How common is clinically inactive disease in a prospective cohort of patients with juvenile idiopathic arthritis? The importance of definition |
| Q38720413 | How common is remission in juvenile idiopathic arthritis: A systematic review |
| Q30369714 | How do parents of children with juvenile idiopathic arthritis (JIA) perceive their therapies? |
| Q59321079 | How important is early magnetic resonance imaging of the temporomandibular joint for the treatment of children with juvenile idiopathic arthritis: a retrospective analysis |
| Q68196671 | Human leukocyte antigen-DRB1*1104 in the chronic iridocyclitis of pauciarticular juvenile rheumatoid arthritis |
| Q70312967 | Human monoclonal anti-T cell antibody from a patient with juvenile rheumatoid arthritis |
| Q69809543 | Human parvovirus B19 infection and juvenile chronic polyarthritis |
| Q46478973 | Hydroxychloroquine does not decrease serum methotrexate concentrations in children with juvenile idiopathic arthritis |
| Q72962263 | Hydroxyproline in blood plasma and urine in patients with juvenile chronic polyarthritis |
| Q74582772 | Hypercalciuria and hematuria in juvenile rheumatoid arthritis |
| Q51637374 | Hypercalciuria in children with juvenile rheumatoid arthritis: association with hematuria. |
| Q44441193 | Hyperhomocysteinemia in children with juvenile idiopathic arthritis is not influenced by methotrexate treatment and folic acid supplementation: a pilot study |
| Q83506262 | Hypersensitive joint reaction after etanercept treatment in a patient with juvenile rheumatoid arthritis |
| Q71133665 | Hypertrophic bursopathy of the subacromial-subdeltoid bursa in juvenile rheumatoid arthritis: sonographic appearance |
| Q67335699 | Hypnotherapy in a Case of Juvenile Rheumatoid Arthritis |
| Q36901665 | Hypocomplementemia associated with macrophage activation syndrome in systemic juvenile idiopathic arthritis and adult onset still's disease: 3 cases. |
| Q70285165 | Hypogammaglobulinemia associated with gold therapy in a patient with juvenile rheumatoid arthritis |
| Q104283196 | Hypogonadotropic Hypogonadism and Juvenile Idiopathic Arthritis in an African Boy: What is the Pathophysiological Link? |
| Q45195005 | Hypohistidinemia in juvenile rheumatoid arthritis |
| Q60459644 | Hypoxic synovial environment and expression of macrophage inflammatory protein 3γ/CCL20 in juvenile idiopathic arthritis |
| Q35935473 | IDO1 Deficiency Does Not Affect Disease in Mouse Models of Systemic Juvenile Idiopathic Arthritis and Secondary Hemophagocytic Lymphohistiocytosis. |
| Q84681262 | IGF-I and IGF-binding proteins in articular exudates of children with post-traumatic knee damage and juvenile idiopathic arthritis |
| Q28078134 | IL-1 Inhibition in Systemic Juvenile Idiopathic Arthritis |
| Q92051567 | IL-18 as a biomarker linking systemic juvenile idiopathic arthritis and macrophage activation syndrome |
| Q92268019 | IL-18 as therapeutic target in a patient with resistant systemic juvenile idiopathic arthritis and recurrent macrophage activation syndrome |
| Q70068330 | IL-2 production in the autologous mixed lymphocyte reaction of patients with juvenile rheumatoid arthritis |
| Q96110761 | IL-21+ CD4+ T helper cells co-expressing IFN-γ and TNF-α accumulate in the joints of antinuclear antibody positive patients with juvenile idiopathic arthritis |
| Q95568944 | IL-27 levels are low in enthesitis-related arthritis category of juvenile idiopathic arthritis |
| Q93491869 | IL-6 as a therapeutic target in systemic-onset juvenile idiopathic arthritis |
| Q52330721 | IL-6 blockade in systemic juvenile idiopathic arthritis - achievement of inactive disease and remission (data from the German AID-registry). |
| Q38661146 | IL-6 blockers in systemic onset juvenile idiopathic arthritis |
| Q64913787 | IL-6 gene polymorphism in rheumatoid arthritis, pauciarticular juvenile rheumatoid arthritis, systemic lupus erythematosus, and in healthy Danes. |
| Q35954465 | IL1 and TNF gene polymorphisms in patients with juvenile idiopathic arthritis treated with TNF inhibitors |
| Q45107680 | IL1 gene polymorphisms in enthesitis related arthritis category of juvenile idiopathic arthritis (ERA-JIA). |
| Q83126597 | IL10 promoter polymorphisms are associated with systemic onset juvenile idiopathic arthritis (SoJIA) |
| Q52612756 | IL1RN Variation Influences both Disease Susceptibility and Response to Human Recombinant IL-1RA Therapy in Systemic Juvenile Idiopathic Arthritis. |
| Q53490070 | IL23R gene polymorphism with juvenile idiopathic arthritis and its association with serum IL-17A. |
| Q51272181 | INTERMITTENT CORTICOSTEROID THERAPY OF JUVENILE RHEUMATOID ARTHRITIS. |
| Q68559851 | Ibuprofen suspension in the treatment of juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group |
| Q92857704 | Identification of Ocular Autoantigens Associated With Juvenile Idiopathic Arthritis-Associated Uveitis |
| Q64111505 | Identification of Target Genes at Juvenile Idiopathic Arthritis GWAS Loci in Human Neutrophils |
| Q77123678 | Identification of Th subsets in juvenile rheumatoid arthritis confirmed by intracellular cytokine staining |
| Q73313516 | Identification of a genetic risk factor for systemic juvenile rheumatoid arthritis in the 5'-flanking region of the TNFalpha gene and HLA genes |
| Q82804342 | Identification of a novel candidate locus for juvenile idiopathic arthritis at 14q13.2 in the Latvian population by association analysis with microsatellite markers |
| Q29417156 | Identification of a novel susceptibility locus for juvenile idiopathic arthritis by genome-wide association analysis. |
| Q35764588 | Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis |
| Q47802260 | Identification of childhood arthritis in archaeological material: juvenile rheumatoid arthritis versus juvenile spondyloarthropathy |
| Q83988775 | Identification of dendritic cells in the blood and synovial fluid of children with Juvenile Idiopathic Arthritis |
| Q58792295 | Identification of enhanced IFN-γ signaling in polyarticular juvenile idiopathic arthritis with mass cytometry |
| Q70637500 | Identification of nonsteroidal antiinflammatory drug-induced gastroduodenal injury in children with juvenile rheumatoid arthritis |
| Q39171371 | Identification of potential peripheral blood diagnostic biomarkers for patients with juvenile idiopathic arthritis by bioinformatics analysis |
| Q46107362 | Identification of predictive parameters of juvenile idiopathic arthritis among a cohort of patients with muskoloskeletal pain |
| Q55101796 | Identification of rare genetic variants in Juvenile Idiopathic Arthritis using whole exome sequencing. |
| Q46968069 | Identification of the best cut-off points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis |
| Q44688787 | Identification of the best cutoff points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis |
| Q35911608 | Identification, frequency, activation and function of CD4+ CD25(high)FoxP3+ regulatory T cells in children with juvenile idiopathic arthritis |
| Q98384019 | Identifying acute lymphoblastic leukemia mimicking juvenile idiopathic arthritis in children |
| Q94913389 | Identifying clinically meaningful severity categories for PROMIS pediatric measures of anxiety, mobility, fatigue, and depressive symptoms in juvenile idiopathic arthritis and childhood-onset systemic lupus erythematosus |
| Q42322137 | Idiopathic Pulmonary Hemosiderosis in a Child with Recurrent Macrophage Activation Syndrome Secondary to Systemic Juvenile Idiopathic Arthritis |
| Q36910284 | IgA transglutaminase levels in children with Juvenile Idiopathic Arthritis |
| Q72116860 | IgE anti-IgG antibodies in patients with juvenile and adult rheumatoid arthritis including Felty's syndrome |
| Q33568779 | IgG, IgA, IgM, and IgD antiglobulins in juvenile rheumatoid arthritis |
| Q54036342 | IgG1 deficiency and high IgA level with juvenile idiopathic arthritis. |
| Q68948890 | IgM rheumatoid factor plaque-forming cells in juvenile rheumatoid arthritis |
| Q45745801 | Illness representation in adolescents with juvenile idiopathic arthritis |
| Q47211986 | Illness trajectories in Mexican children with juvenile idiopathic arthritis and their parents. |
| Q37950543 | Imaging approaches for evaluating peripheral joint abnormalities in juvenile idiopathic arthritis |
| Q94603909 | Imaging assessment of children presenting with suspected or known juvenile idiopathic arthritis: ESSR-ESPR points to consider |
| Q99720914 | Imaging based uveitis surveillance in juvenile idiopathic arthritis: feasibility, acceptability and diagnostic performance |
| Q45746152 | Imaging in early-onset juvenile idiopathic arthritis: ultrasonography (US) and MRI favours conventional radiography in detecting early inflammatory changes in joints |
| Q38123145 | Imaging in juvenile idiopathic arthritis (JIA): an update with particular emphasis on MRI. |
| Q48518130 | Imaging in juvenile idiopathic arthritis - international initiatives and ongoing work. |
| Q38072130 | Imaging in juvenile idiopathic arthritis with a focus on ultrasonography. |
| Q37704024 | Imaging juvenile idiopathic arthritis: assessing the modalities. |
| Q88678208 | Imaging of Juvenile Idiopathic Arthritis |
| Q36495242 | Imaging of juvenile idiopathic arthritis |
| Q28073565 | Imaging of juvenile idiopathic arthritis. Part I: Clinical classifications and radiographs |
| Q27694359 | Imaging of juvenile idiopathic arthritis. Part II: Ultrasonography and MRI |
| Q85733939 | Imaging of juvenile idiopathic arthritis: a multimodality approach |
| Q36823980 | Imaging of juvenile rheumatoid arthritis |
| Q53818687 | Imaging of temporomandibular joint abnormalities in juvenile idiopathic arthritis with a focus on developing a magnetic resonance imaging protocol. |
| Q90903235 | Imaging of the Temporomandibular Joint in Juvenile Idiopathic Arthritis: How Does Quantitative Compare to Semiquantitative MRI Scoring? |
| Q88687472 | Imaging of the hip in juvenile idiopathic arthritis |
| Q39336896 | Imaging of the temporomandibular joint in juvenile idiopathic arthritis. |
| Q37425610 | Imaging of the temporomandibular joint in juvenile rheumatoid arthritis |
| Q40923599 | Imbalance of Th17 and T-regulatory cells in peripheral blood and synovial fluid in treatment naïve children with juvenile idiopathic arthritis |
| Q34027661 | Immature cell populations and an erythropoiesis gene-expression signature in systemic juvenile idiopathic arthritis: implications for pathogenesis |
| Q98467818 | Immature neutrophil signature associated with the sexual dimorphism of systemic juvenile idiopathic arthritis |
| Q26744653 | Immune Complexes in Juvenile Idiopathic Arthritis |
| Q36899687 | Immune abnormalities in the pathogenesis of juvenile rheumatoid arthritis |
| Q68509546 | Immune abnormalities in the pathogenesis of juvenile rheumatoid arthritis |
| Q77964424 | Immune complexes contain immunoglobulin A rheumatoid factor in serum and synovial fluid of patients with polyarticular juvenile rheumatoid arthritis |
| Q70934986 | Immune complexes from sera of patients with juvenile rheumatoid arthritis reveal novel 40 and 60 kd bands |
| Q71711644 | Immune complexes in juvenile rheumatoid arthritis: a comparison of 4 methods |
| Q70456383 | Immune complexes in juvenile rheumatoid arthritis: a comparison of four methods |
| Q46041743 | Immune responses to the Escherichia coli dnaJ heat shock protein in juvenile rheumatoid arthritis and their correlation with disease activity |
| Q73337132 | Immunity to cartilage link protein in patients with juvenile rheumatoid arthritis |
| Q43503121 | Immunity to soluble retinal antigen in patients with uveitis accompanying juvenile rheumatoid arthritis |
| Q37785741 | Immunogenetics of early onset pauciarticular juvenile rheumatoid arthritis |
| Q26797502 | Immunogenetics of juvenile idiopathic arthritis: A comprehensive review |
| Q36695274 | Immunogenetics of rheumatoid arthritis and juvenile arthritis |
| Q38636507 | Immunogenicity and safety of influenza vaccination in patients with juvenile idiopathic arthritis on biological therapy using the microneutralization assay |
| Q42260852 | Immunogenicity and safety of the bivalent HPV vaccine in female patients with juvenile idiopathic arthritis: a prospective controlled observational cohort study |
| Q40117399 | Immunogenicity and safety of the inactivated hepatitis A vaccine in children with juvenile idiopathic arthritis on methotrexate treatment: a matched case-control study |
| Q91950335 | Immunogenicity of biologic agents in juvenile idiopathic arthritis: a systematic review and meta-analysis |
| Q43864560 | Immunogenicity, safety and tolerability of MF59-adjuvanted seasonal influenza vaccine in children with juvenile idiopathic arthritis |
| Q42203501 | Immunogenicity, safety and tolerability of a bivalent human papillomavirus vaccine in adolescents with juvenile idiopathic arthritis |
| Q68342351 | Immunoglobulin D (IgD) in childhood. II. Serum IgD levels in juvenile rheumatoid arthritis |
| Q78526470 | Immunoglobulin E-rheumatoid factor in juvenile rheumatoid arthritis |
| Q40322254 | Immunoglobulin light chain levels can be used to determine disease stage in children with juvenile idiopathic arthritis |
| Q69868810 | Immunoglobulins, anti-IgG antibodies and antinuclear antibodies in paired serum and synovial fluid samples. A comparison between juvenile and adult rheumatoid arthritis |
| Q46018398 | Immunohistochemical study of chronic nongranulomatous anterior uveitis in juvenile idiopathic arthritis. |
| Q70047037 | Immunologic studies in identical twins concordant for juvenile rheumatoid arthritis but discordant for monoclonal gammopathy and amyloidosis |
| Q47732956 | Immunologic studies of juvenile rheumatoid arthritis |
| Q67710597 | Immunological aspects of etiopathogenesis in juvenile rheumatoid arthritis (proceedings) |
| Q40788062 | Immunological aspects of juvenile rheumatoid arthritis. |
| Q33559048 | Immunological characteristics and T-cell receptor clonal diversity in children with systemic juvenile idiopathic arthritis undergoing T-cell-depleted autologous stem cell transplantation |
| Q43718809 | Immunological patterns in monoarticular juvenile rheumatoid arthritis |
| Q67001476 | Immunological studies in juvenile rheumatoid arthritis |
| Q71113976 | Immunological studies in juvenile rheumatoid arthritis |
| Q90196409 | Immunome perturbation is present in patients with juvenile idiopathic arthritis who are in remission and will relapse upon anti-TNFα withdrawal |
| Q59271469 | Immunomodulatory actions of methotrexate on T cells in juvenile idiopathic arthritis |
| Q33742030 | Immunopathogenesis of juvenile rheumatoid arthritis |
| Q41088712 | Immunopathogenesis of juvenile rheumatoid arthritis: role of T cells and MHC. |
| Q44943451 | Immunoregulatory aberrations in patients with polyarticular juvenile rheumatoid arthritis |
| Q44069579 | Immunoregulatory defects in juvenile rheumatoid arthritis. Comparison between patients with the systemic or polyarticular forms |
| Q39577447 | Immunoregulatory drugs in the treatment of juvenile rheumatoid arthritis (JRA). |
| Q37695730 | Immunosenescence and juvenile idiopathic arthritis |
| Q41211941 | Immunosuppressant therapy of juvenile rheumatoid arthritis |
| Q51074474 | Immunosuppressive Activity of Abatacept on Circulating T Helper Lymphocytes from Juvenile Idiopathic Arthritis Patients. |
| Q42596856 | Immunosuppressive Therapy with Cyclosporin A of Severe Treatment Refractory Juvenile Rheumatoid Arthritis. |
| Q35891404 | Immunosuppressive drugs in the management of progressive, corticosteroid-resistant uveitis associated with juvenile rheumatoid arthritis |
| Q37340335 | Impact of Antiinflammatory Treatment on the Onset of Uveitis in Juvenile Idiopathic Arthritis: Longitudinal Analysis From a Nationwide Pediatric Rheumatology Database |
| Q90624051 | Impact of IL1RN Variants on Response to Interleukin-1 Blocking Therapy in Systemic Juvenile Idiopathic Arthritis |
| Q36159528 | Impact of Juvenile Idiopathic Arthritis Associated Uveitis in Early Adulthood |
| Q47434154 | Impact of Uveitis on Quality of Life in Adult Patients With Juvenile Idiopathic Arthritis |
| Q35637479 | Impact of anti-TNF treatment on growth in severe juvenile idiopathic arthritis |
| Q57153830 | Impact of biologics on disease course in systemic onset juvenile idiopathic arthritis |
| Q46065159 | Impact of biologics on growth in children with juvenile idiopathic arthritis |
| Q96232436 | Impact of core stability exercises on bone mineralization and functional capacity in children with polyarticular juvenile idiopathic arthritis: a randomized clinical trial |
| Q45744220 | Impact of involvement of individual joint groups on subdimensions of functional ability scales in juvenile idiopathic arthritis |
| Q62741456 | Impact of involvement of individual joint groups on subdimensions of functional ability scales in juvenile idiopathic arthritis |
| Q40672929 | Impact of juvenile idiopathic arthritis on quality of life during transition period at the era of biotherapies |
| Q34536685 | Impact of juvenile idiopathic arthritis on schooling |
| Q45975049 | Impact of medication withdrawal method on flare-free survival in patients with juvenile idiopathic arthritis on combination therapy. |
| Q55435500 | Impact of systemic juvenile idiopathic arthritis/Still's disease on adolescents as evidenced through social media posts. |
| Q64074567 | Impaired Muscular Fat Metabolism in Juvenile Idiopathic Arthritis in Inactive Disease |
| Q33568597 | Impaired delayed hypersensitivity in juvenile rheumatoid arthritis |
| Q70045512 | Impaired in vivo and in vitro antibody responses to bacteriophage phi X 174 in juvenile rheumatoid arthritis |
| Q44509799 | Impaired mandibular function and its possible effect on mandibular growth in juvenile rheumatoid arthritis |
| Q41136838 | Impaired mandibular growth and micrognathic development in children with juvenile rheumatoid arthritis. A longitudinal study of lateral cephalographs |
| Q84437906 | Impaired suppression of synovial fluid CD4+CD25- T cells from patients with juvenile idiopathic arthritis by CD4+CD25+ Treg cells |
| Q39869234 | Impairment of microcirculation in juvenile idiopathic arthritis - studies by nailfold videocapillaroscopy and correlation with serum levels of sICAM and VEGF. |
| Q53378103 | Implant survival and patient-reported outcomes after total hip arthroplasty in young patients with juvenile idiopathic arthritis. |
| Q42363584 | Implementation of musculoskeletal ultrasonography in detection of early juvenile idiopathic arthritis |
| Q92558699 | Implications of juvenile idiopathic arthritis genetic risk variants for disease pathogenesis and classification |
| Q38185951 | Importance of adherence in the outcome of juvenile idiopathic arthritis |
| Q91950854 | Importance of pediatric rheumatologists and transitional care for juvenile idiopathic arthritis-associated uveitis: a retrospective series of 9 cases |
| Q37974586 | Importance of recognizing and preventing blindness from juvenile idiopathic arthritis-associated uveitis |
| Q40133584 | Improvement in health-related quality of life for children with juvenile idiopathic arthritis after start of treatment with etanercept |
| Q43419169 | Improvement of functional ability in children with juvenile idiopathic arthritis by treatment with etanercept |
| Q81825465 | Improvement of reduced serum cartilage oligomeric matrix protein levels in systemic juvenile idiopathic arthritis patients treated with the anti-interleukin-6 receptor monoclonal antibody tocilizumab |
| Q61831322 | Improvements in growth parameters in children with juvenile idiopathic arthritis associated with the effect of methotrexate on disease activity |
| Q35834311 | Improving adherence to medical regimens for juvenile rheumatoid arthritis |
| Q52274800 | Improving compliance with medical regimens: case study with juvenile rheumatoid arthritis. |
| Q47595071 | Improving the evidence base for treatment of juvenile idiopathic arthritis: the challenge and opportunity facing the MCRN/ARC Paediatric Rheumatology Clinical Studies Group |
| Q84006155 | Improving the quality of care in children with juvenile idiopathic arthritis: a step in the right direction |
| Q90421762 | Improving treatment of the temporomandibular joint in juvenile idiopathic arthritis: let's face it |
| Q40872834 | In Vitro Mitogen Stimulation of Synovial Fluid Lymphocytes from Rheumatoid Arthritis and Juvenile Rheumatoid Arthritis Patients: Dissociation between the Response to Antigens and Polyclonal Mitogens |
| Q84585317 | In a child presenting with features consistent with a diagnosis of juvenile idiopathic arthritis, what clinical features or laboratory findings (at presentation) predict a diagnosis of acute lymphoblastic leukaemia? |
| Q36152966 | In juvenile idiopathic arthritis, is folate supplementation effective against methotrexate toxicity at the expense of methotrexate's efficacy? |
| Q39210343 | In the Pursuit of Methotrexate Treatment Response Biomarker in Juvenile Idiopathic Arthritis-Are We Getting Closer to Personalised Medicine? |
| Q61755132 | In vitro Autoreactivity against Skin and Synovial Cells in Patients with Juvenile Idiopathic and Rheumatoid Arthritis |
| Q46511119 | In vitro autoreactivity against autologous keratinocytes in patients with rheumatoid and juvenile idiopathic arthritis. |
| Q59268821 | In vitro effects of etanercept on the development of different T cell subsets in patients with juvenile idiopathic arthritis |
| Q71521474 | In vitro immune response of human peripheral lymphocytes. VII. Effect of anti-mu and anti-delta antibodies on B colony formation and detection of abnormal B cells in patients with juvenile rheumatoid arthritis |
| Q68100788 | In vitro immunoglobulin production by lymphocytes of patients with juvenile rheumatoid arthritis: effects of Staphylococcus aureus Cowan I stimulation and monocyte depletion |
| Q73867204 | In vitro induction of proinflammatory cytokine secretion by juvenile rheumatoid arthritis synovial fluid immune complexes |
| Q84080062 | Inactive disease in polyarticular juvenile idiopathic arthritis: current patterns and associations |
| Q84803392 | Inadequate dietary intake of children and adolescents with juvenile idiopathic arthritis and systemic lupus erythematosus |
| Q43838933 | Incidence and outcomes of uveitis in juvenile rheumatoid arthritis, a synthesis of the literature |
| Q40078094 | Incidence and predictors of Uveitis in juvenile idiopathic arthritis in a Nordic long-term cohort study. |
| Q42625969 | Incidence and prevalence of juvenile idiopathic arthritis among children in a managed care population, 1996-2009. |
| Q45903387 | Incidence and prevalence of juvenile idiopathic arthritis in Catalonia (Spain). |
| Q41547963 | Incidence of herpes zoster infections in juvenile idiopathic arthritis patients |
| Q50803341 | Incidence of juvenile idiopathic arthritis in children in Estonia: a prospective population-based study. |
| Q44362078 | Incidence of juvenile idiopathic arthritis in the Nordic countries. A population based study with special reference to the validity of the ILAR and EULAR criteria |
| Q39623636 | Incidence of malignancies in patients with juvenile idiopathic arthritis: A retrospective single-center cohort study in Germany |
| Q80686450 | Incidence of temporomandibular involvement in juvenile idiopathic arthritis |
| Q91476366 | Incidence, Clinical Manifestations, and Severity of Juvenile Idiopathic Arthritis Among Maori and Pacific Island Children |
| Q40271742 | Incomplete Kawasaki disease followed by systemic onset juvenile idiopathic arthritis- the diagnostic dilemma. |
| Q40389269 | Incomplete Kawasaki syndrome followed by systemic onset-juvenile idiopathic arthritis mimicking Kawasaki syndrome |
| Q40373887 | Incomplete, atypical kawasaki disease or evolving systemic juvenile idiopathic arthritis: a case report |
| Q67531450 | Increase in CD5+ B cells in juvenile rheumatoid arthritis. Relationship to IgM rheumatoid factor expression and disease activity |
| Q57127349 | Increase of duodenal and ileal mucosal cytotoxic lymphocytes in juvenile idiopathic arthritis |
| Q36502282 | Increased Fas and Bcl-2 expression on peripheral blood T and B lymphocytes from juvenile-onset systemic lupus erythematosus, but not from juvenile rheumatoid arthritis and juvenile dermatomyositis |
| Q90965585 | Increased T Cell Plasticity With Dysregulation of Follicular Helper T, Peripheral Helper T, and Treg Cell Responses in Children With Juvenile Idiopathic Arthritis and Down Syndrome-Associated Arthritis |
| Q47907119 | Increased autophagy contributes to the inflammatory phenotype of juvenile idiopathic arthritis synovial fluid T cells. |
| Q59313415 | Increased body adiposity in severe juvenile idiopathic arthritis |
| Q35856745 | Increased carotid artery intima-media thickness and myeloperoxidase level in children with newly diagnosed juvenile idiopathic arthritis |
| Q67268920 | Increased circulating basophils in juvenile rheumatoid arthritis. A preliminary report |
| Q73101180 | Increased circulating vascular endothelial growth factor is correlated with disease activity in polyarticular juvenile rheumatoid arthritis |
| Q47762924 | Increased expression of alpha(1,3)-fucosyltransferase-VII and P-selectin binding of synovial fluid T cells in juvenile idiopathic arthritis |
| Q44388758 | Increased frequency of extremely skewed X chromosome inactivation in juvenile idiopathic arthritis |
| Q37049286 | Increased frequency of the MZ phenotype of alpha-1-protease inhibitor in juvenile chronic polyarthritis |
| Q47368371 | Increased interleukin-18 expression in bone marrow of a patient with systemic juvenile idiopathic arthritis and unrecognized macrophage-activation syndrome |
| Q81650496 | Increased interleukin-18 in patients with juvenile idiopathic arthritis and early attachment loss |
| Q91796854 | Increased methotrexate intolerance in juvenile idiopathic arthritis compared to acute lymphoblastic leukaemia in children |
| Q44795907 | Increased mortality in adults with a history of juvenile rheumatoid arthritis: a population-based study |
| Q69129036 | Increased prevalence of W27 in juvenile rheumatoid arthritis |
| Q82184614 | Increased prevalence of antithyroid antibodies and subclinical hypothyroidism in children with juvenile idiopathic arthritis |
| Q73537544 | Increased prevalence of dental caries and poor oral hygiene in juvenile idiopathic arthritis |
| Q74479847 | Increased prevalence of familial autoimmunity in simplex and multiplex families with juvenile rheumatoid arthritis |
| Q42170027 | Increased replication of CD4+ naive T cells and changes in T cell homeostasis in a case of acute exacerbation of juvenile idiopathic arthritis: a case comparison study |
| Q35863409 | Increasing feasibility and patient comfort of MRI in children with juvenile idiopathic arthritis |
| Q34769495 | Independent confirmation of juvenile idiopathic arthritis genetic risk loci previously identified by immunochip array analysis |
| Q36710494 | Independent replication analysis of genetic loci with previous evidence of association with juvenile idiopathic arthritis. |
| Q70442757 | Indication for and evaluation of synovectomy in juvenile rheumatoid arthritis (primary chronic polyarthritis) |
| Q44819142 | Indications and method of gold therapy in juvenile rheumatoid arthritis |
| Q67316665 | Indications and results of chemical synovialectomy using varicocid in children with juvenile rheumatoid arthritis |
| Q54546389 | Indications for a disturbed peripheral T-cell homeostasis in juvenile idiopathic arthritis (JIA): absent expansion of CD28 T-cells and no decrease of naive T-cells in cytomegalovirus-positive patients with JIA. |
| Q46963365 | Indirect comparison of etanercept and abatacept efficacy and safety in patients with polyarticular juvenile idiopathic arthritis. |
| Q73987784 | Induction of invasive and degradative phenotype in normal synovial fibroblasts exposed to synovial fluid from patients with juvenile rheumatoid arthritis: role of mononuclear cell population |
| Q43008535 | Induction of metalloproteinases expression by TLR ligands in human fibroblast like synoviocytes from juvenile idiopathic arthritis patients |
| Q40653028 | Infantile-onset multisystem inflammatory disease: a differential diagnosis of systemic juvenile rheumatoid arthritis |
| Q80488259 | Infection of an urachal cyst during etanercept therapy in juvenile idiopathic arthritis |
| Q37288106 | Infection-Related Death among Persons with Refractory Juvenile Idiopathic Arthritis. |
| Q37463702 | Infections in children and adolescents with juvenile idiopathic arthritis and inflammatory bowel disease treated with tumor necrosis factor-α inhibitors: systematic review of the literature |
| Q46963621 | Infectious adverse effects during treatment with IL-1 inhibitors in patients with systemic juvenile idiopathic arthritis and autoinflammatory diseases |
| Q92341944 | Infectious adverse events in children with Juvenile Idiopathic Arthritis treated with Biological Agents in a real-life setting: Data from the JIRcohorte |
| Q38093095 | Infectious complications in juvenile idiopathic arthritis |
| Q62111737 | Inflammation in Juvenile Idiopathic Arthritis |
| Q36093568 | Inflammation in juvenile idiopathic arthritis. |
| Q96429715 | Inflammatory Bowel Disease in Children with Systemic Juvenile Idiopathic Arthritis |
| Q40536475 | Inflammatory Bowel Disease in Juvenile Idiopathic Arthritis Patients Treated with Biologics |
| Q38742750 | Inflammatory Gene Expression Profile and Defective Interferon-γ and Granzyme K in Natural Killer Cells From Systemic Juvenile Idiopathic Arthritis Patients |
| Q50905430 | Inflammatory Markers and Disease Activity in Juvenile Idiopathic Arthritis. |
| Q91006405 | Inflammatory Response 24 h Post-Exercise in Youth with Juvenile Idiopathic Arthritis |
| Q38910734 | Inflammatory bowel disease following anti-interleukin-1-treatment in systemic juvenile idiopathic arthritis |
| Q36617892 | Inflammatory cytokines and systemic-onset juvenile idiopathic arthritis |
| Q57232009 | Inflammatory cytokines in juvenile idiopathic arthritis: Effects on physical growth and the insulin-like-growth factor axis |
| Q38738097 | Inflammatory disorders of the vertebral column: seronegative spondyloarthropathies, adult-onset rheumatoid arthritis, and juvenile chronic arthritis |
| Q69305471 | Inflammatory synovial T cells in different activity subgroups of patients with rheumatoid arthritis and juvenile rheumatoid arthritis |
| Q35760145 | Infliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritis |
| Q36266391 | Infliximab for juvenile idiopathic arthritis-associated uveitis |
| Q83436284 | Infliximab for progressive peripheral ulcerative keratitis in a patient with juvenile rheumatoid arthritis |
| Q74141350 | Infliximab for systemic onset juvenile idiopathic arthritis: experience in 3 children |
| Q41850533 | Infliximab or etanercept in the treatment of children with refractory juvenile idiopathic arthritis: an open label study |
| Q90708284 | Infliximab therapy and outcomes in patients with polyarticular juvenile idiopathic arthritis: a single-center study in China |
| Q45745754 | Infliximab to treat chronic uveitis in juvenile idiopathic arthritis (JIA). |
| Q55429624 | Influence of Reduced Folate Carrier and Aminoimidazole Carboxamide Ribonucleotide Transformylase gene polymorphisms on the efficacy of methotrexate in juvenile idiopathic arthritis. |
| Q41813478 | Influence of etanercept on leptin and ghrelin secretion in children with juvenile idiopathic arthritis. |
| Q46687499 | Influence of methylenetetrahydrofolate reductase polymorphisms on efficacy and toxicity of methotrexate in patients with juvenile idiopathic arthritis. |
| Q36762031 | Influence of past breast feeding on pattern and severity of presentation of juvenile idiopathic arthritis |
| Q34580608 | Influence of polymorphisms within the methotrexate pathway genes on the toxicity and efficacy of methotrexate in patients with juvenile idiopathic arthritis |
| Q46936552 | Influence of proteolytic-antiproteolytic enzymes and prooxidative-antioxidative factors on proteoglycan alterations in children with juvenile idiopathic arthritis |
| Q90842709 | Infrapatellar Ganglion Cyst of the Knee Fat Pad in a Child with Juvenile Idiopathic Arthritis |
| Q57538156 | Infrapatellar bursitis in children with juvenile idiopathic arthritis: a case series |
| Q80409630 | Inherited multicentric osteolysis with carpal-tarsal localisation mimicking juvenile idiopathic arthritis |
| Q36270422 | Inherited predisposition to iridocyclitis with juvenile rheumatoid arthritis: selectivity among HLA-DR5 haplotypes |
| Q80038584 | Inhibited apoptosis of synovial fluid lymphocytes in children with juvenile idiopathic arthritis is associated with increased expression of myeloid cell leukemia 1 and XIAP proteins |
| Q37857938 | Inhibition of IL6 in rheumatoid arthritis and juvenile idiopathic arthritis |
| Q100546703 | Initial Occurrence of Bilateral Anterior Uveitis in a Patient with Juvenile Idiopathic Arthritis following Discontinuation of Topical Steroids after Bilateral Strabismus Surgery |
| Q38054430 | Initial manifestations and clinical course of systemic onset juvenile idiopathic arthritis: a ten-year retrospective study. |
| Q97595381 | Initiating disease-modifying anti-rheumatic drugs rapidly reduces purchases of analgesic drugs in juvenile idiopathic arthritis |
| Q46947105 | Initiating etanercept in a once weekly dose in children with juvenile idiopathic arthritis |
| Q90119961 | Innately Adaptive or Truly Autoimmune: Is There Something Unique About Systemic Juvenile Idiopathic Arthritis? |
| Q59044785 | Innovations and Challenges by Applying Sublingual Laser Blood Irradiation in Juvenile Idiopathic Arthritis |
| Q91859110 | Insufficient IL-10 Production as a Mechanism Underlying the Pathogenesis of Systemic Juvenile Idiopathic Arthritis |
| Q43558331 | Intense immunosuppression followed by purified blood CD34+ cell autografting in a patient with refractory juvenile rheumatoid arthritis |
| Q90748105 | Inter- and intra-observer reliability of contrast-enhanced magnetic resonance imaging parameters in children with suspected juvenile idiopathic arthritis of the hip |
| Q52953688 | Inter- and intrareader variability in the interpretation of two radiographic classification systems for juvenile rheumatoid arthritis. |
| Q52975161 | Inter-observer agreement of the physician's global assessment of disease activity in children with juvenile idiopathic arthritis. |
| Q59697446 | Interaction between HLA-DR and HLA-DP, and Between HLA and interleukin 1α in juvenile rheumatoid arthritis indicates heterogeneity of pathogenic mechanisms of the disease |
| Q73167906 | Interactions between children with juvenile rheumatoid arthritis and their mothers |
| Q52574001 | Interactive Dialogue-Based Patient Education for Juvenile Idiopathic Arthritis Using Argument Theory. |
| Q91171542 | Interdisciplinary Management of Dentofacial Deformity in Juvenile Idiopathic Arthritis |
| Q46861140 | Interferon-gamma (IFNy) in macrophage activation syndrome (MAS) associated with systemic juvenile idiopathic arthritis (sJIA). High levels in patients and a role in a murine mas model. |
| Q77624682 | Interferon-gamma:interleukin 4 ratios and associated type 1 cytokine expression in juvenile rheumatoid arthritis synovial tissue |
| Q57578981 | Interleukin 10 and transforming growth factor beta 1 gene polymorphisms in juvenile idiopathic arthritis |
| Q83178350 | Interleukin 11 and paired immunoglobulin-like type 2 receptor alpha expression correlates with the number of joints with active arthritis in systemic juvenile idiopathic arthritis |
| Q80510869 | Interleukin 17 levels are increased in juvenile idiopathic arthritis synovial fluid and induce synovial fibroblasts to produce proinflammatory cytokines and matrix metalloproteinases |
| Q79892842 | Interleukin 18 as a marker of disease activity and severity in patients with juvenile idiopathic arthritis |
| Q74151333 | Interleukin 1beta mediated calciotropic activity in serum of children with juvenile rheumatoid arthritis |
| Q41515557 | Interleukin 6 and autoantibodies in juvenile rheumatoid arthritis. |
| Q34228665 | Interleukin 6 as a therapeutic target in systemic-onset juvenile idiopathic arthritis |
| Q78108584 | Interleukin 8 and monocyte chemoattractant protein-1 in patients with juvenile rheumatoid arthritis. Relation to onset types, disease activity, and synovial fluid leukocytes |
| Q91935988 | Interleukin-1 Blockade in Systemic Juvenile Idiopathic Arthritis |
| Q89179188 | Interleukin-1 in monocyte activation phenotypes in systemic juvenile idiopathic arthritis: Observations from a clinical trial of rilonacept, an interleukin-1 inhibitor |
| Q40436579 | Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France |
| Q58133794 | Interleukin-17A Levels Increase in Serum of Children With Juvenile Idiopathic Arthritis |
| Q80539821 | Interleukin-18 as a mediator of systemic juvenile idiopathic arthritis |
| Q85435935 | Interleukin-18 for predicting the development of macrophage activation syndrome in systemic juvenile idiopathic arthritis |
| Q88635867 | Interleukin-33 as a marker of disease activity in rheumatoid factor positive polyarticular juvenile idiopathic arthritis |
| Q40420469 | Interleukin-6 as a pathogenic factor of systemic-onset juvenile idiopathic arthritis |
| Q91239796 | Interleukin-6 in juvenile idiopathic arthritis |
| Q49711229 | Interleukin-6 overproduction correlates with disease activity and severity in juvenile idiopathic arthritis. |
| Q53623301 | Interleukin-6 signalling in juvenile idiopathic arthritis is limited by proteolytically cleaved soluble interleukin-6 receptor. |
| Q51427530 | Intermediate monocytes are increased in enthesitis-related arthritis, a category of juvenile idiopathic arthritis. |
| Q28242221 | International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001 |
| Q40556352 | Internet Program for Physical Activity and Exercise Capacity in Children With Juvenile Idiopathic Arthritis: A Multicenter Randomized Controlled Trial. |
| Q52950822 | Interobserver reliability of articular examination in juvenile idiopathic arthritis. |
| Q70393447 | Interphalangeal joint involvement in Gaucher's disease, type I, resembling juvenile rheumatoid arthritis |
| Q45927110 | Interpretation of the Juvenile Arthritis Disease Activity Score: responsiveness, clinically important differences and levels of disease activity in prospective cohorts of patients with juvenile idiopathic arthritis. |
| Q81505185 | Intestinal immune activation in juvenile idiopathic arthritis and connective tissue disease |
| Q96349900 | Intestinal microbiota and juvenile idiopathic arthritis: current understanding and future prospective |
| Q46963333 | Intolerance in oral versus subcutaneous administration of methotrexate in patients with juvenile idiopathic arthritis: a cross-sectional, observational study. |
| Q35281013 | Intra-articular calcifications in a child with juvenile rheumatoid arthritis |
| Q57675074 | Intra-articular corticoid injection induces circulating glucocorticoid bioactivity and systemic immune activation in juvenile idiopathic arthritis |
| Q35070930 | Intra-articular corticosteroid injections in juvenile idiopathic arthritis |
| Q59399454 | Intra-articular corticosteroid injections in juvenile idiopathic arthritis |
| Q48193213 | Intra-articular corticosteroid injections to the temporomandibular joints are safe and appear to be effective therapy in children with juvenile idiopathic arthritis |
| Q37692255 | Intra-articular corticosteroid therapy for juvenile idiopathic arthritis: report of an experiential cohort and literature review |
| Q37358118 | Intra-articular corticosteroids in the treatment of juvenile idiopathic arthritis: Safety, efficacy, and features affecting outcome. A comprehensive review of the literature |
| Q77329147 | Intra-articular corticosteroids in the treatment of juvenile rheumatoid arthritis |
| Q38761381 | Intra-articular corticosteroids versus intra-articular corticosteroids plus methotrexate in oligoarticular juvenile idiopathic arthritis: a multicentre, prospective, randomised, open-label trial. |
| Q34929326 | Intra-articular glucocorticoid injections in patients with juvenile idiopathic arthritis in a Singapore hospital. |
| Q88899830 | Intra-articular injection in patients with juvenile idiopathic arthritis: factors associated with a good response |
| Q95561323 | Intra-articular injection in patients with juvenile idiopathic arthritis: factors associated with a good response |
| Q91651485 | Intra-articular joint injections in juvenile idiopathic arthritis: state of the art |
| Q38076914 | Intra-articular steroid injection for temporomandibular joint arthritis in juvenile idiopathic arthritis: A systematic review on efficacy and safety |
| Q24244793 | Intra-articular steroids and splints/rest for children with juvenile idiopathic arthritis and adults with rheumatoid arthritis |
| Q80862930 | Intra-articular steroids in radiologically confirmed tarsal and hip synovitis of juvenile idiopathic arthritis |
| Q80230213 | Intra-articular triamcinolone: new indication. Juvenile idiopathic arthritis: several months of relief |
| Q67442587 | Intraarticular activation of the complement system in patients with juvenile rheumatoid arthritis |
| Q72104595 | Intraarticular alpha 2-macroglobulin complexes and proteolytic activity in children with juvenile rheumatoid arthritis |
| Q37132958 | Intraarticular corticosteroid injections of the temporomandibular joint in juvenile idiopathic arthritis. |
| Q95512109 | Intraarticular infliximab therapy in patients with juvenile idiopathic arthritis: the role of musculoskeletal ultrasound and disease activity scores in monitoring therapy response |
| Q46171803 | Intraarticular triamcinolone in juvenile idiopathic arthritis. |
| Q39634758 | Intrahepatic cholestasis after gold therapy in juvenile rheumatoid arthritis |
| Q34697678 | Intraocular biomarker identification in uveitis associated with juvenile idiopathic arthritis |
| Q79261156 | Intraocular lens implantation in patients with juvenile idiopathic arthritis-associated uveitis |
| Q41023723 | Intraocular lens implantation in patients with juvenile rheumatoid arthritis |
| Q71225119 | Intraocular lens implantation in patients with juvenile rheumatoid arthritis-associated uveitis: an unresolved management issue |
| Q80164324 | Intraoperative intraocular triamcinolone injection prophylaxis for post-cataract surgery fibrin formation in uveitis associated with juvenile idiopathic arthritis |
| Q81661313 | Intraoral condition in children with juvenile idiopathic arthritis compared to controls |
| Q64080058 | Intravenous abatacept in Japanese patients with polyarticular-course juvenile idiopathic arthritis: results from a phase III open-label study |
| Q92787454 | Intravenous dosing of tocilizumab in patients younger than two years of age with systemic juvenile idiopathic arthritis: results from an open-label phase 1 clinical trial |
| Q67664031 | Intravenous gamma globulin therapy in systemic juvenile rheumatoid arthritis |
| Q24244815 | Intravenous immunoglobulin for juvenile idiopathic arthritis |
| Q71304215 | Intravenous immunoglobulin in the treatment of polyarticular juvenile rheumatoid arthritis: a phase I/II study. Pediatric Rheumatology Collaborative Study Group |
| Q40693776 | Intravenous immunoglobulin in the treatment of systemic juvenile rheumatoid arthritis: a randomized placebo controlled trial. Pediatric Rheumatology Collaborative Study Group. |
| Q40669161 | Intravenous immunoglobulin therapy in systemic onset juvenile rheumatoid arthritis: a followup study |
| Q40363551 | Intravenous immunoglobulin therapy leading to dramatic improvement in a patient with systemic juvenile idiopathic arthritis and severe pericarditis resistant to steroid pulse therapy. |
| Q31130038 | Intravenous laser blood irradiation increases efficacy of etanercept in selected subtypes of juvenile idiopathic arthritis: an innovative clinical research approach |
| Q48138135 | Intravoxel incoherent motion magnetic resonance imaging of the knee joint in children with juvenile idiopathic arthritis |
| Q45744245 | Investigating the use of a limited core outcome variable set for the classification of response following methotrexate treatment in juvenile idiopathic arthritis (JIA). |
| Q45744260 | Investigating which variables from the core outcome variables in juvenile idiopathic arthritis (JIA) are the best predictors of classification as a responder to treatment with methotrexate (MTX). |
| Q85275917 | Investigation of Complement-activating Pattern Recognition Molecules and Associated Enzymes as Possible Inflammatory Markers in Oligoarticular and Systemic Juvenile Idiopathic Arthritis |
| Q44152615 | Investigation of juvenile idiopathic arthritis susceptibility loci: results from a Greek population |
| Q36033341 | Investigation of rheumatoid arthritis susceptibility loci in juvenile idiopathic arthritis confirms high degree of overlap |
| Q34409772 | Investigation of type 1 diabetes and coeliac disease susceptibility loci for association with juvenile idiopathic arthritis. |
| Q38917814 | Investigational drugs for treatment of juvenile idiopathic arthritis |
| Q64112732 | Investigations of cellular immunity in juvenile idiopathic arthritis |
| Q43623585 | Involvement of the Hip in Juvenile Rheumatoid Arthritis: A Radiological Study with Special Reference to Growth Disturbances |
| Q67383798 | Involvement of the facial skeleton in juvenile rheumatoid arthritis |
| Q68437096 | Involvement of the hip in juvenile rheumatoid arthritis. A longitudinal study |
| Q78934910 | Involvement of the hips in juvenile rheumatoid arthritis |
| Q45832762 | Iridocyclisis Associated with Juvenile Rheumatoid Arthritis |
| Q54736591 | Iridocyclitis Associated with Juvenile Rheumatoid Arthritis |
| Q75761165 | Iridocyclitis and bandshaped corneal opacity in juvenile rheumatoid arthritis |
| Q70560590 | Iridocyclitis and pauciarticular juvenile rheumatoid arthritis |
| Q53748766 | Iridocyclitis in juvenile rheumatoid arthritis. |
| Q70679210 | Iris protein antibodies in serum of patients with juvenile rheumatoid arthritis and uveitis |
| Q50559499 | Iron status during anti-TNF therapy in children with juvenile idiopathic arthritis. |
| Q86552205 | Is Antibiotic Exposure Associated With Newly Diagnosed Juvenile Idiopathic Arthritis? |
| Q52838301 | Is Gut Microbial LPS a Potential Trigger of Juvenile Idiopathic Arthritis? |
| Q50526847 | Is Intra-Articular Steroid Injection to the Temporomandibular Joint for Juvenile Idiopathic Arthritis More Effective and Efficient When Performed With Image Guidance? |
| Q49051133 | Is complementary and alternative healthcare use associated with better outcomes in children with juvenile idiopathic arthritis? |
| Q36357837 | Is early TMJ involvement in children with juvenile idiopathic arthritis clinically detectable? Clinical examination of the TMJ in comparison with contrast enhanced MRI in patients with juvenile idiopathic arthritis |
| Q36886704 | Is high-resolution ultrasonography suitable for the detection of temporomandibular joint involvement in children with juvenile idiopathic arthritis? |
| Q40386469 | Is hydrotherapy cost-effective? A randomised controlled trial of combined hydrotherapy programmes compared with physiotherapy land techniques in children with juvenile idiopathic arthritis |
| Q33992259 | Is it juvenile rheumatoid arthritis or fibromyalgia? |
| Q88929591 | Is it possible to predict a risk of osteoporosis in patients with juvenile idiopathic arthritis? A study of serum levels of bone turnover markers |
| Q37775937 | Is it time to move to active comparator trials in juvenile idiopathic arthritis?: a review of current study designs |
| Q46966656 | Is it worth allowing the presence of morning stiffness in the definition of inactive disease in juvenile idiopathic arthritis? |
| Q46862311 | Is it worth including subtalar joint in ultrasound ankle assessment of patients with juvenile idiopathic arthritis? |
| Q43919991 | Is juvenile rheumatoid arthritis a late complication of German measles? |
| Q46508689 | Is juvenile rheumatoid arthritis/juvenile idiopathic arthritis different from rheumatoid arthritis? |
| Q58439059 | Is measurement of IgM and IgA rheumatoid factors (RF) in juvenile rheumatoid arthritis clinically useful? |
| Q37144097 | Is parental coping associated with quality of life in juvenile idiopathic arthritis? |
| Q92515085 | Is power Doppler ultrasound useful to evaluate temporomandibular joint inflammatory activity in juvenile idiopathic arthritis? |
| Q74267057 | Is systemic juvenile rheumatoid arthritis an interleukin 6 mediated disease? |
| Q41454847 | Is the enthesitis-related arthritis subtype of juvenile idiopathic arthritis a form of chronic reactive arthritis? |
| Q46326722 | Is there a link between Escherichia coli septicemia and the onset of systemic lupus erythematosus? Comment on: overlapping juvenile idiopathic arthritis and systemic lupus erythematosus: a case report (Rheumatol Int. 2011 May; 31(5):695-698). |
| Q83193426 | Is there a relationship between juvenile idiopathic arthritis and periodontitis? |
| Q51792930 | Is there a role for arthroscopic synovectomy in oligoarticular juvenile idiopathic arthritis? |
| Q46966740 | Is there an evidence for the role of multidisciplinary team in the management of active juvenile idiopathic arthritis? |
| Q37866723 | Is there any relationship between Chlamydophila pneumoniae infection and juvenile idiopathic arthritis? |
| Q46726249 | Is there hope for juvenile idiopathic arthritis patient-reported outcomes in support of clinical decisions? |
| Q83403717 | Is this acute lymphoblastic leukaemia or juvenile rheumatoid arthritis |
| Q81944138 | Is tocilizumab a good therapeutic option for RA and systemic-onset juvenile idiopathic arthritis? |
| Q84283809 | Is tocilizumab an effective option for treatment of refractory uveitis associated with juvenile idiopathic arthritis? |
| Q37984272 | Is ultrasound a validated imaging tool for the diagnosis and management of synovitis in juvenile idiopathic arthritis? A systematic literature review |
| Q38597227 | Isolated Arthritis of the Temporomandibular Joint as the Initial Manifestation of Juvenile Idiopathic Arthritis. |
| Q39451168 | Isolated digital swelling as the initial presentation of juvenile rheumatoid arthritis |
| Q80884200 | Isolated inflammatory coxitis associated with protrusio acetabuli: a new form of juvenile idiopathic arthritis? |
| Q86183128 | Isolated proximal tibiofibular joint arthritis in a patient with juvenile idiopathic arthritis: A case report |
| Q43685290 | Isolated temporomandibular synovitis as unique presentation of juvenile idiopathic arthritis |
| Q77930283 | Isolated tuberculosis monoarthritis mimicking juvenile rheumatoid arthritis |
| Q31984717 | Isolated tuberculous monoarthritis mimicking oligoarticular juvenile rheumatoid arthritis. |
| Q48635654 | It is time to rethink juvenile idiopathic arthritis classification and nomenclature. |
| Q87059259 | Italian perspective on psoriasis, spondyloarthritis, rheumatoid arthritis and juvenile idiopathic arthritis: immunopathology and role of etanercept. Abstracts of a Seminars in Research. October 14-15, 2011. Italy |
| Q92388070 | JAK inhibitors in refractory juvenile idiopathic arthritis-associated uveitis |
| Q84011441 | JAMA patient page. Juvenile idiopathic arthritis |
| Q55041288 | JAMA patient page. Juvenile idiopathic arthritis. |
| Q40883747 | JRA (juvenile rheumatoid arthritis( and rhematic fever; problems in diagnosis |
| Q44613094 | JRA (juvenile rheumatoid arthritis) and RA (rheumatoid arthritis) in adult |
| Q69654146 | JRA--a juvenile form of rheumatoid arthritis? |
| Q91117537 | JUVENILE IDIOPATHIC ARTHRITIS AND VITAMIN D STATUS IN UKRAINIAN PATIENTS |
| Q78488846 | JUVENILE RHEUMATOID ARTHRITIS |
| Q36060519 | JUVENILE RHEUMATOID ARTHRITIS. A FOLLOW-UP OF 75 CASES. |
| Q67947061 | Jaw deformity caused by juvenile rheumatoid arthritis and its correction |
| Q41361488 | Joint cartilage thickness and automated determination of bone age and bone health in juvenile idiopathic arthritis |
| Q45810752 | Joint cartilage thickness measured by ultrasound in juvenile idiopathic arthritis |
| Q39040899 | Joint hypermobility and oligoarticular juvenile idiopathic arthritis: What relationship? |
| Q46861901 | Joint inflammation assessed by physical examination and MRI of the knee in juvenile idiopathic arthritis: low predictive value for synovitis |
| Q39377681 | Joint lavage for treating recurrent knee involvement in patients with juvenile idiopathic arthritis |
| Q43916956 | Joint pain in childhood. A proposal of guidelines for differential diagnosis of juvenile rheumatoid arthritis |
| Q40471327 | Joint replacement surgery in juvenile rheumatoid arthritis |
| Q43925195 | Jointly managing arthritis: information needs of children with juvenile idiopathic arthritis (JIA) and their parents |
| Q38563021 | Journeys of adjustment: the experiences of adolescents living with juvenile idiopathic arthritis |
| Q38248905 | Judicious use of biologicals in juvenile idiopathic arthritis |
| Q73140480 | Juvenile (chronic) arthritis is not juvenile rheumatoid arthritis |
| Q33572045 | Juvenile Idiopathic Arthritis |
| Q56385543 | Juvenile Idiopathic Arthritis |
| Q87969429 | Juvenile Idiopathic Arthritis - Changing Times, Changing Terms, Changing Treatments |
| Q88508698 | Juvenile Idiopathic Arthritis Associated with Combined JP-HHT Syndrome: A Novel Phenotype Associated with a Novel Variant in SMAD4 |
| Q38617547 | Juvenile Idiopathic Arthritis Practice Patterns Among Oral and Maxillofacial Surgeons |
| Q58490195 | Juvenile Idiopathic Arthritis and Athletic Participation: Are We Adequately Preparing for Sports Integration? |
| Q91916478 | Juvenile Idiopathic Arthritis and Role of Anti CCP Antibody |
| Q91153155 | Juvenile Idiopathic Arthritis and the Gut Microbiome: More Clues, More Questions |
| Q92990300 | Juvenile Idiopathic Arthritis for the Pediatric Orthopedic Surgeon |
| Q37258323 | Juvenile Idiopathic Arthritis in Olmsted County, Minnesota, 1960-2013. |
| Q30235998 | Juvenile Idiopathic Arthritis in the Era of International Cooperation |
| Q53180131 | Juvenile Idiopathic Arthritis with Rice Bodies in a 2-Year-Old Girl. |
| Q84347779 | Juvenile Idiopathic Arthritis with temporomandibular joint involvement: functional treatment |
| Q91427901 | Juvenile Idiopathic Arthritis-Education, Knowledge, and Patient Outcomes |
| Q91274136 | Juvenile Idiopathic Arthritis: A Focus on Pharmacologic Management |
| Q91312135 | Juvenile Idiopathic Arthritis: An Idea Whose Time Has Gone? |
| Q28079246 | Juvenile Idiopathic Arthritis: Diagnosis and Treatment |
| Q90184602 | Juvenile Idiopathic Arthritis: Diffusion-weighted MRI in the Assessment of Arthritis in the Knee |
| Q90383245 | Juvenile Idiopathic Arthritis: Oligoarthritis and Polyarthritis |
| Q91542031 | Juvenile Idiopathic Arthritis: Roma Children Seem to Run More Risk than Non-Roma |
| Q55006074 | Juvenile Rheumatoid Arthritis |
| Q93833169 | Juvenile Rheumatoid Arthritis |
| Q45971944 | Juvenile Rheumatoid Arthritis (Volume six in the Review of Major Problems in Pediatrics). |
| Q67327810 | Juvenile Rheumatoid Arthritis and Systemic Lupus Erythematosus in the Adolescent |
| Q35038478 | Juvenile Rheumatoid Arthritis: A general review and report of 100 patients observed for 15 years |
| Q72220926 | Juvenile Rheumatoid Arthritis: Introduction to the Symposium |
| Q43486731 | Juvenile and adult rheumatoid arthritis. A comparison |
| Q43755894 | Juvenile ankylosing spondylitis (JAS) and juvenile rheumatoid arthritis (JRA) |
| Q46381362 | Juvenile arthritis disease activity score (JADAS) based on C-reactive protein predicts DMARD treatment in juvenile idiopathic arthritis in a Nordic multicenter cohort. |
| Q42957810 | Juvenile arthritis disease activity score is a better reflector of active disease than the disease activity score 28 in adults with polyarticular juvenile idiopathic arthritis. |
| Q73508088 | Juvenile chronic arthritis in adult life: a study of long-term outcome in patients with juvenile chronic arthritis or adult rheumatoid arthritis |
| Q71092718 | Juvenile chronic arthritis with persistently positive tests for rheumatoid factor (sero-positive juvenile rheumatoid arthritis) |
| Q38014937 | Juvenile chronic arthritis, juvenile rheumatoid arthritis, and inflammatory arthropathies of childhood |
| Q38892681 | Juvenile chronic polyarthritis in Ugandan African children. |
| Q72461305 | Juvenile chronic polyarthritis in the hand |
| Q44365325 | Juvenile chronic polyarthritis: clinical sub-groups and response to medication |
| Q40873225 | Juvenile hip pain. 1. Transitory coxitis, rheumatoid coxitis or juvenile rheumatoid arthritis, specific and unspecific coxitis, Perthes diseases |
| Q44125764 | Juvenile idiopathic arthritis |
| Q74627313 | Juvenile idiopathic arthritis |
| Q79870371 | Juvenile idiopathic arthritis |
| Q81632370 | Juvenile idiopathic arthritis |
| Q83877889 | Juvenile idiopathic arthritis |
| Q84072681 | Juvenile idiopathic arthritis |
| Q84388566 | Juvenile idiopathic arthritis |
| Q85105722 | Juvenile idiopathic arthritis |
| Q87834809 | Juvenile idiopathic arthritis |
| Q45745954 | Juvenile idiopathic arthritis (JIA) and early diagnosis of temporo-mandibular joint (TMJ) disorders |
| Q59268802 | Juvenile idiopathic arthritis (JIA) in two tertiary centres in the Western Cape, South Africa |
| Q24674620 | Juvenile idiopathic arthritis (JIA) is primarily associated with HLA-DR8 but not DQ4 on the DR8-DQ4 haplotype |
| Q39876834 | Juvenile idiopathic arthritis (JIA): a screening study to measure class II skeletal pattern, TMJ PDS and use of systemic corticosteroids. |
| Q59268696 | Juvenile idiopathic arthritis (JIA): can an integrated medicine be possible? |
| Q37950506 | Juvenile idiopathic arthritis - an update on pharmacotherapy |
| Q88687467 | Juvenile idiopathic arthritis - the role of imaging from a rheumatologist's perspective |
| Q38154943 | Juvenile idiopathic arthritis - what the clinician needs to know |
| Q40253129 | Juvenile idiopathic arthritis activity and function ability: deleterious effects in periodontal disease? |
| Q50604822 | Juvenile idiopathic arthritis among Nigerians: a case study. |
| Q34048785 | Juvenile idiopathic arthritis and HLA class I and class II interactions and age-at-onset effects |
| Q81918031 | Juvenile idiopathic arthritis and HSP60 vaccination: selective down-regulation? |
| Q40462080 | Juvenile idiopathic arthritis and Lyme disease: a case report |
| Q59268651 | Juvenile idiopathic arthritis and Wegener granulomatosis: causal or casual relationship? |
| Q84228976 | Juvenile idiopathic arthritis and Wegener's granulomatosis--causal or casual acquaintances? |
| Q38088183 | Juvenile idiopathic arthritis and enthesitis-related arthropathies |
| Q39907942 | Juvenile idiopathic arthritis and exposure to fine particulate air pollution |
| Q36932550 | Juvenile idiopathic arthritis and future risk for cardiovascular disease: a multicenter study |
| Q38159458 | Juvenile idiopathic arthritis and malignancy |
| Q26749516 | Juvenile idiopathic arthritis and oral health |
| Q87032043 | Juvenile idiopathic arthritis and pain -- more than simple nociception |
| Q38455651 | Juvenile idiopathic arthritis and physical activity: possible inflammatory and immune modulation and tracks for interventions in young populations |
| Q46641320 | Juvenile idiopathic arthritis and rheumatoid arthritis: bacterial diversity in temporomandibular joint synovial fluid in comparison with immunological and clinical findings |
| Q91673495 | Juvenile idiopathic arthritis and risk of cancer before and after the introduction of biological therapies |
| Q46128158 | Juvenile idiopathic arthritis and risk of cancer: a nationwide cohort study |
| Q90326843 | Juvenile idiopathic arthritis and the gut microbiome: Where are we now? |
| Q38754117 | Juvenile idiopathic arthritis and the temporomandibular joint: A comprehensive review |
| Q33289007 | Juvenile idiopathic arthritis and uveitis: epidemiology including data from a national database |
| Q44951561 | Juvenile idiopathic arthritis and uveitis: screening and anti-inflammatory therapy |
| Q74589205 | Juvenile idiopathic arthritis and uveitis: the classification conundrum |
| Q43260844 | Juvenile idiopathic arthritis associated uveitis in adults: a case series |
| Q93020577 | Juvenile idiopathic arthritis associated with a mutation in GATA3 |
| Q43049601 | Juvenile idiopathic arthritis associated with autoimmune hepatitis type 2. |
| Q74395446 | Juvenile idiopathic arthritis associated with autoimmune thyroid disorders and autoimmune cholangitis |
| Q58565527 | Juvenile idiopathic arthritis at school: who understands? |
| Q51925418 | Juvenile idiopathic arthritis classification criteria: loopholes and diagnosis software. |
| Q45963542 | Juvenile idiopathic arthritis classification. |
| Q78328689 | Juvenile idiopathic arthritis classified by the ILAR criteria: HLA associations in UK patients |
| Q35588819 | Juvenile idiopathic arthritis coexisting with sickle cell disease: two case reports |
| Q40696660 | Juvenile idiopathic arthritis complicated by amyloidosis with secondary nephrotic syndrome - effective treatment with tocilizumab |
| Q102073759 | Juvenile idiopathic arthritis fibroblast-like synoviocytes influence chondrocytes to alter BMP antagonist expression demonstrating an interaction between the two prominent cell types involved in endochondral bone formation |
| Q93026092 | Juvenile idiopathic arthritis flare due to rice bodies in the knee of a 10-year-old girl |
| Q24806352 | Juvenile idiopathic arthritis genetics - what's new? What's next? |
| Q94954974 | Juvenile idiopathic arthritis in Southeast Asia: the Singapore experience over two decades |
| Q97592533 | Juvenile idiopathic arthritis in a center in the Western Anatolia region in Turkey |
| Q46967656 | Juvenile idiopathic arthritis in a child with nijmegen breakage syndrome |
| Q88389783 | Juvenile idiopathic arthritis in a patient with previous diagnosis of severe congenital lupus |
| Q103837155 | Juvenile idiopathic arthritis in a premature baby: rare case report |
| Q84511590 | Juvenile idiopathic arthritis in adulthood and orthopaedic intervention |
| Q37312650 | Juvenile idiopathic arthritis in adulthood: fulfilment of classification criteria for adult rheumatic diseases, long-term outcomes and predictors of inactive disease, functional status and damage |
| Q91951315 | Juvenile idiopathic arthritis in infants with Harlequin Ichthyosis: two cases report and literature review |
| Q52930952 | Juvenile idiopathic arthritis in multicase families. |
| Q38781266 | Juvenile idiopathic arthritis in multiplex families: longitudinal follow-up |
| Q38247202 | Juvenile idiopathic arthritis in relation to maternal prenatal smoking |
| Q33660104 | Juvenile idiopathic arthritis in relation to perinatal and maternal characteristics: a case control study. |
| Q61895915 | Juvenile idiopathic arthritis in the biologic era: predictors of the disease progression and need for early introduction of biologic treatment |
| Q100416482 | Juvenile idiopathic arthritis in the lumbosacral spine of a toddler: Periarticular osteopenia in a rare location |
| Q38104461 | Juvenile idiopathic arthritis in the new world of biologics |
| Q36552319 | Juvenile idiopathic arthritis in two tertiary centres in the Western Cape, South Africa |
| Q45745807 | Juvenile idiopathic arthritis is a diagnosis of exclusion |
| Q46511053 | Juvenile idiopathic arthritis is associated to a functionally active polymorphism in the SH2D2A gene. |
| Q97542158 | Juvenile idiopathic arthritis is associated with higher healthcare utilization after total knee or hip replacement |
| Q46380741 | Juvenile idiopathic arthritis is associated with potentially pathogenic glycosylation of IgG. |
| Q58569345 | Juvenile idiopathic arthritis managed in the new millennium: one year outcomes of an inception cohort of Australian children |
| Q40340373 | Juvenile idiopathic arthritis morbidity rate in rural and urban areas of Poland 2008-2012. |
| Q33442369 | Juvenile idiopathic arthritis of peripheral joints: quality of reporting of diagnostic accuracy of conventional MRI. |
| Q38173941 | Juvenile idiopathic arthritis of the axial joints: a systematic review of the diagnostic accuracy and predictive value of conventional MRI. |
| Q38284640 | Juvenile idiopathic arthritis overview and involvement of the temporomandibular joint: prevalence, systemic therapy |
| Q87081566 | Juvenile idiopathic arthritis patients and their skeletal status: possible role of vitamin D receptor gene polymorphism |
| Q91149971 | Juvenile idiopathic arthritis patients have a distinct cartilage and bone biomarker profile that differs from healthy and knee-injured children |
| Q61988183 | Juvenile idiopathic arthritis patients with low inflammatory activity have increased adiposity |
| Q40335244 | Juvenile idiopathic arthritis presenting with prolonged fever |
| Q80914906 | Juvenile idiopathic arthritis profile in Turkish children |
| Q87979545 | Juvenile idiopathic arthritis subtype- and sex-specific associations with genetic variants in the PSMA6/PSMC6/PSMA3 gene cluster |
| Q81804705 | Juvenile idiopathic arthritis treated by methotrexate: result of treatment and tolerance |
| Q55031958 | Juvenile idiopathic arthritis treated with biological therapies. |
| Q59268644 | Juvenile idiopathic arthritis with dry synovitis: clinical and imaging aspects in a cohort of 6 patients |
| Q80175677 | Juvenile idiopathic arthritis with peripheral gangrene |
| Q44051137 | Juvenile idiopathic arthritis with pulmonary hemosiderosis: a case report. |
| Q81886708 | Juvenile idiopathic arthritis with rice bodies |
| Q86994716 | Juvenile idiopathic arthritis, mitral valve prolapse and a familial variant involving the integrin-binding fragment of FBN1 |
| Q37620418 | Juvenile idiopathic arthritis--current and future therapies |
| Q38024971 | Juvenile idiopathic arthritis-and now?: a systematic literature review of changes in craniofacial morphology |
| Q91921538 | Juvenile idiopathic arthritis-associated uveitis |
| Q54453680 | Juvenile idiopathic arthritis-associated uveitis at an Italian tertiary referral center: clinical features and complications. |
| Q83853425 | Juvenile idiopathic arthritis-associated uveitis complicated by glaucoma and Brown's syndrome |
| Q34950552 | Juvenile idiopathic arthritis-associated uveitis. |
| Q33576645 | Juvenile idiopathic arthritis-associated uveitis: Data from a region in western Greece. |
| Q34935503 | Juvenile idiopathic arthritis-associated uveitis: a nationwide population-based study in Taiwan |
| Q90499047 | Juvenile idiopathic arthritis-associated uveitis: a retrospective analysis from a centre of South Italy |
| Q38129935 | Juvenile idiopathic arthritis-associated uveitis: clinical features and complications, risk factors for severe course, and visual outcome |
| Q79959889 | Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss |
| Q40323217 | Juvenile idiopathic arthritis-its rare presentation |
| Q37223370 | Juvenile idiopathic arthritis-related uveitis |
| Q92931086 | Juvenile idiopathic arthritis-related uveitis mimicking endophthalmitis |
| Q81483153 | Juvenile idiopathic arthritis-type disease associated with chromosomal aberrations |
| Q51581341 | Juvenile idiopathic arthritis. |
| Q55041965 | Juvenile idiopathic arthritis. |
| Q37613133 | Juvenile idiopathic arthritis. Subgroup characteristics and comparisons between rheumatoid arthritis-like subgroups and ankylosing spondylitis-like subgroups. |
| Q45244853 | Juvenile idiopathic arthritis. Thoughts on the current classification |
| Q41533868 | Juvenile idiopathic arthritis: Diagnosis and differential diagnosis |
| Q49596624 | Juvenile idiopathic arthritis: Evidence of gut-driven inflammation in new JIA. |
| Q92358842 | Juvenile idiopathic arthritis: Old disease, new tactics |
| Q53678961 | Juvenile idiopathic arthritis: a chronic pediatric musculoskeletal condition with significant orofacial manifestations. |
| Q33859586 | Juvenile idiopathic arthritis: a clinical overview |
| Q36438325 | Juvenile idiopathic arthritis: a review for the pediatrician |
| Q46966794 | Juvenile idiopathic arthritis: a single center Lebanese study |
| Q35622981 | Juvenile idiopathic arthritis: an update |
| Q38069215 | Juvenile idiopathic arthritis: an update for the clinician |
| Q36446368 | Juvenile idiopathic arthritis: an update on clinical and therapeutic approaches. |
| Q38092899 | Juvenile idiopathic arthritis: an update on current pharmacotherapy and future perspectives. |
| Q37831878 | Juvenile idiopathic arthritis: can you recognize this complex diagnosis? |
| Q37639013 | Juvenile idiopathic arthritis: classification, clinical presentation and current treatments. |
| Q37159227 | Juvenile idiopathic arthritis: clinically relevant imaging in diagnosis and monitoring |
| Q46966629 | Juvenile idiopathic arthritis: cross-sectional study of incidence and prevalence observed in a tertiary center of spain. |
| Q36407354 | Juvenile idiopathic arthritis: current and future treatment options |
| Q38119720 | Juvenile idiopathic arthritis: current practical imaging assessment with emphasis on magnetic resonance imaging |
| Q37159231 | Juvenile idiopathic arthritis: how can the radiologist help the clinician? |
| Q84916833 | Juvenile idiopathic arthritis: improved outcome requires improved access to care |
| Q38057634 | Juvenile idiopathic arthritis: in adolescence and beyond |
| Q48299174 | Juvenile idiopathic arthritis: magnetic resonance imaging of the clinically unaffected knee |
| Q39243858 | Juvenile idiopathic arthritis: management and therapeutic options |
| Q37866288 | Juvenile idiopathic arthritis: new insights into classification, measures of outcome, and pharmacotherapy |
| Q44325148 | Juvenile idiopathic arthritis: parent-child discrepancy on reports of pain and disability |
| Q38099754 | Juvenile idiopathic arthritis: review of the literature and case report |
| Q80855634 | Juvenile idiopathic arthritis: some progress but still many uncertainties |
| Q37762921 | Juvenile idiopathic arthritis: state of the art and future perspectives |
| Q36474955 | Juvenile idiopathic arthritis: the paediatric perspective. |
| Q46967214 | Juvenile idiopathic arthritis: the transition to adulthood |
| Q36964881 | Juvenile idiopathic arthritis: therapies in the 21st century. |
| Q87272617 | Juvenile idiopathic arthritis: updated guide to administering methotrexate |
| Q38746108 | Juvenile idiopathic arthritis: what is the utility of ultrasound? |
| Q39251791 | Juvenile idiopathic arthritis: why do I have to hurt so much? |
| Q79947385 | Juvenile idiopathic arthritis: will etanercept be an improvement over current therapies? |
| Q38757630 | Juvenile idiopathic arthritis–an update on its diagnosis and management |
| Q46244178 | Juvenile idiopathic/rheumatoid arthritis and orthognatic surgery without mandibular osteotomies in the remittent phase |
| Q43762672 | Juvenile monarticular rheumatoid arthritis |
| Q34772547 | Juvenile onset central nervous system folate deficiency and rheumatoid arthritis |
| Q51828398 | Juvenile psoriatic arthritis: longterm outcome and differentiation from other subtypes of juvenile idiopathic arthritis. |
| Q33742025 | Juvenile rheumatoid arthritis |
| Q42014534 | Juvenile rheumatoid arthritis |
| Q43837949 | Juvenile rheumatoid arthritis |
| Q60998461 | Juvenile rheumatoid arthritis |
| Q66875832 | Juvenile rheumatoid arthritis |
| Q66946724 | Juvenile rheumatoid arthritis |
| Q67321233 | Juvenile rheumatoid arthritis |
| Q67323771 | Juvenile rheumatoid arthritis |
| Q67754940 | Juvenile rheumatoid arthritis |
| Q67856292 | Juvenile rheumatoid arthritis |
| Q68327092 | Juvenile rheumatoid arthritis |
| Q68888952 | Juvenile rheumatoid arthritis |
| Q69093105 | Juvenile rheumatoid arthritis |
| Q69360310 | Juvenile rheumatoid arthritis |
| Q69511874 | Juvenile rheumatoid arthritis |
| Q69585407 | Juvenile rheumatoid arthritis |
| Q69601361 | Juvenile rheumatoid arthritis |
| Q69625537 | Juvenile rheumatoid arthritis |
| Q69921908 | Juvenile rheumatoid arthritis |
| Q69975306 | Juvenile rheumatoid arthritis |
| Q70044585 | Juvenile rheumatoid arthritis |
| Q70249249 | Juvenile rheumatoid arthritis |
| Q70307189 | Juvenile rheumatoid arthritis |
| Q70621856 | Juvenile rheumatoid arthritis |
| Q70718625 | Juvenile rheumatoid arthritis |
| Q70735167 | Juvenile rheumatoid arthritis |
| Q70879250 | Juvenile rheumatoid arthritis |
| Q71008244 | Juvenile rheumatoid arthritis |
| Q71158471 | Juvenile rheumatoid arthritis |
| Q71216663 | Juvenile rheumatoid arthritis |
| Q71617577 | Juvenile rheumatoid arthritis |
| Q71773667 | Juvenile rheumatoid arthritis |
| Q71818079 | Juvenile rheumatoid arthritis |
| Q72033399 | Juvenile rheumatoid arthritis |
| Q72111733 | Juvenile rheumatoid arthritis |
| Q72119256 | Juvenile rheumatoid arthritis |
| Q72256228 | Juvenile rheumatoid arthritis |
| Q72403127 | Juvenile rheumatoid arthritis |
| Q72794759 | Juvenile rheumatoid arthritis |
| Q73641195 | Juvenile rheumatoid arthritis |
| Q73733684 | Juvenile rheumatoid arthritis |
| Q74210876 | Juvenile rheumatoid arthritis |
| Q74319598 | Juvenile rheumatoid arthritis |
| Q74663620 | Juvenile rheumatoid arthritis |
| Q78374003 | Juvenile rheumatoid arthritis |
| Q78590838 | Juvenile rheumatoid arthritis |
| Q78596600 | Juvenile rheumatoid arthritis |
| Q79396229 | Juvenile rheumatoid arthritis |
| Q80265431 | Juvenile rheumatoid arthritis |
| Q83831909 | Juvenile rheumatoid arthritis |
| Q86946383 | Juvenile rheumatoid arthritis |
| Q87990816 | Juvenile rheumatoid arthritis |
| Q89572926 | Juvenile rheumatoid arthritis |
| Q93743175 | Juvenile rheumatoid arthritis |
| Q93836000 | Juvenile rheumatoid arthritis |
| Q94682035 | Juvenile rheumatoid arthritis |
| Q33674509 | Juvenile rheumatoid arthritis (JRA). |
| Q68321644 | Juvenile rheumatoid arthritis (Still's disease) |
| Q78770409 | Juvenile rheumatoid arthritis (Still's disease) |
| Q82099821 | Juvenile rheumatoid arthritis (Still's disease) |
| Q43762543 | Juvenile rheumatoid arthritis (Still's disease) and its orthopedic treatment |
| Q40234014 | Juvenile rheumatoid arthritis (Still's disease). |
| Q71958882 | Juvenile rheumatoid arthritis (apropos of 2 cases) |
| Q54256097 | Juvenile rheumatoid arthritis (case report). |
| Q74582663 | Juvenile rheumatoid arthritis (juvenile chronic arthritis) |
| Q71271340 | Juvenile rheumatoid arthritis (progressive chronic polyarthritis) |
| Q77764413 | Juvenile rheumatoid arthritis (study of 30 cases) |
| Q80181345 | Juvenile rheumatoid arthritis affected sibpairs: extent of clinical phenotype concordance |
| Q68007469 | Juvenile rheumatoid arthritis among Arab children |
| Q35228867 | Juvenile rheumatoid arthritis and HLA-B27 |
| Q36151780 | Juvenile rheumatoid arthritis and HLA: report of the Park City III workshop |
| Q72685828 | Juvenile rheumatoid arthritis and amyloidosis |
| Q62658765 | Juvenile rheumatoid arthritis and asthma, but not childhood-onset systemic lupus erythematosus are associated with FCRL3 polymorphisms in Mexicans |
| Q46857227 | Juvenile rheumatoid arthritis and bronchiolitis obliterans organized pneumonia |
| Q47957205 | Juvenile rheumatoid arthritis and common variable hypogammaglobulinemia. |
| Q33681550 | Juvenile rheumatoid arthritis and del(22q11) syndrome: a non-random association |
| Q77923401 | Juvenile rheumatoid arthritis and lymphoedema: lymphangiographic aspects |
| Q40727161 | Juvenile rheumatoid arthritis and macrodactyly |
| Q53709781 | Juvenile rheumatoid arthritis and milk allergy. |
| Q71177648 | Juvenile rheumatoid arthritis and neutrophil chemotaxis |
| Q72560741 | Juvenile rheumatoid arthritis and occupational therapy |
| Q66699073 | Juvenile rheumatoid arthritis and related collagen diseases. Clinical aspects (author's transl) |
| Q47898261 | Juvenile rheumatoid arthritis and renal amyloidosis (case report). |
| Q67375579 | Juvenile rheumatoid arthritis and scleromalacia perforans |
| Q40921591 | Juvenile rheumatoid arthritis and spondyloarthropathies |
| Q77329143 | Juvenile rheumatoid arthritis and spondyloarthropathies |
| Q34015162 | Juvenile rheumatoid arthritis and the spondyloarthropathies |
| Q38789686 | Juvenile rheumatoid arthritis and the spondyloarthropathies in children |
| Q40389060 | Juvenile rheumatoid arthritis and the trimolecular complex (HLA, T cell receptor, and antigen). Differences from rheumatoid arthritis |
| Q71458518 | Juvenile rheumatoid arthritis and uveitis: minimizing the blinding complications |
| Q40861256 | Juvenile rheumatoid arthritis appearing after hepatitis. Causal or casual relationship |
| Q33770760 | Juvenile rheumatoid arthritis as a complex genetic trait |
| Q67858078 | Juvenile rheumatoid arthritis associated with iridocyclitis |
| Q67577554 | Juvenile rheumatoid arthritis at University of Florida: six-year experience |
| Q67373987 | Juvenile rheumatoid arthritis causing hip dislocation. Case report |
| Q67390988 | Juvenile rheumatoid arthritis in 3 siblings |
| Q41591293 | Juvenile rheumatoid arthritis in African Americans. |
| Q69439534 | Juvenile rheumatoid arthritis in Auckland: a long term follow-up study with particular reference to uveitis |
| Q67885215 | Juvenile rheumatoid arthritis in Caribbean children: a clinical characterization |
| Q33929255 | Juvenile rheumatoid arthritis in India--rarity of antinuclear antibody and uveitis |
| Q78639022 | Juvenile rheumatoid arthritis in New York City; 161 cases |
| Q50712916 | Juvenile rheumatoid arthritis in Nigerian children |
| Q51023793 | Juvenile rheumatoid arthritis in Rochester, Minnesota 1960-1993. Is the epidemiology changing? |
| Q41446492 | Juvenile rheumatoid arthritis in Turner's syndrome |
| Q46413661 | Juvenile rheumatoid arthritis in Zambian children |
| Q43878103 | Juvenile rheumatoid arthritis in a Canadian First Nations (aboriginal) population: onset subtypes and HLA associations |
| Q72446497 | Juvenile rheumatoid arthritis in a mother and her identical twin sons |
| Q67933522 | Juvenile rheumatoid arthritis in a rhesus monkey (Macaca mulatta) |
| Q50925158 | Juvenile rheumatoid arthritis in affected sibpairs. |
| Q44312535 | Juvenile rheumatoid arthritis in children with Ebstein Barr virus infection. |
| Q72094776 | Juvenile rheumatoid arthritis in children with diabetes mellitus |
| Q40011896 | Juvenile rheumatoid arthritis in monozygotic twins: a case report and review of the literature |
| Q40920952 | Juvenile rheumatoid arthritis in the adult presenting as fever of unknown origin |
| Q40782010 | Juvenile rheumatoid arthritis in two siblings with congenital leucocyte adhesion deficiency |
| Q72602020 | Juvenile rheumatoid arthritis in two siblings: co-existence with polyarteritis nodosa in one parent |
| Q41927681 | Juvenile rheumatoid arthritis in velo-cardio-facial syndrome: coincidence or unusual complication? |
| Q58404663 | Juvenile rheumatoid arthritis in velo‐cardio‐facial syndrome: Coincidence or unusual complication? |
| Q35640924 | Juvenile rheumatoid arthritis inflammatory eye disease. Parasitization of ocular leukocytes by mollicute-like organisms |
| Q28194658 | Juvenile rheumatoid arthritis manifesting in only limping due to flexion contraction of the knee |
| Q40843388 | Juvenile rheumatoid arthritis of a systemic form in a young infant |
| Q70480288 | Juvenile rheumatoid arthritis of the foot |
| Q67717085 | Juvenile rheumatoid arthritis of the knee: MR evaluation with Gd-DOTA |
| Q72715161 | Juvenile rheumatoid arthritis of the knee: evaluation with US |
| Q74314526 | Juvenile rheumatoid arthritis of the knee: evaluation with contrast-enhanced color Doppler ultrasound |
| Q68234416 | Juvenile rheumatoid arthritis patients manifest immune reactivity to the mycobacterial 65-kDa heat shock protein, to its 180-188 peptide, and to a partially homologous peptide of the proteoglycan link protein |
| Q72094934 | Juvenile rheumatoid arthritis persisting into adulthood |
| Q33333519 | Juvenile rheumatoid arthritis presented with thrombocytopenia |
| Q41937557 | Juvenile rheumatoid arthritis presenting as torticollis |
| Q40909768 | Juvenile rheumatoid arthritis presenting in the adult as fever of unknown origin |
| Q71281687 | Juvenile rheumatoid arthritis sparing the lower extremities in a girl with myelodysplasia |
| Q40852658 | Juvenile rheumatoid arthritis with IgA deficiency and appearance with febrile episode. |
| Q80310828 | Juvenile rheumatoid arthritis with a report of a case in a 15 month old child |
| Q34577333 | Juvenile rheumatoid arthritis with amyloid goiter: report of a case with review of the literature |
| Q33551468 | Juvenile rheumatoid arthritis with cardiac tamponade |
| Q83816315 | Juvenile rheumatoid arthritis with focal segmental glomerulosclerosis: a rare association |
| Q46722692 | Juvenile rheumatoid arthritis with myelofibrosis with myeloid metaplasia |
| Q45033072 | Juvenile rheumatoid arthritis with pauciarticular onset and HLA-A, B, DR in Italian children |
| Q70818380 | Juvenile rheumatoid arthritis with pericardial tamponade in an adult |
| Q70566187 | Juvenile rheumatoid arthritis with renal amyloidosis: a 23-year survival |
| Q41111725 | Juvenile rheumatoid arthritis with rice bodies: light and electron microscopic studies |
| Q72008313 | Juvenile rheumatoid arthritis with unusual X-ray appearance. A case report |
| Q73203777 | Juvenile rheumatoid arthritis, Crohn's disease and Turner's syndrome |
| Q71688188 | Juvenile rheumatoid arthritis, Crohn's disease and Turner's syndrome: a novel association |
| Q40887001 | Juvenile rheumatoid arthritis, Report of 12 cases |
| Q39547858 | Juvenile rheumatoid arthritis, human leukocyte antigen, and other immunoglobulin supergene family polymorphisms |
| Q35457402 | Juvenile rheumatoid arthritis, juvenile chronic arthritis, and juvenile spondyloarthropathies |
| Q39538190 | Juvenile rheumatoid arthritis--Madras experience |
| Q67233489 | Juvenile rheumatoid arthritis--a serologic survey of 200 consecutive patients |
| Q33929250 | Juvenile rheumatoid arthritis--assessment |
| Q40471180 | Juvenile rheumatoid arthritis--cardiac involvement |
| Q33929243 | Juvenile rheumatoid arthritis--clinical manifestations |
| Q68299255 | Juvenile rheumatoid arthritis--parent support group: do parents perceive a need? |
| Q67830719 | Juvenile rheumatoid arthritis-a viral disease |
| Q38491453 | Juvenile rheumatoid arthritis-like polyarthritis in Nijmegen breakage syndrome. |
| Q62111859 | Juvenile rheumatoid arthritis-like polyarthritis in chromosome 22q11.2 deletion syndrome (digeorge anomalad/velocardiofacial syndrome/conotruncal anomaly face syndrome) |
| Q44324717 | Juvenile rheumatoid arthritis. (Retrospective study of thirty cases at West Virginia University Medical Center). |
| Q45028648 | Juvenile rheumatoid arthritis. 29 Sicilian cases |
| Q71326076 | Juvenile rheumatoid arthritis. A comparison of patients from the USSR and USA |
| Q40023762 | Juvenile rheumatoid arthritis. A review. |
| Q51804086 | Juvenile rheumatoid arthritis. Anesthetic and surgical considerations. |
| Q73463813 | Juvenile rheumatoid arthritis. Aquatic exercise and lower-extremity function |
| Q44937499 | Juvenile rheumatoid arthritis. Cellular hypersensitivity and selective IgA deficiency |
| Q67397195 | Juvenile rheumatoid arthritis. Clinical analysis of 7 cases |
| Q93546200 | Juvenile rheumatoid arthritis. Diagnosis and medical management |
| Q73092645 | Juvenile rheumatoid arthritis. Effects of disease activity and recombinant human growth hormone on insulin-like growth factor 1, insulin-like growth factor binding proteins 1 and 3, and osteocalcin |
| Q40851372 | Juvenile rheumatoid arthritis. Mode of onset as key to early diagnosis and management |
| Q50893597 | Juvenile rheumatoid arthritis. Monocyte dysfunction in selected patients. |
| Q40678345 | Juvenile rheumatoid arthritis. Old challenges, new insights. |
| Q70408854 | Juvenile rheumatoid arthritis. Second edition |
| Q40874893 | Juvenile rheumatoid arthritis. Study of 46 cases |
| Q40527769 | Juvenile rheumatoid arthritis: A case report of surgical/orthodontic treatment |
| Q95532731 | Juvenile rheumatoid arthritis: A clinical approach and pharmacological management |
| Q67364258 | Juvenile rheumatoid arthritis: Characterisation of its clinical variations (author's transl) |
| Q43675800 | Juvenile rheumatoid arthritis: Clinical characteristics in 100 Thai patients |
| Q40471138 | Juvenile rheumatoid arthritis: Series 1 |
| Q40471144 | Juvenile rheumatoid arthritis: Series 2 |
| Q36758101 | Juvenile rheumatoid arthritis: The Saudi Experience |
| Q43805162 | Juvenile rheumatoid arthritis: a 14-year posttreatment evaluation |
| Q68654220 | Juvenile rheumatoid arthritis: a child crippled |
| Q34768086 | Juvenile rheumatoid arthritis: a guide for pediatricians |
| Q35935073 | Juvenile rheumatoid arthritis: a medical and social profile of non-Indian and Indian children |
| Q39920235 | Juvenile rheumatoid arthritis: a review |
| Q41777252 | Juvenile rheumatoid arthritis: a serological survey of 200 consecutive patients |
| Q69246859 | Juvenile rheumatoid arthritis: assessment with MR imaging |
| Q73910192 | Juvenile rheumatoid arthritis: benefits from massage therapy |
| Q67910642 | Juvenile rheumatoid arthritis: cases from the coalfields |
| Q71243013 | Juvenile rheumatoid arthritis: cervical spine involvement and MRI in early diagnosis |
| Q78567789 | Juvenile rheumatoid arthritis: challenges and pitfalls in diagnosis and treatment |
| Q40471158 | Juvenile rheumatoid arthritis: clinicoradiologic correlations |
| Q40961641 | Juvenile rheumatoid arthritis: current concepts and practice. |
| Q73686959 | Juvenile rheumatoid arthritis: ethnic differences in diagnostic types |
| Q35960540 | Juvenile rheumatoid arthritis: follow-up into adulthood - medical, sexual and social status |
| Q73092751 | Juvenile rheumatoid arthritis: linkage to HLA demonstrated by allele sharing in affected sibpairs |
| Q36899699 | Juvenile rheumatoid arthritis: outcome and treatment for the 1990s |
| Q72697322 | Juvenile rheumatoid arthritis: pain-related and psychosocial aspects and their relevance for assessment and treatment |
| Q36067287 | Juvenile rheumatoid arthritis: physical therapy and rehabilitation |
| Q79361397 | Juvenile rheumatoid arthritis: protean manifestations |
| Q44263524 | Juvenile rheumatoid arthritis: review and update |
| Q34626968 | Juvenile rheumatoid arthritis: therapeutic perspectives |
| Q67322369 | Juvenile rheumatoid arthritis: up to date |
| Q73045023 | Juvenile rheumatoid arthritis; a long-term follow-up |
| Q35237381 | Juvenile rheumatoid arthritis; a review of the literature. |
| Q82165062 | Juvenile rheumatoid arthritis; a study of fifty-six cases with a note on skeletal changes |
| Q43842504 | Juvenile systemic rheumatoid arthritis and adult-onset Still's disease: comparison of clinical course |
| Q80847682 | Keratoconjunctivitis sicca in juvenile rheumatoid arthritis |
| Q43644593 | Keratonconjunctivitis sicca is not uncommon in children with juvenile rheumatoid arthritis |
| Q42096520 | Ketamine and juvenile chronic polyarthritis (Still's disease). Anaesthetic problems in Still's disease and allied disorders |
| Q42669862 | Ketoprofen (Orudis) in the treatment of juvenile rheumatoid arthritis. A segment I study |
| Q35750540 | Kienbock's disease and juvenile idiopathic arthritis |
| Q67710600 | Kinesitherapy of children with juvenile rheumatoid arthritis (proceedings) |
| Q42270579 | Kinetics of the long-term antibody response after meningococcal C vaccination in patients with juvenile idiopathic arthritis: a retrospective cohort study |
| Q45746132 | Knee disease in juvenile idiopathic arthritis (JIA): correlation between clinical and ultrasonographic findings |
| Q74433436 | Knee in early juvenile rheumatoid arthritis: MR imaging findings |
| Q81025772 | Knee synovectomy in children with juvenile idiopathic arthritis |
| Q34124575 | Kre-Celazine(®) as a viable treatment for juvenile rheumatoid arthritis/juvenile idiopathic arthritis - a pilot study |
| Q62732038 | LACC1 polymorphisms in inflammatory bowel disease and juvenile idiopathic arthritis |
| Q36564656 | Laboratory Indicators of Aggrecan Turnover in Juvenile Idiopathic Arthritis. |
| Q40206094 | Lack of Association between STAT4 Single Nucleotide Polymorphisms and Iranian Juvenile Rheumatoid Arthritis Patients |
| Q89955349 | Lack of Concordance in Interrater Scoring of the Provider's Global Assessment of Children With Juvenile Idiopathic Arthritis With Low Disease Activity |
| Q33725950 | Lack of association between beta 2-adrenergic receptor polymorphisms and juvenile idiopathic arthritis |
| Q79163066 | Lack of association between birth order and juvenile idiopathic arthritis |
| Q57116793 | Lack of association between juvenile idiopathic arthritis and fas gene polymorphism |
| Q42136570 | Lack of association between mannose-binding lectin gene polymorphisms and juvenile idiopathic arthritis in a Han population from the Hubei province of China |
| Q33287486 | Lack of association between the chemokine receptor 5 polymorphism CCR5delta32 in rheumatoid arthritis and juvenile idiopathic arthritis |
| Q36944082 | Lack of association of functional CTLA4 polymorphisms with juvenile idiopathic arthritis |
| Q46790683 | Lack of association of single nucleotide polymorphisms in toll-like receptors 2 and 4 with enthesitis-related arthritis category of juvenile idiopathic arthritis in Indian population |
| Q33633860 | Land-Jump Performance in Patients with Juvenile Idiopathic Arthritis (JIA): A Comparison to Matched Controls |
| Q79424022 | Large pericardial effusion requiring pericardiocentesis as cardinal sign of macrophage activation syndrome in systemic onset-juvenile idiopathic arthritis |
| Q38854208 | Laryngeal involvement in juvenile idiopathic arthritis patients. |
| Q39551010 | Late results of synovectomy in juvenile rheumatoid arthritis. |
| Q70571510 | Late sequelae of juvenile rheumatoid arthritis of the hip: a follow-up study into adulthood |
| Q40454626 | Latent tuberculosis infection screening in juvenile idiopathic arthritis patients preceding anti-TNF therapy in a tuberculosis high-risk country. |
| Q50075734 | Latent tuberculosis infection screening in juvenile idiopathic arthritis patients preceding anti-TNF therapy in a tuberculosis high-risk country. |
| Q43475346 | Later-onset rheumatoid factor negative polyarticular juvenile idiopathic arthritis (JIA): a unique patient group? |
| Q50436730 | Learning the hard way: clinical trials in juvenile idiopathic arthritis. |
| Q40253064 | Lectin pathway factors in patients suffering from juvenile idiopathic arthritis |
| Q87398937 | Leflunomide in systemic onset Juvenile idiopathic arthritis |
| Q40919640 | Leflunomide is associated with a higher flare rate compared to methotrexate in the treatment of chronic uveitis in juvenile idiopathic arthritis |
| Q46448238 | Leflunomide or methotrexate for juvenile rheumatoid arthritis |
| Q92051974 | Leflunomide treatment in juvenile idiopathic arthritis |
| Q45998968 | Leflunomide, a valid and safe drug for the treatment of chronic anterior uveitis associated with juvenile idiopathic arthritis. |
| Q40759976 | Left ventricular diastolic functions in juvenile rheumatoid arthritis |
| Q37680750 | Left ventricular rotational mechanics in identical twins with juvenile idiopathic arthritis (from the MAGYAR-Twin study). |
| Q71479695 | Leg-length discrepancies in monoarticular and pauciarticular juvenile rheumatoid arthritis |
| Q27027518 | Leisure in children and adolescents with juvenile idiopathic arthritis: a systematic review |
| Q86446378 | Leptin concentration in children with juvenile idiopathic arthritis |
| Q67347449 | Letter: Juvenile rheumatoid arthritis |
| Q44535180 | Letter: Serology of rheumation in juvenile rheumatoid arthritis |
| Q70012652 | Letter: Transfer factor in juvenile rheumatoid arthritis |
| Q47859623 | Letter: W27 antigen and juvenile rheumatoid arthritis |
| Q54315263 | Leucine-rich α2-glycoprotein as the acute-phase reactant to detect systemic juvenile idiopathic arthritis disease activity during anti-interleukin-6 blockade therapy: A case series. |
| Q82975750 | Leukocytapheresis for the treatment of refractory systemic-onset juvenile idiopathic arthritis |
| Q83049220 | Level of agreement between children, parents, and physicians in rating pain intensity in juvenile idiopathic arthritis |
| Q72023282 | Level of agreement between parents and children in rating dysfunction in juvenile rheumatoid arthritis and juvenile spondyloarthritides |
| Q89086565 | Levels of Health Theory With the Example of a Case of Juvenile Rheumatoid Arthritis |
| Q91534851 | Levels of Selected Matrix Metalloproteinases, Their Inhibitors in Saliva, and Oral Status in Juvenile Idiopathic Arthritis Patients vs. Healthy Controls |
| Q80947157 | Levels of matrix metalloproteinase (MMP)-1 in paired sera and synovial fluids of juvenile idiopathic arthritis patients: relationship to inflammatory activity, MMP-3 and tissue inhibitor of metalloproteinases-1 in a longitudinal study |
| Q67293555 | Levels of serum immunoglobulins in juvenile rheumatoid arthritis |
| Q84874292 | Levels of serum matrix metalloproteinase-3 correlate with disease activity in the enthesitis-related arthritis category of juvenile idiopathic arthritis |
| Q71634715 | Levels of soluble Fas/APO-1/CD95 in systemic lupus erythematosus and juvenile rheumatoid arthritis |
| Q53850443 | Life changes as etiologic factors in juvenile rheumatoid arthritis |
| Q68087305 | Life changes related to the onset of juvenile rheumatoid arthritis |
| Q40204915 | Life-threatening pneumonitis complicating low-dose methotrexate treatment for juvenile idiopathic arthritis in a child. |
| Q67321950 | Light- and electron-microscopic findings of juvenile rheumatoid arthritis synovium: Comparison with normal juvenile synovium |
| Q98388937 | Limited Mandibular Movements as a Consequence of Unilateral or Asymmetrical Temporomandibular Joint Involvement in Juvenile Idiopathic Arthritis Patients |
| Q67547152 | Limited heterogeneity of T cell receptor variable region gene usage in juvenile rheumatoid arthritis synovial T cells |
| Q46542282 | Limited value of cyclosporine A for the treatment of patients with uveitis associated with juvenile idiopathic arthritis |
| Q37072649 | Limits of Peripheral Blood Mononuclear Cells for Gene Expression-Based Biomarkers in Juvenile Idiopathic Arthritis |
| Q44028058 | Linear growth and final height in patients with systemic juvenile idiopathic arthritis treated with longterm glucocorticoids |
| Q34523727 | Linear growth in children suffering from juvenile idiopathic arthritis requiring steroid therapy: natural history and effects of growth hormone treatment on linear growth. |
| Q53142722 | Linked semiconstrained and unlinked total elbow replacement in juvenile idiopathic arthritis: a case comparison series with mean 11.7-year follow-up. |
| Q92179980 | Linking Joint Impairment and Gait Biomechanics in Patients with Juvenile Idiopathic Arthritis |
| Q35112757 | Lipid profiles alter from pro-atherogenic into less atherogenic and proinflammatory in juvenile idiopathic arthritis patients responding to anti TNF-α treatment. |
| Q45208398 | Lipids and homocysteine level in juvenile idiopathic arthritis |
| Q42369530 | Lipoprotein cholesterol fractions are related to markers of inflammation in children and adolescents with juvenile idiopathic arthritis: a cross sectional study. |
| Q70873022 | Liver biopsy findings in patients with juvenile rheumatoid arthritis receiving long-term, weekly methotrexate therapy |
| Q53995622 | Liver biopsy with the use of methotrexate for juvenile rheumatoid arthritis. |
| Q67703323 | Liver pathology in juvenile chronic polyarthritis |
| Q57257792 | Living with Juvenile Idiopathic Arthritis: Children's Experiences of Participating in Home Exercise Programmes |
| Q54940995 | Living with Juvenile Idiopathic Arthritis: Parent and Physician Perspectives. |
| Q90245618 | Living with juvenile idiopathic arthritis |
| Q72429133 | Local synthesis of both macrophage and T cell cytokines by synovial fluid cells from children with juvenile rheumatoid arthritis |
| Q70195115 | Localization of IgM in plasma cells in the iris of a patient with iridocyclitis and juvenile rheumatoid arthritis |
| Q46972961 | Localized scleroderma in a cohort of juvenile idiopathic arthritis children |
| Q95937463 | Long non‑coding RNA RP11‑340F14.6 promotes a shift in the Th17/Treg ratio by binding with P2X7R in juvenile idiopathic arthritis |
| Q54855282 | Long term efficacy and safety of canakinumab in children with systemic juvenile idiopathic arthritis with and without fever. |
| Q46008535 | Long term follow-up after sudden withdrawal from a multicentric study of abatacept in juvenile idiopathic arthritis – data from the Portuguese cohort. |
| Q46862157 | Long term functional outcome and quality of life of patients with refractory juvenile idiopathic arthritis treated with etanercept: results of the dutch arthritis and biologicals in children register |
| Q43416962 | Long term outcome following knee replacement in patients with juvenile idiopathic arthritis |
| Q39709631 | Long term therapy of juvenile rheumatoid arthritis (author's transl) |
| Q72007889 | Long term therapy with indomethacin in juvenile rheumatoid arthritis and in Still's disease |
| Q99628289 | Long-Term Control of Macular Edema With Adalimumab After Cataract Surgery in a Japanese Child With Juvenile Idiopathic Arthritis: Case Report and Review of 26 Japanese Patients |
| Q90280197 | Long-Term Effect of Pulsed Nd:YAG Laser in the Treatment of Children with Juvenile Rheumatoid Arthritis: A Randomized Controlled Trial |
| Q35999254 | Long-Term Health-Related Quality of Life in German Patients with Juvenile Idiopathic Arthritis in Comparison to German General Population |
| Q88340678 | Long-Term Outcomes Following Achievement of Clinically Inactive Disease in Juvenile Idiopathic Arthritis: The Importance of Definition |
| Q91570607 | Long-Term Outcomes in Juvenile Idiopathic Arthritis: Eighteen Years of Follow-Up in the Population-Based Nordic Juvenile Idiopathic Arthritis Cohort |
| Q91811682 | Long-term breastfeeding influences disease activity in a low-income juvenile idiopathic arthritis cohort |
| Q44042413 | Long-term effects of azathioprine therapy for juvenile rheumatoid arthritis. |
| Q59270114 | Long-term efficacy and safety of adalimumab in 4-12 year old patients with juvenile idiopathic arthritis |
| Q33185715 | Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trial |
| Q34157346 | Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension. |
| Q38779665 | Long-term efficacy of adalimumab in the treatment of uveitis associated with juvenile idiopathic arthritis |
| Q48587839 | Long-term evaluation of cardiac function in juvenile idiopathic arthritis under anti-TNF therapy. |
| Q53661983 | Long-term follow-up of 246 adults with juvenile idiopathic arthritis: education and employment. |
| Q35018285 | Long-term follow-up of 246 adults with juvenile idiopathic arthritis: functional outcome |
| Q51034027 | Long-term follow-up of 246 adults with juvenile idiopathic arthritis: predictive factors for mood and pain. |
| Q53661981 | Long-term follow-up of 246 adults with juvenile idiopathic arthritis: social function, relationships and sexual activity. |
| Q35204115 | Long-term follow-up of autologous stem cell transplantation for refractory juvenile idiopathic arthritis. |
| Q84774197 | Long-term follow-up of craniofacial alterations in juvenile idiopathic arthritis |
| Q73040004 | Long-term follow-up of cytokines and soluble cytokine receptors in peripheral blood of patients with juvenile rheumatoid arthritis |
| Q67858236 | Long-term follow-up of juvenile chronic polyarthritis [proceedings] |
| Q83765063 | Long-term follow-up of patients with uveitis associated with juvenile idiopathic arthritis: a cohort study |
| Q55715614 | Long-term follow-up of systemic onset juvenile idiopathic arthritis patients treated with Anakinra. |
| Q81087476 | Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register |
| Q28374443 | Long-term followup of naproxen-induced pseudoporphyria in juvenile rheumatoid arthritis |
| Q81001046 | Long-term followup of temporomandibular joint involvement in juvenile idiopathic arthritis |
| Q41469348 | Long-term health outcomes and quality of life in American and Italian inception cohorts of patients with juvenile rheumatoid arthritis. I. Outcome status. |
| Q40896478 | Long-term health outcomes and quality of life in American and Italian inception cohorts of patients with juvenile rheumatoid arthritis. II. Early predictors of outcome. |
| Q46967153 | Long-term impact of juvenile idiopathic arthritis in the Greek adults' psychosocial life |
| Q44161254 | Long-term ocular complications in aphakic versus pseudophakic eyes of children with juvenile idiopathic arthritis-associated uveitis |
| Q42647107 | Long-term open-label preliminary study of the safety and efficacy of leflunomide in patients with polyarticular-course juvenile rheumatoid arthritis |
| Q41716505 | Long-term outcome among patients with juvenile rheumatoid arthritis. |
| Q74175888 | Long-term outcome and prognosis in oligoarticular-onset juvenile idiopathic arthritis |
| Q78301176 | Long-term outcome in patients with juvenile idiopathic arthritis |
| Q36204110 | Long-term outcome of juvenile idiopathic arthritis following a placebo-controlled trial: sustained benefits of early sulfasalazine treatment |
| Q94659548 | Long-term outcomes and disease course of children with juvenile idiopathic arthritis in the ReACCh-Out cohort: a two-centre experience |
| Q34974941 | Long-term outcomes and predictors of outcomes for patients with juvenile idiopathic arthritis |
| Q97521216 | Long-term outcomes in patients with polyarticular juvenile idiopathic arthritis receiving adalimumab with or without methotrexate |
| Q41666654 | Long-term quality of life and functional outcome of patients with juvenile idiopathic arthritis in the biologic era: a longitudinal follow-up study in the Dutch Arthritis and Biologicals in Children Register |
| Q43039431 | Long-term remission of nephrotic syndrome with etanercept for concomitant juvenile idiopathic arthritis |
| Q83411133 | Long-term response of juvenile idiopathic arthritis after conditioning with 8 Gy total body irradiation followed by autologous peripheral blood stem cells: case report |
| Q91398594 | Long-term results after primary intraocular lens implantation in children with juvenile idiopathic arthritis-associated uveitis |
| Q44420592 | Long-term results of total hip arthroplasty in patients with juvenile rheumatoid arthritis |
| Q42632072 | Long-term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritis |
| Q42651098 | Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis |
| Q33245010 | Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis |
| Q40244928 | Long-term safety and efficacy of rilonacept in patients with systemic juvenile idiopathic arthritis. |
| Q41121955 | Long-term safety and efficacy of varicella vaccination in children with juvenile idiopathic arthritis treated with biologic therapy |
| Q40995768 | Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA). |
| Q37320554 | Long-term safety, efficacy, and quality of life in patients with juvenile idiopathic arthritis treated with intravenous abatacept for up to seven years |
| Q92040377 | Long-term surveillance of biologic therapies in systemic-onset juvenile idiopathic arthritis: data from the German BIKER registry |
| Q44710711 | Long-term treatment of systemic juvenile idiopathic arthritis with tocilizumab: results of an open-label extension study in Japan |
| Q86218610 | Long-term treatment with rituximab in severe juvenile idiopathic arthritis-associated uveitis |
| Q78581083 | Long-term use of prednisone and prednisolone in juvenile rheumatoid arthritis; a report of fifteen cases |
| Q52588943 | Long-term, interventional, open-label extension study evaluating the safety of tocilizumab treatment in patients with polyarticular-course juvenile idiopathic arthritis from Poland and Russia who completed the global, international CHERISH trial. |
| Q92402914 | Longitudinal Health Status from Early Disease to Adulthood and Associated Prognostic Factors in Juvenile Idiopathic Arthritis |
| Q46201873 | Longitudinal analysis of HLA associated risks for iridocyclitis in juvenile rheumatoid arthritis |
| Q51808849 | Longitudinal analysis of complementary and alternative health care use in children with juvenile idiopathic arthritis. |
| Q102058072 | Longitudinal assessment of racial disparities in juvenile idiopathic arthritis disease activity in a treat-to-target intervention |
| Q57927386 | Longitudinal evaluation of bone mass in adolescents and young adults with juvenile idiopathic arthritis: the role of bone mass determinants in a large cohort of patients |
| Q47416147 | Longitudinal growth attainments of Indian boys with juvenile rheumatoid arthritis |
| Q72767812 | Longitudinal study of the presence of hidden 19S IgM rheumatoid factor in juvenile rheumatoid arthritis |
| Q90114808 | Longterm Outcomes of Temporomandibular Joints in Juvenile Idiopathic Arthritis: 17 Years of Followup of a Nordic Juvenile Idiopathic Arthritis Cohort |
| Q52587399 | Longterm Safety and Efficacy of Adalimumab and Infliximab for Uveitis Associated with Juvenile Idiopathic Arthritis. |
| Q68911171 | Longterm auranofin therapy in patients with juvenile rheumatoid arthritis |
| Q46669747 | Longterm outcome of amyloidosis associated with juvenile idiopathic arthritis |
| Q87452033 | Longterm safety and effectiveness of the anti-interleukin 6 receptor monoclonal antibody tocilizumab in patients with systemic juvenile idiopathic arthritis in Japan |
| Q41942846 | Looking through the patient lens - Improving best practice for young people with juvenile idiopathic arthritis transitioning into adult care |
| Q60932373 | Low Serum IGF-1 in Boys with Recent Onset of Juvenile Idiopathic Arthritis |
| Q43219919 | Low cortisol levels in active juvenile idiopathic arthritis |
| Q73929184 | Low density neutrophils in patients with juvenile idiopathic arthritis |
| Q43050479 | Low dose methotrexate osteopathy in a patient with polyarticular juvenile idiopathic arthritis |
| Q43918813 | Low dose methotrexate osteopathy in a patient with polyarticular juvenile idiopathic arthritis |
| Q75261857 | Low levels of anti-histone antibodies in north Indian children with juvenile rheumatoid arthritis |
| Q51550151 | Low pretreatment levels of myeloid-related protein-8/14 and C-reactive protein predict poor adherence to treatment with tumor necrosis factor inhibitors in juvenile idiopathic arthritis. |
| Q46788175 | Low-dose methotrexate in the treatment of severe juvenile rheumatoid arthritis and sarcoid iritis. |
| Q46475191 | Low-dose methotrexate treatment for oligoarticular juvenile idiopathic arthritis nonresponsive to intra-articular corticosteroids |
| Q71615936 | Low-molecular urinary substances in juvenile rheumatoid arthritis |
| Q47216435 | Lower extremity isometric strength in children with juvenile idiopathic arthritis. |
| Q91295672 | Lower genital tract infections in young female juvenile idiopathic arthritis patients |
| Q73897520 | Lowered IL-4-producing T cells and decreased IL-4 secretion in peripheral blood from subjects with juvenile rheumatoid arthritis |
| Q46727479 | Lung function in children and adolescents with juvenile idiopathic arthritis during long-term treatment with methotrexate: a retrospective study |
| Q92107620 | Lung function in children with juvenile idiopathic arthritis: A cross-sectional analysis |
| Q86551824 | Lyme disease and juvenile idiopathic arthritis - A pediatric case report |
| Q49652543 | Lyme disease and juvenile idiopathic arthritis - A pediatric case report. |
| Q68735214 | Lyme disease masquerading as juvenile rheumatoid arthritis |
| Q45744758 | Lymph act, TCR αβ, TCR γδ cells in peripheral blood in children with juvenile idiopathic arthritis |
| Q38713994 | Lymphedema associated with juvenile rheumatoid arthritis |
| Q66881977 | Lymphocyte Populations and Cellular Immune Reactions in Juvenile Rheumatoid Arthritis |
| Q72093332 | Lymphocyte stimulation by gangliosides, cerebrosides and basic protein in juvenile rheumatoid arthritis |
| Q71097179 | Lymphocyte transformation to connective tissue antigens in adult and juvenile rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, systemic lupus erythematosus, and a nonarthritic control population |
| Q40770991 | Lymphocytes eluted from synovial tissue of juvenile rheumatoid arthritis patients |
| Q36655122 | Lymphocytes in juvenile rheumatoid arthritis (JRA) studied by means of electron and scanning microscope. |
| Q41925457 | Lymphocytic interstitial pneumonitis preceding polyarticular juvenile rheumatoid arthritis. |
| Q40821834 | Lymphocytotoxic antibodies in children suffering from juvenile rheumatoid arthritis and rheumatoid fever. |
| Q70678274 | Lymphoid interstitial pneumonia in juvenile rheumatoid arthritis |
| Q53608231 | Lymphoid neogenesis in juvenile idiopathic arthritis correlates with ANA positivity and plasma cells infiltration. |
| Q38069053 | Lymphomatoid papulosis in a patient treated with adalimumab for juvenile rheumatoid arthritis. |
| Q76850827 | MANDIBULAR GROWTH AND DENTAL OCCLUSION IN JUVENILE RHEUMATOID ARTHRITIS |
| Q78363732 | MEDICAL MANAGEMENT OF JUVENILE RHEUMATOID ARTHRITIS |
| Q40251072 | MEFV gene mutations in Turkish children with juvenile idiopathic arthritis. |
| Q39189860 | MEFV mutations in Egyptian children with systemic-onset juvenile idiopathic arthritis. |
| Q46968737 | MEFV mutations in Iranian children with systemic onset juvenile idiopathic arthritis |
| Q40405557 | MEFV mutations in systemic onset juvenile idiopathic arthritis |
| Q50847500 | MR Imaging of the Temporomandibular Joint in Juvenile Idiopathic Arthritis: Technique and Findings. |
| Q70711611 | MR evaluation of the temporomandibular joint in juvenile rheumatoid arthritis |
| Q68091562 | MR imaging in juvenile rheumatoid arthritis |
| Q52982579 | MRI Protocol for the Assessment of Juvenile Idiopathic Arthritis of the Wrist: Recommendations from the OMERACT MRI in JIA Working Group and Health-e-Child. |
| Q53097298 | MRI assessment of bone marrow in children with juvenile idiopathic arthritis: intra- and inter-observer variability. |
| Q43515845 | MRI assessment of tenosynovitis in children with juvenile idiopathic arthritis: inter- and intra-observer variability |
| Q55191865 | MRI evaluation of clinical remission in juvenile idiopathic arthritis. |
| Q38141158 | MRI evaluation of the temporomandibular joints in juvenile rheumatoid arthritis: a retrospective review. |
| Q37403683 | MRI in juvenile idiopathic arthritis and juvenile dermatomyositis |
| Q45535646 | MRI of the wrist in juvenile idiopathic arthritis: erosions or normal variants? A prospective case-control study. |
| Q61911620 | MRI of the wrist in juvenile idiopathic arthritis: proposal of a paediatric synovitis score by a consensus of an international working group. Results of a multicentre reliability study |
| Q36336411 | MRI thresholds for discrimination between normal and mild temporomandibular joint involvement in juvenile idiopathic arthritis |
| Q84524302 | MRI versus conventional measures of disease activity and structural damage in evaluating treatment efficacy in juvenile idiopathic arthritis |
| Q92435635 | MRP8/14 and neutrophil elastase for predicting treatment response and occurrence of flare in patients with juvenile idiopathic arthritis |
| Q35926593 | MRP8/14 serum levels as a predictor of response to starting and stopping anti-TNF treatment in juvenile idiopathic arthritis. |
| Q92376104 | MS score in systemic juvenile idiopathic arthritis: suitable for routine use? |
| Q45744570 | MTHFR polymorphism and red cell folate levels are not useful as biomarkers of methotrexate efficacy and toxicity in children with juvenile idiopathic arthritis. |
| Q91664888 | MTX intolerance in children and adolescents with juvenile idiopathic arthritis |
| Q92309262 | Machine learning identifies an immunological pattern associated with multiple juvenile idiopathic arthritis subtypes |
| Q38356706 | Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis under Treatment with Tocilizumab. |
| Q81517396 | Macrophage activation is a key component in the pathogenesis of systemic juvenile idiopathic arthritis: comment on the article by Blessing et al |
| Q45745639 | Macrophage activation sydrome with systemic onset juvenile idiopathic arthritis (SOJIA) in Chinese childern |
| Q78822126 | Macrophage activation syndrome after autologous stem cell transplantation for systemic juvenile idiopathic arthritis |
| Q48012891 | Macrophage activation syndrome and etanercept in children with systemic juvenile rheumatoid arthritis |
| Q50095600 | Macrophage activation syndrome as a complication of juvenile rheumatoid arthritis. |
| Q37993678 | Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment. |
| Q43854828 | Macrophage activation syndrome as the initial manifestation of systemic onset juvenile idiopathic arthritis |
| Q82530778 | Macrophage activation syndrome associated with etanercept in a child with systemic onset juvenile idiopathic arthritis |
| Q40518260 | Macrophage activation syndrome associated with systemic juvenile idiopathic arthritis |
| Q79980842 | Macrophage activation syndrome associated with systemic onset juvenile rheumatoid arthritis |
| Q46968490 | Macrophage activation syndrome due to systemic onset juvenile idiopathic arthritis in a case with liver transplantation |
| Q45848242 | Macrophage activation syndrome during treatment with biological therapy in patients with systemic juvenile idiopathic arthritis |
| Q78874963 | Macrophage activation syndrome following initiation of etanercept in a child with systemic onset juvenile rheumatoid arthritis |
| Q40413331 | Macrophage activation syndrome in 13 children with systemic-onset juvenile idiopathic arthritis |
| Q28187372 | Macrophage activation syndrome in a child with systemic juvenile rheumatoid arthritis |
| Q40174333 | Macrophage activation syndrome in a patient with systemic juvenile idiopathic arthritis |
| Q33433845 | Macrophage activation syndrome in a patient with systemic onset of the juvenile idiopathic arthritis |
| Q33389802 | Macrophage activation syndrome in an inadequately treated patient with systemic onset juvenile idiopathic arthritis. |
| Q40093291 | Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus |
| Q46317191 | Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis: a retrospective study on 7 patients |
| Q36420991 | Macrophage activation syndrome in children with systemic lupus erythematosus and children with juvenile idiopathic arthritis |
| Q37827375 | Macrophage activation syndrome in children with systemic onset juvenile idiopathic arthritis: clinical experience from northwest India. |
| Q36519537 | Macrophage activation syndrome in juvenile idiopathic arthritis |
| Q28213004 | Macrophage activation syndrome in juvenile rheumatoid arthritis successfully treated with cyclosporine A: a case report |
| Q24654925 | Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13-4 polymorphisms |
| Q46863079 | Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis treated with tocilizumab. |
| Q71776291 | Macrophage activation syndrome in systemic juvenile rheumatoid arthritis |
| Q71093219 | Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporine |
| Q80195889 | Macrophage migration inhibitory factor (MIF) and oligoarticular juvenile idiopathic arthritis (o-JIA): association of MIF promoter polymorphisms with response to intra-articular glucocorticoids |
| Q43870763 | Macrophage migration inhibitory factor in patients with juvenile idiopathic arthritis |
| Q38887813 | Macrophages - silent enemies in juvenile idiopathic arthritis. |
| Q80512903 | Maculopathy in uveitis of juvenile idiopathic arthritis: an optical coherence tomography study |
| Q48640374 | Magnetic Resonance Imaging (MRI) of the Knee as an Outcome Measure in Juvenile Idiopathic Arthritis: An OMERACT Reliability Study on MRI Scales. |
| Q85275920 | Magnetic Resonance Imaging Assessment of Temporomandibular Joint Involvement and Mandibular Growth Following Corticosteroid Injection in Juvenile Idiopathic Arthritis |
| Q41433441 | Magnetic Resonance Imaging Findings following Intraarticular Infliximab Therapy for Refractory Temporomandibular Joint Arthritis among Children with Juvenile Idiopathic Arthritis |
| Q90114779 | Magnetic Resonance Imaging Followup of Temporomandibular Joint Inflammation, Deformation, and Mandibular Growth in Juvenile Idiopathic Arthritis Patients Receiving Systemic Treatment |
| Q48738935 | Magnetic resonance imaging and radiographic assessment of carpal depressions in children with juvenile idiopathic arthritis: normal variants or erosions? |
| Q47425859 | Magnetic resonance imaging evaluation of the effects of juvenile rheumatoid arthritis on distal femoral weight-bearing cartilage |
| Q41683414 | Magnetic resonance imaging in juvenile rheumatoid arthritis |
| Q46682400 | Magnetic resonance imaging of articular destruction in juvenile rheumatoid arthritis |
| Q38164539 | Magnetic resonance imaging of the temporomandibular joint in children with juvenile idiopathic arthritis |
| Q82734929 | Magnetic resonance imaging, ultrasonography, and conventional radiography in the assessment of bone erosions in juvenile idiopathic arthritis |
| Q51285149 | Magnitude and clinical profile of juvenile idiopathic arthritis in a medical college hospital of a socio-economically disadvantaged country. |
| Q43052825 | Magnitude of the genetic component in juvenile idiopathic arthritis |
| Q89842580 | Maintenance of antibody response to diphtheria/tetanus vaccine in patients aged 2-5 years with polyarticular-course juvenile idiopathic arthritis receiving subcutaneous abatacept |
| Q78008521 | Major histocompatibility complex class I chain related (MIC) A gene, TNFa microsatellite alleles and TNFB alleles in juvenile idiopathic arthritis patients from Latvia |
| Q49142222 | Major improvements in health-related quality of life during the use of etanercept in patients with previously refractory juvenile idiopathic arthritis. |
| Q92276852 | Making Decisions About Stopping Medicines for Well-Controlled Juvenile Idiopathic Arthritis: A Mixed-Methods Study of Patients and Caregivers |
| Q80707134 | Making the case for exercise in children with juvenile idiopathic arthritis: what we know and where we go from here |
| Q85123532 | Malar rash in systemic juvenile idiopathic arthritis |
| Q51569407 | Male gender and poor visual outcome in uveitis associated with juvenile idiopathic arthritis. |
| Q51562836 | Male gender as a risk factor for complications in uveitis associated with juvenile idiopathic arthritis. |
| Q38440863 | Malignancies in juvenile idiopathic arthritis: a preliminary report |
| Q43039434 | Malignancy and tumor necrosis factor inhibitors in juvenile idiopathic arthritis |
| Q97677303 | Malignant Syphilis in a Young Patient With Juvenile Idiopathic Arthritis Under Biological Therapy |
| Q38440728 | Management of Children with Juvenile Idiopathic Arthritis |
| Q54595872 | Management of Juvenile Idiopathic Arthritis 2015: A Position Statement from the Pediatric Committee of the Canadian Rheumatology Association. |
| Q88375341 | Management of Juvenile Idiopathic Arthritis in ABO-incompatible Kidney Transplantation: A Case Report |
| Q38916421 | Management of Juvenile Idiopathic Arthritis: A Clinical Guide |
| Q37050081 | Management of growth retardation in juvenile idiopathic arthritis |
| Q78568824 | Management of juvenile idiopathic arthritis |
| Q38308454 | Management of juvenile idiopathic arthritis: hitting the target |
| Q71734458 | Management of juvenile rheumatoid arthritis |
| Q67424238 | Management of juvenile rheumatoid arthritis (author's transl) |
| Q41925438 | Management of juvenile rheumatoid arthritis. |
| Q42379831 | Management of juvenile rheumatoid arthritis; the problem of long-term rehabilitation |
| Q86979135 | Management of temporomandibular joint arthritis-related orofacial symptoms in juvenile idiopathic arthritis by the use of a stabilization splint |
| Q41911818 | Management of the upper extremity in juvenile rheumatoid arthritis. |
| Q38645394 | Managing juvenile idiopathic arthritis-associated uveitis. |
| Q45745721 | Mandibular condyle destruction in juvenile idiopathic arthritis (JIA). |
| Q80538829 | Mandibular condyle lesions in children with juvenile idiopathic arthritis |
| Q54042059 | Mandibular condyle lesions related to age at onset and subtypes of juvenile rheumatoid arthritis in 15-year-old children. |
| Q68755250 | Mandibular condyle lesions, jaw movements, and occlusal status in 15-year-old children with juvenile rheumatoid arthritis |
| Q59268794 | Mandibular distraction osteogenesis in patients with unilateral TMJ involvement in juvenile idiopathic arthritis |
| Q68086869 | Mandibular dysfunction in patients with juvenile rheumatoid arthritis |
| Q70957901 | Mandibular growth, temporomandibular joint changes and dental occlusion in juvenile rheumatoid arthritis. A 17-year follow-up study |
| Q69850674 | Mandibular morphology and position in juvenile rheumatoid arthritis. A study on postero-anterior radiographs |
| Q55626688 | Mandibular ramus length and condylar changes in Juvenile Idiopathic Arthritis. |
| Q36757070 | Mannose-binding lectin deficiency is associated with early onset of polyarticular juvenile rheumatoid arthritis: a cohort study |
| Q42287719 | Markedly decreased antibody titers against hepatitis B in previously immunised children presenting with juvenile idiopathic arthritis |
| Q40856275 | Massive calcification of the mitral annulus in a 17-year-old patient with juvenile rheumatoid arthritis and systemic lupus erythematosis |
| Q52167769 | Masticatory function in patients with juvenile rheumatoid arthritis. |
| Q59715465 | Maternal Stressors, Maternal Wellbeing and Children's Wellbeing in the Context of Juvenile Idiopathic Arthritis |
| Q41044289 | Maternal juvenile rheumatoid arthritis may be associated with preterm birth but not poor fetal growth |
| Q88012097 | Maternal stress associated with juvenile idiopathic arthritis |
| Q45745694 | May antihistone antibodies replace antinuclear antibodies (ANA) as a predictor of uveitis in Juvenile idiopathic arthritis? |
| Q45745872 | Measles, Mumps, Rubella serology in juvenile idiopathic arthritis |
| Q28244791 | Measurement and evaluation of isotypes of anti-citrullinated fibrinogen and anti-citrullinated alpha-enolase antibodies in juvenile idiopathic arthritis |
| Q81520888 | Measurement of biomarkers in juvenile idiopathic arthritis patients and their significant association with disease severity: a comparative study |
| Q37737646 | Measurement of blood calprotectin (MRP-8/MRP-14) levels in patients with juvenile idiopathic arthritis |
| Q86716786 | Measurement of bone mineral density by dual energy X-ray absorptiometry in juvenile idiopathic arthritis |
| Q72871584 | Measurement of health status in children with juvenile rheumatoid arthritis |
| Q81440078 | Measurement of health status, functional status, and quality of life in children with juvenile idiopathic arthritis: clinical science for the pediatrician |
| Q53301705 | Measurement of health status, functional status, and quality of life in children with juvenile idiopathic arthritis: clinical science for the pediatrician. |
| Q64067967 | Measurement properties and performance of an eight-minute submaximal treadmill test in patients with juvenile idiopathic arthritis: a controlled study |
| Q100940508 | Measures of Health Status and Quality of Life in Juvenile Idiopathic Arthritis |
| Q37012857 | Measures of health status and quality of life in juvenile rheumatoid arthritis: Pediatric Quality of Life Inventory (PedsQL) Rheumatology Module 3.0, Juvenile Arthritis Quality of Life Questionnaire (JAQQ), Paediatric Rheumatology Quality of Life Sc |
| Q38862649 | Measuring Physical Activity in Juvenile Idiopathic Arthritis: Activity Diary Versus Accelerometer |
| Q36925351 | Measuring clinical response and remission in juvenile idiopathic arthritis |
| Q77228071 | Measuring disability in early juvenile rheumatoid arthritis: evaluation of a Norwegian version of the childhood Health Assessment Questionnaire |
| Q73664832 | Measuring health status in early juvenile idiopathic arthritis: determinants and responsiveness of the child health questionnaire |
| Q33693030 | Measuring process of arthritis care: a proposed set of quality measures for the process of care in juvenile idiopathic arthritis |
| Q78328674 | Measuring the nutritional status of children with juvenile idiopathic arthritis using the bioelectrical impedance method |
| Q68012564 | Mediating effects of family social support on child psychological adjustment in juvenile rheumatoid arthritis |
| Q69976381 | Medical and dental coordination in juvenile rheumatoid arthritis |
| Q47753519 | Medical clowns facilitate nitrous oxide sedation during intra-articular corticosteroid injection for juvenile idiopathic arthritis |
| Q55669685 | Medical clowns: dream doctors as an important team member in the treatment of young children with juvenile idiopathic arthritis. |
| Q33793215 | Medical management of children with juvenile rheumatoid arthritis |
| Q92243248 | Medical pathways of children with juvenile idiopathic arthritis before referral to pediatric rheumatology centers |
| Q67075534 | Medical rehabilitation in juvenile rheumatoid arthritis |
| Q34456860 | Medical treatment of juvenile idiopathic arthritis |
| Q37308992 | Medically Significant Infections Are Increased in Patients With Juvenile Idiopathic Arthritis Treated With Etanercept: Results From the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study |
| Q47875919 | Medication adherence in patients with juvenile idiopathic arthritis |
| Q50427876 | Medication adherence in patients with juvenile idiopathic arthritis. |
| Q37349277 | Medication choices in juvenile rheumatoid arthritis. |
| Q45926861 | Medication therapy patients with juvenile idiopathic arthritis (JIA), who needed joint replacement in adult life. |
| Q44110330 | Meeting the special needs of children with juvenile rheumatoid arthritis |
| Q54532253 | Membrane-bound toll-like receptors are overexpressed in peripheral blood and synovial fluid mononuclear cells of enthesitis-related arthritis category of juvenile idiopathic arthritis (JIA–ERA) patients and lead to secretion of inflammatory mediator |
| Q36304349 | Mental health and adjustment to juvenile idiopathic arthritis: Level of agreement between parent and adolescent reports according to Strengths and Difficulties Questionnaire and Adolescent Outcomes Questionnaire |
| Q52007097 | Mental health of mothers of children with juvenile rheumatoid arthritis: appraisal as a mediator. |
| Q85891412 | Mesenchymal stromal cells isolated from children with systemic juvenile idiopathic arthritis suppress innate and adaptive immune responses |
| Q46963271 | Mesenchymal stromal cells suppress synovial fluid-derived t cells from juvenile idiopathic arthritis patients in vitro |
| Q26991453 | Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody for juvenile idiopathic arthritis |
| Q37815009 | Metabolic syndrome and juvenile idiopathic arthritis. |
| Q26768171 | Metabolism of glycosaminoglycans in the course of juvenile idiopathic arthritis |
| Q70376138 | Methodology and studies of children with juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group (PRCSG) |
| Q104288088 | Methotrexate Hepatotoxicity in Children with Juvenile Idiopathic Arthritis: A Single Center Study |
| Q82184676 | Methotrexate and chronic uveitis associated with juvenile idiopathic arthritis |
| Q73816009 | Methotrexate as a possible trigger of macrophage activation syndrome in systemic juvenile idiopathic arthritis |
| Q74141320 | Methotrexate as a possible trigger of macrophage activation syndrome in systemic juvenile idiopathic arthritis |
| Q82868343 | Methotrexate bioavailability after oral and subcutaneous dministration in children with juvenile idiopathic arthritis |
| Q45745185 | Methotrexate does not primarily affect Foxp3+ regulatory T cells in poly-articular juvenile idiopathic arthritis |
| Q40697632 | Methotrexate efficacy and tolerability after switching from oral to subcutaneous route of administration in juvenile idiopathic arthritis |
| Q68022626 | Methotrexate for juvenile rheumatoid arthritis |
| Q68075898 | Methotrexate for juvenile rheumatoid arthritis |
| Q54127851 | Methotrexate for resistant chronic uveitis in children with juvenile rheumatoid arthritis. |
| Q37089689 | Methotrexate for the treatment of juvenile idiopathic arthritis: process to approval for JIA indication in Japan |
| Q34424214 | Methotrexate for treating juvenile idiopathic arthritis |
| Q81433188 | Methotrexate for uveitis associated with juvenile idiopathic arthritis: value and requirement for additional anti-inflammatory medication |
| Q67927114 | Methotrexate hepatotoxic effects in children with juvenile rheumatoid arthritis |
| Q53176089 | Methotrexate improves the health-related quality of life of children with juvenile idiopathic arthritis. |
| Q55617607 | Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting. |
| Q74214621 | Methotrexate in juvenile idiopathic arthritis: answers and questions |
| Q38214382 | Methotrexate in juvenile idiopathic arthritis: towards tailor-made treatment |
| Q40800506 | Methotrexate in juvenile rheumatoid arthritis. Do the benefits outweigh the risks? |
| Q72281579 | Methotrexate in juvenile rheumatoid arthritis. Evidence of age dependent pharmacokinetics |
| Q46963952 | Methotrexate in oligoarticular persistent juvenile idiopathic arthritis |
| Q44719227 | Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group |
| Q42969813 | Methotrexate in the therapy of juvenile idiopathic arthritis |
| Q41635870 | Methotrexate in the treatment of juvenile rheumatoid arthritis and other pediatric rheumatoid and nonrheumatic disorders |
| Q73373359 | Methotrexate inhibits interleukin-6 production in patients with juvenile rheumatoid arthritis |
| Q40932239 | Methotrexate intolerance in oral and subcutaneous administration in patients with juvenile idiopathic arthritis: a cross-sectional, observational study |
| Q36031057 | Methotrexate is an effective treatment for chronic uveitis associated with juvenile idiopathic arthritis. |
| Q92239493 | Methotrexate persistence and adverse drug reactions in patients with juvenile idiopathic arthritis |
| Q36202845 | Methotrexate polyglutamates as a potential marker of adherence to long-term therapy in children with juvenile idiopathic arthritis and juvenile dermatomyositis: an observational, cross-sectional study |
| Q54519389 | Methotrexate polyglutamates in erythrocytes are associated with lower disease activity in juvenile idiopathic arthritis patients. |
| Q59268787 | Methotrexate restores effector T cell responsiveness in juvenile idiopathic arthritis |
| Q70169963 | Methotrexate therapy for juvenile rheumatoid arthritis |
| Q69539321 | Methotrexate therapy in juvenile rheumatoid arthritis: a retrospective study |
| Q74545227 | Methotrexate therapy in systemic-onset juvenile rheumatoid arthritis in Saudi Arabia: a retrospective analysis |
| Q44208812 | Methotrexate therapy may prevent the onset of uveitis in juvenile idiopathic arthritis. |
| Q87121955 | Methotrexate treatment affects effector but not regulatory T cells in juvenile idiopathic arthritis |
| Q35553829 | Methotrexate treatment in juvenile idiopathic arthritis: when is the right time to stop? |
| Q39625961 | Methotrexate treatment may prevent uveitis onset in patients with juvenile idiopathic arthritis: experiences and subgroup analysis in a cohort with frequent methotrexate use. |
| Q70603891 | Methotrexate use in juvenile rheumatoid arthritis |
| Q38374642 | Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial |
| Q93092501 | Methotrexate-Induced Vasculitis in a Child with Systemic Onset Juvenile Idiopathic Arthritis |
| Q41329489 | Methotrexate-associated appearance and rapid progression of rheumatoid nodules in systemic-onset juvenile rheumatoid arthritis |
| Q74591085 | Methotrexate-induced hypersensitivity pneumonitis in a child with juvenile rheumatoid arthritis |
| Q90796548 | Methotrexate-induced pseudotumor cerebri in a patient with juvenile idiopathic arthritis |
| Q46824281 | Methotrexate/naproxen-associated severe hepatitis in a child with juvenile idiopathic arthritis. |
| Q39473510 | MiR-146a modulates macrophage polarization in systemic juvenile idiopathic arthritis by targeting INHBA. |
| Q84600176 | MiR-146a polymorphism is associated with asthma but not with systemic lupus erythematosus and juvenile rheumatoid arthritis in Mexican patients |
| Q49977551 | MicroRNA networks associated with active systemic juvenile idiopathic arthritis regulate CD163 expression and anti-inflammatory functions in macrophages through two distinct mechanisms. |
| Q92127813 | MicroRNA-125b regulates Th17/Treg cell differentiation and is associated with juvenile idiopathic arthritis |
| Q92605823 | MicroRNAs in juvenile idiopathic arthritis: Can we learn more about pathophysiological mechanisms? |
| Q91949288 | Microbial orchestra in juvenile idiopathic arthritis: Sounds of disarray? |
| Q90789379 | Microbiome Analytics of the Gut Microbiota in Patients With Juvenile Idiopathic Arthritis: A Longitudinal Observational Cohort Study |
| Q72026449 | Micrognathia, temporomandibular joint changes and dental occlusion in juvenile rheumatoid arthritis of adolescents and adults |
| Q72863111 | Migratory activity of blood polymorphonuclear leukocytes during juvenile rheumatoid arthritis, demonstrated with a new whole-blood membrane filter assay |
| Q92879521 | Mimickers of Juvenile Idiopathic Arthritis: Getting Clues From Imaging |
| Q35773310 | Mineral Oil Aspiration Related Juvenile Idiopathic Arthritis |
| Q37917410 | Misdiagnosis of knee venous malformation as juvenile idiopathic arthritis |
| Q71229318 | Mitral and aortic insufficiency in polyarticular juvenile rheumatoid arthritis |
| Q72098954 | Mitral and aortic insufficiency in polyarticular juvenile rheumatoid arthritis |
| Q91691832 | Mixed Cryoglobulinemia in a Patient with Juvenile Idiopathic Arthritis |
| Q77770390 | Mizoribine in the treatment of rheumatoid arthritis and juvenile idiopathic arthritis |
| Q79433302 | Mizoribine oral pulse therapy for a patient with polyarticular juvenile idiopathic arthritis |
| Q104104735 | Model-Based Selection and Recommendation for SC Abatacept Dose in Patients With Polyarticular Juvenile Idiopathic Arthritis |
| Q55109378 | Modeling Transcriptional Rewiring in Neutrophils Through the Course of Treated Juvenile Idiopathic Arthritis. |
| Q43091460 | Moderate deterioration in glucose tolerance during high-dose growth hormone therapy in glucocorticoid-treated patients with juvenile idiopathic arthritis |
| Q36513593 | Molecular cytogenetic characterization of two independent karyotypic anomalies in a patient with severe mental retardation and juvenile idiopathic arthritis |
| Q90042432 | Molecular signature characterisation of different inflammatory phenotypes of systemic juvenile idiopathic arthritis |
| Q73807597 | Molteno implantation for secondary glaucoma in juvenile rheumatoid arthritis |
| Q71302713 | Monarticular juvenile rheumatoid arthritis |
| Q72222724 | Monarticular juvenile rheumatoid arthritis |
| Q43240937 | Monitoring methotrexate toxicity in juvenile idiopathic arthritis |
| Q40518156 | Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations |
| Q40760159 | Monitoring of Epstein-Barr virus load and killer T cells in patients with juvenile idiopathic arthritis treated with methotrexate or tocilizumab. |
| Q40318743 | Monitoring serum IL-18 levels is useful for treatment of a patient with systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome |
| Q53104610 | Monitoring serum etanercept levels in juvenile idiopathic arthritis: a pilot study. |
| Q44953666 | Monitoring the long-term safety of therapies for children with juvenile idiopathic arthritis: time for a consolidated patient registry |
| Q41363297 | Monoarthritis in a 28-Year-Old Man With Juvenile Idiopathic Arthritis |
| Q40362824 | Monoarticular septic arthritis in a patient with juvenile rheumatoid arthritis under etanercept treatment. |
| Q40959067 | Monocyte MicroRNA Expression in Active Systemic Juvenile Idiopathic Arthritis Implicates MicroRNA-125a-5p in Polarized Monocyte Phenotypes |
| Q104072836 | Monocyte and bone marrow macrophage transcriptional phenotypes in systemic juvenile idiopathic arthritis reveal TRIM8 as a mediator of IFN-γ hyper-responsiveness and risk for macrophage activation syndrome |
| Q70278276 | Monocyte bone degradation: in vitro analysis of monocyte activity in patients with juvenile rheumatoid arthritis |
| Q53919449 | Monocytes and neutrophils in the inflammatory cascade of systemic onset Juvenile Idiopathic Arthritis. |
| Q33987294 | Monocytes are resistant to apoptosis in systemic juvenile idiopathic arthritis |
| Q35894989 | Morbidity associated with long-term methotrexate therapy in juvenile rheumatoid arthritis |
| Q37372292 | Moroccan parents caring for children with juvenile idiopathic arthritis: positive and negative aspects of their experiences |
| Q44688683 | Mortality in juvenile rheumatoid arthritis is diminished |
| Q48258658 | Mortality rates are increased in patients with systemic juvenile idiopathic arthritis. |
| Q36921557 | Mothers' reports of the difficulties that their children experience in taking methotrexate for Juvenile Idiopathic Arthritis and how these impact on quality of life |
| Q42171420 | Motor performance and functional ability in preschool- and early school-aged children with Juvenile Idiopathic Arthritis: a cross-sectional study. |
| Q46966935 | Multicenter retrospective study of biological tolerance in juvenile idiopathic arthritis (jir-cohort). |
| Q45745827 | Multicentric Castleman's Disease (CD) in juvenile idiopathic arthritis (JIA) treated with etanercept: coincidence or causal relationship? |
| Q38125390 | Multicentric osteolysis with nodulosis and arthropathy (MONA) with cardiac malformation, mimicking polyarticular juvenile idiopathic arthritis: case report and literature review. |
| Q47834818 | Multidisciplinary approach in the management of absolute trismus with bilateral temporomandibular joint replacements for a patient with juvenile idiopathic arthritis |
| Q41465160 | Multiple dislocations of the cervical spine in a patient with juvenile rheumatoid arthritis and Down's syndrome |
| Q36195303 | Multiple juvenile idiopathic arthritis subtypes demonstrate proinflammatory IgG glycosylation |
| Q50106942 | Multiple keratoacanthoma centrifugum marginatum associated with juvenile idiopathic arthritis and persistent corneal epithelial defect: an unusual case. |
| Q55116651 | Multiplex Cytokine Analysis of Aqueous Humor in Juvenile Idiopathic Arthritis-Associated Anterior Uveitis With or Without Secondary Glaucoma. |
| Q91385248 | Multisite Randomized Clinical Trial Evaluating an Online Self-Management Program for Adolescents With Juvenile Idiopathic Arthritis |
| Q68271854 | Muscle atrophy and leg length discrepancies in pauciarticular juvenile rheumatoid arthritis |
| Q95270078 | Muscle function and architecture in children with juvenile idiopathic arthritis |
| Q80517570 | Muscle involvement in juvenile idiopathic arthritis |
| Q36735007 | Muscle strength, physical fitness and well-being in children and adolescents with juvenile idiopathic arthritis and the effect of an exercise programme: a randomized controlled trial. |
| Q52926113 | Musculoskeletal abnormalities in juvenile idiopathic arthritis--a 4-year longitudinal study. |
| Q79910241 | Musculoskeletal abnormalities of the forearm in patients with juvenile idiopathic arthritis relate mainly to bone geometry |
| Q79844578 | Musculoskeletal abnormalities of the tibia in juvenile rheumatoid arthritis |
| Q45746698 | Musculoskeletal ultrasound versus magnetic resonance in supporting clinical management of juvenile idiopathic arthritis |
| Q86747850 | Mutation in the type II collagen gene (COL2A1) as a cause of early osteoarthritis and juvenile idiopathic arthritis-A pseudorheumatoid arthritis variant |
| Q40700680 | Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis |
| Q36634766 | Mutations in the MTHFR gene are not associated with Methotrexate intolerance in patients with juvenile idiopathic arthritis |
| Q39761819 | Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis. |
| Q46863014 | Mutations of familial hemophagocytic lymphohistiocytosis (FHL) related genes and abnormalities of cytotoxicity function tests in patients with macrophage activation syndrome (MAS) occurring in systemic juvenile idiopathic arthritis (sJIA). |
| Q28266838 | Mutations of the hemophagocytic lymphohistiocytosis-associated gene UNC13D in a patient with systemic juvenile idiopathic arthritis |
| Q55611167 | MyastheniaGravis(MG) in a patient with Juvenile Idiopathic Arthritis. |
| Q70703528 | Mycoplasma in Juvenile Rheumatoid Arthritis |
| Q73075705 | Myelodysplastic features in juvenile rheumatoid arthritis |
| Q44281724 | Myelogram in systemic juvenile rheumatoid arthritis |
| Q35552384 | Myeloid related protein 8 and 14 secretion reflects phagocyte activation and correlates with disease activity in juvenile idiopathic arthritis treated with autologous stem cell transplantation |
| Q47603426 | Myeloid related proteins MRP8/MRP14 may predict disease flares in juvenile idiopathic arthritis. |
| Q73574466 | Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis |
| Q67544518 | Myocarditis in juvenile rheumatoid arthritis |
| Q64986832 | Myocarditis in juvenile rheumatoid arthritis. |
| Q53618304 | Myositis as a presenting feature of systemic onset juvenile idiopathic arthritis. |
| Q53859169 | Naproxen and acetylsalicylic acid in the treatment of pauciarticular and polyarticular juvenile rheumatoid arthritis. Assessment of tolerance and efficacy in a single-centre 24-week double-blind parallel study. |
| Q40862528 | Naproxen in the Treatment of Juvenile Rheumatoid Arthritis: Metabolism, safety and efficacy |
| Q72348573 | Naproxen-induced pseudoporphyria in patients with juvenile rheumatoid arthritis |
| Q81581710 | Nasal septal perforation: a novel clinical manifestation of systemic juvenile idiopathic arthritis/adult onset Still's disease |
| Q47929003 | National study of cause-specific mortality in rheumatoid arthritis, juvenile chronic arthritis, and other rheumatic conditions: a 20 year followup study |
| Q72360385 | Natural History of Radiological Changes of Knee Joint in Juvenile Rheumatoid Arthritis |
| Q89495103 | Natural Killer Cells in Systemic Autoinflammatory Diseases: A Focus on Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome |
| Q37639016 | Natural history of growth and body composition in juvenile idiopathic arthritis |
| Q48177669 | Natural history of juvenile rheumatoid arthritis. A follow-up study of a case with special reference to clinical, electroencephalographic and neuropathological findings |
| Q33553973 | Natural killer (NK) cell activity of peripheral blood, synovial fluid, and synovial tissue lymphocytes from patients with rheumatoid arthritis and juvenile rheumatoid arthritis |
| Q68826726 | Natural killer (NK) cells at inflammatory sites of patients with rheumatoid arthritis and IgM rheumatoid factor positive polyarticular juvenile rheumatoid arthritis |
| Q43825311 | Natural killer cell activity and frequency of killer cell immunoglobulin-like receptors in children with different forms of juvenile idiopathic arthritis |
| Q85733562 | Natural killer cell and gamma delta T cell alterations in enthesitis related arthritis category of juvenile idiopathic arthritis |
| Q40663505 | Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome |
| Q24798867 | Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome |
| Q35691671 | Natural killer cell dysfunction: A common pathway in systemic-onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis? |
| Q46966710 | Nearly 20% of children are not correctly classified according to current ilar classification in a PRINTO dataset of more than 12,000 juvenile idiopathic arthritis patients. |
| Q44028356 | Nephrolithiasis in juvenile rheumatoid arthritis |
| Q44436176 | Nephrotic syndrome due to immunoglobulin M mesangial glomerulonephritis preceding juvenile idiopathic arthritis |
| Q43701147 | Nephrotic syndrome with early renal amyloidosis in juvenile rheumatoid arthritis |
| Q63236519 | Neprilysin levels in plasma and synovial fluid of juvenile idiopathic arthritis patients |
| Q69503381 | Nerve conduction velocity in juvenile rheumatoid arthritis |
| Q26740527 | Network analysis and juvenile idiopathic arthritis (JIA): a new horizon for the understanding of disease pathogenesis and therapeutic target identification |
| Q40870528 | Network analysis identifies protein clusters of functional importance in juvenile idiopathic arthritis |
| Q38184843 | Neural mechanisms underlying the pain of juvenile idiopathic arthritis |
| Q80257844 | Neuroblastoma masquerading as juvenile idiopathic arthritis |
| Q48523665 | Neuroendocrine gene polymorphisms and susceptibility to juvenile idiopathic arthritis. |
| Q92061056 | Neutropenia During Tocilizumab Treatment Is Not Associated with Infection Risk in Systemic or Polyarticular-course Juvenile Idiopathic Arthritis |
| Q39629368 | Neutropenia associated with chrysotherapy for juvenile rheumatoid arthritis |
| Q47293883 | Neutrophil activation signature in juvenile idiopathic arthritis indicates the presence of low-density granulocytes. |
| Q81444191 | Neutrophilic panniculitis in infancy: a cutaneous manifestation of juvenile rheumatoid arthritis |
| Q52633867 | Neutrophilic urticarial dermatosis as a presenting feature of systemic juvenile idiopathic arthritis. |
| Q60949723 | Neutrophils From Children With Systemic Juvenile Idiopathic Arthritis Exhibit Persistent Proinflammatory Activation Despite Long-Standing Clinically Inactive Disease |
| Q50095402 | Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade. |
| Q87602635 | New HLA associations identified in Romanian juvenile idiopathic arthritis patients |
| Q38000774 | New advances in juvenile idiopathic arthritis |
| Q37601162 | New advances in the management of juvenile idiopathic arthritis--1: non-biological therapy |
| Q37601164 | New advances in the management of juvenile idiopathic arthritis--2: the era of biologicals |
| Q53102504 | New classification for juvenile idiopathic arthritis: Is the Tower of Babel falling? |
| Q69482970 | New criteria for juvenile rheumatoid arthritis |
| Q39424746 | New frontiers in the treatment of systemic juvenile idiopathic arthritis |
| Q36986267 | New insights in systemic juvenile idiopathic arthritis--from pathophysiology to treatment |
| Q96308333 | New medications are needed for children with juvenile idiopathic arthritis |
| Q67781690 | New possibilities of pharmacotherapy in juvenile rheumatoid arthritis |
| Q34501610 | New treatments for juvenile idiopathic arthritis |
| Q73592279 | New-onset juvenile dermatomyositis: comparisons with a healthy cohort and children with juvenile rheumatoid arthritis |
| Q36151699 | Newer functional outcome measurements in juvenile rheumatoid arthritis: a progress report |
| Q33583241 | Next-Generation Sequencing Reveals Restriction and Clonotypic Expansion of Treg Cells in Juvenile Idiopathic Arthritis |
| Q45167262 | Niacin-like reaction to infliximab infusion in systemic juvenile rheumatoid arthritis. |
| Q36993938 | Nicotinamide Phosphoribosyltransferase Attenuates Methotrexate Response in Juvenile Idiopathic Arthritis and In Vitro |
| Q51922702 | Nitric oxide levels and the severity of juvenile idiopathic arthritis. |
| Q44881643 | Nitric oxide-derived species in synovial fluid from patients with juvenile idiopathic arthritis. |
| Q43054306 | Nitrous Oxide sedation for intra-articular injection in juvenile idiopathic arthritis |
| Q35571142 | Nitrous oxide analgesia during intra-articular injection for juvenile idiopathic arthritis |
| Q91138266 | No Association of Discontinuing Tumor Necrosis Factor Inhibitors Before Gestational Week Twenty in Well-Controlled Rheumatoid Arthritis and Juvenile Idiopathic Arthritis With a Disease Worsening in Late Pregnancy |
| Q50059307 | No association between types of unilateral mandibular condylar abnormalities and facial asymmetry in orthopedic-treated patients with juvenile idiopathic arthritis. |
| Q50571596 | No association between vitamin D levels around time of birth and later risk of developing oligo- and polyarticular juvenile idiopathic arthritis: a Danish case-cohort study. |
| Q42089676 | No association of IL-12p40 pro1.1 polymorphism with juvenile idiopathic arthritis |
| Q46380478 | No benefit of the combination therapy etanercept and methotrexate compared to etanercept mono therapy in juvenile idiopathic arthritis – a matched pair analysis |
| Q40886380 | No effect of transfer factor in juvenile rheumatoid arthritis by double-blind trial |
| Q57322685 | No evidence for genetic association of interferon regulatory factor 1 in juvenile idiopathic arthritis |
| Q45210571 | No evidence for hyperhomocysteinemia or increased prevalence of genetic polymorphisms in the homocysteine pathway in patients with moderate juvenile idiopathic arthritis. |
| Q67981913 | No firm basis to advocate auranofin in the treatment of juvenile rheumatoid arthritis |
| Q51932778 | No independent role of the -1123 G>C and+2740 A>G variants in the association of PTPN22 with type 1 diabetes and juvenile idiopathic arthritis in two Caucasian populations. |
| Q58589428 | No preventive or therapeutic efficacy of infliximab against macrophage activation syndrome due to systemic juvenile idiopathic arthritis |
| Q93103849 | No radiographic wrist damage after treatment to target in recent-onset juvenile idiopathic arthritis |
| Q40231471 | Nocardia brasiliensis infection mimicking juvenile idiopathic arthritis in a 4-year-old girl |
| Q44955625 | Nodular regenerative hyperplasia of the liver as a complication of long-standing systemic-onset juvenile idiopathic arthritis |
| Q84747530 | Nodulosis in systemic onset juvenile idiopathic arthritis: an uncommon event with spontaneous resolution |
| Q48712087 | Nomenclature and classification in chronic childhood arthritis: time for a change? |
| Q38175177 | Nomenclature and classification of juvenile idiopathic arthritis: where to after Durban? |
| Q51158792 | Non-HLA gene polymorphisms in juvenile idiopathic arthritis: associations with disease outcome. |
| Q35581206 | Non-HLA gene polymorphisms in juvenile rheumatoid arthritis |
| Q57176258 | Non-steroidal anti-inflammatory drug induces luteinized unruptured follicle syndrome in young female juvenile idiopathic arthritis patients |
| Q40788073 | Non-steroidal anti-inflammatory drugs and slow-acting anti-rheumatic drugs in juvenile rheumatoid arthritis. |
| Q38155765 | Non-systemic juvenile idiopathic arthritis outcome after reaching clinical remission with anti-TNF-α therapy: a clinical practice observational study of patients who discontinued treatment. |
| Q64896509 | Noninflammatory disorders mimic juvenile idiopathic arthritis. |
| Q71677945 | Nonreducible rotational head tilt and atlantoaxial lateral mass collapse. Clinical and roentgenographic features in patients with juvenile rheumatoid arthritis and ankylosing spondylitis |
| Q72096231 | Nonspecific alpha-naphthyl acetate esterase activity of T-lymphocytes: study in healthy newborns and children, in immune deficiencies and juvenile rheumatoid arthritis |
| Q91976853 | Nonspecific interstitial pneumonia in refractory systemic juvenile idiopathic arthritis responded to tocilizumab treatment |
| Q88445309 | Normal MRI findings of the knee in patients with clinically active juvenile idiopathic arthritis |
| Q42725535 | Notice of redundant publication: Aerobic capacity and disease activity in children, adolescents and young adults with juvenile idiopathic arthritis (JIA). |
| Q35605706 | Novel IL10 gene family associations with systemic juvenile idiopathic arthritis |
| Q50159971 | Novel UNC13D intronic variant disrupting a NFκB enhancer in a patient with recurrent macrophage activation syndrome and systemic juvenile idiopathic arthritis. |
| Q24792928 | Novel approaches to gene expression analysis of active polyarticular juvenile rheumatoid arthritis |
| Q51364277 | Novel automated system for magnetic resonance imaging quantification of the inflamed synovial membrane volume in patients with juvenile idiopathic arthritis. |
| Q97530704 | Novel biomarkers for early targeted and individualized treatment in Juvenile Idiopathic Arthritis |
| Q35630087 | Novel self-epitopes derived from aggrecan, fibrillin, and matrix metalloproteinase-3 drive distinct autoreactive T-cell responses in juvenile idiopathic arthritis and in health. |
| Q35040784 | Novel therapies for the treatment of juvenile rheumatoid arthritis (juvenile idiopathic arthritis). |
| Q38570721 | Novel treatment options for juvenile idiopathic arthritis |
| Q89405742 | Nuclear cataract as an early predictive factor for recalcitrant juvenile idiopathic arthritis-associated uveitis |
| Q72588106 | Nursing management of a child with juvenile rheumatoid arthritis |
| Q37346628 | Nutritional aspects of juvenile rheumatoid arthritis |
| Q80825712 | Nutritional impairment in juvenile idiopathic arthritis |
| Q84197704 | Nutritional status and clinical characteristics in children with juvenile rheumatoid arthritis |
| Q41212849 | Nutritional status and growth in juvenile rheumatoid arthritis |
| Q52763880 | OCULAR INVOLVEMENT IN JUVENILE RHEUMATOID ARTHRITIS, (STILL'S DISEASE). |
| Q67918637 | OKT4:OKT8 ratios of circulating T cells and in vitro suppressor cell function of patients with juvenile rheumatoid arthritis (JRA) |
| Q53046344 | ON MICROGNATHIA IN JUVENILE RHEUMATOID ARTHRITIS. |
| Q61308120 | OP0210-PARE The development and evaluation of an interactive health communication application to educate and empower young people living with juvenile idiopathic arthritis: a pilot study |
| Q35768965 | Obesity and disease activity in juvenile idiopathic arthritis |
| Q45746088 | Observation of juvenile idiopathic arthritis in children with MEVF gene mutations in Armenia |
| Q40455988 | Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. |
| Q87265984 | Occupational therapy intervention for the adolescent with juvenile rheumatoid arthritis |
| Q41965958 | Occurrence and management of ocular hypertension and secondary glaucoma in juvenile idiopathic arthritis-associated uveitis: An observational series of 104 patients |
| Q68402409 | Occurrence and types of juvenile rheumatoid arthritis in the County of Jutland 1970-1977 and 1978-1986 |
| Q40838895 | Occurrence of and Risk Factors for Ocular Hypertension and Secondary Glaucoma in Juvenile Idiopathic Arthritis-associated Uveitis |
| Q73395357 | Occurrence of chronic inflammatory rheumatic diseases among parents of multiple offspring affected by juvenile idiopathic arthritis |
| Q34619656 | Occurrence of inflammatory bowel disease during treatment of juvenile idiopathic arthritis with etanercept: a French retrospective study. |
| Q85088564 | Occurrence of inflammatory bowel disease in four patients with juvenile idiopathic arthritis receiving etanercept or infliximab |
| Q87270970 | Ocular Fluid Analysis in Children Reveals Interleukin-29/Interferon-λ1 as a Biomarker for Juvenile Idiopathic Arthritis-Associated Uveitis |
| Q36143787 | Ocular Hypotony in Patients With Juvenile Idiopathic Arthritis-Associated Uveitis |
| Q38235720 | Ocular Involvement in Juvenile Idiopathic Arthritis: Classification and Treatment |
| Q34431120 | Ocular concerns in juvenile rheumatoid arthritis |
| Q67018825 | Ocular histopathology in juvenile rheumatoid arthritis |
| Q35144371 | Ocular involvement in juvenile rheumatoid arthritis (Still's disease) |
| Q69403662 | Ocular manifestations during juvenile rheumatoid arthritis |
| Q41941511 | Ocular manifestations in juvenile rheumatoid arthritis |
| Q28336276 | Ocular manifestations of juvenile rheumatoid arthritis |
| Q80587547 | Ocular manifestations of juvenile rheumatoid arthritis in Olmsted County, Minnesota: a population-based study |
| Q39847023 | Ocular morbidities of juvenile idiopathic arthritis-associated uveitis in adulthood: results from a tertiary center study. |
| Q61831299 | Ocular threat in juvenile idiopathic arthritis |
| Q45746037 | Ocular threat in juvenile idiopathic arthritis (JIA). |
| Q60044792 | Off-label use of tocilizumab to treat non-juvenile idiopathic arthritis in pediatric rheumatic patients: a literature review |
| Q38177661 | Oligoarticular juvenile idiopathic arthritis among Saudi children |
| Q90243658 | Oligoarticular onset juvenile idiopathic arthritis as the most common cause of disability of children and young adults |
| Q57956167 | Oligoclonal expansion of T cells in persistent oligoarticular juvenile idiopathic arthritis |
| Q46854748 | Omega-3 fatty acids in juvenile idiopathic arthritis: effect on cytokines (IL-1 and TNF-α), disease activity and response criteria |
| Q33721208 | On beyond methotrexate treatment of severe juvenile rheumatoid arthritis. |
| Q71438426 | On the etiology of growth disturbance of the mandible in juvenile rheumatoid arthritis |
| Q82842089 | On the etiology of growth disturbance of the mandible in juvenile rheumatoid arthritis |
| Q70996709 | On the heterogeneity of HLA association in juvenile rheumatoid arthritis |
| Q42238507 | One-year followup study on clinical findings and changes in magnetic resonance imaging-based disease activity scores in juvenile idiopathic arthritis |
| Q59268720 | One-year observation of leflunomide effectiveness and saftey in juvenile idiopathic arthritis : a clinical practice review (preliminary data) |
| Q58069239 | Ongoing disease activity and changing categories in a long-term nordic cohort study of juvenile idiopathic arthritis |
| Q46381974 | Ongoing disease-activity and change in ILAR categories in a Nordic juvenile idiopathic arthritis cohort. |
| Q42134670 | Onset of polyarticular juvenile idiopathic arthritis with both anti-cyclic citrullinated peptide antibodies and rheumatoid factor in a 3-year-old girl |
| Q42694391 | Open issues in the assessment and management of pain in juvenile idiopathic arthritis |
| Q45745686 | Open label multicenter study of once weekly Etanercept 0.8 mg/kg in active polyarticular Juvenile idiopathic arthritis (JIA). |
| Q79402022 | Open reduction of the dislocated hip in juvenile idiopathic arthritis: a case report |
| Q37095775 | Operative stabilization of the remaining mobile segment in ankylosed cervical spine in systemic onset - juvenile idiopathic arthritis: A case report |
| Q83228568 | Ophthalmologic examinations in children with juvenile rheumatoid arthritis |
| Q44332950 | Opioid therapy for the treatment of refractory pain in children with juvenile rheumatoid arthritis |
| Q91705002 | Opportunistic infections in immunosuppressed patients with juvenile idiopathic arthritis: analysis by the Pharmachild Safety Adjudication Committee |
| Q46307434 | Optic Disk Neovascularization in Juvenile Rheumatoid Arthritis |
| Q81239962 | Optic neuritis associated with etanercept therapy in two patients with extended oligoarticular juvenile idiopathic arthritis |
| Q37314034 | Optimal treatment of knee monarthritis in juvenile idiopathic arthritis: a decision analysis |
| Q38264519 | Optimisation of disease assessments in juvenile idiopathic arthritis. |
| Q47598629 | Optimization of Quantitative Dynamic Postgadolinium MRI Technique Using Normalized Ratios for the Evaluation of Temporomandibular Joint Synovitis in Patients with Juvenile Idiopathic Arthritis. |
| Q84864112 | Optimizing the Wingate Anaerobic Cycling Test for youth with juvenile idiopathic arthritis |
| Q70515652 | Oral gold (auranofin) in juvenile rheumatoid arthritis: a 48-week phase II study |
| Q33942515 | Oral health and juvenile idiopathic arthritis: a review |
| Q37135730 | Oral health and orthodontic considerations in children with juvenile idiopathic arthritis: review of the literature and report of a case. |
| Q92017068 | Oral health and plaque microbial profile in juvenile idiopathic arthritis |
| Q41500942 | Oral health and quality of life of children and adolescents with juvenile idiopathic arthritis according to their caregivers' perceptions |
| Q92128265 | Oral health in children and adolescents with juvenile idiopathic arthritis - a systematic review and meta-analysis |
| Q44541363 | Oral health of children with juvenile idiopathic arthritis. |
| Q91693882 | Oral phospholipidic curcumin in juvenile idiopathic arthritis-associated uveitis |
| Q46565973 | Orbital pseudotumor in a child with juvenile rheumatoid arthritis. |
| Q61054135 | Orbital varices diagnosed as episcleritis in a child with juvenile idiopathic arthritis |
| Q45808274 | Orofacial pain and dysfunction in children with juvenile idiopathic arthritis: a case-control study. |
| Q92128580 | Orofacial pain in juvenile idiopathic arthritis is associated with stress as well as psychosocial and functional limitations |
| Q55668726 | Orofacial symptoms and oral health-related quality of life in juvenile idiopathic arthritis: a two-year prospective observational study. |
| Q87400074 | Orofacial symptoms related to temporomandibular joint arthritis in juvenile idiopathic arthritis: smallest detectable difference in self-reported pain intensity |
| Q37902712 | Orthodontic and dentofacial orthopedic management of juvenile idiopathic arthritis: a systematic review of the literature |
| Q36465391 | Orthognathic surgery in juvenile rheumatoid arthritis patients |
| Q72327526 | Orthopaedic aid in juvenile chronic polyarthritis |
| Q46551050 | Orthopaedic splint treatment can reduce mandibular asymmetry caused by unilateral temporomandibular involvement in juvenile idiopathic arthritis |
| Q40890660 | Orthopedic Overview of Juvenile Rheumatoid Arthritis |
| Q36439124 | Orthopedic surgical management of hip and knee involvement in patients with juvenile rheumatoid arthritis. |
| Q46383281 | Osteoblast differentiation from synovial fluid cells in juvenile idiopathic arthritis (JIA). |
| Q36246107 | Osteoblastogenesis from synovial fluid-derived cells is related to the type and severity of juvenile idiopathic arthritis |
| Q36827874 | Osteochondral lesions in children with juvenile idiopathic arthritis |
| Q92668134 | Osteochondritis Dissecans in Pediatric Patients with Juvenile Idiopathic Arthritis |
| Q89543152 | Osteochondritis dissecans shows a severe course and poor outcome in patients with juvenile idiopathic arthritis: a matched pair study of 22 cases |
| Q52982219 | Osteoid osteoma mimicking monoarticular juvenile idiopathic arthritis in a girl. |
| Q46381279 | Osteoid osteoma of the scaphoid bone mimicking juvenile idiopathic arthritis |
| Q82087562 | Osteolysis syndrome mimicking juvenile idiopathic arthritis |
| Q59268807 | Osteonecrosis of the femoral heads in patients with systemic onset juvenile idiopathic arthritis: comparison of the results of radiological and morphological methods |
| Q74141285 | Osteopenia in adults with a history of juvenile rheumatoid arthritis. A population based study |
| Q46447504 | Osteopenia in children with juvenile idiopathic arthritis |
| Q80038570 | Osteopenia is common in adult male patients with active juvenile idiopathic arthritis |
| Q34404122 | Osteoporosis in juvenile idiopathic arthritis |
| Q36792639 | Osteoporosis in juvenile idiopathic arthritis--a practical approach to diagnosis and therapy |
| Q47655877 | Osteoprotegerin (OPG)/RANK-L system in juvenile idiopathic arthritis: is there a potential modulating role for OPG/RANK-L in bone injury? |
| Q51682809 | Osteoprotegerin/RANKL system imbalance in active polyarticular-onset juvenile idiopathic arthritis: a bone damage biomarker? |
| Q40471184 | Other extraarticular manifestations of juvenile rheumatoid arthritis |
| Q30251990 | Ottawa Panel Evidence-Based Clinical Practice Guidelines for Foot Care in the Management of Juvenile Idiopathic Arthritis |
| Q30240137 | Ottawa Panel Evidence-Based Clinical Practice Guidelines for Structured Physical Activity in the Management of Juvenile Idiopathic Arthritis |
| Q67977637 | Our initial experience in using reaferon in juvenile rheumatoid arthritis |
| Q100940518 | Outcome Measures for Juvenile Idiopathic Arthritis Disease Activity |
| Q91900881 | Outcome Monitoring and Clinical Decision Support in Polyarticular Juvenile Idiopathic Arthritis |
| Q39663220 | Outcome and Trends in Treatment of Systemic Juvenile Idiopathic Arthritis in the German National Pediatric Rheumatologic Database, 2000-2013. |
| Q48264478 | Outcome and predicting factors of single and multiple intra-articular corticosteroid injections in children with juvenile idiopathic arthritis. |
| Q74267170 | Outcome and predictive factors in juvenile rheumatoid arthritis and juvenile spondyloarthropathy |
| Q47396290 | Outcome in adults with juvenile idiopathic arthritis. Comparison of the DUTCH-AIMS2 between JIA and RA. |
| Q73114813 | Outcome in adults with juvenile idiopathic arthritis: a quality of life study |
| Q90984306 | Outcome in juvenile idiopathic arthritis: a population-based study from Sweden |
| Q44788738 | Outcome in juvenile rheumatoid arthritis in India. |
| Q58134161 | Outcome of Juvenile Idiopathic Arthritis Associated Uveitis in Two Disease Subtypes |
| Q39274965 | Outcome of primary total hip arthroplasty in Charnley Class C patients with juvenile idiopathic arthritis: a case series |
| Q47190952 | Outcome of transition phase patients with juvenile idiopathic arthritis. |
| Q73635958 | Outcome status in children with sustained polyarticular and systemic juvenile idiopathic arthritis |
| Q102381054 | Outcomes and predictors of juvenile idiopathic arthritis in Southeast Asia: a Singapore longitudinal study over a decade |
| Q40611034 | Outcomes of patients with juvenile idiopathic arthritis on biological therapy and have a varicella-zoster virus infection |
| Q82289680 | Outcomes of treatment with immunomodulatory therapy in patients with corticosteroid-resistant juvenile idiopathic arthritis-associated chronic iridocyclitis |
| Q52590243 | Ovarian Reserve in Young Juvenile Idiopathic Arthritis Patients. |
| Q46176678 | Over expression of toll-like receptors in peripheral blood and synovial fluid monocytes of enthesitis related arthritis category of juvenile idiopathic arthritis (JIA-ERA) patients contributes to secretion of inflammatory mediators |
| Q82936667 | Overlap between atrophoderma Pasini-Pierini and juvenile idiopathic arthritis |
| Q34110041 | Overlap of disease susceptibility loci for rheumatoid arthritis and juvenile idiopathic arthritis |
| Q72116102 | Overlap syndrome of juvenile rheumatoid arthritis and systemic lupus erythematosus |
| Q84629910 | Overlapping juvenile idiopathic arthritis and systemic lupus erythematosus: a case report |
| Q33859563 | Overview of the radiology of juvenile idiopathic arthritis (JIA). |
| Q77070224 | Oxidant-antioxidant imbalance in blood of children with juvenile rheumatoid arthritis |
| Q46797437 | P wave dispersion and cardiac involvement in patients with juvenile idiopathic arthritis |
| Q41829182 | P wave dispersion in juvenile idiopathic arthritis patients with diastolic dysfunction. |
| Q90259255 | PADI4 (rs2240340), PDCD1 (rs10204525), and CTLA4 (231775) Gene Polymorphisms and Polyarticular Juvenile Idiopathic Arthritis |
| Q36275323 | PADI4 and the HLA-DRB1 shared epitope in juvenile idiopathic arthritis |
| Q89090269 | PAIN PERCEPTION AND PAIN COPING MECHANISMS IN CHILDREN AND ADOLESCENTS WITH JUVENILE FIBROMYALGIA AND POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS |
| Q41146381 | PAINLESS JUVENILE RHEUMATOID ARTHRITIS: A Case Report |
| Q59893826 | PARE0013 Juvenile Idiopathic Arthritis: It's Not Just An Old Person's Disease |
| Q50146735 | PDCD1 Single Nucleotide Polymorphisms in Iranian Patients With Juvenile Idiopathic Arthritis. |
| Q40980270 | PERICARDITIS IN JUVENILE RHEUMATOID ARTHRITIS |
| Q43044578 | PET assessment of disease activity in children with juvenile idiopathic arthritis |
| Q91958758 | PRECORDIAL PAIN, LEUKOCYTOSIS AND BICYTOPENIA IN A TEENAGER WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS UNDER IMMUNOSUPPRESSIVE THERAPY |
| Q91338392 | PROMIS Computer Adaptive Tests and Their Correlation With Disease Activity in Juvenile Idiopathic Arthritis |
| Q55544262 | PReS-FINAL-1001: Lymphocytes from the inflamed joint of juvenile idiopathic arthritis patients express reduced levels of cd73 and have a functional defect in adenosine production. |
| Q55533738 | PReS-FINAL-1003: Intrinsic cd4 and cd8 effector t cell resistance to suppression in the synovial fluid of juvenile idiopathic arthritis patients. |
| Q45851380 | PReS-FINAL-1005: Hypertransaminasemia in systemic juvenile idiopathic arthritis during anti-interleukin 1 treatment |
| Q46006842 | PReS-FINAL-1016: Micro vesicles as a magnifying glass; uncovering potential biomarkers in juvenile idiopathic arthritis. |
| Q47096958 | PReS-FINAL-2001: The impact of adalimumab on growth in patients with juvenile idiopathic arthritis. |
| Q55532735 | PReS-FINAL-2003: Remission and predictors of persistent disease activity at 30 years follow-up in a Norwegian cohort of juvenile idiopathic arthritis patients. |
| Q55540693 | PReS-FINAL-2007: Adolescent clinic for young patients with juvenile idiopathic arthritis. |
| Q46613675 | PReS-FINAL-2017: Systemic onset juvenile idiopathic arthritis (SOJIA)-a 5-year survey in a pediatric rheumatology department |
| Q55535922 | PReS-FINAL-2018: The P53 gene polymorphisms and juvenile idiopathic arthritis. |
| Q55539330 | PReS-FINAL-2019: Tuberculosis infection observed in patients receiving biological DMARDs for treatment of juvenile idiopathic arthritis. |
| Q46855559 | PReS-FINAL-2020: Cell type specific transcriptome analysis in patients with enthesitis related arthritis category of juvenile idiopathic arthritis (JIA-ERA). |
| Q45842171 | PReS-FINAL-2022: Juvenile idiopathic arthritis after allogeneic bone marrow transplantation: a case report |
| Q54941172 | PReS-FINAL-2023: Uveitis surveillance through lean-six sigma for quality assurance in juvenile idiopathic arthritis. |
| Q50280991 | PReS-FINAL-2026: Glucose and lipid metabolism in children with juvenile idiopathic arthritis treated with anti-TNF-alpha. |
| Q55534694 | PReS-FINAL-2028: ANA positivity and a younger age at onset, but not disease category, predict the risk of uveitis in italian children with juvenile idiopathic arthritis. |
| Q55544394 | PReS-FINAL-2029: Long-term follow-up of patients with juvenile idiopathic arthritis (JIA) in a single center: a systematic chart review. |
| Q55535701 | PReS-FINAL-2030: Treatment with leflunomide results in a higher flare rate of chronic uveitis compared to methotrexate in patients with juvenile idiopathic arthritis treated with both drugs. |
| Q55454635 | PReS-FINAL-2031: Hyaluronic acid is a marker of active arthritis, but not systemic inflammation in systemic juvenile idiopathic arthritis. |
| Q55533620 | PReS-FINAL-2032: Changes in immunogenic profile in patients with juvenile idiopathic arthritis exposed to anti tumoral necrosis factor therapy. |
| Q55543308 | PReS-FINAL-2033: Increase of adverse mild and moderate adverse events among patients with juvenile idiopathic arthritis treated with biological therapies. |
| Q55221774 | PReS-FINAL-2036: Proteins of the lectin pathway of the complement system in juvenile idiopathic arthritis. |
| Q55532895 | PReS-FINAL-2039: Evaluation of local activity of wrists and finger joints damage in patients with juvenile idiopathic arthritis: the values of radiology methods. |
| Q49299372 | PReS-FINAL-2041: Macrophage activation syndrome in the children with systemic juvenile idiopathic arthritis during the course of tocilizumab. |
| Q55534223 | PReS-FINAL-2042: Health-related quality of-life in Turkish children and adolescents with juvenile idiopathic arthritis. |
| Q45849258 | PReS-FINAL-2043: Cardiac involvement in juvenile idiopathic arthritis. |
| Q55527570 | PReS-FINAL-2044: TNF-alpha inhibitors in treatment of children with systemic form of juvenile idiopathic arthritis. |
| Q55082947 | PReS-FINAL-2045: Mutational analysis of sialic acid acetylesterase (siae) in juvenile idiopathic arthritis (JIA). |
| Q45796909 | PReS-FINAL-2046: Uveitis in the Nordic juvenile idiopathic arthritis cohort; high incidence, frequent complications, and gender-associated risk factors. |
| Q55535501 | PReS-FINAL-2048: Treatment with methotrexate plus leflunomide for juvenile idiopathic arthritis. |
| Q55538359 | PReS-FINAL-2052: Costs of biologics in juvenile idiopathic arthritis: past, present and future. |
| Q55527798 | PReS-FINAL-2053: Vitamin D receptor polymorphisms in a cohort of Italian patients with juvenile idiopathic arthritis. |
| Q55537033 | PReS-FINAL-2054: Latent tuberculosis infection in patients with juvenile idiopathic arthritis undergoing methotrexate therapy: a longitudinal study with TST and ELISPOT. |
| Q50285062 | PReS-FINAL-2059: Th17 cells highly enriched in peripheral blood in children with HLA B27-associated arthritis and systemic onset juvenile idiopathic arthritis. |
| Q55537879 | PReS-FINAL-2060: The role of stress factors in the onset of juvenile idiopathic arthritis. |
| Q55535776 | PReS-FINAL-2061: Abatacept in therapy of juvenile idiopathic arthritis in real clinical practice. |
| Q55537365 | PReS-FINAL-2062: The need for conducting different rehabilitation complexes for patients with juvenile idiopathic arthritis (JIA). |
| Q46559997 | PReS-FINAL-2063: Proposed criteria for activity, damage and impact of juvenile idiopathic arthritis associated uveitis: consensus effort from the multinational interdisciplinary working group for uveitis in childhood (MIWGUC). |
| Q47131299 | PReS-FINAL-2064: Effect of Goloimumab a new anti-TNF, in patients with the diagnosis of juvenile idiopathic arthritis |
| Q46077458 | PReS-FINAL-2066: Use of chiropractic care in danish children with juvenile idiopathic arthritis |
| Q55535860 | PReS-FINAL-2067: How does the self-experienced HRQOL work for children with JIA - juvenile idiopathic arthritis in Stockholm? |
| Q50108760 | PReS-FINAL-2068: S100 A8/A9 serum levels reflect disease activity in juvenile idiopathic arthritis-associated uveitis. |
| Q54968594 | PReS-FINAL-2070: Efficacy of biologic treatments in juvenile idiopathic arthritis with a polyarticular course: an indirect comparison. |
| Q46210872 | PReS-FINAL-2071: Anti-type II collagen antibodies, anti-CCP, IgA-RF and IgM-RF are associated with joint damage eight years after onset of juvenile idiopathic arthritis (JIA). |
| Q55529972 | PReS-FINAL-2072: How does the management of enthesitis related arthritis differ from other sub-types of juvenile idiopathic arthritis? A retrospective study of jia at an adolescent rheumatology centre. |
| Q55460730 | PReS-FINAL-2077: Lung function evaluation in a juvenile idiopathic arthritis cohort. |
| Q55529810 | PReS-FINAL-2078: Single nucleotide polymorphisms of toll like receptors 2 and 4 in enthesitis related arthritis and oligo and polyarticular juvenile idiopathic arthritis. |
| Q45783990 | PReS-FINAL-2080: Overlap syndrome between primary sclerosing cholangitis and autoimmune hepatitis associated with ulcerative colitis - a case of unusual presentation in a patient with systemic juvenile idiopathic arthritis. |
| Q50274436 | PReS-FINAL-2081: Accelerometer-assessed daily activity in juvenile idiopathic arthritis. |
| Q55543236 | PReS-FINAL-2084: Prevalence of cervical spine involvement in children with juvenile idiopathic arthritis. |
| Q55536308 | PReS-FINAL-2085: The p38-mediated rapid downregulation of cell surface gp130 expression impairs IL-6 signaling in the synovial fluid of juvenile idiopathic arthritis patients. |
| Q55536207 | PReS-FINAL-2088: Risk of severe adverse events in juvenile idiopathic arthritis and pediatric-onset inflammatory bowel disease, treated with anti-tnf drugs. |
| Q55252015 | PReS-FINAL-2089: Temporomandibular joint involvement and quality of life in juvenile idiopathic arthritis. |
| Q55164151 | PReS-FINAL-2094: Evaluation of the benefits of sequential addition of leflunomide in patients with polyarticular course juvenile idiopathic arthritis failing standard dose methotrexate. |
| Q47103668 | PReS-FINAL-2095: Older age predicts poor response to 6-months methotrexate therapy in a juvenile idiopathic arthritis cohort of patients |
| Q47120010 | PReS-FINAL-2096: Herpes virus infections in patients with juvenile idiopathic arthritis (JIA) treated with etanercept |
| Q49860032 | PReS-FINAL-2097: Evaluation of gait in children with juvenile idiopathic arthritis. |
| Q50349575 | PReS-FINAL-2098: Evaluation of the disease course of Italian children with juvenile idiopathic arthritis treated with etanercept: preliminary results in 313 patients. |
| Q45844485 | PReS-FINAL-2099: Assessing the standards of oral health in children and adolescents with juvenile idiopathic arthritis |
| Q55543779 | PReS-FINAL-2100: Methotrexate treatment affects effector, but not regulatory T cells in juvenile idiopathic arthritis. |
| Q55003927 | PReS-FINAL-2101: Nitrous oxide analgesia for intra-articular injection in juvenile idiopathic arthritis: our experience. |
| Q46650879 | PReS-FINAL-2109: Genetic variations in patients with juvenile idiopathic arthritis and uveitis. |
| Q55537491 | PReS-FINAL-2110: Tocilizumab for patients with oligoarticular juvenile idiopathic arthritis refractory to conventional therapy. |
| Q59300197 | PReS-FINAL-2111: Cytomegalovirus, Epstein Barr virus and Varicella-Zoster virus infections in children with juvenile idiopathic arthritis treated with biologics |
| Q46800934 | PReS-FINAL-2112: Mapping the treatment effect of infliximab on a case of refractory anterior uveitis related to juvenile idiopathic arthritis (JIA). |
| Q55427446 | PReS-FINAL-2113: The association of the NFKB1 gene polymorphism with systemic onset juvenile idiopathic arthritis in Russia. |
| Q55533965 | PReS-FINAL-2116: Assessment of disease activity by patients with juvenile idiopathic arthritis and the parents compared to the assessment by pediatric rheumatologists. |
| Q55541584 | PReS-FINAL-2117: Dream doctors - medical clowns increase the effect of nitrous oxide sedation in intra-articular corticosteroid injection for juvenile idiopathic arthritis. |
| Q45935184 | PReS-FINAL-2132: Defining criteria for high disease activity in juvenile idiopathic arthritis: definition and validation of juvenile arthritis disease activity score cutoffs. |
| Q55527753 | PReS-FINAL-2133: Drug survival and switching of biological agents in systemic juvenile idiopathic arthritis. |
| Q55538114 | PReS-FINAL-2134: Assessment of radiographic progression in patients (pts) with systemic juvenile idiopathic arthritis (sjia) treated with tocilizumab (TCZ): 2-year results from the tender trial. |
| Q47130868 | PReS-FINAL-2135: Analysis of the HLA region in a large cohort of juvenile idiopathic arthritis cases identifies independent effects at HLA-DRB1. |
| Q45960297 | PReS-FINAL-2138: Abatacept (orencia) in treatment of different types of juvenile idiopathic arthritis. |
| Q47135018 | PReS-FINAL-2140: Neutropenia with Tocilizumab (TCZ) treatment is not associated with increased infection risk in patients with systemic juvenile idiopathic arthritis (SJIA). |
| Q55540243 | PReS-FINAL-2142: Predictors of persistent remission following etanercept (ETN) withdrawal in patients with juvenile idiopathic arthritis (JIA). |
| Q55533521 | PReS-FINAL-2143: Treat-to-target strategy in juvenile idiopathic arthritis: experience in 175 newly-diagnosed patients. |
| Q46884207 | PReS-FINAL-2144: Bone mineral status in patients with juvenile idiopathic arthritis after 12 months of treatment with etanercept |
| Q55541038 | PReS-FINAL-2145: MRP8/14 serum complexes as predictor of response to etanercept treatment in juvenile idiopathic arthritis. |
| Q55527390 | PReS-FINAL-2146: Trends in prescription of biologics and outcomes of juvenile idiopathic arthritis; results of the Dutch national arthritis and biologicals in children register. |
| Q55369520 | PReS-FINAL-2147: Immunological consequences of biologicals in juvenile idiopathic arthritis. |
| Q55099281 | PReS-FINAL-2148: Rheumates@work a cognitive behavioural internet based intervention promoting physical activity in children with juvenile idiopathic arthritis: preliminary results of a randomized clinical trail. |
| Q55537183 | PReS-FINAL-2149: Interaction of PTPN2 and vitamin D GC sequence variants and risk of juvenile idiopathic arthritis. |
| Q45805591 | PReS-FINAL-2150: Antiocular antibodies in children with juvenile idiopathic arthritis-associated uveitis |
| Q55535513 | PReS-FINAL-2152: Biomarkers as predictors of early inactive disease in children with juvenile idiopathic arthritis. |
| Q55538624 | PReS-FINAL-2155: Genetic variability of methotrexate transporters in patients with juvenile idiopathic arthritis. |
| Q55532828 | PReS-FINAL-2156: Analysis of gene expression and inflammation biomarkers in systemic juvenile idiopathic arthritis (SJIA) patients on canakinumab therapy. |
| Q46225400 | PReS-FINAL-2157: Efficacy of canakinumab in the treatment of systemic juvenile idiopathic arthritis: a 12-week pooled post-hoc analysis |
| Q46771497 | PReS-FINAL-2158: Effect of canakinumab on functional ability and health-related quality of life in systemic juvenile idiopathic arthritis (SJIA) patients |
| Q45814178 | PReS-FINAL-2159: Tocilizumab (TCZ) dosing in juvenile idiopathic arthritis (JIA): optimising for different JIA type and body weight patients |
| Q55527799 | PReS-FINAL-2160: Intestinal microbiome in polyarticular juvenile idiopathic arthritis: a pilot study. |
| Q55543720 | PReS-FINAL-2161: Safety and effectiveness of adalimumab in children with polyarticular juvenile idiopathic arthritis aged 2 to <4 years or >=4 years weighing <15 kg. |
| Q55535446 | PReS-FINAL-2162: Development of a risk model to predict methotrexate intolerance in juvenile idiopathic arthritis. |
| Q46127958 | PReS-FINAL-2163: Disease activity in a juvenile idiopathic arthritis population after 5 years follow-up |
| Q55538425 | PReS-FINAL-2164: Agreement among musculoskeletal pediatric specialists in the assessment of radiographic joint damage in juvenile idiopathic arthritis. |
| Q55128461 | PReS-FINAL-2165: Pharmacogenetic determinants of response to methotrexate in juvenile idiopathic arthritis. |
| Q49242891 | PReS-FINAL-2166: Long-term safety and effectiveness of anti-interleukin-6 receptor monoclonal antibody, tocilizumab, in patients with systemic juvenile idiopathic arthritis in Japan. |
| Q50318639 | PReS-FINAL-2167: What is the potential of intra-articular corticosteroid injections to induce sustained remission in children with juvenile idiopathic arthritis? |
| Q45993899 | PReS-FINAL-2169: Exposure-response modeling of canakinumab in the avoidance of flares in children with systemic juvenile idiopathic arthritis. |
| Q50355439 | PReS-FINAL-2170: Work disability in adult patients with juvenile idiopathic arthritis (JIA). |
| Q45859405 | PReS-FINAL-2176: Declines in levels of disease activity and physical disability in children with juvenile idiopathic arthritis seen in standard clinical care over the last 25 years |
| Q55537744 | PReS-FINAL-2177: Safety and lack of autoantibody production following influenza H1N1 vaccination in patients with juvenile idiopathic arthritis (JIA). |
| Q55542364 | PReS-FINAL-2180: Efficacy and safety of tocilizumab (TCZ) in patients with polyarticular-course juvenile idiopathic arthritis (pcJIA): 2-year data from CHERISH. |
| Q55536030 | PReS-FINAL-2181: Recombinant il-1ra restores the il-18-nk cell axis in steroid naive systemic juvenile idiopathic arthritis. |
| Q55527503 | PReS-FINAL-2263: Progressive pseudorheumatoid dysplasia in differential diagnosis of juvenile idiopathic arthritis. |
| Q55537540 | PReS-FINAL-2315: Severe cutaneous vasculitis in two patients with juvenile idiopathic arthritis and biologic therapy. |
| Q55539111 | PReS-FINAL-2343: Cartilage thickness of the knee in juvenile idiopathic arthritis. comparative assessment by ultrasonography and magnetic resonance imaging. |
| Q47121069 | PReS-FINAL-2344: Radiographic evaluation of joint space width compared to cartilage thickness as assessed by ultrasonography in knees of children with juvenile idiopathic arthritis |
| Q46091901 | PReS-FINAL-2345: Frequency of radiographic damage and progression in individual joints in children with juvenile idiopathic arthritis |
| Q55416375 | PReS13-SPK-1332: Assessment of disease activity and damage in juvenile idiopathic arthritis. |
| Q64049216 | Pachidermoperiostosis as a cause of massive joint effusion with polyarticular involvement mimicking juvenile idiopathic arthritis: A case report |
| Q84903693 | Pachydermatodactyly mimics polyarticular juvenile idiopathic arthritis |
| Q81238107 | Pachydermodactyly may mimic juvenile idiopathic arthritis |
| Q86931420 | Pachydermodactyly mimicking juvenile idiopathic arthritis |
| Q38135386 | Paediatric rheumatology practice in the UK benchmarked against the British Society for Paediatric and Adolescent Rheumatology/Arthritis and Musculoskeletal Alliance Standards of Care for juvenile idiopathic arthritis |
| Q85900527 | Paediatric rheumatology: Biologic therapy for systemic juvenile idiopathic arthritis--times they are a'changing! |
| Q87035681 | Paediatric rheumatology: Juvenile idiopathic arthritis--are biologic agents effective for pain? |
| Q60718103 | Pain as a quality of care measure in juvenile idiopathic arthritis: One step forward, but is it the best foot? Comment on the article by Lovell et al |
| Q38669757 | Pain associated with juvenile rheumatoid arthritis |
| Q73899210 | Pain experience and pain coping strategies in children with juvenile idiopathic arthritis |
| Q45744652 | Pain experience in children with juvenile idiopathic arthritis on TNFalpha-inhibitors. |
| Q36843390 | Pain experience in children with juvenile idiopathic arthritis treated with anti-TNF agents compared to non-biologic standard treatment |
| Q34227193 | Pain hypersensitivity in juvenile idiopathic arthritis: a quantitative sensory testing study |
| Q37532470 | Pain in School: Patterns of Pain-Related School Impairment among Adolescents with Primary Pain Conditions, Juvenile Idiopathic Arthritis Pain, and Pain-Free Peers |
| Q71527743 | Pain in children with juvenile rheumatoid arthritis: a descriptive study |
| Q39553765 | Pain intensity variability and its relationship with quality of life in youths with juvenile idiopathic arthritis |
| Q46055260 | Pain intensity, psychological inflexibility, and acceptance of pain as predictors of functioning in adolescents with juvenile idiopathic arthritis: a preliminary investigation |
| Q92566603 | Pain interference and associated factors in young adults with juvenile idiopathic arthritis |
| Q101372683 | Pain sensitivity in young adults with juvenile idiopathic arthritis: a quantitative sensory testing study |
| Q46972646 | Pain threshold in adolescents with juvenile idiopathic arthritis and fibromyalgia |
| Q47351596 | Pain-specific beliefs and pain experience in children with juvenile idiopathic arthritis: a longitudinal study |
| Q68804171 | Painless juvenile rheumatoid arthritis |
| Q46076120 | Palisaded Neutrophilic Granulomatous Dermatitis in a Child with Juvenile Idiopathic Arthritis on Etanercept |
| Q92799193 | Palmoplantar pustulosis-like eruption following tofacitinib therapy for juvenile idiopathic arthritis |
| Q92381026 | Pancreatitis in systemic juvenile idiopathic arthritis |
| Q40914109 | Panel discussion. 3. Case of periodic fever and rush anticipated to develop to juvenile rheumatoid arthritis |
| Q90058201 | Parent Pain Cognitions and Treatment Adherence in Juvenile Idiopathic Arthritis |
| Q48488816 | Parent and child acceptable symptom state in juvenile idiopathic arthritis. |
| Q33727326 | Parent pain responses as predictors of daily activities and mood in children with juvenile idiopathic arthritis: the utility of electronic diaries |
| Q52946973 | Parent perceptions of problems experienced by their children in complying with treatments for juvenile rheumatoid arthritis. |
| Q92184997 | Parental Perception of Dietary Intervention in Juvenile Idiopathic Arthritis |
| Q93046202 | Parental Perspectives about Research and Knowledge Translation in Juvenile Idiopathic Arthritis |
| Q92912302 | Parental Smoking Influence in Disease Activity in a Low-Income Juvenile Idiopathic Arthritis Cohort |
| Q45748413 | Parental preferences for treatment: Preliminary report from a randomised comparison of treatment strategies in (early) juvenile idiopathic arthritis (BeSt for Kids trial). |
| Q47246688 | Parenting a Child with Juvenile Idiopathic Arthritis, Orofacial Pain, and Dysfunction: A Qualitative Study. |
| Q50951381 | Parents' preferences for drug treatments in juvenile idiopathic arthritis: a discrete choice experiment. |
| Q39197279 | Parents' willingness to pay for biologic treatments in juvenile idiopathic arthritis |
| Q68041949 | Pars plana lensectomy and vitrectomy for complicated cataracts in juvenile rheumatoid arthritis |
| Q43509457 | Partial C4 deficiency in juvenile idiopathic arthritis patients |
| Q34037891 | Partial and Total Descemet's Detachments in a Patient with Severe Terrien's Marginal Degeneration and Juvenile Idiopathic Arthritis |
| Q57538150 | Participation in Juvenile Idiopathic Arthritis |
| Q48528603 | Participation in Leisure Activities by Children and Adolescents with Juvenile Idiopathic Arthritis. |
| Q60942504 | Participation in a single-blinded pediatric therapeutic strategy study for juvenile idiopathic arthritis: are parents and patient-participants in equipoise? |
| Q91895302 | Participation in school and physical education in juvenile idiopathic arthritis in a Nordic long-term cohort study |
| Q64237585 | Participation in school sports among children and adolescents with juvenile idiopathic arthritis in the German National Paediatric Rheumatologic Database, 2000-2015: results from a prospective observational cohort study |
| Q45015675 | Parvovirus B19 in the acute arthropathies and juvenile rheumatoid arthritis |
| Q51754403 | Parvovirus B19 may have a role in the pathogenesis of juvenile idiopathic arthritis. |
| Q51653011 | Patellar resurfacing reduces pain after TKA for juvenile rheumatoid arthritis. |
| Q34449130 | Pathogenesis and clinical manifestations of juvenile rheumatoid arthritis |
| Q38240625 | Pathogenesis of juvenile idiopathic arthritis associated uveitis: the known and unknown |
| Q38212949 | Pathogenesis of systemic inflammatory diseases in childhood: "Lessons from clinical trials of anti-cytokine monoclonal antibodies for Kawasaki disease, systemic onset juvenile idiopathic arthritis, and cryopyrin-associated periodic fever syndrome". |
| Q34269827 | Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions |
| Q66940528 | Pathogenic implications of age of onset in juvenile rheumatoid arthritis |
| Q40208102 | Pathological changes in the TMJ and the length of the ramus in patients with confirmed juvenile idiopathic arthritis. |
| Q35710090 | Pathophysiology of juvenile idiopathic arthritis induced pes planovalgus in static and walking condition: a functional view using 3D gait analysis |
| Q39147872 | Pathway analysis based on Monte Carlo Cross-Validation in polyarticular juvenile idiopathic arthritis |
| Q47229149 | Patient characteristics associated with response to NSAID monotherapy in children with systemic juvenile idiopathic arthritis |
| Q90115387 | Patient factors associated with waiting time to pediatric rheumatologist consultation for patients with juvenile idiopathic arthritis |
| Q36050908 | Patient perceptions of foot disability in Juvenile Idiopathic Arthritis: a comparison of the juvenile arthritis foot disability index and the Oxford ankle foot questionnaire for children |
| Q94954790 | Patient satisfaction and clinical effectiveness of switching from intravenous tocilizumab to subcutaneous tocilizumab in patients with juvenile idiopathic arthritis: an observational study |
| Q49539345 | Patient's experiences with the care for juvenile idiopathic arthritis across Europe. |
| Q91503445 | Patient-Reported Barriers at School for Children with Juvenile Idiopathic Arthritis |
| Q36118097 | Patient-reported Outcomes across Categories of Juvenile Idiopathic Arthritis |
| Q39092710 | Patient-reported joint count in juvenile idiopathic arthritis: the reliability of a manikin format |
| Q46966686 | Patient-reported joint count in juvenile idiopathic arthritis: the reliability of a mannequin format |
| Q81484663 | Patients with antinuclear antibody-positive juvenile idiopathic arthritis constitute a homogeneous subgroup irrespective of the course of joint disease |
| Q59268783 | Patients with early-onset systemic juvenile idiopathic arthritis show more inflammation and worse outcome |
| Q95520629 | Patients with juvenile idiopathic arthritis become adults: the role of transitional care |
| Q50046016 | Patients with juvenile idiopathic arthritis in clinical remission with positive power Doppler signal in joint ultrasonography have an increased rate of clinical flare: a prospective study. |
| Q100570515 | Patients with juvenile idiopathic arthritis on TNF inhibitors exposed to COVID-19 family members |
| Q85901996 | Patients with very early-onset systemic juvenile idiopathic arthritis exhibit more inflammatory features and a worse outcome |
| Q70261361 | Pattern of rheumatic diseases in south India. IV. Clinical profile of juvenile rheumatoid arthritis |
| Q71750936 | Patterns of T lymphocyte clonal expansion in HLA-typed patients with juvenile rheumatoid arthritis |
| Q36299612 | Patterns of clinical remission in select categories of juvenile idiopathic arthritis. |
| Q40696267 | Patterns of compensation of functional deficits of the knee joint in patients with juvenile idiopathic arthritis |
| Q71620545 | Patterns of expression of tumor necrosis factor alpha, tumor necrosis factor beta, and their receptors in synovia of patients with juvenile rheumatoid arthritis and juvenile spondylarthropathy |
| Q74508512 | Patterns of joint involvement at onset differentiate oligoarticular juvenile psoriatic arthritis from pauciarticular juvenile rheumatoid arthritis |
| Q64102772 | Patterns of joint involvement in juvenile idiopathic arthritis and prediction of disease course: A prospective study with multilayer non-negative matrix factorization |
| Q47413300 | Patterns of pain over time among children with juvenile idiopathic arthritis |
| Q43541437 | Pauciarticular arthritis of childhood (pauciarticular juvenile rheumatoid arthritis). |
| Q68102996 | Pauciarticular juvenile rheumatoid arthritis presenting in an adult |
| Q33670610 | Pauciarticular juvenile rheumatoid arthritis: clinical and immunogenetic aspects |
| Q52911897 | Pediatric Escola Paulista de Medicina Range of Motion Scale: a reduced joint count scale for general use in juvenile rheumatoid arthritis. |
| Q73190276 | Pediatric management problems. What is your assessment? Juvenile rheumatoid arthritis |
| Q36925094 | Pediatric rheumatology for the adult rheumatologist II: uveitis in juvenile idiopathic arthritis. |
| Q91208797 | Pediatrician Beliefs about Juvenile Idiopathic Arthritis May Result in Referral Delays: A Spanish National Survey |
| Q41915477 | Penicillamine and hydroxychloroquine in the treatment of severe juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind placebo-controlled trial |
| Q39167651 | Pentraxin 3 is a marker of early joint inflammation in patients with juvenile idiopathic arthritis. |
| Q50068009 | Peptide-based electrochemical biosensor for juvenile idiopathic arthritis detection. |
| Q38977474 | Perceived Oral Health and Care of Children with Juvenile Idiopathic Arthritis: A Qualitative Study |
| Q79850331 | Perceived adherence to prescribed treatment in juvenile idiopathic arthritis over a one-year period |
| Q93122997 | Perceptions of Methotrexate Intolerance and Its Impact on Daily Life in School-Age Children with Juvenile Idiopathic Arthritis |
| Q57257794 | Perceptions of Play and Leisure in Junior School Aged Children with Juvenile Idiopathic Arthritis: What are the Implications for Occupational Therapy? |
| Q45328485 | Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. |
| Q45744127 | Performance of different sets of criteria for clinical response evaluation in a non-selected cohort of juvenile idiopathic arthritis (JIA) patients |
| Q57751929 | Performance of rheumatoid arthritis disease activity measures and juvenile arthritis disease activity scores in polyarticular-course juvenile idiopathic arthritis: Analysis of their ability to classify the American College of Rheumatology pediatric m |
| Q83611927 | Performance of tuberculin skin test and interferon gamma assay for the diagnosis of latent tuberculosis infection in juvenile idiopathic arthritis |
| Q102212277 | Performances of the "MS-score" And "HScore" in the diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis patients |
| Q44413456 | Pericardial tamponade in juvenile rheumatoid arthritis |
| Q70921291 | Pericarditis and cardiac tamponade in juvenile rheumatoid arthritis |
| Q70381265 | Pericarditis in juvenile rheumatoid arthritis |
| Q41502959 | Pericarditis. An initial manifestation of juvenile rheumatoid arthritis |
| Q43865310 | Perinatal characteristics, early life infections and later risk of rheumatoid arthritis and juvenile idiopathic arthritis |
| Q82477690 | Periodontal and hematological characteristics associated with aggressive periodontitis, juvenile idiopathic arthritis, and rheumatoid arthritis |
| Q47221149 | Periodontal conditions in patients with juvenile idiopathic arthritis. |
| Q42952462 | Perioperative anesthetic concerns in a child with systemic onset juvenile idiopathic arthritis syndrome |
| Q85337450 | Periostin gene variants are associated with disease course and severity in juvenile idiopathic arthritis |
| Q43493441 | Periostitis: an early diagnostic sign of juvenile rheumatoid arthritis |
| Q90173179 | Peripheral Blood B and T Cell Profiles in Children with Active Juvenile Idiopathic Arthritis |
| Q104575184 | Peripheral Blood Lymphocyte Analysis in Oligo- and Polyarticular Juvenile Idiopathic Arthritis Patients Receiving Methotrexate or Adalimumab Therapy: A Cross-Sectional Study |
| Q44700591 | Peripheral Joint Imaging in Juvenile Rheumatoid Arthritis* |
| Q61740089 | Peripheral blood mononuclear cell responses to heat shock proteins and their derived synthetic peptides in juvenile idiopathic arthritis patients |
| Q87922638 | Peripheral regulatory T cells and anti-inflammatory cytokines in children with juvenile idiopathic arthritis |
| Q42777575 | Peripheral ulcerative keratitis in a patient with systemic-onset juvenile idiopathic arthritis. |
| Q61863513 | Peritonitis and cervical arthritis as presenting manifestations of systemic juvenile idiopathic arthritis |
| Q57282647 | Persistence and adverse events of biological treatment in adult patients with juvenile idiopathic arthritis: results from BIOBADASER |
| Q50699508 | Persistence of protein oxidation products and plasma antioxidants in juvenile idiopathic arthritis. A one-year follow-up study. |
| Q103837232 | Persistent Tenosynovitis, Steroid Dependency and a Hyperpigmented Scaly Macular Rash in a Child With Juvenile Idiopathic Arthritis |
| Q71052451 | Persistent and transient IgA deficiency in juvenile rheumatoid arthritis |
| Q44882826 | Persistent elevation of fibrin D-dimer predicts longterm outcome in systemic juvenile idiopathic arthritis |
| Q85222319 | Persistent improper upregulation of Th17 and TReg cells in patients with juvenile idiopathic arthritis |
| Q82416659 | Perspectives on quality and content of information for juvenile idiopathic arthritis on Italian Web pages: a different way to meet the needs of families? |
| Q33529264 | Phacoemulsification with intraocular lens implantation in juvenile idiopathic arthritis. |
| Q58429085 | Phagocyte-specific S100 proteins and high-sensitivity C reactive protein as biomarkers for a risk-adapted treatment to maintain remission in juvenile idiopathic arthritis: a comparative study |
| Q51256062 | Phalangeal bone ultrasound is of limited value in patients with juvenile idiopathic arthritis. |
| Q89239542 | Pharmacoeconomic Evaluation of Treatment With Tocilizumab in Russian Children With Systemic Juvenile Idiopathic Arthritis |
| Q49232396 | Pharmacokinetic and safety profile of tofacitinib in children with polyarticular course juvenile idiopathic arthritis: results of a phase 1, open-label, multicenter study. |
| Q41723872 | Pharmacokinetic monitoring of salicylate therapy in children with juvenile rheumatoid arthritis |
| Q53122163 | Pharmacokinetics and Pharmacodynamics of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis. |
| Q42614050 | Pharmacokinetics of etodolac in patients with stable juvenile rheumatoid arthritis |
| Q51648411 | Pharmacokinetics of fenclofenac in children with juvenile rheumatoid arthritis. |
| Q45001564 | Pharmacokinetics of meloxicam in patients with juvenile rheumatoid arthritis |
| Q79211793 | Pharmacokinetics, efficacy, and safety of short-term (12 weeks) etanercept for methotrexate-refractory polyarticular juvenile idiopathic arthritis in Japan |
| Q89599681 | Pharmacological conditioning for juvenile idiopathic arthritis: a potential solution to reduce methotrexate intolerance |
| Q35329389 | Pharmacological management of juvenile rheumatoid arthritis |
| Q68153298 | Pharmacotherapy of juvenile rheumatoid arthritis |
| Q70704727 | Pharmacotherapy of juvenile rheumatoid arthritis |
| Q46863527 | Pharmacovigilance in juvenile idiopathic arthritis patients (Pharmachild) treated with biologic agents and/or methotrexate. Consolidated baseline characteristics from Pharmachild and other national registries |
| Q60930184 | Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and national registries |
| Q90235429 | Phenotype of Innate Immune Cells in Uveitis Associated with Axial Spondyloarthritis- and Juvenile Idiopathic Arthritis-associated Uveitis |
| Q70037020 | Phenotypes of T lymphocytes from peripheral blood and synovial fluid of patients with rheumatoid arthritis and juvenile rheumatoid arthritis. Evidence in favour of normal helper and suppressor functions of T lymphocytes from patients with juvenile r |
| Q46834101 | Phenotypes of juvenile idiopathic arthritis |
| Q70060669 | Phenotypes of peripheral blood T lymphocytes in rheumatoid arthritis and juvenile rheumatoid arthritis. Findings in patients with varying disease activity and clinical subgroups |
| Q36759092 | Phenotypic Characterization of Juvenile Idiopathic Arthritis in African American Children. |
| Q24803862 | Phenotypic and functional characterisation of CCR7+ and CCR7- CD4+ memory T cells homing to the joints in juvenile idiopathic arthritis |
| Q42264060 | Phenotypic and functional characterization of switch memory B cells from patients with oligoarticular juvenile idiopathic arthritis |
| Q54626703 | Phospholipase A2 in juvenile rheumatoid arthritis: correlation to disease type and activity. |
| Q55073264 | Physical Examination Tools Used to Identify Swollen and Tender Lower Limb Joints in Juvenile Idiopathic Arthritis: A Scoping Review. |
| Q39400802 | Physical Exercise and Physical Activity for Children and Adolescents With Juvenile Idiopathic Arthritis: A Literature Review |
| Q93363287 | Physical Fitness in Patients With Oligoarticular and Polyarticular Juvenile Idiopathic Arthritis Diagnosed in the Era of Biologics: A Controlled Cross-Sectional Study |
| Q47663488 | Physical Functioning, Pain and Health-Related Quality of Life in Adults with Juvenile Idiopathic Arthritis: A Longitudinal 30-Year Follow-Up Study |
| Q35553114 | Physical activity and health related physical fitness in children with juvenile idiopathic arthritis. |
| Q91562973 | Physical activity and sedentary levels in children with juvenile idiopathic arthritis and inflammatory bowel disease. A systematic review and meta-analysis |
| Q103722604 | Physical activity assessment in children and adolescents with juvenile idiopathic arthritis compared with controls |
| Q82097682 | Physical activity in adolescents with juvenile idiopathic arthritis |
| Q39624393 | Physical activity in children with Juvenile Idiopathic Arthritis compared to controls |
| Q72344207 | Physical activity in children with juvenile rheumatoid arthritis: quantification and evaluation |
| Q58548207 | Physical activity in patients with oligo- and polyarticular juvenile idiopathic arthritis diagnosed in the era of biologics: a controlled cross-sectional study |
| Q33836429 | Physical activity recommendations for children with specific chronic health conditions: Juvenile idiopathic arthritis, hemophilia, asthma and cystic fibrosis. |
| Q45858877 | Physical activity recommendations for children with specific chronic health conditions: juvenile idiopathic arthritis, hemophilia, asthma, and cystic fibrosis |
| Q48082446 | Physical activity, functional ability, and disease activity in children and adolescents with juvenile idiopathic arthritis |
| Q38092983 | Physical activity, physical fitness, and exercise therapy in children with juvenile idiopathic arthritis |
| Q39454485 | Physical and mechanical therapies for lower limb problems in juvenile idiopathic arthritis: a systematic review with meta- analysis |
| Q81329545 | Physical disability, articular, and extra-articular damage in patients with juvenile idiopathic arthritis |
| Q44621392 | Physical findings associated with active temporomandibular joint inflammation in children with juvenile idiopathic arthritis |
| Q40417084 | Physical fitness in children with juvenile rheumatoid arthritis and other chronic pediatric illnesses |
| Q67903170 | Physical fitness levels in children with polyarticular juvenile rheumatoid arthritis |
| Q40471317 | Physical measures in the treatment of juvenile rheumatoid arthritis |
| Q66968779 | Physical therapy for juvenile rheumatoid arthritis |
| Q37494354 | Physical therapy management of patients with juvenile rheumatoid arthritis |
| Q72090325 | Physical therapy of juvenile rheumatoid arthritis |
| Q80569646 | Physicians' and parents' ratings of inactive disease are frequently discordant in juvenile idiopathic arthritis |
| Q81811473 | Physiologic response of the six-minute walk test in children with juvenile idiopathic arthritis |
| Q87416074 | Physiotherapy in pauciarticular juvenile idiopathic arthritis. Case study |
| Q72742722 | Pilot investigation of naproxen/methotrexate interaction in patients with juvenile rheumatoid arthritis |
| Q37747792 | Pilot study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic Juvenile Idiopathic Arthritis Consensus Treatment Plans |
| Q70036085 | Piroxicam in juvenile rheumatoid arthritis |
| Q70376149 | Pirprofen (Rengasil) in the treatment of juvenile rheumatoid arthritis. A segment I study |
| Q40804489 | Pitfalls in the diagnosis of juvenile rheumatoid arthritis |
| Q87763416 | Pixel-by-pixel analysis of DCE-MRI curve shape patterns in knees of active and inactive juvenile idiopathic arthritis patients |
| Q31061128 | Placement of a collagen glaucoma drainage device to control intraocular pressure and chronic iritis secondary to juvenile rheumatoid arthritis. |
| Q80419785 | Plantar- and dorsiflexor strength in prepubertal girls with juvenile idiopathic arthritis |
| Q81120687 | Plasma TNF binding capacity in patients with juvenile idiopathic arthritis |
| Q41432726 | Plasma and urinary glycosaminoglycans in the course of juvenile idiopathic arthritis |
| Q72084897 | Plasma exchange in selected patients with juvenile rheumatoid arthritis |
| Q40064398 | Plasma exchange successfully treated macrophage activation syndrome in rheumatoid factor-positive polyarticular juvenile idiopathic arthritis with combined pneumonia |
| Q57281137 | Plasma interleukin-37 is increased and inhibits the production of inflammatory cytokines in peripheral blood mononuclear cells in systemic juvenile idiopathic arthritis patients |
| Q72377992 | Plasma levels after oral methotrexate in children with juvenile rheumatoid arthritis |
| Q38719056 | Plasma levels of D-dimer in a 5-year-old girl with systemic juvenile idiopathic arthritis: A case report and literature review |
| Q51724807 | Plasma miR-26a as a Diagnostic Biomarker Regulates Cytokine Expression in Systemic Juvenile Idiopathic Arthritis. |
| Q36453159 | Plasma profiles in active systemic juvenile idiopathic arthritis: Biomarkers and biological implications |
| Q73926213 | Plastic splints in the treatment of juvenile rheumatoid arthritis |
| Q67064319 | Platelet Count and Disease Activity in Juvenile Rheumatoid Arthritis |
| Q100739295 | Platelet glycoprotein Ib alpha chain as a putative therapeutic target for juvenile idiopathic arthritis: a Mendelian randomization study |
| Q71289367 | Platelet-activating activity in synovial fluids of patients with rheumatoid arthritis, juvenile rheumatoid arthritis, gout, and noninflammatory arthropathies |
| Q47206133 | Pneumonia in children with juvenile idiopathic arthritis in Finland 1999-2014: a nationwide retrospective register linkage study |
| Q44675265 | Pneumopathy in children with juvenile rheumatoid arthritis |
| Q72425690 | Polyarthritis resembling juvenile rheumatoid arthritis in a girl with chronic granulomatous disease |
| Q46967349 | Polyarticular juvenile idiopathic arthritis (pJIA): clinical and serologic predictors of inactive disease (ID). |
| Q34434750 | Polyarticular juvenile idiopathic arthritis - epidemiology and management approaches |
| Q34503913 | Polyarticular juvenile idiopathic arthritis treated with methotrexate complicated by the development of non-Hodgkin's lymphoma |
| Q54125743 | Polymorphic haplotypes of the interleukin-10 5' flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. |
| Q73904660 | Polymorphism at NRAMP1 and D2S1471 loci associated with juvenile rheumatoid arthritis |
| Q48193290 | Polymorphism in a T-cell receptor variable gene is associated with susceptibility to a juvenile rheumatoid arthritis subset |
| Q71322258 | Polymorphism in the LMP2 gene influences disease susceptibility and severity in HLA-B27 associated juvenile rheumatoid arthritis |
| Q59697452 | Polymorphism of human major histocompatibility complex-encoded transporter associated with antigen processing (TAP) genes and susceptibility to juvenile rheumatoid arthritis |
| Q40764610 | Polymorphisms of genes encoding interleukin-4 and its receptor in Iranian patients with juvenile idiopathic arthritis |
| Q83951864 | Polymorphisms within interleukin 15 are associated with juvenile idiopathic arthritis |
| Q79866300 | Polymorphisms within the IL-1 gene cluster: effects on cytokine profiles in peripheral blood and whole blood cell cultures of patients with aggressive periodontitis, juvenile idiopathic arthritis, and rheumatoid arthritis |
| Q35173398 | Polysomnography and actigraphy concordance in juvenile idiopathic arthritis, asthma and healthy children |
| Q48448877 | Polysomnography and self-reported sleep, pain, fatigue, and anxiety in children with active and inactive juvenile rheumatoid arthritis. |
| Q41913654 | Poor correlation between the erythrocyte sedimentation rate and clinical activity in juvenile rheumatoid arthritis |
| Q69395375 | Poor response in two cases of juvenile rheumatoid arthritis to treatment with cyclophosphamide |
| Q70981798 | Popliteal cysts in juvenile rheumatoid arthritis |
| Q81386014 | Population pharmacokinetic analysis and simulation of the time-concentration profile of etanercept in pediatric patients with juvenile rheumatoid arthritis |
| Q91476428 | Population pharmacokinetics of tacrolimus in pediatric patients with systemic-onset juvenile idiopathic arthritis: Initial dosage recommendations |
| Q46801582 | Population pharmacokinetics of the active metabolite of leflunomide in pediatric subjects with polyarticular course juvenile rheumatoid arthritis |
| Q34169257 | Population-based cohort study on the risk of malignancy in East Asian children with juvenile idiopathic arthritis |
| Q38927231 | Population-based study of outcomes of patients with juvenile idiopathic arthritis (JIA) compared to non-JIA subjects |
| Q47944843 | Porphyromonas Gingivalis and IgG1 and IgG2 Subclass Antibodies in Patients with Juvenile Idiopathic Arthritis |
| Q56966357 | Portuguese recommendations for the use of biological therapies in children and adolescents with juvenile idiopathic arthritis--December 2011 update |
| Q43729312 | Positive and negative results of corticosteroid therapy in juvenile chronic polyarthritis and its special forms--a 20-year review (proceedings) |
| Q28295598 | Positive association of SLC26A2 gene polymorphisms with susceptibility to systemic-onset juvenile idiopathic arthritis |
| Q73792257 | Positive family history of psoriasis does not affect the clinical expression and course of juvenile idiopathic arthritis patients with oligoarthritis |
| Q70724660 | Positive serology for Lyme borreliosis in patients with juvenile rheumatoid arthritis in a Lyme borreliosis endemic area: analysis by immunoblot |
| Q46511718 | Positivity of HLA-DRB1 rheumatoid epitope does not predict the course of juvenile idiopathic arthritis in Czech children |
| Q83743191 | Positron emission tomography findings in systemic juvenile idiopathic arthritis |
| Q72461298 | Possibility of alloplastic treatment of hip and knee joint in juvenile chronic polyarthritis |
| Q39321576 | Possible discontinuation of therapies after clinical remission in juvenile idiopathic arthritis |
| Q37645698 | Possible environmental determinants of juvenile idiopathic arthritis |
| Q80388406 | Possible role of streptococcal infection in flares of juvenile idiopathic arthritis |
| Q46968781 | Posterior reversible encephalopathy syndrome complicating macrophage activation syndrome in a patient with systemic juvenile idiopathic arthritis |
| Q93069296 | Posterior reversible encephalopathy syndrome during treatment with tocilizumab in juvenile idiopathic arthritis |
| Q38810963 | Postpartum complications in new mothers with juvenile idiopathic arthritis: a population-based cohort study |
| Q53195270 | Potential Effects of Interleukins on the Pathogenesis of Systemic Onset Juvenile Idiopathic Arthritis. |
| Q46861864 | Potential value of cartilage and bone soluble biomarkers in evaluating joint damage in juvenile idiopathic arthritis |
| Q48005598 | Power Color Doppler and Spectral Doppler Ultrasonography to Evaluate Response to Intra-articular Steroid Injection in Knee Joints in Juvenile Idiopathic Arthritis. |
| Q74276824 | Power Doppler sonography in the evaluation and follow-up of knee involvement in patients with juvenile idiopathic arthritis |
| Q48514200 | Practice and consensus-based strategies in diagnosing and managing systemic juvenile idiopathic arthritis in Germany. |
| Q92466051 | Predicting Remission Remains a Challenge in Patients with Juvenile Idiopathic Arthritis |
| Q47604471 | Predicting Which Children with Juvenile Idiopathic Arthritis Will Have a Severe Disease Course: Results from the ReACCh-Out Cohort |
| Q91062269 | Predicting Which Children with Juvenile Idiopathic Arthritis Will Not Attain Early Remission with Conventional Treatment: Results from the ReACCh-Out Cohort |
| Q92089755 | Predicting disease outcomes in juvenile idiopathic arthritis: challenges, evidence, and new directions |
| Q91998039 | Predicting disease severity and remission in juvenile idiopathic arthritis: are we getting closer? |
| Q68801626 | Predicting outcome at the knee in juvenile rheumatoid arthritis |
| Q58802313 | Predicting pain among children with juvenile rheumatoid arthritis |
| Q41093121 | Predicting remission in juvenile rheumatoid arthritis with methotrexate treatment. |
| Q55023560 | Predicting unfavorable long-term outcome in juvenile idiopathic arthritis: results from the Nordic cohort study. |
| Q92383550 | Predicting uveitis in juvenile idiopathic arthritis: from biomarkers to clinical practice |
| Q59268669 | Prediction of clinical non-response to methotrexate treatment in juvenile idiopathic arthritis |
| Q83802522 | Prediction of clinical non-response to methotrexate treatment in juvenile idiopathic arthritis |
| Q50417053 | Prediction of clinical non-response to methotrexate treatment in juvenile idiopathic arthritis. |
| Q100532559 | Prediction of inactive disease and relapse in oligoarticular juvenile idiopathic arthritis |
| Q57145579 | Prediction of inactive disease in juvenile idiopathic arthritis: a multicentre observational cohort study |
| Q86499679 | Prediction of long-term remission of oligo/polyarticular juvenile idiopathic arthritis with S100A12 and vascular endothelial growth factor |
| Q26991741 | Prediction of methotrexate efficacy and adverse events in patients with juvenile idiopathic arthritis: a systematic literature review |
| Q46834478 | Prediction of methotrexate efficacy and adverse events in patients with juvenile idiopathic arthritis: a systematic literature review. |
| Q35147847 | Prediction of methotrexate intolerance in juvenile idiopathic arthritis: a prospective, observational cohort study |
| Q90842714 | Predictive Value of Musculoskeletal Ultrasound for Flares in Juvenile Idiopathic Arthritis |
| Q64947350 | Predictive factors and biomarkers for the 2-year outcome of uveitis in juvenile idiopathic arthritis: data from the Inception Cohort of Newly diagnosed patients with Juvenile Idiopathic Arthritis (ICON-JIA) study. |
| Q54537567 | Predictive plain X-ray findings in distinguishing early stage acute lymphoblastic leukemia from juvenile idiopathic arthritis. |
| Q38153093 | Predictive value of selected biomarkers, polymorphisms, and clinical features for oligoarticular juvenile idiopathic arthritis-associated uveitis |
| Q47582373 | Predictors and long-term outcome in Greek adults with juvenile idiopathic arthritis: a 17-year continuous follow-up study |
| Q46378356 | Predictors of 2 year outcomes of juvenile idiopathic arthritis in a multicenter Canadian cohort: the ReACCh out experience |
| Q91062294 | Predictors of Effectiveness of Anakinra in Systemic Juvenile Idiopathic Arthritis |
| Q88537529 | Predictors of Flare Following Etanercept Withdrawal in Patients with Rheumatoid Factor-negative Juvenile Idiopathic Arthritis Who Reached Remission while Taking Medication |
| Q34518924 | Predictors of disease course and remission in systemic juvenile idiopathic arthritis: significance of early clinical and laboratory features |
| Q49107589 | Predictors of early inactive disease in a juvenile idiopathic arthritis cohort: results of a Canadian multicenter, prospective inception cohort study. |
| Q48498347 | Predictors of health-related quality of life in children and adolescents with juvenile idiopathic arthritis. |
| Q39665275 | Predictors of health-related quality of life in children and adolescents with juvenile idiopathic arthritis: results from a Web-based survey |
| Q40335477 | Predictors of hip disease in the systemic arthritis subtype of juvenile idiopathic arthritis |
| Q36842433 | Predictors of juvenile idiopathic arthritis course |
| Q49719439 | Predictors of methotrexate response in Turkish children with oligoarticular and polyarticular juvenile idiopathic arthritis. |
| Q79910107 | Predictors of pain in children with established juvenile rheumatoid arthritis |
| Q84357867 | Predictors of poor response to methotrexate in polyarticular-course juvenile idiopathic arthritis: analysis of the PRINTO methotrexate trial |
| Q87407335 | Predictors of response to etanercept in polyarticular-course juvenile idiopathic arthritis |
| Q34069374 | Predictors of response to methotrexate in juvenile idiopathic arthritis. |
| Q33801499 | Predictors of the response to etanercept in patients with juvenile idiopathic arthritis without systemic manifestations within 12 months: results of an open-label, prospective study conducted at the National Scientific and Practical Center of [...] |
| Q73867165 | Predictors of total body bone mineral density in non-corticosteroid-treated prepubertal children with juvenile rheumatoid arthritis |
| Q83966340 | Preferential immunoglobulin oxidation in children with juvenile idiopathic arthritis |
| Q70211053 | Pregnancy in patients with a history of juvenile rheumatoid arthritis |
| Q92886292 | Pregnancy outcomes and perinatal complications of Asian mothers with juvenile idiopathic arthritis - a case-control registry study |
| Q92617032 | Pregnancy outcomes in DMARD-exposed patients with juvenile idiopathic arthritis-results from a JIA biologic registry |
| Q54911532 | Pregnancy outcomes in women affected by juvenile idiopathic arthritis (JIA). |
| Q51265046 | Pregnancy outcomes in women with juvenile idiopathic arthritis: a population-based study. |
| Q47758009 | Prehistoric juvenile rheumatoid arthritis in a precontact Louisiana native population reconsidered |
| Q91633749 | Preliminary Definitions for Sacroiliac Joint Pathologies in the OMERACT Juvenile Idiopathic Arthritis Magnetic Resonance Imaging Score (OMERACT JAMRIS-SIJ) |
| Q40471593 | Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. |
| Q46315654 | Preliminary data on insulin sensitivity in non-obese prepubertal children affected by juvenile idiopathic arthritis |
| Q74141282 | Preliminary definition of disease flare in juvenile rheumatoid arthritis |
| Q36116060 | Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis |
| Q46061906 | Preliminary evidence for cyclosporin A as an alternative in the treatment of recalcitrant juvenile rheumatoid arthritis and juvenile dermatomyositis. |
| Q81980673 | Preliminary evidence that etanercept may reduce radiographic progression in juvenile idiopathic arthritis |
| Q67873991 | Preliminary findings of a controlled study on gold and D-penicillamine therapy in juvenile rheumatoid arthritis |
| Q67965315 | Preliminary report of higher dose methotrexate treatment in juvenile rheumatoid arthritis |
| Q41857685 | Preliminary results of a controlled study of gold and D-penicillamine therapy in juvenile rheumatoid arthritis (proceedings) |
| Q46926477 | Preliminary study of regionalised centre-of-pressure analysis in patients with juvenile idiopathic arthritis |
| Q36398236 | Preliminary validation of clinical remission criteria using the OMERACT filter for select categories of juvenile idiopathic arthritis. |
| Q81514418 | Premature aging of the immune system in children with juvenile idiopathic arthritis |
| Q37060405 | Premature cell senescence and T cell receptor-independent activation of CD8+ T cells in juvenile idiopathic arthritis |
| Q44989877 | Premature maturation of the carpal bones as an early diagnostic sign of juvenile rheumatoid arthritis |
| Q35170545 | Premature ovarian failure in women with juvenile idiopathic arthritis (JIA). |
| Q53995588 | Preoperative cataract surgery use of an intravitreal dexamethasone implant (Ozurdex) in a patient with juvenile idiopathic arthritis and chronic anterior uveitis. |
| Q40572020 | Preschool sarcoidosis manifesting as juvenile rheumatoid arthritis: a case report and a review of the literature of Japanese cases. |
| Q37999728 | Preschool sarcoidosis masquerading as juvenile rheumatoid arthritis: two case reports and a review of the literature |
| Q73280654 | Preschool sarcoidosis mimicking juvenile rheumatoid arthritis: the significance of gallium scintigraphy and skin biopsy in the differential diagnosis |
| Q46974111 | Prescribed but not approved: biologic agents used without approval in juvenile idiopathic arthritis in Switzerland, France and Belgium. |
| Q34185017 | Prescription patterns for children with juvenile idiopathic arthritis in Michigan Medicaid: a comparison by prescriber type |
| Q41098308 | Presence of a Juvenile Idiopathic Arthritis and Chronic Granulomatous Disease in a Child. |
| Q46380872 | Presence of anti-cyclic citrullinated peptide antibody isotypes in juvenile idiopathic arthritis synovial fluid indicates autoantibody production at the site of inflammation |
| Q41206493 | Presence of glycosaminoglycans in purified AA type amyloid fibrils associated with juvenile rheumatoid arthritis |
| Q49652587 | Presence of riziform bodies in a patient with juvenile idiopathic arthritis: case report and literature review. |
| Q73134858 | Preseptal cellulitis in systemic onset juvenile idiopathic arthritis |
| Q96034380 | Pressure pain threshold over masticatory muscles and temporomandibular joint in patients with juvenile idiopathic arthritis |
| Q64078297 | Presumed tubercular choroidal nodule following adalimumab therapy for juvenile idiopathic arthritis |
| Q40020795 | Prevalence and clinical pattern of juvenile idiopathic arthritis in a semi-urban area of Bangladesh |
| Q35551700 | Prevalence and clinical significance of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. |
| Q80086972 | Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines |
| Q44744201 | Prevalence and concentration of IgM rheumatoid factor in polyarticular onset disease as compared to systemic or pauciarticular onset disease in active juvenile rheumatoid arthritis as measured by ELISA. |
| Q60948842 | Prevalence and course of lower limb disease activity and walking disability over the first 5 years of juvenile idiopathic arthritis: results from the childhood arthritis prospective study |
| Q45034290 | Prevalence and distribution of juvenile idiopathic arthritis in a region of Western France. |
| Q59268826 | Prevalence and incidence of juvenile idiopathic arthritis in children in the republic of Bashkortostan: the epidemiological study |
| Q38161163 | Prevalence and incidence of juvenile idiopathic arthritis: a systematic review |
| Q51763137 | Prevalence and outcome of juvenile idiopathic arthritis-associated uveitis and relation to articular disease. |
| Q73789423 | Prevalence and outcome of uveitis in a regional cohort of patients with juvenile rheumatoid arthritis |
| Q47957176 | Prevalence and outcome of uveitis in a regional cohort of patients with juvenile rheumatoid arthritis. |
| Q51691180 | Prevalence and patterns of anti-nuclear antibodies in Korean children with juvenile idiopathic arthritis according to ILAR criteria. |
| Q81337879 | Prevalence and short-term outcome of juvenile idiopathic arthritis: a population-based study in Estonia |
| Q81461465 | Prevalence and significance of isotypes of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis |
| Q90094257 | Prevalence of Depression in Patients with Juvenile Idiopathic Arthritis Presenting at a Tertiary Care Hospital |
| Q40696741 | Prevalence of HLA-B27 antigen in patients with juvenile idiopathic arthritis. |
| Q39777830 | Prevalence of IgA deficiency in children with juvenile rheumatoid arthritis. |
| Q30455529 | Prevalence of IgM, IgA and IgG rheumatoid factors in juvenile rheumatoid arthritis |
| Q98829826 | Prevalence of and factors associated to chronic kidney disease and hypertension in a cohort of children with juvenile idiopathic arthritis |
| Q42914934 | Prevalence of antibodies against mutated citrullinated vimentin and cyclic citrullinated peptide in children with juvenile idiopathic arthritis. |
| Q30455974 | Prevalence of antibody to Borrelia burgdorferi in children with juvenile rheumatoid arthritis |
| Q72484693 | Prevalence of antihuman parvovirus B19 IgG antibodies in patients with refractory rheumatoid arthritis and polyarticular juvenile rheumatoid arthritis |
| Q96170377 | Prevalence of co-existing autoimmune disease in juvenile idiopathic arthritis: a cross-sectional study |
| Q77631497 | Prevalence of human leukocyte antigen (HLA) DRB1 alleles in Kuwaiti children with juvenile rheumatoid arthritis |
| Q38857487 | Prevalence of juvenile idiopathic arthritis in Sharkia Governorate, Egypt: epidemiological study. |
| Q44647541 | Prevalence of juvenile idiopathic arthritis in children aged 6 to 12 years in Embu das Artes, state of Sao Paulo, Brazil |
| Q92180778 | Prevalence of juvenile idiopathic arthritis in schoolchildren from the city of São Paulo, the largest city in Latin America |
| Q92438765 | Prevalence of juvenile idiopathic arthritis in the Alaska Native population |
| Q43628932 | Prevalence of musculoskeletal complaints and juvenile idiopathic arthritis in children from a developing country: a school-based study |
| Q61882844 | Prevalence of overweight among Moroccan children and adolescents with juvenile idiopathic arthritis |
| Q38873008 | Prevalence of overweight among Moroccan children and adolescents with juvenile idiopathic arthritis. |
| Q39032614 | Prevalence of overweight in children and adolescents with juvenile idiopathic arthritis |
| Q70580047 | Prevalence of pericardial effusion by echocardiography in juvenile rheumatoid arthritis |
| Q68062888 | Prevalence of rheumatoid factors in juvenile rheumatoid arthritis |
| Q57899164 | Prevalence of sinonasal disease in children with Juvenile idiopathic arthritis |
| Q100532785 | Prevalence of temporomandibular disorder in children and adolescents with juvenile idiopathic arthritis - a Norwegian cross- sectional multicentre study |
| Q82764754 | Prevalence of vertebral compression fractures and associated factors in children and adolescents with severe juvenile idiopathic arthritis |
| Q53764675 | Prevalence, presentation and treatment of lower limb pathologies in juvenile idiopathic arthritis: A narrative review. |
| Q79695070 | Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: a long-term followup study |
| Q37115017 | Prevention and management of cataracts in children with juvenile idiopathic arthritis-associated uveitis |
| Q73165848 | Prevention of leg length discrepancy in young children with pauciarticular juvenile rheumatoid arthritis by treatment with intraarticular steroids |
| Q78517756 | Prevention of nonadherence to nonsteroidal anti-inflammatory medications for newly diagnosed patients with juvenile rheumatoid arthritis |
| Q40415569 | Prevention of osteoporosis: a randomized clinical trial to increase calcium intake in children with juvenile rheumatoid arthritis |
| Q68757313 | Prevention of tooth erosion from salicylate therapy in juvenile rheumatoid arthritis |
| Q92774846 | Primary Hypertrophic Osteoarthropathy Mimicking Juvenile Idiopathic Arthritis: A Novel SLCO2A1 Mutation and Imaging Findings |
| Q41599492 | Primary Ovarian Failure, Juvenile Rheumatoid Arthritis, and Vitiligo |
| Q64047696 | Primary ovarian large B-cell lymphoma in patient with juvenile rheumatoid arthritis treated with low dose Methotrexate |
| Q73831644 | Primary pulmonary hypertension, Raynaud's phenomenon and generalised vasculitis in juvenile rheumatoid arthritis |
| Q40450982 | Primary varicella infection in children with systemic juvenile idiopathic arthritis under tocilizumab therapy. |
| Q47196195 | Prior to extension, Transcriptomes of fibroblast-like Synoviocytes from extended and Polyarticular juvenile idiopathic arthritis are indistinguishable |
| Q64940241 | Probability of remission of juvenile idiopathic arthritis following treatment with steroid joint injection. |
| Q91144602 | Procalcitonin Differs in Children With Infection and Children With Disease Flares in Juvenile Idiopathic Arthritis |
| Q62513298 | Procedural sedation for intra-articular corticosteroid injections in juvenile idiopathic arthritis (JIA) should be a standard of care |
| Q87002817 | Procedural sedation for intra-articular corticosteroid injections in juvenile idiopathic arthritis (JIA) should be a standard of care: reply |
| Q97568272 | Proceedings from the 2nd Next Gen Therapies for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome symposium held on October 3-4, 2019 |
| Q30682175 | Proceedings: Comparison of early patterns of rheumatoid arthritis (RA) in juveniles and young adults: data supporting a unified disease concept |
| Q41328314 | Proceedings: Defective cellular immunity in juvenile rheumatoid arthritis |
| Q66940538 | Proceedings: Distribution of HL-A antigens in patients with juvenile rheumatoid arthritis (JRA) |
| Q39538417 | Proceedings: Long-term radiological assessment of juvenile rheumatoid arthritis |
| Q36376422 | Profiling anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis |
| Q34248642 | Profiling risk factors for chronic uveitis in juvenile idiopathic arthritis: a new model for EHR-based research |
| Q71052937 | Prognosis and rehabilitation in juvenile rheumatoid arthritis |
| Q71750732 | Prognosis in juvenile rheumatoid arthritis with systemic onset. A follow-up study |
| Q79153986 | Prognosis of Juvenile Rheumatoid Arthritis-Associated Uveitis |
| Q40471204 | Prognosis of juvenile rheumatoid arthritis |
| Q91627377 | Prognosis, complications and treatment response in systemic juvenile idiopathic arthritis patients: A single-center experience |
| Q47321706 | Prognostic factors for radiographic progression, radiographic damage, and disability in juvenile idiopathic arthritis. |
| Q46862197 | Prognostic factors for the disease course and 8-year outcome in Nordic children with oligoarticular-onset juvenile idiopathic arthritis. |
| Q34374469 | Prognostic factors in juvenile idiopathic arthritis |
| Q51950745 | Prognostic factors in juvenile rheumatoid arthritis: a case-control study revealing early predictors and outcome after 14.9 years. |
| Q69454531 | Prognostic factors in the uveitis of juvenile rheumatoid arthritis |
| Q67744454 | Prognostic indicators of joint destruction in systemic-onset juvenile rheumatoid arthritis |
| Q38216261 | Prognostic value of antinuclear antibodies in juvenile idiopathic arthritis and anterior uveitis. Results from a systematic literature review |
| Q70840801 | Progress of mandibular condyle lesions in juvenile rheumatoid arthritis |
| Q51407425 | Progression of articular and extraarticular damage in oligoarticular juvenile idiopathic arthritis. |
| Q40135654 | Progression of palindromic rheumatism to juvenile idiopathic arthritis in a Japanese girl carrying heterozygous L110P-E148Q substitutions of MEFV gene. |
| Q41478647 | Progressive Pseudorheumatoid Dysplasia Misdiagnosed as Seronegative Juvenile Idiopathic Arthritis |
| Q55062822 | Progressive pseudorheumatoid arthropathy of childhood (PPAC): a hereditary disorder simulating juvenile rheumatoid arthritis. |
| Q43754559 | Progressive pseudorheumatoid chondrodysplasia simulating juvenile rheumatoid arthritis |
| Q53902349 | Progressive pseudorheumatoid dysplasia: a close mimicker of juvenile idiopathic arthritis. |
| Q48122220 | Proinflammatory Cytokine Environments Can Drive Interleukin-17 Overexpression by γ/δ T Cells in Systemic Juvenile Idiopathic Arthritis |
| Q85703277 | Proinflammatory cytokines in monitoring the course of disease and effectiveness of treatment with etanercept (ETN) of children with oligo- and polyarticular juvenile idiopathic arthritis (JIA) |
| Q40626780 | Proinflammatory responses to self HLA epitopes are triggered by molecular mimicry to Epstein-Barr virus proteins in oligoarticular juvenile idiopathic arthritis. |
| Q40363053 | Proliferative changes of the hip in juvenile rheumatoid arthritis |
| Q71204240 | Prolonged remission of juvenile rheumatoid arthritis (Still's disease) following measles |
| Q91303494 | Prolonged time between intravenous contrast administration and image acquisition results in increased synovial thickness at magnetic resonance imaging in patients with juvenile idiopathic arthritis |
| Q73471501 | Prominent expression of mRNA for proinflammatory cytokines in synovium in patients with juvenile rheumatoid arthritis or chronic Lyme arthritis |
| Q88353776 | Prominent midfoot involvement in children with enthesitis-related arthritis category of juvenile idiopathic arthritis |
| Q83074597 | Promoting physical activity in children with juvenile idiopathic arthritis through an internet-based program: results of a pilot randomized controlled trial |
| Q43995793 | Prophylactic and therapeutic significance of lateral tenotomy of the knee in juvenile rheumatoid arthritis |
| Q36967869 | Proposal for juvenile idiopathic arthritis guidance on diagnosis and treatment for primary care pediatricians and nonpediatric rheumatologists (2007). |
| Q38648407 | Proposed Core Set of Items for Measuring Disease Activity in Systemic Juvenile Idiopathic Arthritis |
| Q37995987 | Proposed outcome measures for prospective clinical trials in juvenile idiopathic arthritis-associated uveitis: a consensus effort from the multinational interdisciplinary working group for uveitis in childhood. |
| Q70376145 | Proquazone (Biarsan) in the treatment of juvenile rheumatoid arthritis. A segment I study |
| Q57461369 | Prospective Determination of the Incidence and Risk Factors of New-Onset Uveitis in Juvenile Idiopathic Arthritis: The Research in Arthritis in Canadian Children Emphasizing Outcomes Cohort |
| Q85035010 | Prospective evaluation of clinical and ultrasound findings in ankle disease in juvenile idiopathic arthritis: importance of ankle ultrasound |
| Q43405443 | Prospective monitoring of Epstein-Barr virus and other herpesviruses in patients with juvenile idiopathic arthritis treated with methotrexate and tocilizumab |
| Q36698141 | Prospective surveillance study of acute respiratory infections, influenza-like illness and seasonal influenza vaccine in a cohort of juvenile idiopathic arthritis patients |
| Q98951489 | Prosthetic temporomandibular joint reconstruction in a cohort of adolescent females with juvenile idiopathic arthritis |
| Q59794280 | Protective parents and permissive children: what qualitative interviews with parents and children can tell us about the feasibility of juvenile idiopathic arthritis trials |
| Q55456482 | Protective role of HLA-DRB1*11 against juvenile idiopathic arthritis living in North Eastern Iran. |
| Q49627615 | Proteinuria in children with juvenile idiopathic arthritis: Making the case for early urinary screening. |
| Q42784768 | Proteomic analysis of circulating immune complexes in juvenile idiopathic arthritis reveals disease-associated proteins |
| Q53591389 | Proteomic analysis of recurrent joint inflammation in juvenile idiopathic arthritis. |
| Q37272672 | Protocol for the Foot in Juvenile Idiopathic Arthritis trial (FiJIA): a randomised controlled trial of an integrated foot care programme for foot problems in JIA. |
| Q51059000 | Protrusio acetabuli in juvenile rheumatoid arthritis. |
| Q57330812 | Proxy-reported health-related quality of life of patients with juvenile idiopathic arthritis: The pediatric rheumatology international trials organization multinational quality of life cohort study |
| Q43970668 | Pruritus associated with the rash of juvenile rheumatoid arthritis |
| Q71471129 | Pruritus in juvenile rheumatoid arthritis |
| Q67249647 | Pseudarthrosis of the proximal femoral epiphysis in juvenile rheumatoid arthritis. A case report |
| Q73324399 | Pseudoporphyria induced by celecoxib in a patient with juvenile rheumatoid arthritis |
| Q92330338 | Pseudorheumatoid Arthropathy of Childhood: A Mimicker of Juvenile Idiopathic Arthritis |
| Q43844887 | Pseudorheumatoid dysplasia. A rare genetic disorder simulating juvenile idiopathic arthritis. |
| Q92481428 | Psoriasiform Dermatitis Developing during Treatment of Juvenile Idiopathic Arthritis with Tocilizumab |
| Q42955581 | Psoriasis after treatment of juvenile idiopathic arthritis with etanercept |
| Q37658174 | Psoriasis and associated variables in classification and outcome of juvenile idiopathic arthritis - an eight-year follow-up study |
| Q52144277 | Psoriasis in a patient with juvenile rheumatoid arthritis. |
| Q41901169 | Psoriatic juvenile idiopathic arthritis associated with uveitis: a case report |
| Q37895077 | Psoriatic juvenile idiopathic arthritis: a tale of two subgroups |
| Q73091283 | Psychiatric adjustment in chronic fatigue syndrome of childhood and in juvenile idiopathic arthritis |
| Q51926678 | Psychiatric morbidity, stressors, impact, and burden in juvenile idiopathic arthritis. |
| Q46463769 | Psychological characteristics of the patients with juvenile idiopathic arthritis (JIA) of various age groups |
| Q72742403 | Psychological factors affecting reported pain in juvenile rheumatoid arthritis |
| Q72709184 | Psychological factors in juvenile rheumatoid arthritis |
| Q50798812 | Psychological functioning of children and adolescents with juvenile idiopathic arthritis is related to physical disability but not to disease status. |
| Q44321585 | Psychological intervention for adolescents with juvenile idiopathic arthritis: for whom and when? |
| Q52625744 | Psychological profile in children and adolescents with severe course Juvenile Idiopathic Arthritis. |
| Q50894402 | Psychological side effects of MTX treatment in juvenile idiopathic arthritis: a pilot study. |
| Q77388394 | Psychological symptoms in chronic fatigue and juvenile rheumatoid arthritis |
| Q37946837 | Psychometric characteristics of outcome measures in juvenile idiopathic arthritis: a systematic review |
| Q39410588 | Psychometric properties evaluation of the childhood health assessment questionnaire (CHAQ) in Moroccan juvenile idiopathic arthritis |
| Q90815120 | Psychometric properties of the pediatric Patient-Reported Outcomes Measurement Information System (PROMIS®) item banks in a Dutch clinical sample of children with Juvenile Idiopathic Arthritis |
| Q81198265 | Psychosocial aspects of Turkish mothers of children with juvenile idiopathic arthritis |
| Q67315514 | Psychosocial factors in juvenile rheumatoid arthritis |
| Q77430969 | Psychosocial outcomes and health status in adults who have had juvenile rheumatoid arthritis: comment on the article by Peterson et al |
| Q50627166 | Psychosocial outcomes and health status of adults who have had juvenile rheumatoid arthritis: a controlled, population-based study. |
| Q67561390 | Psychosomatic aspects of juvenile rheumatoid arthritis |
| Q46570166 | Pulmonary autograft failure after aortic root replacement in a patient with juvenile rheumatoid arthritis |
| Q84744080 | Pulmonary capillaritis leading to alveolar hemorrhage in a juvenile idiopathic arthritis patient: first description |
| Q54776673 | Pulmonary fibrosis and other clinical manifestations of small vessel vasculitis in a family with seropositive juvenile rheumatoid arthritis. |
| Q51714367 | Pulmonary function in children with juvenile idiopathic arthritis and effects of methotrexate therapy. |
| Q70832372 | Pulmonary function in juvenile rheumatoid arthritis |
| Q41940786 | Pulmonary haemosiderosis with juvenile idiopathic arthritis in a Malaysian child. |
| Q74148974 | Pulmonary hemosiderosis with juvenile rheumatoid arthritis: a case report |
| Q35766646 | Pulmonary hypertension and other potentially fatal pulmonary complications in systemic juvenile idiopathic arthritis |
| Q40317853 | Pulmonary manifestations of juvenile rheumatoid arthritis. A report of eight cases and review |
| Q67956001 | Pulse therapy with methylprednisolone and cyclophosphamide in systemic juvenile rheumatoid arthritis: the results of an open, parallel, controlled, randomized, 12-month study |
| Q72113607 | Pure red cell aplasia associated with juvenile rheumatoid arthritis: effects of T-lymphocytes on hemopoietic progenitor cells |
| Q42060638 | Pure red cell aplasia in systemic onset juvenile idiopathic arthritis |
| Q84334307 | Purified protein derivative response in juvenile idiopathic arthritis |
| Q81639448 | Pyoderma gangrenosum in association with juvenile rheumatoid arthritis |
| Q84986123 | QT dispersion and cardiac involvement in patients with juvenile idiopathic arthritis |
| Q49181980 | QT dispersion and cardiac involvement in patients with juvenile idiopathic arthritis. |
| Q47246889 | Qualitative and semi-quantitative assessment of temporomandibular joint MRI protocols for juvenile idiopathic arthritis at 1.5 and 3.0T. |
| Q36826454 | Quality of life after TKA for patients with juvenile rheumatoid arthritis |
| Q51898144 | Quality of life and impact of the disease on primary caregivers of juvenile idiopathic arthritis patients. |
| Q44183898 | Quality of life and psychosocial adaptation in children and adolescents with juvenile idiopathic arthritis and reactive arthritis |
| Q89845772 | Quality of life in children suffering from juvenile idiopathic arthritis-associated uveitis |
| Q37075783 | Quality of randomized clinical trials in juvenile idiopathic arthritis |
| Q80397866 | Quality-of-Life Measurements in Juvenile Rheumatoid Arthritis Patients Treated with Etanercept |
| Q53600596 | Quantification of dynamic contrast-enhanced MR imaging of the knee in children with juvenile rheumatoid arthritis based on pharmacokinetic modeling. |
| Q34063395 | Quantification of the familial contribution to juvenile idiopathic arthritis |
| Q41540865 | Quantifying Temporomandibular Joint Synovitis in Children With Juvenile Idiopathic Arthritis |
| Q81026032 | Quantifying dynamic contrast-enhanced MRI of the knee in children with juvenile rheumatoid arthritis using an arterial input function (AIF) extracted from popliteal artery enhancement, and the effect of the choice of the AIF on the kinetic parameter |
| Q38836205 | Quantifying the Effect of Temporomandibular Joint Intra-Articular Steroid Injection on Synovial Enhancement in Juvenile Idiopathic Arthritis |
| Q80079366 | Quantitative MR characterization of disease activity in the knee in children with juvenile idiopathic arthritis: a longitudinal pilot study |
| Q83017983 | Quantitative alterations of CD8+ T cells in juvenile idiopathic arthritis patients in remission |
| Q89471686 | Quantitative analysis of facial asymmetry based on three-dimensional photography: a valuable indicator for asymmetrical temporomandibular joint affection in juvenile idiopathic arthritis patients? |
| Q69574191 | Quantitative assessment of immunoglobulins in juvenile rheumatoid arthritis |
| Q45746126 | Quantitative assessment of synovitis in juvenile idiopathic arthritis using Dynamic Contrast-Enhanced Magnetic Resonance Imaging |
| Q81162774 | Quantitative magnetic resonance imaging of the hands and wrists of children with juvenile rheumatoid arthritis |
| Q51233440 | Quantitative ultrasonometry of the calcaneus in children with juvenile idiopathic arthritis. |
| Q91823593 | Question 2: Etanercept or adalimumab: which is a better biological therapy for juvenile idiopathic arthritis? |
| Q98663894 | Questionnaire survey on transitional care for patients with juvenile idiopathic arthritis (JIA) and families |
| Q92982564 | Questions Regarding the Relationship Between Serum S100A8/A9 and S100A12 Levels, and the Maintenance of Clinically Inactive Disease in Juvenile Idiopathic Arthritis: Comment on the Article by Hinze et al |
| Q79992055 | RANTES and monocyte chemoattractant protein 1 as sensitive markers of disease activity in patients with juvenile rheumatoid arthritis: a six-year longitudinal study |
| Q46769745 | Race, ethnicity, and disease outcomes in juvenile idiopathic arthritis: a cross-sectional analysis of the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry |
| Q84091888 | Radiographic TMJ abnormalities in patients with juvenile idiopathic arthritis followed for 27 years |
| Q71079553 | Radiographic Temporomandibular Joint Abnormality in Adults with Micrognathia and Juvenile Rheumatoid Arthritis |
| Q71023365 | Radiographic abnormalities of the temporomandibular joint in children with juvenile rheumatoid arthritis |
| Q83941152 | Radiographic and clinical outcome in early juvenile rheumatoid arthritis and juvenile spondyloarthropathy: a 3-year prospective study |
| Q37747685 | Radiographic damage in hands and wrists of patients with juvenile idiopathic arthritis after 29 years of disease duration. |
| Q44810226 | Radiographic findings in juvenile rheumatoid arthritis (proceedings) |
| Q83608365 | Radiographic improvement of damaged large joints in children with systemic juvenile idiopathic arthritis following tocilizumab treatment |
| Q35555333 | Radiographic progression in children with polyarticular juvenile rheumatoid arthritis: a pilot study |
| Q53254469 | Radiologic Improvement of juvenile idiopathic arthritis-enthesitis-related arthritis following anti-tumor necrosis factor-alpha blockade with etanercept. |
| Q84569553 | Radiologic analysis of the effect of tocilizumab on hands and large joints in children with systemic juvenile idiopathic arthritis |
| Q69743757 | Radiologic case study. Juvenile rheumatoid arthritis |
| Q74218040 | Radiologic case study. Overgrowth of an epiphysis in juvenile rheumatoid arthritis |
| Q44305355 | Radiologic features in juvenile idiopathic arthritis: a first step in the development of a standardized assessment method |
| Q40496179 | Radiologic features of systemic onset juvenile rheumatoid arthritis |
| Q53024995 | Radiologic features of temporomandibular joint osseous structures in children with juvenile idiopathic arthritis. Cone beam computed tomography study. |
| Q34262091 | Radiologic mimics of juvenile rheumatoid arthritis |
| Q73207766 | Radiologic outcome and its relationship to functional disability in juvenile rheumatoid arthritis |
| Q39572529 | Radiologic review: the cervical spine in juvenile rheumatoid arthritis |
| Q45247209 | Radiological assessment of fifty patients with juvenile rheumatoid arthritis: correlation with clinical and laboratory abnormalities |
| Q70809878 | Radiological assessment of knees in juvenile chronic arthritis (juvenile rheumatoid arthritis) |
| Q61831238 | Radiological cervical spine involvement in young adults with polyarticular juvenile idiopathic arthritis |
| Q33556176 | Radiological findings in seropositive juvenile chronic arthritis (juvenile rheumatoid arthritis) with particular reference to progression |
| Q53546741 | Radiological improvement by tocilizumab in polyarticular juvenile idiopathic arthritis. |
| Q44522388 | Radiological peripheral involvement in a cohort of patients with polyarticular juvenile idiopathic arthritis at adulthood |
| Q57927632 | Radiological picture of juvenile rheumatoid arthritis |
| Q47413356 | Radix Tripterygium Wilfordii Hook F in rheumatoid arthritis, ankylosing spondylitis and juvenile rheumatoid arthritis |
| Q44863879 | Raised IgM antibodies to parvovirus B19 in juvenile rheumatoid arthritis |
| Q40263864 | Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis |
| Q35041117 | Randomized, double-blind, placebo-controlled trial of the efficacy and safety of rilonacept in the treatment of systemic juvenile idiopathic arthritis |
| Q101153910 | Rapid Resolution of Erosive Psoriatic Juvenile Idiopathic Arthritis With Anti-Tumor Necrosis Factor Therapy |
| Q82950882 | Rapid and sustained remission of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome through treatment with anakinra and corticosteroids |
| Q35574379 | Rapid and sustained response to tocilizumab, anti-interleukin-6 receptor antibody, in a patient with nephrotic syndrome secondary to systemic juvenile idiopathic arthritis-related amyloidosis |
| Q85248217 | Rare presentation of polyarticular juvenile idiopathic arthritis and the role of the radiograph in initial diagnosis |
| Q40947312 | Rash associated with juvenile rheumatoid arthritis |
| Q41029387 | Rate and Clinical Presentation of Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Canakinumab |
| Q36131029 | Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment |
| Q35861269 | Rates of malignancy associated with juvenile idiopathic arthritis and its treatment |
| Q30707232 | Rationale, design and baseline data of a mixed methods study examining the clinical impact of a brief transition programme for young people with juvenile idiopathic arthritis: the DON'T RETARD project. |
| Q66961003 | Re-Examination of Histocompatibility Antigens Found in Patients with Juvenile Rheumatoid Arthritis |
| Q90204067 | Re: Hughes et al.: Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with juvenile idiopathic arthritis (Ophthalmology. 2019;126:415-424) |
| Q91899463 | Re: Hughes et al.: Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with juvenile idiopathic arthritis (Ophthalmology. 2019;126:415-424) |
| Q95576806 | Re: Hughes et al.: Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with juvenile idiopathic arthritis (Ophthalmology. 2019;126:415-424) |
| Q95576808 | Re: Hughes et al.: Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with juvenile idiopathic arthritis (Ophthalmology. 2019;126:415-424) |
| Q88012677 | Re: oligoarticular juvenile idiopathic arthritis among Saudi children |
| Q35143951 | Reactive oxygen species and serum antioxidant defense in juvenile idiopathic arthritis |
| Q69086594 | Reactivity of antinuclear antibodies with histones and other antigens in juvenile rheumatoid arthritis |
| Q69706083 | Reactivity of autonomic nervous control of heart rate in diabetes mellitus and juvenile rheumatoid arthritis |
| Q42376653 | Readout-segmented multi-shot diffusion-weighted MRI of the knee joint in patients with juvenile idiopathic arthritis |
| Q91912529 | Real-World Effectiveness of Common Treatment Strategies for Juvenile Idiopathic Arthritis: Results from a Canadian Cohort |
| Q40683169 | Real-life practice of methotrexate toxicity monitoring in juvenile idiopathic arthritis in Germany, Switzerland and Austria: results of a cross-sectional assessment conducted in 2012. |
| Q47663504 | Reasons for inactive disease and flare in systemic onset juvenile idiopathic arthritis patients during tocilizumab treatment |
| Q46967442 | Reasons for stopping methotrexate treatment in patients with juvenile idiopathic arthritis. |
| Q57055149 | Recent advances in our understanding of the pathogenesis of juvenile idiopathic arthritis and their potential clinical implications |
| Q38711172 | Recent advances in the use of Anti-TNFα therapy for the treatment of juvenile idiopathic arthritis. |
| Q35538399 | Recent advances in uveitis of juvenile idiopathic arthritis |
| Q37207120 | Recent developments in anti-rheumatic drugs in pediatrics: treatment of juvenile idiopathic arthritis |
| Q38102977 | Recent developments in disease activity indices and outcome measures for juvenile idiopathic arthritis |
| Q88719893 | Recent therapeutic advances in juvenile idiopathic arthritis |
| Q38419448 | Recent trends in medication usage for the treatment of juvenile idiopathic arthritis and the influence of tumor necrosis factor inhibitors |
| Q90365519 | Recommendations for a Standard Magnetic Resonance Imaging Protocol of Temporomandibular Joints in Juvenile Idiopathic Arthritis |
| Q84357281 | Recommendations for juvenile idiopathic arthritis by the American College of Rheumatology: comment on the article by Beukelman et al |
| Q100759948 | Recommendations for the Management of Uveitis Associated With Juvenile Idiopathic Arthritis: The Czech and Slovak adaptation of SHARE Initiative |
| Q53450290 | Recommendations for the Use of Ultrasound and Magnetic Resonance in Patients With Spondyloarthritis, Including Psoriatic Arthritis, and Patients With Juvenile Idiopathic Arthritis. |
| Q36677248 | Recommendations for the use of methotrexate in juvenile idiopathic arthritis |
| Q38041435 | Recurrent cardiac tamponade in a child with newly diagnosed systemic-onset juvenile idiopathic arthritis |
| Q40329129 | Recurrent fever of unknown origin (FUO): aseptic meningitis, hepatosplenomegaly, pericarditis and a double quotidian fever due to juvenile rheumatoid arthritis (JRA). |
| Q42841163 | Recurrent hypopyon in chronic anterior uveitis of pauciarticular juvenile idiopathic arthritis |
| Q39395638 | Recurrent knee arthritis diagnosed as juvenile idiopathic arthritis with a 10-year asymptomatic period after arthroscopic synovectomy: a case report |
| Q35548368 | Recurrent lung shadowing in adult juvenile idiopathic arthritis |
| Q85809309 | Recurrent macrophage activation syndrome associated with heterozygous perforin W374X gene mutation in a child with systemic juvenile idiopathic arthritis |
| Q54474558 | Recurrent tonsillitis and tonsillectomy in juvenile idiopathic arthritis. |
| Q85857431 | Reduced activation and CD3 lymphocyte recruitment after TNF-inhibitor use: evaluation of clinical and 99mTc-OKT3 scintigraphic response in a patient with juvenile idiopathic arthritis |
| Q49652558 | Reduced activation and CD3 lymphocyte recruitment after TNF-inhibitor use: evaluation of clinical and 99mTc-OKT3 scintigraphic response in a patient with juvenile idiopathic arthritis. |
| Q33567104 | Reduced bone mineral content and normal serum osteocalcin in non-steroid-treated patients with juvenile rheumatoid arthritis |
| Q43515602 | Reduced joint assessment vs comprehensive assessment for ultrasound detection of synovitis in juvenile idiopathic arthritis |
| Q35564348 | Reduced levels of circulating progenitor cells in juvenile idiopathic arthritis are counteracted by anti TNF-α therapy |
| Q77653136 | Reduced levels of testosterone and dehydroepiandrosterone sulphate in the serum and synovial fluid of juvenile rheumatoid arthritis patients correlates with disease severity |
| Q41437555 | Reduced mandibular dimensions and asymmetry in juvenile rheumatoid arthritis. Pathogenetic factors |
| Q73023710 | Reduced perforin expression in systemic juvenile idiopathic arthritis is restored by autologous stem-cell transplantation |
| Q36364223 | Reduced physical activity in children and adolescents with Juvenile Idiopathic Arthritis despite satisfactory control of inflammation. |
| Q38333494 | Reduction in IgG galactose in juvenile and adult onset rheumatoid arthritis measured by a lectin binding method and its relation to rheumatoid factor |
| Q40018521 | Reduction in alveolar bone density of patients with juvenile idiopathic arthritis |
| Q45746061 | Reduction in missed school days and improvement in parent activity participation in children with juvenile idiopathic arthritis treated with abatacept |
| Q89998121 | Reduction in the utilization of prednisone or methotrexate in Canadian claims data following initiation of etanercept in pediatric patients with juvenile idiopathic arthritis |
| Q36654520 | Refractory juvenile idiopathic arthritis: using autologous stem cell transplantation as a treatment strategy |
| Q46969070 | Refractory systemic juvenile idiopathic arthritis complicated by coxarthrosis |
| Q89515031 | Regional differences in temporomandibular joint inflammation in patients with juvenile idiopathic arthritis: a dynamic post-contrast magnetic resonance imaging study |
| Q88530666 | Regression of unusual optic disk neovascularization after adalimumab in a case of juvenile idiopathic arthritis-related uveitis |
| Q41939285 | Regular aerobic training combined with range of motion exercises in juvenile idiopathic arthritis |
| Q90893932 | Regulation of JAK/STAT signal pathway by miR-21 in the pathogenesis of juvenile idiopathic arthritis |
| Q47655063 | Regulation of peripheral blood and synovial fluid lymphocyte apoptosis in juvenile idiopathic arthritis |
| Q91061995 | Regulatory Role for NK Cells in a Mouse Model of Systemic Juvenile Idiopathic Arthritis |
| Q55207348 | Regulatory T cells from the inflamed joints of patients with juvenile idiopathic arthritis (JIA) are dysregulated and display a pro-inflammatory profile. |
| Q49926018 | Relapse of Juvenile Idiopathic Arthritis-Associated Uveitis after Discontinuation of Immunomodulatory Therapy. |
| Q36362249 | Relapse of systemic juvenile idiopathic arthritis after influenza vaccination in a patient receiving tocilizumab |
| Q82822774 | Relapse rate of uveitis post-methotrexate treatment in juvenile idiopathic arthritis |
| Q35398585 | Relation between functional ability and health-related quality of life of children with juvenile rheumatoid arthritis |
| Q46506318 | Relation of dry eye to disease activity in juvenile rheumatoid arthritis |
| Q47770285 | Relation of interleukin-6, TNF-alpha and interleukin-1alpha with disease activity and severity in juvenile idiopathic arthritis patients |
| Q40220238 | Relationship Between Life Stress Factors And Viral Antibody Levels In Patients With Juvenile Rheumatoid Arthritis |
| Q38749973 | Relationship Between Polymorphisms in Methotrexate Pathway Genes and Outcome of Methotrexate Treatment in a Cohort of 119 Patients with Juvenile Idiopathic Arthritis |
| Q33352545 | Relationship between bone mineral content and growth disorders in children with juvenile idiopathic arthritis |
| Q45745736 | Relationship between delayed menarche and bone density in patients affected by juvenile idiopathic arthritis |
| Q40487219 | Relationship between disease course in the temporomandibular joints and mandibular growth rotation in patients with juvenile idiopathic arthritis followed from childhood to adulthood |
| Q53378283 | Relationship between functional ability and physical fitness in juvenile idiopathic arthritis patients. |
| Q37424437 | Relationship between impaired apoptosis of lymphocytes and distribution of dendritic cells in peripheral blood and synovial fluid of children with juvenile idiopathic arthritis |
| Q45669904 | Relationship between inflammatory markers, oxidant-antioxidant status and intima-media thickness in prepubertal children with juvenile idiopathic arthritis |
| Q71181649 | Relationship between saliva salicylate concentration and free or total salicylate concentration in serum of children with juvenile rheumatoid arthritis |
| Q73090197 | Relationship between sex and antibodies to high mobility group proteins 1 and 2 in juvenile idiopathic arthritis |
| Q47281823 | Relationship of pain-coping strategies and pain-specific beliefs to pain experience in children with juvenile idiopathic arthritis |
| Q46712496 | Relationship of serum ghrelin, leptin, resistin, adiponectin levels with nutritional status and inflammatory determinants in juvenile idiopathic arthritis |
| Q45141237 | Relative ineffectiveness of triamcinolone acetonide in the treatment of juvenile idiopathic arthritis |
| Q35555214 | Relative responsiveness of condition specific and generic health status measures in juvenile idiopathic arthritis |
| Q68191450 | Relatonship between interleukin–6 levels and platelet counts in systemic juvenile rheumatoid arthritis: comment on the article by De benedetti et al |
| Q88201618 | Reliability of clinical symptoms in diagnosing temporomandibular joint arthritis in juvenile idiopathic arthritis |
| Q52889630 | Reliability of the articular examination in children with juvenile rheumatoid arthritis: interobserver agreement and sources of disagreement. |
| Q58733527 | Reliability of ultrasonography to detect inflammatory lesions and structural damage in juvenile idiopathic arthritis |
| Q36644114 | Remission in juvenile idiopathic arthritis. |
| Q37738105 | Remission in juvenile idiopathic arthritis: current facts |
| Q56977534 | Remission of Refractory Systemic-Onset Juvenile Idiopathic Arthritis After Treatment With Siltuximab |
| Q45184611 | Remission of juvenile idiopathic arthritis with primary Epstein-Barr virus infection. |
| Q66696690 | Remission of juvenile rheumatoid arthritis (Still's disease) after measles |
| Q40630391 | Remission of juvenile rheumatoid arthritis after infection with parvovirus B19. |
| Q30304133 | Remission of juvenile rheumatoid arthritis with varicella infection. |
| Q47887369 | Remission rate is not dependent on the presence of antinuclear antibodies in juvenile idiopathic arthritis |
| Q80020383 | Remission status follow-up in children with juvenile idiopathic arthritis |
| Q44541879 | Remission, minimal disease activity, and acceptable symptom state in juvenile idiopathic arthritis: defining criteria based on the juvenile arthritis disease activity score |
| Q71061674 | Remodeling of the Hip Joint in Juvenile Rheumatoid Arthritis |
| Q72841959 | Renal amyloidosis in juvenile rheumatoid arthritis |
| Q50603205 | Renal amyloidosis in juvenile rheumatoid arthritis. |
| Q71536011 | Renal amyloidosis in juvenile rheumatoid arthritis: sonographic features |
| Q46784342 | Renal amyloidosis: an uncommon complication of juvenile idiopathic arthritis |
| Q68602187 | Renal disease in juvenile rheumatoid arthritis |
| Q46974211 | Renal disorder and biological treatment in juvenile idiopathic arthritis |
| Q80275388 | Renal involvement in a patient with juvenile idiopathic arthritis presenting after treatment for Hodgkin lymphoma |
| Q44849865 | Renal involvement in juvenile rheumatoid arthritis. A clinical and histopathological study |
| Q40603106 | Renal involvement in juvenile rheumatoid arthritis: report of two cases |
| Q42272104 | Renal papillary necrosis in juvenile rheumatoid arthritis |
| Q70724283 | Repair of osteopenia in children with juvenile rheumatoid arthritis |
| Q87711249 | Repair of radiographic hip joint in juvenile rheumatoid arthritis patients treated with etanercept plus methotrexate |
| Q41699378 | Repeated exposure to antibiotics in infancy: a predisposing factor for juvenile idiopathic arthritis or a sign of this group's greater susceptibility to infections? |
| Q54065376 | Repetitive use of pulse therapy with methylprednisolone and cyclophosphamide in addition to oral methotrexate in children with systemic juvenile rheumatoid arthritis--preliminary results of a longterm study |
| Q46054057 | Replication of the association of the COG6 gene with juvenile idiopathic arthritis (JIA). |
| Q50500453 | Report - Recurrent hip arthritis diagnosed as juvenile idiopathic arthritis: A case report. |
| Q82837105 | Report on malignancies in the German juvenile idiopathic arthritis registry |
| Q100959683 | Reproducibility of the Six-Minute Walk Test in Children and Youth with Juvenile Idiopathic Arthritis |
| Q92831353 | Republished: Severe acute ocular hypertension following pulsed methylprednisolone for juvenile idiopathic arthritis |
| Q91765566 | Resilience Factors in Children with Juvenile Idiopathic Arthritis and Their Parents: The Role of Child and Parent Psychological Flexibility |
| Q33376118 | Resolution of juvenile idiopathic arthritis-associated uveitis after development of common variable immunodeficiency. |
| Q81710003 | Response of systemic onset juvenile rheumatoid arthritis to etanercept: is the glass half full or half empty? |
| Q83714760 | Response to etanercept in juvenile idiopathic arthritis |
| Q51810461 | Response to: 'Bivalent HPV vaccine safety depending on subtypes of juvenile idiopathic arthritis' by Dr Akioka. |
| Q92128618 | Response to: 'Successful treatment of plasma exchange for refractory systemic juvenile idiopathic arthritis complicated with macrophage activation syndrome and severe lung disease' by Sato et al |
| Q93128477 | Response to: Current Status of Treatment With Intra-Articular Infiltrations in Juvenile Idiopathic Arthritis |
| Q81878507 | Responsiveness of clinical measures to flare of disease activity in juvenile idiopathic arthritis |
| Q45744198 | Responsiveness of different sets of criteria for clinical response evaluation in a non-selected cohort of juvenile idiopathic arthritis (JIA) patients |
| Q73010758 | Resting energy expenditure and nutritional status in children with juvenile rheumatoid arthritis |
| Q37800959 | Restoration of the immune balance by autologous bone marrow transplantation in juvenile idiopathic arthritis |
| Q64241032 | Restoring T Cell Tolerance, Exploring the Potential of Histone Deacetylase Inhibitors for the Treatment of Juvenile Idiopathic Arthritis |
| Q93269416 | Results 5 to 10 years after cataract surgery with primary IOL implantation in juvenile idiopathic arthritis-related uveitis |
| Q69748116 | Results of a comparative study of rheumatoid factor in patients with juvenile rheumatoid arthritis their close relatives and a control group |
| Q37542442 | Results of a multinational survey regarding the diagnosis and treatment of temporomandibular joint involvement in juvenile idiopathic arthritis |
| Q50910478 | Results of bilateral combined hip and knee arthroplasty in very young patients with juvenile rheumatoid arthritis. |
| Q41747570 | Results of conservative and surgical therapy of juvenile chronic polyarthritis |
| Q72344963 | Results of the treatment of juvenile rheumatoid arthritis with indomethacine |
| Q88135930 | Resurfacing hemiarthroplasty of the shoulder for patients with juvenile idiopathic arthritis |
| Q37686517 | Retinal complications of juvenile idiopathic arthritis-related uveitis: a microperimetry and optical coherence tomography study |
| Q59037895 | Retracted: chronic recurrent multifocal osteomyelitis with concomitant features of juvenile idiopathic arthritis |
| Q71248293 | Retroperitoneal fibrosis and juvenile rheumatoid arthritis |
| Q58997590 | Retrospective Analysis of Efficacy and Safety of Tocilizumab Treatment in Patients with Severe Systemic-Onset Juvenile Idiopathic Arthritis Followed for 12 Months |
| Q39273343 | Retrospective Study Evaluating Treatment Decisions and Outcomes of Childhood Uveitis Not Associated with Juvenile Idiopathic Arthritis |
| Q91835403 | Retrospective review of immobilization vs. immediate resumption of activity in patients with Oligoarticular juvenile idiopathic arthritis following knee injections |
| Q48016375 | Reversal of selective IgA deficiency in a child with juvenile rheumatoid arthritis after plasma transfusions |
| Q30874058 | Reversible posterior leukoencephalopathy syndrome secondary to systemic-onset juvenile idiopathic arthritis: A case report and review of the literature |
| Q38109932 | Review for disease of the year: epidemiology of juvenile idiopathic arthritis and its associated uveitis: the probable risk factors |
| Q37093920 | Review of biomarkers in systemic juvenile idiopathic arthritis: helpful tools or just playing tricks? |
| Q91738459 | Review of environmental factors and juvenile idiopathic arthritis |
| Q36709942 | Review of medications used in juvenile rheumatoid arthritis |
| Q27002805 | Review: is there a window of opportunity for treatment of systemic juvenile idiopathic arthritis? |
| Q73892416 | Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997 |
| Q77436077 | Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997 |
| Q49797302 | Revisiting Type 1 Diabetes as a Comorbidity in Patients with Juvenile Idiopathic Arthritis. |
| Q42228956 | Reye syndrome and juvenile rheumatoid arthritis in Michigan |
| Q68003033 | Reye's syndrome among patients with juvenile rheumatoid arthritis |
| Q57224609 | Reye's syndrome and juvenile rheumatoid arthritis: a case report in Texas |
| Q39040941 | Rheumatoid arthritis and connective tissue disorders: juvenile chronic arthritis |
| Q40394180 | Rheumatoid arthritis and juvenile chronic arthritis: the role of the neuro-endocrine system |
| Q46938019 | Rheumatoid arthritis complicated with pericarditis--focused mainly on juvenile idiopathic arthritis |
| Q41150797 | Rheumatoid arthritis, juvenile arthritis, iridocyclitis and the Epstein-Barr virus |
| Q73128395 | Rheumatoid factor positive, oligoarticular onset juvenile rheumatoid arthritis |
| Q39536170 | Rheumatoid rosette in juvenile rheumatoid arthritis |
| Q46568181 | Rice Bodies and a Partial Flexor Tendon Rupture in a Patient with Juvenile Idiopathic Arthritis: A Case Report and Review of the Literature |
| Q93045572 | Rice Bodies in a Patient with Oligoarticular Juvenile Idiopathic Arthritis |
| Q75248302 | Rice bodies imaging in juvenile idiopathic arthritis |
| Q83644866 | Rice bodies in juvenile idiopathic arthritis: a clinical image |
| Q74272108 | Rice bodies in juvenile rheumatoid arthritis |
| Q72252839 | Rifamycin SV administered by intra-articular infiltrations shows disease modifying activity in patients with pauci- or polyarticular juvenile rheumatoid arthritis |
| Q84749144 | Right ventricular function in Juvenile idiopathic arthritis patients |
| Q34771827 | Rilonacept pharmacokinetics in children with systemic juvenile idiopathic arthritis |
| Q47216463 | Risk Factors Associated with Juvenile Idiopathic Arthritis: Exposure to Cigarette Smoke and Air Pollution from Pregnancy to Disease Diagnosis. |
| Q56969198 | Risk Factors and Biomarkers for the Occurrence of Uveitis in Juvenile Idiopathic Arthritis: Data From the Inception Cohort of Newly Diagnosed Patients With Juvenile Idiopathic Arthritis Study |
| Q57172912 | Risk Factors for Intraarticular Heterotopic Bone Formation in the Temporomandibular Joint in Juvenile Idiopathic Arthritis |
| Q73821481 | Risk and resistance factors in the adaptation in mothers of children with juvenile rheumatoid arthritis |
| Q80713163 | Risk factors and longterm outcome of juvenile idiopathic arthritis-associated uveitis in Switzerland |
| Q86590476 | Risk factors associated with the relapse of uveitis in patients with juvenile idiopathic arthritis: a preliminary report |
| Q37697138 | Risk factors for development of uveitis differ between girls and boys with juvenile idiopathic arthritis |
| Q52631546 | Risk factors for hypersensitivity reactions to tocilizumab introduction in systemic juvenile idiopathic arthritis. |
| Q46862127 | Risk factors for juvenile idiopathic arthritis: exposure to tobacco and environmental factors during and before pregnancy |
| Q34444734 | Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the Systemic Immunosuppressive Therapy for Eye Diseases Study |
| Q35843799 | Risk factors for ocular complications and poor visual acuity at presentation among patients with uveitis associated with juvenile idiopathic arthritis |
| Q38010416 | Risk factors for temporomandibular joint arthritis in children with juvenile idiopathic arthritis |
| Q80812558 | Risk factors for the development of cataract requiring surgery in uveitis associated with juvenile idiopathic arthritis |
| Q33981536 | Risk markers of juvenile idiopathic arthritis-associated uveitis in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry |
| Q90572948 | Risk of Cataract Development among Children with Juvenile Idiopathic Arthritis-Related Uveitis Treated with Topical Corticosteroids |
| Q40681315 | Risk of Hypotony in Juvenile Idiopathic Arthritis-Associated Uveitis. |
| Q40621384 | Risk of Serious Infection in Juvenile Idiopathic Arthritis Patients Associated With Tumor Necrosis Factor Inhibitors and Disease Activity in the German Biologics in Pediatric Rheumatology Registry |
| Q57476291 | Risk of Serious Infections Associated with Biologic Agents in Juvenile Idiopathic Arthritis: A Systematic Review and Meta-Analyses |
| Q35654296 | Risk of Tuberculosis in Children with Juvenile Idiopathic Arthritis: A Nationwide Population-Based Study in Taiwan |
| Q33976794 | Risk of cataract development among children with juvenile idiopathic arthritis-related uveitis treated with topical corticosteroids |
| Q92711757 | Risk of juvenile idiopathic arthritis among children conceived after fertility treatment: a nationwide registry-based cohort study |
| Q83916018 | Risk of malignancy in children with juvenile idiopathic arthritis not treated with biologic agents |
| Q36669838 | Risk of new-onset uveitis in patients with juvenile idiopathic arthritis treated with anti-TNFalpha agents |
| Q40242247 | Risk of serious bacterial infection associated with tumour necrosis factor-alpha inhibitors in children with juvenile idiopathic arthritis |
| Q52617055 | Risk, Timing and Predictors of Disease Flare after Discontinuation of Anti-Tumor Necrosis Factor (TNF) Therapy in Children with Polyarticular Forms of Juvenile Idiopathic Arthritis (JIA) in Clinical Inactive Disease. |
| Q40151899 | Risks of serious infections in children treated with biologic response-modifying drugs: Bacterial infection risk in children with juvenile idiopathic arthritis |
| Q45745940 | Rituximab in ANA positive polyarticular juvenile idiopathic arthritis (JIA) with uveitis |
| Q51768781 | Rituximab therapy for refractory systemic-onset juvenile idiopathic arthritis. |
| Q40371565 | Rituximab therapy produced rapid and sustained clinical improvement in a patient with systemic onset juvenile idiopathic arthritis refractory to TNF alpha antagonists |
| Q85358791 | Rituximab use in young adults diagnosed with juvenile idiopathic arthritis unresponsive to conventional treatment: report of 6 cases |
| Q71383427 | Roentgen diagnosis of juvenile rheumatoid arthritis |
| Q67873994 | Roentgenmorphology findings in juvenile rheumatoid arthritis |
| Q67873997 | Roentgenmorphology of juvenile rheumatoid arthritis in in adults (using hands as examples) |
| Q67470297 | Roentgenologic follow-up after synovectomy in juvenile rheumatoid arthritis |
| Q79004128 | Roentgenologic manifestations of juvenile rheumatoid arthritis |
| Q43806343 | Role of HLA-DRB1 and PTPN22 genes in susceptibility to juvenile idiopathic arthritis in Hungarian patients. |
| Q74150353 | Role of IgM & IgA rheumatoid factors in complement activation in patients with juvenile rheumatoid arthritis |
| Q88440362 | Role of Interleukin 37 as a Novel Proangiogenic Factor in Juvenile Idiopathic Arthritis |
| Q47421703 | Role of PTPN22 1858 C/T Polymorphisms in Juvenile Idiopathic Arthritis in Egyptian Patients |
| Q97552291 | Role of Serum MRP8/14 in Predicting Response to Methotrexate in Children With Juvenile Idiopathic Arthritis |
| Q45746008 | Role of Vγ9Vδ2+ γδ T cells in juvenile idiopathic arthritis |
| Q37561994 | Role of adalimumab in the management of children and adolescents with juvenile idiopathic arthritis and other rheumatic conditions |
| Q97569640 | Role of alloplastic reconstruction of the temporomandibular joint in the juvenile idiopathic arthritis population |
| Q73624102 | Role of human leukocyte antigen DRB1*0307 and DRB1*0308 in susceptibility to juvenile rheumatoid arthritis |
| Q36403583 | Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade |
| Q54337987 | Role of polymorphonucleates in the pathogenesis of systemic juvenile idiopathic arthritis and Still's disease: a proof of concept study. |
| Q46911519 | Role of power Doppler sonography in evaluation of therapeutic response of the knee in juvenile rheumatoid arthritis |
| Q70267702 | Role of self-esteem and autonomy in determining medication compliance among adolescents with juvenile rheumatoid arthritis |
| Q38066445 | Role of ultrasound in the assessment of juvenile idiopathic arthritis |
| Q102326050 | Roles of Interactions Between Toll-Like Receptors and Their Endogenous Ligands in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still's Disease |
| Q45009112 | Room for improvement: patient, parent, and practitioners' perceptions of foot problems and foot care in juvenile idiopathic arthritis |
| Q84608810 | Ross operation in a patient with juvenile rheumatoid arthritis |
| Q33569442 | Rubella antibody levels in juvenile rheumatoid arthritis |
| Q39328462 | Rubella-virus infection in juvenile rheumatoid arthritis |
| Q48262195 | S100A12 Is Associated with Response to Therapy in Juvenile Idiopathic Arthritis. |
| Q58578291 | S100A12 and vascular endothelial growth factor can differentiate Blau syndrome and familial Mediterranean fever from systemic juvenile idiopathic arthritis |
| Q37187378 | S100A12 is a novel molecular marker differentiating systemic-onset juvenile idiopathic arthritis from other causes of fever of unknown origin |
| Q61963990 | SAT0493 Farber Disease: First Natural History Cohort Demonstrates a Broad Clinical Spectrum with Implications for Juvenile Idiopathic Arthritis Patients |
| Q76528668 | SEROLOGICAL PATTERNS IN JUVENILE RHEUMATOID ARTHRITIS |
| Q47101422 | SIAE Rare Variants in Juvenile Idiopathic Arthritis and Primary Antibody Deficiencies |
| Q100474030 | SLCO1B1 variants as predictors of methotrexate-related toxicity in children with juvenile idiopathic arthritis |
| Q35956467 | SNPs in the FOXP3 gene region show no association with Juvenile Idiopathic Arthritis in a UK Caucasian population |
| Q35186565 | STAT4 rs7574865 G/T and PTPN22 rs2488457 G/C polymorphisms influence the risk of developing juvenile idiopathic arthritis in Han Chinese patients |
| Q92670785 | Safety and Effectiveness of Adalimumab in Patients With Polyarticular Course of Juvenile Idiopathic Arthritis: STRIVE Registry 7-Year Interim Results |
| Q61911617 | Safety and Efficacy of Infliximab and Adalimumab for Refractory Uveitis in Juvenile Idiopathic Arthritis: 1-year Followup Data from the Italian Registry |
| Q93264563 | Safety and effectiveness of adalimumab in Japanese patients with juvenile idiopathic arthritis: Results from a real-world postmarketing study |
| Q38817268 | Safety and effectiveness of etanercept for treatment of juvenile idiopathic arthritis: Results from a postmarketing surveillance |
| Q82610043 | Safety and efficacy of adalimumab treatment in Greek children with juvenile idiopathic arthritis |
| Q61633704 | Safety and efficacy of an oral histone deacetylase inhibitor in systemic-onset juvenile idiopathic arthritis |
| Q45972582 | Safety and efficacy of biological therapy with TNF-inhibitors and non TNF-inhibitors in a cohort of young adults affected by juvenile idiopathic arthritis (JIA): data from a single centre experience. |
| Q31152676 | Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry |
| Q61452601 | Safety and efficacy of dexamethasone implant along with phacoemulsification and intraocular lens implantation in children with juvenile idiopathic arthritis associated uveitis |
| Q35194346 | Safety and efficacy of disease-modifying antirheumatic agents in rheumatoid arthritis and juvenile rheumatoid arthritis |
| Q51425096 | Safety and efficacy of etanercept and adalimumab in children aged 2 to 4 years with juvenile idiopathic arthritis. |
| Q43858787 | Safety and efficacy of etanercept in a cohort of patients with juvenile idiopathic arthritis under 4 years of age. |
| Q85289038 | Safety and efficacy of etanercept in children with juvenile idiopathic arthritis below the age of 2 years |
| Q44747942 | Safety and efficacy of etanercept in children with juvenile idiopathic arthritis below the age of 4 years |
| Q34317154 | Safety and efficacy of high dose etanercept in treatment of juvenile rheumatoid arthritis. |
| Q30575712 | Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1-year followup data from the Italian Registry. |
| Q51182841 | Safety and efficacy of influenza vaccination in a prospective longitudinal study of 31 children with juvenile idiopathic arthritis. |
| Q48505199 | Safety and efficacy of long-term etanercept in the treatment of methotrexate-refractory polyarticular-course juvenile idiopathic arthritis in Japan. |
| Q79695065 | Safety and efficacy of meningococcal c vaccination in juvenile idiopathic arthritis |
| Q40758033 | Safety and efficacy of methotrexate therapy for juvenile rheumatoid arthritis |
| Q47686788 | Safety and efficacy of once weekly etanercept 0.8 mg/kg in a multicentre 12 week trial in active polyarticular course juvenile idiopathic arthritis |
| Q80643968 | Safety and efficacy of once-weekly application of Etanercept in children with juvenile idiopathic arthritis |
| Q46639900 | Safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis |
| Q59268601 | Safety and efficacy of tocilizumab treatment in children with systemic onset of juvenile idiopathic arthritis |
| Q84343327 | Safety and efficacy of tocilizumab, an anti-IL-6-receptor monoclonal antibody, in patients with polyarticular-course juvenile idiopathic arthritis |
| Q55289277 | Safety and efficacy of ultrasound guided corticosteroid injections into temporomandibular joints in children with active juvenile idiopathic arthritis. |
| Q33330958 | Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis |
| Q30561242 | Safety and feasibility of a home-based six week resistance training program in juvenile idiopathic arthritis |
| Q83418080 | Safety and response to influenza vaccine in patients with systemic-onset juvenile idiopathic arthritis receiving tocilizumab |
| Q90578129 | Safety of Adalimumab in Pediatric Patients with Polyarticular Juvenile Idiopathic Arthritis, Enthesitis-Related Arthritis, Psoriasis, and Crohn's Disease |
| Q35745540 | Safety of anti-TNFalpha therapy in children with juvenile idiopathic arthritis. |
| Q38530469 | Safety of biologic therapies for the treatment of juvenile idiopathic arthritis |
| Q33936827 | Safety of celecoxib and nonselective nonsteroidal anti-inflammatory drugs in juvenile idiopathic arthritis: results of the Phase 4 registry |
| Q37639032 | Safety of growth hormone treatment in children with juvenile idiopathic arthritis |
| Q36013929 | Safety of measles, mumps and rubella vaccination in juvenile idiopathic arthritis |
| Q30235357 | Safety of tocilizumab in the treatment of juvenile idiopathic arthritis. |
| Q47226473 | Safety of weekly adalimumab in the treatment of juvenile idiopathic arthritis and pediatric chronic uveitis. |
| Q34169347 | Safety, effectiveness, and pharmacokinetics of adalimumab in children with polyarticular juvenile idiopathic arthritis aged 2 to 4 years |
| Q69492107 | Salicylate hepatotoxicity in patients with juvenile rheumatoid arthritis |
| Q66973693 | Salicylate induced hepatotoxicity in juvenile rheumatoid arthritis--a case report |
| Q71202393 | Salicylate therapy in juvenile rheumatoid arthritis. Dose, serum level, and toxicity |
| Q103729351 | Salivary Oral Microbiome of Children With Juvenile Idiopathic Arthritis: A Norwegian Cross-Sectional Study |
| Q33575269 | Salivary antioxidants and metalloproteinases in juvenile idiopathic arthritis |
| Q79402388 | Salivary gland involvement and oxidative stress in juvenile idiopathic arthritis: novel observation in oligoarticular-type patients |
| Q90488115 | Same but different? A thematic analysis on adalimumab biosimilar switching among patients with juvenile idiopathic arthritis |
| Q68691580 | Sarcoidosis in children: differentiation from juvenile rheumatoid arthritis |
| Q77751295 | Sarcoidosis in preschool children with hepatic involvement mimicking juvenile rheumatoid arthritis |
| Q77429759 | Saving the vision of children with juvenile rheumatoid arthritis-associated uveitis |
| Q95414450 | Scarring following steroid tendon sheath injections for tenosynovitis in children with juvenile idiopathic arthritis: a single-centre experience |
| Q69332826 | School problems and teacher responsibilities in juvenile rheumatoid arthritis |
| Q68755450 | Scoliosis and juvenile rheumatoid arthritis. A case report of surgical treatment |
| Q70809884 | Scoliosis in children with juvenile rheumatoid arthritis |
| Q68807858 | Scoliosis in juvenile rheumatoid arthritis |
| Q37329220 | Screening Mucopolysaccharidosis Type IX in Patients with Juvenile Idiopathic Arthritis. |
| Q74315919 | Screening for uveitis in juvenile rheumatoid arthritis |
| Q51324312 | Screening of patients with juvenile idiopathic arthritis and those with rheumatoid arthritis for celiac disease in southwestern Iran. |
| Q92018834 | Scurvy Masquerading as Juvenile Idiopathic Arthritis or Vasculitis with Elevated Inflammatory Markers: A Case Series |
| Q40926092 | Seasonal onset of systemic-onset juvenile rheumatoid arthritis |
| Q69198707 | Seasonal variation in systemic onset juvenile rheumatoid arthritis |
| Q33638274 | Seasonal variation in systemic onset juvenile rheumatoid arthritis in Israel. |
| Q53642170 | Seasonality of birth of patients with juvenile idiopathic arthritis. |
| Q46769753 | Secondary Cushing's syndrome in children with juvenile idiopathic arthritis following intra-articular triamcinolone acetonide administration |
| Q73092848 | Secondary glaucoma in patients with juvenile rheumatoid arthritis-associated iridocyclitis |
| Q81001349 | Secondary osteonecrosis mimicking a femur bone tumor in an adolescent with juvenile idiopathic arthritis |
| Q34595120 | Secondary osteoporosis in patients with juvenile idiopathic arthritis |
| Q51238480 | Secretion of pro-inflammatory cytokines and chemokines and loss of regulatory signals by fibroblast-like synoviocytes in juvenile idiopathic arthritis. |
| Q45154340 | Sedation for intra-articular corticosteroid injections in juvenile idiopathic arthritis: the views of patients and their parents |
| Q38542609 | Sedation methods for intra-articular corticosteroid injections in Juvenile Idiopathic Arthritis: a review |
| Q64065849 | Seeking the state of the art in standardized measurement of health care resource use and costs in juvenile idiopathic arthritis: a scoping review |
| Q42241973 | Selecting magnetic resonance imaging (MRI) outcome measures for juvenile idiopathic arthritis (JIA) clinical trials: first report of the MRI in JIA special interest group |
| Q83937246 | Selective elimination of pathogenic synovial fluid T-cells from rheumatoid arthritis and juvenile idiopathic arthritis by targeted activation of Fas-apoptotic signaling |
| Q73678514 | Selective recruitment of polarized T cells expressing CCR5 and CXCR3 to the inflamed joints of children with juvenile idiopathic arthritis |
| Q58587552 | Self-management needs of Irish adolescents with Juvenile Idiopathic Arthritis (JIA): how can a Canadian web-based programme meet these needs? |
| Q43407069 | Self-rated physical and psychosocial health in a cohort of young adults with juvenile idiopathic arthritis |
| Q58584403 | Self-rated walking disability and dynamic ankle joint stiffness in children and adolescents with Juvenile Idiopathic Arthritis receiving intraarticular corticosteroid joint injections of the foot |
| Q33440560 | Self-reported pain and disease symptoms persist in juvenile idiopathic arthritis despite treatment advances: an electronic diary study |
| Q41485071 | Sensitivity and specificity of adenosine deaminase in diagnosis of juvenile idiopathic arthritis |
| Q46086511 | Sensitivity and specificity of current diagnostic guidelines in children with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis |
| Q59270115 | Sensitivity and specificity of current diagnostic guidelines in children with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis |
| Q68904632 | Separation and characterization of complement-fixing immune complexes in juvenile rheumatoid arthritis patients |
| Q83049650 | Septic abscess in a child with juvenile idiopathic arthritis receiving anti-tumor necrosis factor-alpha |
| Q79822996 | Septic arthritis in a patient with juvenile rheumatoid arthritis |
| Q43404971 | Septic arthritis or juvenile idiopathic arthritis--the case of a 2 year old boy. |
| Q42013166 | Sequence feature variant type (SFVT) analysis of the HLA genetic association in juvenile idiopathic arthritis. |
| Q44844220 | Sequential changes to clinical parameters and adhesion molecules following intravenous pulse cyclophosphamide and methylprednisolone treatment of refractory juvenile idiopathic arthritis. |
| Q33566487 | Serial measurements of soluble interleukin 2 receptor levels (sIL2-R) in children with juvenile rheumatoid arthritis treated with oral methotrexate |
| Q47198925 | Serious Adverse Events Associated with Anti-Tumor Necrosis Factor Alpha Agents in Pediatric-Onset Inflammatory Bowel Disease and Juvenile Idiopathic Arthritis in A Real-Life Setting |
| Q96293692 | Serious adverse events in children with juvenile idiopathic arthritis and other rheumatic diseases on tocilizumab - a real-world experience |
| Q47793879 | Serologic Evidence of Gut-driven Systemic Inflammation in Juvenile Idiopathic Arthritis |
| Q71180180 | Serologic findings in juvenile rheumatoid arthritis |
| Q39598325 | Serologic studies in juvenile rheumatoid arthritis: a review |
| Q45804996 | Serologic studies on the association of rubella virus infection and juvenile rheumatoid arthritis |
| Q70072594 | Serological findings in cases of juvenile rheumatoid arthritis |
| Q92640118 | Serological screening for coeliac disease in patients with juvenile idiopathic arthritis |
| Q69368338 | Serology of juvenile rheumatoid arthritis |
| Q68289506 | Seronegative juvenile rheumatoid arthritis and mast cell–associated gastritis |
| Q36392404 | Seroprevalence of parvovirus B19 IgG in children affected by juvenile idiopathic arthritis |
| Q37371332 | Serum 25-hydroxyvitamin D and biochemical markers of bone metabolism in patients with juvenile idiopathic arthritis. |
| Q45773130 | Serum 25-hydroxyvitamin D in juvenile idiopathic arthritis patients in Finland |
| Q35614273 | Serum Angiogenesis Markers and Their Correlation with Ultrasound-Detected Synovitis in Juvenile Idiopathic Arthritis |
| Q46945967 | Serum IL-18 as a potential specific marker for differentiating systemic juvenile idiopathic arthritis from incomplete Kawasaki disease |
| Q71584567 | Serum IgG and IgM rheumatoid factors by solid phase radioimmunoassay. A comparison between adult and juvenile rheumatoid arthritis |
| Q72580328 | Serum IgM rheumatoid factor by enzyme-linked immunosorbent assay (ELISA) delineates a subset of patients with deforming joint disease in seronegative juvenile rheumatoid arthritis |
| Q64250582 | Serum Leucine-Rich 2-Glycoprotein as a Biomarker for Monitoring Disease Activity in Patients with Systemic Juvenile Idiopathic Arthritis |
| Q30481097 | Serum S100A12 and temporomandibular joint magnetic resonance imaging in juvenile idiopathic arthritis Egyptian patients: a case control study |
| Q91501907 | Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti-Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Disc |
| Q45854602 | Serum TNF-α levels and indicators of disease activity in children with oligoarticular juvenile idiopathic arthritis (oJIA) in the first year of the disease. |
| Q54977312 | Serum activity of joint destruction proteinases in management of juvenile rheumatoid arthritis. |
| Q36178078 | Serum amyloid A circulating levels and disease activity in patients with juvenile idiopathic arthritis |
| Q58326267 | Serum amyloid A circulating levels and disease activity in patients with juvenile idiopathic arthritis |
| Q34366234 | Serum amyloid P component scintigraphy and turnover studies for diagnosis and quantitative monitoring of AA amyloidosis in juvenile rheumatoid arthritis |
| Q41292450 | Serum antigammaglobulins in juvenile rheumatoid arthritis |
| Q72098447 | Serum antiocular antibodies in patients with juvenile rheumatoid arthritis |
| Q42318626 | Serum calreticulin as a novel biomarker of juvenile idiopathic arthritis disease activity |
| Q86345798 | Serum cytokine levels in children with newly diagnosed active systemic juvenile idiopathic arthritis |
| Q72526700 | Serum cytokines in juvenile rheumatoid arthritis. Correlation with conventional inflammation parameters and clinical subtypes |
| Q50858602 | Serum enzyme abnormalities in juvenile rheumatoid arthritis |
| Q50234930 | Serum ferritin levels as a useful diagnostic marker for the distinction of systemic juvenile idiopathic arthritis and Kawasaki disease. |
| Q46276779 | Serum from children with polyarticular juvenile idiopathic arthritis (pJIA) inhibits differentiation, mineralization and may increase apoptosis of human osteoblasts "in vitro". |
| Q83459567 | Serum heat shock protein 60 can predict remission of flare-up in juvenile idiopathic arthritis |
| Q41318899 | Serum immunoglobulin and beta 1C-beta 1A globulin concentrations in juvenile rheumatoid arthritis |
| Q43660022 | Serum immunoglobulin and complement interrelationships in juvenile rheumatoid arthritis |
| Q33579916 | Serum immunoglobulins in juvenile rheumatoid arthritis |
| Q50457585 | Serum interleukin 18 as a diagnostic remission criterion in systemic juvenile idiopathic arthritis. |
| Q71787874 | Serum levels of hyaluronic acid indicate the severity of joint symptoms in patients with systemic and polyarticular juvenile rheumatoid arthritis |
| Q34461706 | Serum levels of osteoprotegerin and receptor activator of nuclear factor -κB ligand in children with early juvenile idiopathic arthritis: a 2-year prospective controlled study |
| Q43578669 | Serum lipid concentrations in juvenile rheumatoid arthritis |
| Q46206225 | Serum melatonin in juvenile rheumatoid arthritis: correlation with disease activity |
| Q41352576 | Serum microRNAs as Potential Biomarkers of Juvenile Idiopathic Arthritis |
| Q84411044 | Serum osteopontin as a predictive marker of responsiveness to methotrexate in juvenile idiopathic arthritis |
| Q55401338 | Serum profile of transferrin isoforms in juvenile idiopathic arthritis: a preliminary study. |
| Q24817009 | Serum protein profile in systemic-onset juvenile idiopathic arthritis differentiates response versus nonresponse to therapy |
| Q34537434 | Serum sclerostin in high-activity adult patients with juvenile idiopathic arthritis |
| Q40336418 | Serum soluble interleukin 6 (IL-6) receptor and IL-6/soluble IL-6 receptor complex in systemic juvenile rheumatoid arthritis |
| Q38987254 | Serum thrombomodulin in systemic lupus erythematosus and juvenile idiopathic arthritis |
| Q40076517 | Serum vitamin D levels during activation and remission periods of patients with juvenile idiopathic arthritis and familial Mediterranean fever. |
| Q90642964 | Severe Recurrent Fever Episodes With Clinical Diagnosis of Hemophagocytic Lymphohistiocytosis, Incomplete Kawasaki Disease and Systemic-Onset Juvenile Idiopathic Arthritis: A Case Report and Literature Review |
| Q64994109 | Severe acute ocular hypertension following pulsed methylprednisolone for juvenile idiopathic arthritis. |
| Q68145050 | Severe anemia associated with active systemic-onset juvenile rheumatoid arthritis successfully treated with recombinant human erythropoietin: a pilot study |
| Q74667131 | Severe aortic regurgitation with mechanical prosthetic valve replacement in pauciarticular juvenile rheumatoid arthritis |
| Q46413317 | Severe carpal tunnel syndrome in a patient with juvenile idiopathic arthritis due to proximal migration of hypertrophic lumbrical muscles |
| Q70757850 | Severe generalized (Charcot-like) joint destruction in juvenile rheumatoid arthritis |
| Q53572500 | Severe isolated temporomandibular joint involvement in juvenile idiopathic arthritis. |
| Q37140151 | Severe macular edema in patients with juvenile idiopathic arthritis-related uveitis |
| Q40522225 | Severe outcome of juvenile idiopathic arthritis (JIA) associated with familial Mediterranean fever (FMF). |
| Q71094483 | Sex difference in incidence of antinuclear factors in juvenile rheumatoid arthritis |
| Q47223002 | Sex ratio and sibship size in juvenile rheumatoid arthritis kindreds |
| Q92559283 | Sexual function in female juvenile idiopathic arthritis patients |
| Q39204135 | Sexual maturation in Egyptian boys and girls with juvenile rheumatoid arthritis |
| Q38984168 | Sexual maturation in Moroccan patients with juvenile idiopathic arthritis |
| Q47392656 | Sexual maturation in boys with juvenile rheumatoid arthritis |
| Q46966573 | Share – Workpackage 5: evidence based recommendations for diagnosis and treatment of juvenile idiopathic arthritis. |
| Q92052216 | Shared decision-making aid for juvenile idiopathic arthritis: moving from informative patient education to interactive critical thinking |
| Q41566339 | Short and long-term immunogenicity and safety following the 23-valent polysaccharide pneumococcal vaccine in juvenile idiopathic arthritis patients under conventional DMARDs with or without anti-TNF therapy |
| Q42377396 | Short term effectiveness and experiences of a peer guided web-based self-management intervention for young adults with juvenile idiopathic arthritis |
| Q90321547 | Short-term outcome of surgical arthrodiastasis of the ankle with Ilizarov frame in a cohort of children and young people with juvenile idiopathic arthritis |
| Q56975644 | Short-term outcomes in patients with systemic juvenile idiopathic arthritis treated with either tocilizumab or anakinra |
| Q38478781 | Shortening femoral osteotomy with stemmed resurfacing total knee arthroplasty for severe flexion contracture in Juvenile Rheumatoid Arthritis |
| Q87439101 | Should 2016 Criteria for Macrophage Activation Syndrome be applied in children with Kawasaki disease, as well as with systemic-onset juvenile idiopathic arthritis? |
| Q48010606 | Should baseline-dependent cut-offs really be used to define disease improvement in juvenile idiopathic arthritis? And few other considerations |
| Q36155286 | Should children under treatment for juvenile idiopathic arthritis receive flu vaccination? |
| Q79222777 | Should steroids be used in juvenile rheumatoid arthritis? |
| Q84309805 | Should the Food and Drug Administration warning of malignancy in children receiving tumor necrosis factor alpha blockers change the way we treat children with juvenile idiopathic arthritis? |
| Q92510390 | Shoulder arthroplasty for juvenile idiopathic arthritis |
| Q39330688 | Shoulder arthroplasty for patients with juvenile idiopathic arthritis |
| Q67837662 | Shoulder bursitis in juvenile chronic polyarthritis |
| Q39367759 | Shoulder hemiarthroplasty in patients with juvenile idiopathic arthritis |
| Q71334535 | Shoulder joint rupture in juvenile rheumatoid arthritis producing bicipital masses and a hemorrhagic sign |
| Q70210831 | Shoulder limitation in juvenile rheumatoid arthritis |
| Q52026570 | Sialochemistry in juvenile idiopathic arthritis. |
| Q41160047 | Sibling Exposure and Risk of Juvenile Idiopathic Arthritis |
| Q33370987 | Side effects of anti-TNFalpha therapy in juvenile idiopathic arthritis |
| Q108591287 | Signals and Mechanisms Regulating Monocyte and Macrophage Activation in the Pathogenesis of Juvenile Idiopathic Arthritis |
| Q44488422 | Significance of complement components C1q and C4 bound to circulating immune complexes in juvenile idiopathic arthritis: support for classical complement pathway activation |
| Q58900322 | Significance of cytokine measurements in patients with juvenile rheumatoid arthritis: comment on the article by mangge et al |
| Q33551228 | Significance of rubella virus infection in juvenile chronic polyarthritis |
| Q72078637 | Similar patterns of juvenile rheumatoid arthritis within families |
| Q91951461 | Similarities in clinical course and outcome between juvenile idiopathic arthritis (JIA)-associated and ANA-positive idiopathic anterior uveitis: data from a population-based nationwide study in Germany |
| Q55469219 | Simultaneous Quadruple Joint Replacement (QJR) in Disabling Juvenile Rheumatoid Arthritis - a Case Report with Review of Literature. |
| Q50776276 | Simultaneous juvenile idiopathic arthritis and diabetes mellitus type 1 -- a Finnish nationwide study. |
| Q73569503 | Simultaneous occurrence of type I diabetes mellitus and juvenile rheumatoid arthritis |
| Q90219065 | Single Bout Exercise in Children with Juvenile Idiopathic Arthritis: Impact on Inflammatory Markers |
| Q47243850 | Single nucleotide polymorphism of Methyl-CpG-binding protein 2 gene associates with juvenile idiopathic arthritis |
| Q46590136 | Single nucleotide polymorphism of NLRP3 (Q705K) In juvenile spondyloarthritis and oligo/ polyarticular juvenile idiopathic arthritis. |
| Q45744482 | Single-nucleotide polymorphisms in the folate pathway are associated with response to methotrexate treatment in juvenile idiopathic arthritis |
| Q43740578 | Sinusoidal modulated currents alone and in combination with carbon dioxide-hydrogen sulfide baths in juvenile rheumatoid arthritis |
| Q44368266 | Size distribution of lymphocytes in juvenile rheumatoid arthritis |
| Q60609048 | Sjogren syndrome: an unexpected disease occurring fourteen years after oligoarticular onset juvenile idiopathic arthritis |
| Q43669849 | Sjogren's syndrome and juvenile rheumatoid arthritis |
| Q45861759 | Skeletal changes in neuromuscular disorders mimicking juvenile rheumatoid arthritis and hemophilia |
| Q33375946 | Skeletal mineralization in a prepubertal female population affected by juvenile idiopathic arthritis |
| Q48332071 | Skin Manifestations of Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, and Spondyloarthritides. |
| Q60445903 | Skin Rash Occurring with Olanzapine Pamoate, but not with Oral Olanzapine, in a Male with Juvenile Idiopathic Arthritis |
| Q83611933 | Skin manifestations induced by TNF-alpha inhibitors in juvenile idiopathic arthritis |
| Q47774511 | Sleep Disturbances and Neurobehavioral Performance in Juvenile Idiopathic Arthritis |
| Q47923357 | Sleep Fragmentation and Biomarkers in Juvenile Idiopathic Arthritis |
| Q48286239 | Sleep and fatigue and the relationship to pain, disease activity and quality of life in juvenile idiopathic arthritis and juvenile dermatomyositis |
| Q39460562 | Sleep and its relationship to pain, dysfunction, and disease activity in juvenile idiopathic arthritis |
| Q48671292 | Sleep and its relationship to pain, dysfunction, and disease activity in juvenile rheumatoid arthritis. |
| Q55689793 | Sleep disorders in patients with juvenile idiopathic arthritis as assessed by the sleep disturbance scale for children. |
| Q33635459 | Sleep disturbance, daytime sleepiness, and neurocognitive performance in children with juvenile idiopathic arthritis. |
| Q35082339 | Sleep disturbances and neurobehavioral functioning in children with and without juvenile idiopathic arthritis |
| Q48795388 | Sleep fragmentation in children with juvenile rheumatoid arthritis. |
| Q38221129 | Sleep problems and associated factors in children with juvenile idiopathic arthritis: a systematic review. |
| Q35188201 | Sleep quality in children with juvenile rheumatoid arthritis |
| Q45745794 | Sleep, fatigue and quality of life in juvenile idiopathic arthritis (JIA) and Juvenile Dermatomyositis (JDM). |
| Q41916986 | Slow acting antirheumatic drugs in patients with juvenile rheumatoid arthritis--evaluated in a randomized, parallel 50-week clinical trial |
| Q64904130 | Slow speed resistance exercise training in children with polyarticular juvenile idiopathic arthritis. |
| Q73358084 | Small hand joint involvement in juvenile rheumatoid arthritis |
| Q50879592 | Smallest detectable differences in clinical functional temporomandibular joint examination variables in juvenile idiopathic arthritis. |
| Q59268653 | Smallest detectable differences in clinical variables related to temporomandibular joint arthritis in juvenile idiopathic arthritis |
| Q60706078 | Social Outcomes Among Emerging Adults With Juvenile Idiopathic Arthritis |
| Q51080080 | Social, emotional, and behavioral functioning of children with juvenile rheumatoid arthritis. |
| Q39845094 | Social/economic costs and health-related quality of life in patients with juvenile idiopathic arthritis in Europe |
| Q36092980 | Socioeconomic costs and health-related quality of life in juvenile idiopathic arthritis: a cost-of-illness study in the United Kingdom |
| Q70376141 | Sodium meclofenamate (Meclomen) in the treatment of juvenile rheumatoid arthritis. A segment I study |
| Q59360484 | Soluble CD163, a unique biomarker to evaluate the disease activity, exhibits macrophage activation in systemic juvenile idiopathic arthritis |
| Q33412621 | Soluble CD25 in serum: a potential marker for subclinical macrophage activation syndrome in patients with active systemic onset juvenile idiopathic arthritis |
| Q100630429 | Soluble Low-density Lipoprotein Receptor-related Protein 1 in Juvenile Idiopathic Arthritis |
| Q59268640 | Soluble Receptor for Advanced Glycation End Products (sRAGE) is decreased in patients with Juvenile Idiopathic Arthritis (ERA category) and inversely correlates with disease activity and S100A12 levels |
| Q45173142 | Soluble ST2 as a marker of disease activity in systemic juvenile idiopathic arthritis |
| Q73010760 | Soluble adhesion molecules in juvenile rheumatoid arthritis |
| Q81364978 | Soluble intercellular adhesion molecule-1 and E-selectin as markers of disease activity and endothelial activation in juvenile idiopathic arthritis |
| Q67794220 | Soluble interleukin-2 receptor in juvenile rheumatoid arthritis |
| Q37956803 | Soluble mediators of articular cartilage degradation in juvenile rheumatoid arthritis |
| Q84494853 | Soluble receptor for advanced glycation endproducts is decreased in patients with juvenile idiopathic arthritis (ERA category) and inversely correlates with disease activity and S100A12 levels |
| Q67288755 | Some anthropological traits in patients with juvenile rheumatoid arthritis (author's transl) |
| Q67451651 | Some aspects of juvenile rheumatoid arthritis |
| Q74640427 | Some aspects of juvenile rheumatoid arthritis |
| Q76417270 | Some clinical features of juvenile rheumatoid arthritis |
| Q36556113 | Sonographic evaluation of the temporomandibular joints in juvenile idiopathic arthritis(). |
| Q79850320 | Sonographic investigation of the temporomandibular joint in patients with juvenile idiopathic arthritis: a pilot study |
| Q41933202 | Special problems of juvenile rheumatoid arthritis |
| Q40401931 | Specialized neuromuscular training to improve neuromuscular function and biomechanics in a patient with quiescent juvenile rheumatoid arthritis. |
| Q39763771 | Specialty Practice and Cost Considerations in the Management of Uveitis Associated With Juvenile Idiopathic Arthritis |
| Q34612436 | Specific HLA-DR4-associated histocompatibility molecules characterize patients with seropositive juvenile rheumatoid arthritis |
| Q57789915 | Specific Sport Habits, Leisure-Time and School-Educational Physical Activity in Children with Juvenile Idiopathic Arthritis - Patterns and Barriers |
| Q62898164 | Specific gene expression profiles in systemic juvenile idiopathic arthritis |
| Q36352181 | Specific genomic markers for the HLA-DQ subregion discriminate between DR4+ insulin-dependent diabetes mellitus and DR4+ seropositive juvenile rheumatoid arthritis |
| Q70996644 | Specificity of hidden 19s igm rheumatoid factor in patients with juvenile rheumatoid arthritis |
| Q88922733 | Spectrum of Joint Deformities in Children with Juvenile Idiopathic Arthritis |
| Q54562277 | Spinal cord compression by epidural lipomatosis in juvenile rheumatoid arthritis. |
| Q72367172 | Spinal cord lesions in juvenile rheumatoid arthritis |
| Q98460843 | Spinal interleukin-6 contributes to central sensitisation and persistent pain hypersensitivity in a model of juvenile idiopathic arthritis |
| Q30747717 | Spirometric evaluation in juvenile idiopathic arthritis: data from eastern India |
| Q68979068 | Splinting as a method of treatment for juvenile rheumatoid arthritis |
| Q33570392 | Spondylitis in post-pubertal patients with rheumatoid arthritis of juvenile onset |
| Q44311723 | Spondyloepiphyseal dysplasia associated with progressive arthropathy. An unusual disorder mimicking juvenile rheumatoid arthritis |
| Q73143620 | Spondyloepiphyseal dysplasia tarda with progressive arthropathy: an important form of osteodysplasia in the differential diagnosis of juvenile rheumatoid arthritis |
| Q72221866 | Spontaneous axial subluxation in a child as the first sign of juvenile rheumatoid arthritis |
| Q40781791 | Spontaneous improvement of juvenile rheumatoid arthritis after T lymphocytosis with suppressor phenotype and function. |
| Q74425700 | Spontaneous liver and kidney hematomas in a 27-year-old male patient with a history of juvenile rheumatoid arthritis |
| Q33806671 | Spontaneous regression of Epstein-Barr virus-associated lymphoproliferative disorder in a juvenile idiopathic arthritis patient after the discontinuation of methotrexate and etanercept |
| Q55450700 | Sport and exercise habits in children with juvenile idiopathic arthritis (JIA). |
| Q35086829 | Spotlight on etanercept in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis |
| Q70697560 | Sr-87m bone scans in juvenile rheumatoid arthritis |
| Q91062283 | Standardizing Terminology and Assessment for Orofacial Conditions in Juvenile Idiopathic Arthritis: International, Multidisciplinary Consensus-based Recommendations |
| Q91581490 | Standardizing the clinical orofacial examination in Juvenile idiopathic arthritis: An interdisciplinary, consensus-based, short screening protocol |
| Q64986673 | Status of the glucocorticoid function of the adrenal glands in patients with juvenile rheumatoid arthritis |
| Q43542446 | Stem cell transplantation for autoimmune disorders. Refractory juvenile idiopathic arthritis |
| Q44394884 | Steroid myopathy in a child with juvenile rheumatoid arthritis. Case report |
| Q46882450 | Steroid-responsive nephrotic syndrome in a child with juvenile idiopathic arthritis |
| Q44266166 | Steroid-sensitive nephrotic syndrome and juvenile idiopathic arthritis |
| Q43484969 | Still's disease (juvenile chronic polyarthritis) in adulthood |
| Q40811116 | Still's disease. Acute systemic juvenile rheumatoid arthritis--differential diagnosis of fever of unknown origin in children and adults |
| Q41643124 | Still's disease: juvenile rheumatoid arthritis |
| Q35658719 | Still's syndrome in juvenile rheumatoid arthritis; its clinical aspécts with a review of the literature on the peculiarities of this syndrome. |
| Q40899825 | Still??s disease in an adult: a link between juvenile and adult rheumatoid arthritis |
| Q52176570 | Stomatognathic function in juvenile rheumatoid arthritis and in developmental open-bite subjects. |
| Q92474723 | Storm Warning: Lung Disease in Systemic Juvenile Idiopathic Arthritis |
| Q52836520 | Strategies for the prevention and management of methotrexate-related nausea and vomiting in juvenile idiopathic arthritis: results of a UK Paediatric Rheumatology prescriber survey. |
| Q101165748 | Strategies for the withdrawal of classic and biological DMARD in clinically inactive patients with juvenile idiopathic arthritis |
| Q33511831 | Stratification and monitoring of juvenile idiopathic arthritis patients by synovial proteome analysis |
| Q77174811 | Stress fractures: diagnostic pitfalls in juvenile idiopathic arthritis |
| Q73056597 | Stress induces increases in IL-6 production by leucocytes of patients with the chronic inflammatory disease juvenile rheumatoid arthritis: a putative role for alpha(1)-adrenergic receptors |
| Q69757240 | Stridor due to cricoarytenoid arthritis in pauciarticular onset juvenile rheumatoid arthritis |
| Q82689311 | Strong relationships between disease activity, foot-related impairments, activity limitations and participation restrictions in children with juvenile idiopathic arthritis |
| Q87283933 | Structural damage to the hip in systemic juvenile idiopathic arthritis: A case of regression with Anakinra |
| Q51768824 | Structural polymorphisms in the mannose-binding lectin gene are associated with juvenile idiopathic arthritis. |
| Q30961265 | Structure of synovial lymphatic capillaries in rheumatoid arthritis and juvenile idiopathic arthritis. |
| Q51947107 | Struggle and adjustment to an insecure everyday life and an unpredictable life course. Living with juvenile idiopathic arthritis from childhood to adult life - an interview study. |
| Q38640044 | Struggling in the Dark to Help My Child: Parents' Experience in Caring for a Young Child with Juvenile Idiopathic Arthritis |
| Q45870008 | Studies of antibody to herpes simplex virus Fc gamma-binding protein gE in patients with rheumatoid arthritis, juvenile rheumatoid arthritis and normal controls |
| Q40826336 | Studies on peripheral lymphocytes from patients with rheumatic fever and juvenile rheumatoid arthritis. Subpopulations of T-cells, B-cells, IgG-Fc receptor (+) cells and in vitro lymphocyte transformation to several mitogens |
| Q39806017 | Studies with the NBT test in various clinical forms of juvenile rheumatoid arthritis |
| Q92110865 | Study of role of serum amyloid A (SAA) as a marker of disease activity in juvenile idiopathic arthritis |
| Q45328854 | Study of serological and clinical factors among juvenile rheumatoid arthritis cases admitted to Mofid Children's Hospital and Imam Hossein Hospital, Tehran, Iran |
| Q35753979 | Study of the association between CD28/CTLA-4 expression and disease activity in juvenile idiopathic arthritis |
| Q100694406 | Study of vitamin D status and vitamin D receptor polymorphisms in a cohort of Italian patients with juvenile idiopathic arthritis |
| Q38016359 | Subacute thyroiditis in a patient with juvenile idiopathic arthritis undergoing etanercept treatment: a case report and review of the literature |
| Q51657048 | Subaxial cervical vertebrae in patients with juvenile idiopathic arthritis--something special? |
| Q97516676 | Subclinical cardiovascular risk signs in adults with juvenile idiopathic arthritis in sustained remission |
| Q36716845 | Subclinical cardiovascular system changes in obese patients with juvenile idiopathic arthritis |
| Q52685007 | Subcutaneous Abatacept in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis: Results From a Phase III Open-Label Study. |
| Q53843116 | Subcutaneous Tocilizumab May Be Less Effective than Intravenous Tocilizumab in the Treatment of Juvenile Idiopathic Arthritis-associated Uveitis. |
| Q90560474 | Subcutaneous Tocilizumab for Cystoid Macular Edema Secondary to Juvenile Idiopathic Arthritis (JIA)-associated Uveitis: A Case Report |
| Q46231376 | Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trial |
| Q51196987 | Subcutaneous panniculitis-like T-cell lymphoma with haemophagocytic syndrome during tocilizumab therapy for juvenile idiopathic arthritis. |
| Q33832726 | Subspecialty referrals for pauciarticular juvenile rheumatoid arthritis |
| Q77607569 | Substance use among adolescents with juvenile rheumatoid arthritis |
| Q39540909 | Substance use and sexual function in juvenile idiopathic arthritis |
| Q39961958 | Substance use and sexual function in juvenile idiopathic arthritis |
| Q88623363 | Subtype frequencies, demographic features, and remission rates in juvenile idiopathic arthritis - 265 cases from a Turkish center |
| Q21195357 | Subtype specific genetic associations for juvenile idiopathic arthritis: ERAP1 with the enthesitis related arthritis subtype and IL23R with juvenile psoriatic arthritis |
| Q37435011 | Subtype-specific peripheral blood gene expression profiles in recent-onset juvenile idiopathic arthritis |
| Q40618178 | Subtyping of juvenile idiopathic arthritis using latent class analysis. British Paediatric Rheumatology Group |
| Q67873897 | Success and hazards of corticoid therapy in juvenile chronic polyarthritis and its variations --a 20-year review |
| Q92428850 | Successful Interprofessional Treatment of Juvenile Rheumatoid Arthritis: A Case Report |
| Q96762894 | Successful Rituximab Monotherapy in Advanced-stage, Epstein-Barr Virus-positive Diffuse Large B-Cell Lymphoma in an Adolescent With Systemic Juvenile Idiopathic Arthritis |
| Q39815667 | Successful Treatment of Focal Segmental Glomerulosclerosis after Kidney Transplantation with Plasma Exchange and Abatacept in a Patient with Juvenile Rheumatoid Arthritis |
| Q40241400 | Successful remission induced by plasma exchange combined with leukocytapheresis against refractory systemic juvenile idiopathic arthritis |
| Q86240105 | Successful tocilizumab desensitization in an adult with juvenile idiopathic arthritis |
| Q73367260 | Successful treatment of juvenile rheumatoid arthritis associated haemophagocytic syndrome by cyclosporin A with transient exacerbation by conventional-dose G-CSF |
| Q85650774 | Successful treatment of macrophage activation syndrome due to systemic onset juvenile idiopathic arthritis with antithymocyte globulin |
| Q49810866 | Successful treatment of methotrexate intolerance in juvenile idiopathic arthritis using eye movement desensitization and reprocessing - treatment protocol and preliminary results. |
| Q91554188 | Successful treatment of plasma exchange for refractory systemic juvenile idiopathic arthritis complicated with macrophage activation syndrome and severe lung disease |
| Q46135583 | Successful treatment of pyoderma gangrenosum associated with juvenile idiopathic arthritis with a combination of topical tacrolimus and oral prednisolone |
| Q80142000 | Successful treatment of refractory polyarticular juvenile idiopathic arthritis with rituximab |
| Q83227105 | Successful treatment with B-cell depleting therapy for refractory systemic onset juvenile idiopathic arthritis: a case report |
| Q35084293 | Successful treatment with tocilizumab every 4 weeks of a low disease activity group who achieve a drug-free remission in patients with systemic-onset juvenile idiopathic arthritis |
| Q86248891 | Successful treatment with tocilizumab of a psoriasiform skin lesion induced by etanercept in a patient with juvenile idiopathic arthritis |
| Q80201635 | Successful use of a humanized anti-interleukin-6 receptor antibody, tocilizumab, to treat amyloid A amyloidosis complicating juvenile idiopathic arthritis |
| Q91624081 | Successful use of tocilizumab in amyloidosis secondary to systemic juvenile idiopathic arthritis |
| Q51798744 | Sudden visual loss in a child with juvenile idiopathic arthritis-related uveitis. |
| Q43591085 | Sulfasalazine for the management of juvenile rheumatoid arthritis |
| Q69924783 | Sulfasalazine in juvenile rheumatoid arthritis |
| Q71707644 | Sulfasalazine therapy for juvenile rheumatoid arthritis |
| Q44051067 | Sulfasalazine therapy for juvenile rheumatoid arthritis. |
| Q69880498 | Sulphasalazine in the treatment of juvenile rheumatoid arthritis: a preliminary open trial |
| Q33567532 | Sulphasalazine induced hepatitis in juvenile rheumatoid arthritis |
| Q27014677 | Summary of AHRQ's Comparative Effectiveness Review of Disease-Modifying Antirheumatic Drugs for Children with Juvenile Idiopathic Arthritis |
| Q92924610 | Superb Microvascular Imaging Compared With Power Doppler Ultrasound in Assessing Synovitis of the Knee in Juvenile Idiopathic Arthritis: A Preliminary Study |
| Q46629774 | Superoxide dismutase and and its isoenzymes in children with juvenile idiopathic arthritis |
| Q104504432 | Suppression of lncRNA MALAT1 reduces pro-inflammatory cytokines production by regulating miR-150-5p/ZBTB4 axis through JAK/STAT signal pathway in systemic juvenile idiopathic arthritis |
| Q36767444 | Surface expression and genotypes of Toll-like receptors 2 and 4 in patients with juvenile idiopathic arthritis and systemic lupus erythematosus |
| Q84075228 | Surfing for juvenile idiopathic arthritis: perspectives on quality and content of information on the Internet |
| Q79965934 | Surgery for hypotony in patients with juvenile idiopathic arthritis-associated uveitis |
| Q50079719 | Surgical Treatment of Dentofacial Deformities Caused by Juvenile Idiopathic Arthritis. |
| Q92290951 | Surgical Treatment of Juvenile Idiopathic Arthritis A Review |
| Q91295860 | Surgical correction of dentofacial deformities in juvenile idiopathic arthritis: a systematic literature review |
| Q35145989 | Surgical management of cataracts in children with juvenile rheumatoid arthritis-associated uveitis |
| Q85849396 | Surgical management of severe complications arising from uveitis in juvenile idiopathic arthritis |
| Q38246924 | Surgical management of the juvenile idiopathic arthritis patient with multiple joint involvement |
| Q97650977 | Surgical outcomes of open hip reduction with synovectomy for developmental dysplasia of the hip patient with Juvenile idiopathic arthritis: A case report |
| Q68717790 | Surgical treatment of atlanto-axial subluxation in rheumatoid arthritis and juvenile rheumatoid arthritis |
| Q70988959 | Surgical treatment of complicated cataract in juvenile rheumatoid arthritis |
| Q72792877 | Surgical treatment of juvenile rheumatoid arthritis |
| Q39810144 | Surgical treatment of juvenile rheumatoid arthritis. |
| Q72308155 | Surgical treatment of the hip and knee joint in juvenile rheumatoid arthritis |
| Q58569876 | Surveillance of adverse drug events associated with etanercept prescribed for juvenile idiopathic arthritis in a single center up to 9-years: A retrospective observational study |
| Q49956549 | Survey of the awareness of adult rheumatologists regarding transitional care for patients with juvenile idiopathic arthritis in Japan. |
| Q92993470 | Sustained hyperferritinemia in a child with macrophage activation syndrome secondary to systemic juvenile idiopathic arthritis - perforinopathy: case based review |
| Q38843440 | Sustained-release dexamethasone intravitreal implant in juvenile idiopathic arthritis-related uveitis |
| Q46963655 | Switch of biotherapies in patients with juvenile idiopathic arthritis: analyses of the JIR cohort data |
| Q50112220 | Switched Memory B Cells Are Increased In Oligoarticular And Polyarticular Juvenile Idiopathic Arthritis And Their Change Over Time Is Related To Response To TNF Inhibitors. |
| Q45745708 | Switching from a first to a second tumour necrosis factor (TNF) alpha antagonist in patients with juvenile idiopathic arthritis |
| Q46846959 | Switching the therapy from etanercept to infliximab in a child with rheumatoid factor positive polyarticular juvenile idiopathic arthritis |
| Q59268778 | Switching to an alternative biological agent in juvenile idiopathic arthritis (I) |
| Q47163458 | Switching to an alternative biological agent in juvenile idiopathic arthritis (II). |
| Q82257882 | Sydenham's chorea in a girl with juvenile idiopathic arthritis treated with anti-TNFalpha therapy |
| Q43799361 | Symposium I. 1. Clinical manifestations and diagnosis of juvenile rheumatoid arthritis |
| Q69564954 | Symposium I. 3. Pathophysiology of juvenile rheumatoid arthritis of orthopedics |
| Q44081215 | Symposium I. 4. Diagnosis, treatment and clinical course of juvenile rheumatoid arthritis from the standpoint of orthopedics |
| Q69564957 | Symposium I. 5-1. Clinical manifestations of juvenile rheumatoid arthritis |
| Q69564959 | Symposium I. 5-2. Findings in an autopsy case of juvenile rheumatoid arthritis and some pathoanatomical statistics |
| Q69564964 | Symposium II. 3-1. Gold therapy for juvenile rheumatoid arthritis and related diseases |
| Q44583433 | Symptomatic cardiac involvement in juvenile rheumatoid arthritis |
| Q36565784 | Symptoms of periodontitis and antibody responses to Porphyromonas gingivalis in juvenile idiopathic arthritis. |
| Q40169491 | Synovectomies in juvenile rheumatoid arthritis |
| Q33627029 | Synovectomy in juvenile rheumatoid arthritis |
| Q44004889 | Synovectomy in juvenile rheumatoid arthritis |
| Q66860288 | Synovectomy in juvenile rheumatoid arthritis |
| Q71848773 | Synovectomy in juvenile rheumatoid arthritis. Indications and short-term results |
| Q33990003 | Synovectomy of the Hip in Juvenile Rheumatoid Arthritis |
| Q42630543 | Synovectomy of the hip in patients with juvenile rheumatoid arthritis |
| Q70724681 | Synovectomy of the knee joint in juvenile rheumatoid arthritis |
| Q67710602 | Synovectomy of the knee joints in juvenile rheumatoid arthritis (proceedings) |
| Q37739886 | Synovial and inflammatory diseases in childhood: role of new imaging modalities in the assessment of patients with juvenile idiopathic arthritis |
| Q54276814 | Synovial cyst in juvenile idiopathic arthritis. |
| Q41109213 | Synovial cysts in juvenile rheumatoid arthritis |
| Q54706191 | Synovial cysts in juvenile rheumatoid arthritis. |
| Q73155139 | Synovial dendritic cells in juvenile idiopathic arthritis (JIA) express receptor activator of NF-kappaB (RANK) |
| Q47337291 | Synovial expression of osteopontin correlates with angiogenesis in juvenile idiopathic arthritis |
| Q82819465 | Synovial fluid RANKL and matrix metalloproteinase levels in enthesitis related arthritis subtype of juvenile idiopathic arthritis |
| Q72624318 | Synovial fluid in seronegative juvenile rheumatoid arthritis: studies of immunoglobulins, complements, and alpha 2-macroglobulin |
| Q44212118 | Synovial fluid lymphocytes in different subtypes of juvenile rheumatoid arthritis |
| Q103829170 | Synovial fluid neutrophils from patients with juvenile idiopathic arthritis display a hyperactivated phenotype |
| Q33539890 | Synovial fluid proteins differentiate between the subtypes of juvenile idiopathic arthritis |
| Q84390176 | Synovial membrane immunohistology in early untreated juvenile idiopathic arthritis: differences between clinical subgroups |
| Q37690985 | Synovial membrane protein expression differs between juvenile idiopathic arthritis subtypes in early disease |
| Q57990600 | Synovial sarcoma with extended occult period treated as juvenile rheumatoid arthritis: a case report |
| Q91514696 | Synovial-Fluid miRNA Signature for Diagnosis of Juvenile Idiopathic Arthritis |
| Q36153306 | Systematic review of effectiveness of bisphosphonates in treatment of low bone mineral density and fragility fractures in juvenile idiopathic arthritis |
| Q91950586 | Systematic review of measurement instruments for patients with juvenile idiopathic arthritis in the foot and ankle |
| Q46860661 | Systematic review on treatment of juvenile idiopathic arthritis – associated uveitis |
| Q90383255 | Systemic Juvenile Idiopathic Arthritis |
| Q99589131 | Systemic Juvenile Idiopathic Arthritis Accompanied by Immune Myocarditis |
| Q38538426 | Systemic Juvenile Idiopathic Arthritis Complicated by Macrophage Activation Syndrome |
| Q53320021 | Systemic Juvenile Idiopathic Arthritis with Amyloidosis: An Uncommon Complication with a Favourable Outcome. |
| Q92399558 | Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease: Characterization and Risk Factors |
| Q38750832 | Systemic Juvenile Idiopathic Arthritis: Diagnosis and Management |
| Q96125059 | Systemic Treatment for Temporomandibular Joint Arthritis in Juvenile Idiopathic Arthritis |
| Q38075289 | Systemic adverse events following intraarticular corticosteroid injections for the treatment of juvenile idiopathic arthritis: two patients with dermatologic adverse events and review of the literature |
| Q37049621 | Systemic features and early prognostic factors in Hispanic and non-Hispanic children from the United States of America and Mexico with systemic juvenile idiopathic arthritis. |
| Q38033873 | Systemic juvenile idiopathic arthritis |
| Q54976999 | Systemic juvenile idiopathic arthritis and macrophage activation syndrome: update on pathogenesis and treatment. |
| Q96580260 | Systemic juvenile idiopathic arthritis and recurrent macrophage activation syndrome due to a CASP1 variant causing inflammasome hyperactivation |
| Q55079902 | Systemic juvenile idiopathic arthritis as a fever of unknown origin. |
| Q59268730 | Systemic juvenile idiopathic arthritis in the republic of Bashkortostan |
| Q46381425 | Systemic juvenile idiopathic arthritis is associated with HLA-DRB1 in Europeans and Americans of European descent |
| Q40543919 | Systemic juvenile idiopathic arthritis mimics multicentric Castleman's disease |
| Q35553623 | Systemic juvenile idiopathic arthritis presenting in a young child with long term disability as an adolescent. |
| Q99207455 | Systemic juvenile idiopathic arthritis versus adult-onset Still´s disease: the pertinence of changing the current classification criteria |
| Q75319842 | Systemic juvenile idiopathic arthritis, Kikuchi's disease and haemophagocytic lymphohistiocytosis |
| Q73155149 | Systemic juvenile idiopathic arthritis, Kikuchi's disease and haemophagocytic lymphohistiocytosis--is there a link? Case report and literature review |
| Q87177558 | Systemic juvenile idiopathic arthritis-like syndrome in mice following stimulation of the immune system with Freund's complete adjuvant: regulation by interferon-γ |
| Q88719899 | Systemic juvenile idiopathic arthritis: New insights into pathogenesis and cytokine directed therapies |
| Q38118331 | Systemic juvenile idiopathic arthritis: a review |
| Q36577397 | Systemic juvenile idiopathic arthritis: diagnosis, management, and outcome |
| Q48888925 | Systemic juvenile rheumatoid arthritis (Still's disease) |
| Q72993314 | Systemic juvenile rheumatoid arthritis and associated Isaacs' syndrome |
| Q74446439 | Systemic juvenile rheumatoid arthritis complicated by two different renal lesions |
| Q50956902 | Systemic juvenile rheumatoid arthritis: cognitive function and social adjustment. |
| Q80152463 | Systemic lupus erythematosus in a patient treated with etanercept for polyarticular juvenile rheumatoid arthritis |
| Q40793936 | Systemic lupus erythematosus with Jaccoud's arthropathy mimicking juvenile rheumatoid arthritis |
| Q80094949 | Systemic lupus erythematosus with major organ involvement in a patient with systemic-onset juvenile idiopathic arthritis |
| Q55321353 | Systemic onset Juvenile Idiopathic Arthritis (SoJIA): a monocentric study of 114 patients. |
| Q40403368 | Systemic onset juvenile idiopathic arthritis and exposure to fine particulate air pollution |
| Q40097034 | Systemic onset juvenile idiopathic arthritis with macrophage activation syndrome and coronary artery dilatation misdiagnosed as Kawasaki disease |
| Q37816283 | Systemic onset juvenile idiopathic arthritis with macrophage activation syndrome misdiagnosed as Kawasaki disease: case report and literature review |
| Q40417306 | Systemic onset juvenile idiopathic arthritis--its unusual presentation |
| Q73483704 | Systemic onset juvenile idiopathic arthritis: a retrospective study of 80 consecutive patients followed for 10 years |
| Q52081857 | Systemic onset juvenile idiopathic arthritis: a retrospective study of 80 consecutive patients followed for 10 years. |
| Q90063454 | Systemic onset juvenile idiopathic arthritis: a single center experience |
| Q77798477 | Systemic onset juvenile rheumatoid arthritis |
| Q53575154 | Systemic onset juvenile rheumatoid arthritis presenting with absence of B lymphocytes. |
| Q38890393 | Systemic-onset juvenile idiopathic arthritis |
| Q44837336 | Systemic-onset juvenile idiopathic arthritis and HLA-B27 juvenile-onset undifferentiated spondyloarthritis in the same patient. |
| Q49584207 | Systemic-onset juvenile idiopathic arthritis and incomplete Kawasaki disease may belong to a single clinical syndrome within a spectrum of severity. |
| Q40369770 | Systemic-onset juvenile idiopathic arthritis complicated by early onset amyloidosis in a patient carrying a mutation in the MEFV gene |
| Q53808412 | Systemic-onset juvenile idiopathic arthritis or incomplete Kawasaki disease: a diagnostic challenge. |
| Q34273838 | Systemic-onset juvenile idiopathic arthritis: the changing life of a rare disease |
| Q45745347 | Systemic-onset juvenile rheumatoid arthritis and ANCA-associated glomerulonephritis. |
| Q53091981 | Systems-level analysis of genome wide association study results for a pilot juvenile idiopathic arthritis family study. |
| Q58799147 | T Cell Receptor-Independent, CD31/IL-17A-Driven Inflammatory Axis Shapes Synovitis in Juvenile Idiopathic Arthritis |
| Q40809458 | T and B lymphocytes in children with rheumatic fever and juvenile rheumatoid arthritis |
| Q70459102 | T cell receptor rearrangements in juvenile rheumatoid arthritis: a search for oligoclonality |
| Q38957800 | T cell subpopulations in juvenile idiopathic arthritis and their modifications after biotherapies |
| Q68436727 | T gamma delta cells in juvenile rheumatoid arthritis and rheumatoid arthritis. In the juvenile rheumatoid arthritis synovium the T gamma delta cells express activation antigens and are predominantly V delta 1+, and a significant proportion of these |
| Q72086951 | T gamma subset specificity of lymphocyte reactive factors in juvenile rheumatoid arthritis and systemic lupus erythematosus sera |
| Q24807227 | T-cell activation without proliferation in juvenile idiopathic arthritis |
| Q34035124 | T-cell and T-cell receptor abnormalities in the immunopathogenesis of juvenile rheumatoid arthritis |
| Q83838405 | T-cell lymphoma masquerading as juvenile rheumatoid arthritis |
| Q71708180 | T-cell receptor BV6S1 null alleles and HLA-DR1 haplotypes in polyarticular outcome juvenile rheumatoid arthritis |
| Q70685474 | T-cell receptor V beta chain expression in patients with juvenile rheumatoid arthritis |
| Q70060995 | T/non-T and CD4/non-T cell autologous mixed lymphocyte reactions in juvenile rheumatoid arthritis |
| Q91212046 | T1ρ-mapping for assessing knee joint cartilage in children with juvenile idiopathic arthritis - feasibility and repeatability |
| Q85063149 | T2 relaxation time changes in distal femoral articular cartilage in children with juvenile idiopathic arthritis: a 3-year longitudinal study |
| Q41850338 | TCR gamma/delta+ cell subsets in the synovial membranes of patients with rheumatoid arthritis and juvenile rheumatoid arthritis |
| Q46862169 | TH17-phenotypes of juvenile idiopathic arthritis |
| Q76850826 | THE DEPRESSED SYNOVIAL COMPLEMENT ACTIVITY IN ADULT AND JUVENILE RHEUMATOID ARTHRITIS |
| Q58085740 | THE KNEE JOINT IN EARLY JUVENILE IDIOPATHIC ARTHRITIS: An ROC study for evaluating the diagnostic accuracy of contrast-enhanced MR imaging |
| Q41944036 | THE RESULTS OF GOLD THERAPY IN JUVENILE RHEUMATOID ARTHRITIS |
| Q37658226 | TLR4 rs41426344 increases susceptibility of rheumatoid arthritis (RA) and juvenile idiopathic arthritis (JIA) in a central south Chinese Han population |
| Q47989741 | TNF and LT binding capacities in the plasma of arthritis patients: effect of etanercept treatment in juvenile idiopathic arthritis |
| Q92086197 | TNF blockade contributes to restore lipid oxidation during exercise in children with juvenile idiopathic arthritis |
| Q46969361 | TNF inhibitors in the treatment of uveitis in the course of juvenile idiopathic arthritis |
| Q57330566 | TNF promoter −308 A/G and −238 A/G polymorphisms and juvenile idiopathic arthritis: a meta-analysis |
| Q50150870 | TNF-alpha 863C > A promoter and TNFRII 196T > G exonic variationsmay be risk factors for juvenile idiopathic arthritis |
| Q24234429 | TNF-alpha inhibitors for juvenile idiopathic arthritis |
| Q36361083 | TNF-α Polymorphisms in Juvenile Idiopathic Arthritis: Which Potential Clinical Implications? |
| Q48042115 | TNF-α gene polymorphisms and juvenile idiopathic arthritis: Influence on disease outcome and therapeutic response |
| Q94398812 | TNF‐alpha inhibitors for juvenile idiopathic arthritis |
| Q58075027 | TNF‐α promoter gene polymorphisms in Spanish children with persistent oligoarticular and systemic‐onset juvenile idiopathic arthritis |
| Q81601382 | Taiwan experience with etanercept in juvenile rheumatoid arthritis |
| Q90701097 | Takayasu arteritis with an initial presentation of chronic monoarthritis mimicking oligoarticular juvenile idiopathic arthritis |
| Q69883290 | Takayasu's arteritis and juvenile rheumatoid arthritis |
| Q24803735 | Tapasin gene polymorphism in systemic onset juvenile rheumatoid arthritis: a family-based case-control study |
| Q98387488 | Tapering Canakinumab Monotherapy in Patients with Systemic Juvenile Idiopathic Arthritis in Clinical Remission: Results from an Open-label, Randomized Phase IIIb/IV Study |
| Q46860842 | Tapering and withdrawal of tocilizumab in patients with systemic juvenile idiopathic arthritis in inactive disease: results from an alternative dosing regimen in the TENDER study |
| Q61809085 | Targeting Tregs in Juvenile Idiopathic Arthritis and Juvenile Dermatomyositis-Insights From Other Diseases |
| Q81484725 | Targeting the interleukin-6 receptor: a new treatment for systemic juvenile idiopathic arthritis? |
| Q68330787 | Tarsal ankylosis in juvenile and adult onset rheumatoid arthritis |
| Q57658686 | Task complexity and response certainty in discrete choice experiments: An application to drug treatments for juvenile idiopathic arthritis |
| Q72813866 | Teamwork in a center for juvenile rheumatoid arthritis |
| Q91291055 | Teenaged Boy With Lipoma Arborescens of the Knee and Elbow and Presumed Juvenile Idiopathic Arthritis |
| Q98158224 | Teens Taking Charge: A Randomized Controlled Trial of a Web-Based Self-Management Program With Telephone Support for Adolescents With Juvenile Idiopathic Arthritis |
| Q41266278 | Temporal patterns of response to D-penicillamine, hydroxychloroquine, and placebo in juvenile rheumatoid arthritis patients |
| Q104499102 | Temporomandibular Disorders and Juvenile Idiopathic Arthritis: Scoping review with a case report |
| Q47668191 | Temporomandibular Joint Involvement in Association With Quality of Life, Disability, and High Disease Activity in Juvenile Idiopathic Arthritis |
| Q34227357 | Temporomandibular condylar alterations in juvenile idiopathic arthritis most common in longitudinally severe disease despite medical treatment |
| Q84539390 | Temporomandibular disorder in patients with juvenile idiopathic arthritis: clinical evaluation and correlation with the findings of cone beam computed tomography |
| Q80271952 | Temporomandibular involvement in juvenile idiopathic arthritis |
| Q26853346 | Temporomandibular joint alterations and their orofacial complications in patients with juvenile idiopathic arthritis |
| Q54001615 | Temporomandibular joint and mandibular growth alterations in patients with juvenile rheumatoid arthritis. |
| Q53071375 | Temporomandibular joint arthritis in juvenile idiopathic arthritis, now what? |
| Q80791206 | Temporomandibular joint arthritis in juvenile idiopathic arthritis: prevalence, clinical and radiological signs, and relation to dentofacial morphology |
| Q36560147 | Temporomandibular joint arthritis in juvenile idiopathic arthritis: the forgotten joint |
| Q45746067 | Temporomandibular joint arthritis in patients with juvenile idiopathic arthritis: efficacy of intraarticular corticosteroid injection as measured by MRI and clinical examination |
| Q50040251 | Temporomandibular joint atlas for detection and grading of juvenile idiopathic arthritis involvement by magnetic resonance imaging. |
| Q91143193 | Temporomandibular joint damage in juvenile idiopathic arthritis: Diagnostic validity of diagnostic criteria for temporomandibular disorders |
| Q92008049 | Temporomandibular joint damage in juvenile idiopathic arthritis: Diagnostic validity of diagnostic criteria for temporomandibular disorders |
| Q58757359 | Temporomandibular joint disorders as the only manifestation of juvenile idiopathic arthritis: a case report |
| Q53079897 | Temporomandibular joint dysfunction and disorders in the development of the mandible in patients with juvenile idiopathic arthritis - preliminary study. |
| Q53288708 | Temporomandibular joint findings in adults with long-standing juvenile idiopathic arthritis: CT and MR imaging assessment. |
| Q35623758 | Temporomandibular joint involvement in Juvenile Idiopathic Arthritis: reliability and validity of a screening protocol for the rheumatologist |
| Q45746112 | Temporomandibular joint involvement in children with juvenile idiopathic arthritis |
| Q82897627 | Temporomandibular joint involvement in children with juvenile idiopathic arthritis |
| Q91046172 | Temporomandibular joint involvement in children with juvenile idiopathic arthritis: a preliminary report |
| Q79717844 | Temporomandibular joint involvement in juvenile idiopathic arthritis: clinical predictors of magnetic resonance imaging signs |
| Q69763131 | Temporomandibular joint involvement in juvenile rheumatoid arthritis. Clinical diagnostic criteria |
| Q72035971 | Temporomandibular joint involvement in juvenile rheumatoid arthritis: report of two cases |
| Q98214738 | Temporomandibular joint involvement in patients with juvenile idiopathic arthritis: a retrospective chart review |
| Q91726137 | Temporomandibular joint magnetic resonance imaging findings in adolescents with anterior disk displacement compared to those with juvenile idiopathic arthritis |
| Q36393632 | Temporomandibular joint steroid injections in patients with juvenile idiopathic arthritis: an observational pilot study on the long-term effect on signs and symptoms. |
| Q42839459 | Temporomandibular signs, symptoms, joint alterations and disease activity in juvenile idiopathic arthritis - an observational study. |
| Q46963984 | Ten years of experience of biologics in juvenile idiopathic arthritis: focus for the reasons of withdrawals |
| Q88204190 | Ten-year Perplexing Panuveitis Course in a Case with Juvenile Idiopathic Arthritis and a History of Tuberculosis |
| Q49140382 | Tenascin-C Levels, A Toll-like Receptor 4 Ligand, in Enthesitis-related Arthritis Category of Juvenile Idiopathic Arthritis: A Cross-sectional and Longitudinal Study. |
| Q70075224 | Tenosynovitis of the superior oblique muscle (Brown syndrome) associated with juvenile rheumatoid arthritis |
| Q92621343 | Testing population-based performance measures identifies gaps in juvenile idiopathic arthritis (JIA) care |
| Q92774372 | Testing the Model for Predicting Effectiveness of Anakinra in Systemic Juvenile Idiopathic Arthritis |
| Q84075239 | Th1 and Th17 Predominance in the Enthesitis-related Arthritis Form of Juvenile Idiopathic Arthritis |
| Q36252768 | Th1 and Th17 cell subpopulations are enriched in the peripheral blood of patients with systemic juvenile idiopathic arthritis |
| Q36001772 | Th1-Induced CD106 Expression Mediates Leukocytes Adhesion on Synovial Fibroblasts from Juvenile Idiopathic Arthritis Patients. |
| Q64092917 | Th17 and Th1 Lymphocytes in Oligoarticular Juvenile Idiopathic Arthritis |
| Q90661480 | Th17 reprogramming of T cells in systemic juvenile idiopathic arthritis |
| Q43300189 | Th17 transcription factor RORC2 is inversely correlated with FOXP3 expression in the joints of children with juvenile idiopathic arthritis. |
| Q45174121 | Thalidomide for severe systemic onset juvenile rheumatoid arthritis: A multicenter study |
| Q86331452 | Thalidomide for systemic onset juvenile idiopathic arthritis |
| Q43869678 | Thalidomide therapy for recalcitrant systemic onset juvenile rheumatoid arthritis. |
| Q45745931 | Thalidomide: efficacy and side effects in juvenile idiopathic arthritis (JIA). |
| Q83463797 | The 'head-to-head' comparison of etanercept and infliximab in treating children with juvenile idiopathic arthritis |
| Q40546279 | The -174G allele of the interleukin-6 gene confers susceptibility to systemic arthritis in children: a multicenter study using simplex and multiplex juvenile idiopathic arthritis families |
| Q91400767 | The Assessment of Serum Endocan Levels in Children With Juvenile Idiopathic Arthritis |
| Q100306269 | The Assessment of Steroid Injections as a Potential Risk Factor for Osteochondral Lesions in Children with Juvenile Idiopathic Arthritis |
| Q36282148 | The Association between PTPN22 Genetic Polymorphism and Juvenile Idiopathic Arthritis (JIA) Susceptibility: An Updated Meta-Analysis |
| Q69592560 | The Charnley total hip arthroplasty in juvenile rheumatoid arthritis patients |
| Q47669632 | The DNA methylation landscape of CD4+ T cells in oligoarticular juvenile idiopathic arthritis. |
| Q44866067 | The Effect of Intra-Articular Osmic Acid in Juvenile Rheumatoid Arthritis |
| Q91062143 | The Effect of Morning Stiffness Duration on the Definition of Clinically Inactive Disease in Juvenile Idiopathic Arthritis |
| Q35177150 | The Effect of Pregnancy on Ankylosing Spondylitis, Psoriatic Arthritis, and Juvenile Rheumatoid Arthritis |
| Q86232424 | The Effect of Tumor Necrosis Factor α Blockers on Growth Velocity in Juvenile Idiopathic Arthritis |
| Q57257793 | The Effectiveness of Splinting as Perceived by the Parents of Children with Juvenile Idiopathic Arthritis |
| Q39358537 | The Effects of Orthopedic Manual Physical Therapy in the Management of Juvenile Idiopathic Arthritis: A Case Report |
| Q38266664 | The Etiology of Juvenile Idiopathic Arthritis |
| Q80161055 | The FCRL3 -169T>C polymorphism is associated with rheumatoid arthritis and shows suggestive evidence of involvement with juvenile idiopathic arthritis in a Scandinavian panel of autoimmune diseases |
| Q35553680 | The German etanercept registry for treatment of juvenile idiopathic arthritis |
| Q101117862 | The Impact of Epstein-Barr Virus Infection on Juvenile Idiopathic Arthritis Activity and Patient's Response to Treatment |
| Q37394918 | The Importance of General Self-Efficacy for the Quality of Life of Adolescents with Diabetes or Juvenile Rheumatoid Arthritis Over Time: A Longitudinal Study among Adolescents and Parents |
| Q93089425 | The Influence of Overweight and Obesity on Treatment Response in Juvenile Idiopathic Arthritis |
| Q53600986 | The Juvenile Arthritis Quality of Life Questionnaire--development of a new responsive index for juvenile rheumatoid arthritis and juvenile spondyloarthritides. |
| Q70144404 | The L1 protein as a new indicator of inflammatory activity in patients with juvenile rheumatoid arthritis |
| Q100735171 | The Multi-Omics Architecture of Juvenile Idiopathic Arthritis |
| Q36600574 | The Pattern of Juvenile Idiopathic Arthritis in a Single Tertiary Center in Saudi Arabia |
| Q30992501 | The Pediatric Outcomes Data Collection Instrument for Polish sample with juvenile idiopathic arthritis: psychometric properties of proxy version |
| Q72228991 | The Possibility of Surgical Treatment in Cases of Juvenile Rheumatoid Arthritis |
| Q57257795 | The Prevocational and Early Employment Needs of Adolescents with Juvenile Idiopathic Arthritis: The Occupational Therapy Perspective |
| Q90460542 | The Psychological Impact of Dental Aesthetics in Patients with Juvenile Idiopathic Arthritis Compared with Healthy Peers: A Cross-Sectional Study |
| Q91581439 | The Risk of Diabetes Mellitus in Patients with Juvenile Idiopathic Arthritis |
| Q88042006 | The Systemic Juvenile Idiopathic Arthritis Cohort of the Childhood Arthritis and Rheumatology Research Alliance Registry: 2010-2013 |
| Q40101219 | The Systemic Juvenile Idiopathic Arthritis Cohort of the Childhood Arthritis and Rheumatology Research Alliance Registry: 2010-2013. |
| Q58326096 | The Systemic-Onset Variant of Juvenile Idiopathic Arthritis Needs to Be Recorded as an Autoinflammatory Syndrome: Comment on the Review by Nigrovic |
| Q45745644 | The TLR4 ligands MRP8 and MRP14 in the diagnosis and pathogenesis of systemic onset juvenile idiopathic arthritis |
| Q58234902 | The TRAF1/C5 region is a risk factor for polyarthritis in juvenile idiopathic arthritis |
| Q45744164 | The TRAF1/C5 region is a risk factor for polyarthritis in juvenile idiopathic arthritis. |
| Q72114037 | The Therapeutic Potential of Synovectomy in Juvenile Rheumatoid Arthritis |
| Q59313394 | The Thoracic and Lumbar Spine in Severe Juvenile Idiopathic Arthritis: Magnetic Resonance Imaging Analysis in 50 Children |
| Q40298553 | The Toll-like receptor 4 agonist MRP8/14 protein complex is a sensitive indicator for disease activity and predicts relapses in systemic-onset juvenile idiopathic arthritis. |
| Q28305303 | The Varni/Thompson Pediatric Pain Questionnaire. I. Chronic musculoskeletal pain in juvenile rheumatoid arthritis |
| Q76474333 | The Waaler-Rose reaction in juvenile forms of rheumatoid arthritis |
| Q83966335 | The activity of exoglycosidases in the synovial membrane and knee fluid of patients with rheumatoid arthritis and juvenile idiopathic arthritis |
| Q39689234 | The amyloidosis of juvenile rheumatoid arthritis - comparative studies in Polish and American children II. Serum immunoglobulins, kappa and lambda light chain and C3 levels |
| Q67435344 | The amyloidosis of juvenile rheumatoid arthritis--comparative studies in Polish and American children. I. Levels of serum SAA protein |
| Q39680090 | The amyloidosis of juvenile rheumatoid arthritis--comparative studies in Polish and American children. I. Serum immunoglobulins, lambda and kappa light chains and C3 levels |
| Q44989711 | The amyloidosis of juvenile rheumatoid arthritis--comparative studies in Polish and American children. IV. Is endotoxin a precipitory factor? |
| Q72094053 | The amyloidosis of juvenile rheumatoid arthritis-comparative studies in Polish and American children. The distribution of alpha-antitrypsin phenotypes |
| Q58597751 | The association between TNF-α 238A/G and 308A/G polymorphisms and juvenile idiopathic arthritis: An updated PRISMA-compliant meta-analysis |
| Q78166611 | The association between Turner's syndrome and juvenile rheumatoid arthritis |
| Q35099938 | The association between lean mass and bone mineral content in the high disease activity group of adult patients with juvenile idiopathic arthritis |
| Q36532896 | The association between low socioeconomic status with high physical limitations and low illness self-perception in patients with juvenile idiopathic arthritis: results from the Childhood Arthritis Prospective Study. |
| Q57330594 | The association between the functional PTPN22 1858 C/T and MIF −173 C/G polymorphisms and juvenile idiopathic arthritis: a meta-analysis |
| Q91214513 | The association of CAT-262C/T polymorphism with catalase activity and treatment response in juvenile idiopathic arthritis |
| Q94596102 | The association of MEFV gene mutations with the disease risk and severity of systemic juvenile idiopathic arthritis |
| Q41467604 | The association of PTPN22 rs2476601 with juvenile idiopathic arthritis is specific to females. |
| Q46897903 | The association of PTPN22 with rheumatoid arthritis and juvenile idiopathic arthritis |
| Q69139515 | The association of antinuclear antibodies with the chronic iridocyclitis of juvenile rheumatoid arthritis (Still's disease) |
| Q68025107 | The association of pauciarticular juvenile arthritis and myasthenia gravis |
| Q34658828 | The association with the -159C/T polymorphism in the promoter region of the CD14 gene and juvenile idiopathic arthritis in a Chinese Han population |
| Q48572969 | The associations among economic hardship, caregiver psychological distress, disease activity, and health-related quality of life in children with juvenile idiopathic arthritis. |
| Q33802006 | The autoimmune burden in juvenile idiopathic arthritis |
| Q48836088 | The autonomic nervous system and the immune system in juvenile rheumatoid arthritis. |
| Q95660247 | The benefit-risk balance for biological agents in juvenile idiopathic arthritis: a meta-analysis of randomized clinical trials |
| Q34803472 | The biologic basis of clinical heterogeneity in juvenile idiopathic arthritis |
| Q95512093 | The burden of systemic juvenile idiopathic arthritis for patients and caregivers: an international survey and retrospective chart review |
| Q40231391 | The cervical spine in juvenile rheumatoid arthritis |
| Q66855140 | The child with juvenile rheumatoid arthritis |
| Q70487987 | The child with juvenile rheumatoid arthritis |
| Q68096914 | The clinical associations of antinuclear antibodies in juvenile rheumatoid arthritis |
| Q43764343 | The clinical course of juvenile idiopathic arthritis-associated uveitis in childhood and puberty |
| Q36004923 | The clinical effectiveness and cost-effectiveness of abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis: a systematic review and economic evaluation. |
| Q26825309 | The clinical effectiveness of intra-articular corticosteroids for arthritis of the lower limb in juvenile idiopathic arthritis: a systematic review |
| Q47977161 | The clinical impact of a brief transition programme for young people with juvenile idiopathic arthritis: results of the DON'T RETARD project |
| Q92377625 | The clinical presentation in adulthood of juvenile idiopathic arthritis |
| Q40864151 | The clinical progression of apparent juvenile rheumatoid arthritis to systemic lupus erythematosus. |
| Q37981131 | The clinical spectrum of juvenile idiopathic arthritis in a large urban population |
| Q67345312 | The combined pediatric-orthopedic approach to the management of juvenile rheumatoid arthritis |
| Q89385280 | The comparisons between thermography and ultrasonography with physical examination for wrist joint assessment in juvenile idiopathic arthritis |
| Q88157496 | The correlation between the Childhood Health Assessment Questionnaire and disease activity in juvenile idiopathic arthritis |
| Q45797603 | The correlations of serum interleukin-6 (il-6) levels and serum soluble il-6 receptor levels with disease activity in systemic juvenile idiopathic arthritis patients with and without tocilizumab treatment |
| Q51780525 | The decreasing prevalence of uveitis associated with juvenile rheumatoid arthritis: do NSAIDs play a role? |
| Q82321421 | The dental attitudes, knowledge and health practices of patients with Juvenile Idiopathic Arthritis |
| Q45073665 | The detection of subclinical synovitis by ultrasound in oligoarticular juvenile idiopathic arthritis: a pilot study |
| Q54155778 | The development of classification criteria for children with juvenile rheumatoid arthritis. |
| Q81432765 | The development of erythema elevatum diutinum in a patient with juvenile idiopathic arthritis under treatment with abatacept |
| Q83937815 | The diagnosis and management of juvenile idiopathic arthritis |
| Q53113681 | The diagnostic accuracy of unenhanced MRI in the assessment of joint abnormalities in juvenile idiopathic arthritis. |
| Q79844555 | The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis |
| Q51787494 | The diagnostic value of anti-cyclic citrullinated peptide (CCP) antibodies in children with Juvenile Idiopathic Arthritis. |
| Q36433216 | The difference of disease perception by juvenile idiopathic arthritis patients and their parents: analysis of the JAMAR questionnaire |
| Q40901014 | The direct coombs test in juvenile rheumatoid arthritis. |
| Q40336075 | The distribution of juvenile idiopathic arthritis in the eastern Mediterranean: results from the registry of the Turkish Paediatric Rheumatology Association. |
| Q72907990 | The dynamics of the disease process in cases of juvenile rheumatoid arthritis when a surgical treatment is applied |
| Q79448197 | The dysfunctional muscle-bone unit in juvenile idiopathic arthritis |
| Q72307799 | The early clinical recognition of juvenile-onset ankylosing spondylitis and its differentiation from juvenile rheumatoid arthritis |
| Q74313145 | The early magnetic resonance imaging features of the knee in juvenile idiopathic arthritis |
| Q40947421 | The early natural history of juvenile rheumatoid arthritis. A 10-year follow-up study of 100 cases |
| Q34972576 | The early pattern of joint involvement predicts disease progression in children with oligoarticular (pauciarticular) juvenile rheumatoid arthritis |
| Q44806023 | The economic burden of juvenile idiopathic arthritis-results from the German paediatric rheumatologic database |
| Q67908642 | The economic impacts of juvenile rheumatoid arthritis |
| Q51044143 | The effect of ACTH on body water compartment in juvenile rheumatoid arthritis. |
| Q54437704 | The effect of a functional appliance in the management of temporomandibular joint disorders in patients with juvenile idiopathic arthritis. |
| Q43063060 | The effect of anti-TNF treatment on the immunogenicity and safety of the 7-valent conjugate pneumococcal vaccine in children with juvenile idiopathic arthritis |
| Q37800874 | The effect of genotype on methotrexate polyglutamate variability in juvenile idiopathic arthritis and association with drug response. |
| Q42414184 | The effect of infliximab plus methotrexate on the modulation of inflammatory disease markers in juvenile idiopathic arthritis: analyses from a randomized, placebo-controlled trial |
| Q82945345 | The effect of methotrexate on the temporomandibular joint in polyarticular juvenile rheumatoid arthritis patients |
| Q67842604 | The effect of non-specifically acting transfer factor component on cellular immunity in juvenile rheumatoid arthritis |
| Q34983106 | The effect of penicillamine on growth as height in juvenile chronic polyarthritis |
| Q67919047 | The effect of photosensitive dye Platonin on juvenile rheumatoid arthritis |
| Q33552101 | The effect of positive family history of autoimmunity in juvenile idiopathic arthritis characteristics; a case control study |
| Q86567354 | The effectiveness of a multidisciplinary foot care program for children and adolescents with juvenile idiopathic arthritis: an exploratory trial |
| Q93084776 | The effects of 8-week water-running program on exercise capacity in children with juvenile idiopathic arthritis: a controlled trial |
| Q47972857 | The effects of adrenocorticotrophic hormone (ACTH) in a case of juvenile rheumatoid arthritis |
| Q35586088 | The effects of celecoxib or naproxen on blood pressure in pediatric patients with juvenile idiopathic arthritis |
| Q73893296 | The effects of daily intake of folic acid on the efficacy of methotrexate therapy in children with juvenile rheumatoid arthritis. A controlled study |
| Q54122948 | The efficacy and safety of auranofin in the treatment of juvenile rheumatoid arthritis. A long-term open study. |
| Q37803416 | The efficacy and safety of interleukin-1-receptor antagonist anakinra in the treatment of systemic juvenile idiopathic arthritis |
| Q44062260 | The efficacy and safety of intraarticular corticosteroid therapy for coxitis in juvenile rheumatoid arthritis |
| Q46221048 | The efficacy and safety profile of biologic therapy with etanercept in juvenile idiopathic arthritis |
| Q89017364 | The emerging role of cardiovascular magnetic resonance imaging in the assessment of cardiac involvement in juvenile idiopathic arthritis |
| Q44591857 | The evaluation of the therapeutic efficacy of auranofin in juvenile rheumatoid arthritis (the results of Soviet-American research) |
| Q51697756 | The evaluation of uveitis in juvenile idiopathic arthritis (JIA) patients: are current ophthalmologic screening guidelines adequate? |
| Q36366049 | The experience of taking methotrexate for juvenile idiopathic arthritis: results of a cross-sectional survey with children and young people. |
| Q92413976 | The expression of DNMTs is dramatically decreased in peripheral blood mononuclear cells of male patients with juvenile idiopathic arthritis |
| Q78254396 | The extended oligoarticular subtype is the best predictor of methotrexate efficacy in juvenile idiopathic arthritis |
| Q69152445 | The eye in juvenile rheumatoid arthritis |
| Q38558803 | The family journey-to-diagnosis with systemic juvenile idiopathic arthritis: a cross-sectional study of the changing social media presence |
| Q91207965 | The feasibility of developing biomarkers from peripheral blood mononuclear cell RNAseq data in children with juvenile idiopathic arthritis using machine learning approaches |
| Q37014000 | The financial burden of juvenile idiopathic arthritis: a Nova Scotia experience |
| Q83475015 | The forgotten chamber: right-ventricular functions in juvenile idiopathic arthritis |
| Q101124726 | The frequency and clinical course of COVID-19 infection in children with juvenile idiopathic arthritis |
| Q46560663 | The frequency and outcome of uveitis in patients with newly diagnosed juvenile idiopathic arthritis in two 4-year cohorts from 1990-1993 and 2000-2003. |
| Q83057116 | The frequency of autoimmune thyroid disorders in juvenile idiopathic arthritis |
| Q93196489 | The frequency of infections in patients with juvenile idiopathic arthritis on biologic agents: 1-year prospective study |
| Q92961629 | The frequency of macrophage activation syndrome and disease course in systemic juvenile idiopathic arthritis |
| Q94691751 | The future of the IL-1 receptor antagonist anakinra: from rheumatoid arthritis to adult-onset Still's disease and systemic-onset juvenile idiopathic arthritis |
| Q38139352 | The genetics of juvenile idiopathic arthritis: current understanding and future prospects |
| Q37738107 | The genetics of juvenile idiopathic arthritis: what is new in 2010? |
| Q40525200 | The genetics of juvenile rheumatoid arthritis. |
| Q40359635 | The hand in the child with juvenile rheumatoid arthritis |
| Q72607883 | The hazards of gold injections in children with juvenile rheumatoid arthritis: comment on the article by Lehman |
| Q28072377 | The human microbiome and juvenile idiopathic arthritis |
| Q38421293 | The humanistic and economic burden of juvenile idiopathic arthritis in the era of biologic medication |
| Q46308776 | The hypoxic synovial environment regulates expression of vascular endothelial growth factor and osteopontin in juvenile idiopathic arthritis |
| Q96955455 | The iCanCope pain self-management application for adolescents with juvenile idiopathic arthritis: a pilot randomized controlled trial |
| Q37230819 | The iPeer2Peer Program: a pilot randomized controlled trial in adolescents with Juvenile Idiopathic Arthritis |
| Q45382579 | The imbalance of IL-18/IL-18BP in patients with systemic juvenile idiopathic arthritis |
| Q36899670 | The immunogenetics of juvenile rheumatoid arthritis. |
| Q40711205 | The immunologic and clinical associations of the split products of C3 in plasma in juvenile rheumatoid arthritis |
| Q55099169 | The impact of a 2-year Etanercept administration on growth of patients with juvenile idiopathic arthritis. |
| Q53239373 | The impact of a coordinated transitional care programme on adolescents with juvenile idiopathic arthritis. |
| Q40876695 | The impact of disease activity and tumour necrosis factor-α inhibitor therapy on cytokine levels in juvenile idiopathic arthritis |
| Q70657314 | The impact of juvenile rheumatoid arthritis on the growth of the mandible |
| Q99618675 | The impact of single nucleotide polymorphisms in ADORA2A and ADORA3 genes on the early response to methotrexate and presence of therapy side effects in children with juvenile idiopathic arthritis: Results of a preliminary study |
| Q89022140 | The impact of temporomandibular joint arthritis on functional disability and global health in patients with juvenile idiopathic arthritis |
| Q46472836 | The impact on health-related quality of life from non-steroidal anti-inflammatory drugs, methotrexate, or steroids in treatment for juvenile idiopathic arthritis |
| Q38285508 | The importance of an ophthalmologic examination in patients with juvenile idiopathic arthritis |
| Q104739025 | The importance of transition from pediatric to adult rheumatology care in juvenile idiopathic arthritis |
| Q33516172 | The incidence of juvenile rheumatoid arthritis in Quebec: a population data-based study |
| Q53307284 | The influence of heredity for psoriasis on the ILAR classification of juvenile idiopathic arthritis. |
| Q77941091 | The influence of patient characteristics, disease variables, and HLA alleles on the development of radiographically evident sacroiliitis in juvenile idiopathic arthritis |
| Q45745608 | The influencing of environmental and genetics factors on bone metabolism in juvenile idiopathic arthritis children |
| Q67709805 | The interferon system in juvenile rheumatoid arthritis |
| Q68807750 | The involvement of the temporomandibular joint in juvenile rheumatoid arthritis |
| Q68086054 | The iridocyclitis of early onset pauciarticular juvenile rheumatoid arthritis: outcome in immunogenetically characterized patients |
| Q35650440 | The joints in juvenile idiopathic arthritis |
| Q43426872 | The kappa immunoglobulin light chain repertoire of peripheral blood B cells in patients with juvenile rheumatoid arthritis |
| Q46965438 | The late atlantoaxial subluxation in a patient with juvenile idiopathic arthritis |
| Q46966895 | The levels of proinflammatory cytokines in blood serum of patients with juvenile idiopathic arthritis |
| Q36351200 | The limited role of interferon-γ in systemic juvenile idiopathic arthritis cannot be explained by cellular hyporesponsiveness |
| Q27303519 | The lived experience of juvenile idiopathic arthritis in young people receiving etanercept. |
| Q40772069 | The liver in juvenile rheumatoid arthritis |
| Q46862293 | The local and systemic cytokine signatures of juvenile idiopathic arthritis are attributable to tcr-independent activation of two novel subsets of prematurely senescent t cells found in synovial fluid |
| Q73994682 | The long-term effect of methotrexate therapy on the liver in patients with juvenile rheumatoid arthritis |
| Q83780301 | The long-term outcome of hip replacement in adults with juvenile idiopathic arthritis: the influence of steroids and methotrexate |
| Q62741468 | The magnitude of early response to methotrexate therapy predicts long-term outcome of patients with juvenile idiopathic arthritis |
| Q72032136 | The major histocompatibility complex antigens in rheumatoid arthritis and juvenile arthritis |
| Q45414840 | The major rheumatoid factor crossreactive idiotype and IgA rheumatoid factor in juvenile rheumatoid arthritis |
| Q31033140 | The majority of newly diagnosed patients with juvenile idiopathic arthritis reach an inactive disease state within the first year of specialised care: data from a German inception cohort |
| Q55192377 | The majority of patients with newly diagnosed juvenile idiopathic arthritis achieve a health-related quality of life that is similar to that of healthy peers: results of the German multicenter inception cohort (ICON). |
| Q67830224 | The management of juvenile chronic polyarthritis |
| Q72327527 | The management of juvenile chronic polyarthritis |
| Q70342180 | The management of juvenile chronic polyarthritis (Still's disease) |
| Q54455919 | The many shades of enhancement: timing of post-gadolinium images strongly influences the scoring of juvenile idiopathic arthritis wrist involvement on MRI. |
| Q37378370 | The meaning of clinical remission in polyarticular juvenile idiopathic arthritis: gene expression profiling in peripheral blood mononuclear cells identifies distinct disease states |
| Q91613216 | The mortality rate and causes of death among juvenile idiopathic arthritis patients in Finland |
| Q47331153 | The most important needs and preferences of patients for support from health care professionals: A reflective practice on (transitional) care for young adults with Juvenile Idiopathic Arthritis |
| Q40396179 | The myeloid-related proteins 8 and 14 complex, a novel ligand of toll-like receptor 4, and interleukin-1beta form a positive feedback mechanism in systemic-onset juvenile idiopathic arthritis |
| Q72431828 | The natural course of juvenile rheumatoid arthritis: A Study of Two Hundred Thirty Cases |
| Q41653664 | The natural history of hip involvement in juvenile rheumatoid arthritis: a radiological and magnetic resonance imaging follow-up study |
| Q91658707 | The necessity, efficacy and safety of biologics in juvenile idiopathic arthritis |
| Q67664146 | The nitroblue tetrazolium test in juvenile rheumatoid arthritis and the stimulation of granulocytes by patients sera |
| Q42318623 | The novel use of combined IL-1 and IL-6 inhibition in a patient with severe, aggressive, erosive, systemic-onset juvenile idiopathic arthritis |
| Q40471174 | The ocular manifestations of juvenile rheumatoid arthritis |
| Q90448722 | The ophthalmologic examination of children with juvenile idiopathic arthritis should be emphasized in Taiwan |
| Q72461278 | The orthopedist's general orientation on the symptoms and differential diagnosis of juvenile rheumatoid arthritis |
| Q88034783 | The outcome of total elbow arthroplasty in juvenile idiopathic arthritis (juvenile rheumatoid arthritis) patients |
| Q44646094 | The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort |
| Q54379042 | The p38-mediated rapid down-regulation of cell surface gp130 expression impairs interleukin-6 signaling in the synovial fluid of juvenile idiopathic arthritis patients. |
| Q73223371 | The p53 status in juvenile chronic arthritis and rheumatoid arthritis |
| Q92910053 | The pain trajectory of juvenile idiopathic arthritis (JIA): translating from adolescent patient report to behavioural sensitivity in a juvenile animal model |
| Q37841854 | The pathogenesis of oligoarticular/polyarticular vs systemic juvenile idiopathic arthritis |
| Q36251472 | The pathophysiology of the growth plate in juvenile idiopathic arthritis |
| Q89851473 | The patient and parent perspective on methotrexate in recent Juvenile Idiopathic Arthritis guidelines |
| Q34774277 | The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis |
| Q42080161 | The pediatric rheumatology quality of life scale: validation of the English version in a US cohort of juvenile idiopathic arthritis |
| Q74141360 | The place of juvenile onset spondyloarthropathies in the Durban 1997 ILAR classification criteria of juvenile idiopathic arthritis. International League of Associations for Rheumatology |
| Q41840145 | The presence of high mobility group box-1 and soluble receptor for advanced glycation end-products in juvenile idiopathic arthritis and juvenile systemic lupus erythematosus |
| Q53919702 | The prevalence and incidence of juvenile rheumatoid arthritis in an urban Black population. |
| Q46100624 | The prevalence of coagulation abnormalities in juvenile rheumatoid arthritis |
| Q81387171 | The prevalence of human leukocyte antigen (HLA) DR/DQ/DP alleles in Kuwaiti children with oligoarticular juvenile idiopathic arthritis |
| Q44299880 | The prevalence of uveitis in juvenile rheumatoid arthritis |
| Q46378745 | The primary complement components contained in circulating immune complexes in oligoarticular and polyarticular juvenile idiopathic arthritis patient sera are C1q and C4: evidence of classical complement activation |
| Q69788718 | The problem of temporomandibular joints in juvenile rheumatoid arthritis |
| Q33840528 | The profile of polyunsaturated fatty acids in juvenile idiopathic arthritis and association with disease activity. |
| Q92633703 | The protease systems and their pathogenic role in juvenile idiopathic arthritis |
| Q72637198 | The putative oncoprotein DEK, part of a chimera protein associated with acute myeloid leukaemia, is an autoantigen in juvenile rheumatoid arthritis |
| Q36936015 | The radiology of juvenile rheumatoid arthritis. A review of the English language literature |
| Q30453327 | The referral pattern and evaluation of children prior to the diagnosis of pauciarticular juvenile rheumatoid arthritis |
| Q71233553 | The relationship between exposed galactose and N-acetylglucosamine residues on IgG in rheumatoid arthritis (RA), juvenile chronic arthritis (JCA) and Sjögren's syndrome (SS) |
| Q79181138 | The relationship between health-related quality of life, pain and coping strategies in juvenile idiopathic arthritis |
| Q73899213 | The relationship between impairments in joint function and disabilities in independent function in children with systemic juvenile idiopathic arthritis |
| Q69539317 | The relationship between ocular and articular disease activity in children with juvenile rheumatoid arthritis and associated uveitis |
| Q69439878 | The relationship between ocular and articular disease activity in juvenile rheumatoid arthritis complicated by chronic anterior uveitis |
| Q45901881 | The relationship between physical activity level, anxiety, depression, and functional ability in children and adolescents with juvenile idiopathic arthritis. |
| Q45056478 | The relationship between physical activity levels and pain in children with juvenile idiopathic arthritis |
| Q48381405 | The relationship between strength and function in females with juvenile rheumatoid arthritis. |
| Q50849215 | The relationship of hepatotoxic risk factors and liver histology in methotrexate therapy for juvenile rheumatoid arthritis. |
| Q72370664 | The relationship of rheumatoid factor to age of onset in Juvenile rheumatoid arthritis |
| Q92771228 | The relationship of the immune response mediator genes polymorphic variants with the methotrexate efficacy in juvenile idiopathic arthritis |
| Q48434687 | The relationships between adult juvenile idiopathic arthritis and employment. |
| Q46015782 | The relevance of using the Childhood Health Assessment Questionnaire (CHAQ) in revised versions for the assessment of juvenile idiopathic arthritis. |
| Q85556780 | The results of uncemented total hip replacement in children with juvenile idiopathic arthritis at ten years |
| Q72081781 | The rheumatoid factor cross-reactive idiotype in juvenile rheumatoid arthritis: role of the CD5-positive B cell |
| Q41731211 | The risk and nature of flares in juvenile idiopathic arthritis: results from the ReACCh-Out cohort |
| Q46861333 | The risk and nature of flares in juvenile idiopathic arthritis: results from the reACCh-Out cohort |
| Q37274470 | The risk of hospitalized infection following initiation of biologic agents versus methotrexate in the treatment of juvenile idiopathic arthritis. |
| Q66881563 | The risk of iridocyclitis in juvenile rheumatoid arthritis |
| Q55206915 | The role of IL-1 inhibition in systemic juvenile idiopathic arthritis: current status and future perspectives. |
| Q77877677 | The role of MRI in the evaluation of hip joint disease in clinical subtypes of juvenile idiopathic arthritis |
| Q82972652 | The role of Power Doppler ultrasonography in comparison with biological markers in the evaluation of disease activity in Juvenile Idiopathic Arthritis |
| Q45745917 | The role of antibodies to mutated citrulinated vimentin (anti-MCV) in juvenile idiopathic arthritis patients |
| Q46862277 | The role of cannabinoid receptor 2 in oligo/poly-articular juvenile idiopathic arthritis |
| Q46961885 | The role of clinical pilates exercises in children wıth juvenile idiopathic arthritis: a pilot study |
| Q37654499 | The role of exercise therapy in the management of juvenile idiopathic arthritis |
| Q60909251 | The role of extracellular histones in systemic-onset juvenile idiopathic arthritis |
| Q27010572 | The role of gender in juvenile idiopathic arthritis-associated uveitis |
| Q81225220 | The role of gene transcript signature in diagnosing systemic onset juvenile idiopathic arthritis |
| Q83413813 | The role of heme oxygenase-1 in systemic-onset juvenile idiopathic arthritis |
| Q89419056 | The role of imaging in juvenile idiopathic arthritis |
| Q40784284 | The role of sleep in Juvenile idiopathic arthritis patients and their caregivers |
| Q75221597 | The role of subcutaneous administration of methotrexate in children with juvenile idiopathic arthritis who have failed oral methotrexate |
| Q38672339 | The role of synthetic drugs in the biologic era: therapeutic strategies for treating juvenile idiopathic arthritis. |
| Q69594152 | The role of the time factor in the radon therapy of patients with juvenile rheumatoid arthritis |
| Q33940062 | The role of transforming growth factor β signaling in fibroblast-like synoviocytes from patients with oligoarticular juvenile idiopathic arthritis: dysregulation of transforming growth factor β signaling, including overexpression of bone morphogenet |
| Q40950014 | The safety and effectiveness of HBV vaccination in patients with juvenile idiopathic arthritis controlled by treatment |
| Q73460633 | The safety and efficacy of chicken type II collagen on uveitis associated with juvenile rheumatoid arthritis |
| Q37784384 | The safety profile of biologic therapies for juvenile idiopathic arthritis |
| Q55505296 | The self versus proxy report conundrum in juvenile idiopathic arthritis: implications for a cost-effectiveness analysis of integrated podiatry care. |
| Q72116765 | The significance of antinuclear antibodies in juvenile rheumatoid arthritis associated with chronic bilateral iridocyclitis |
| Q84794560 | The significance of elevated serologic markers of celiac disease in children with juvenile rheumatoid arthritis |
| Q95298565 | The socio-material self-care practices of children living with hemophilia or juvenile idiopathic arthritis in Denmark |
| Q73855915 | The spondylitis of juvenile rheumatoid arthritis |
| Q39358308 | The spontaneous NBT-test in granulocytes of patients with juvenile rheumatoid arthritis |
| Q43872556 | The spontaneous remission of juvenile idiopathic arthritis is characterized by CD30+ T cells directed to human heat-shock protein 60 capable of producing the regulatory cytokine interleukin-10. |
| Q86063695 | The surgical management of atlanto-axial subluxation in juvenile rheumatoid arthritis |
| Q34268514 | The susceptibility loci juvenile idiopathic arthritis shares with other autoimmune diseases extend to PTPN2, COG6, and ANGPT1 |
| Q102059593 | The synovium under arthroscopy in a juvenile idiopathic arthritis patient with selective immunoglobulin A deficiency |
| Q100522926 | The temporal relationship between juvenile idiopathic arthritis disease activity and uveitis activity |
| Q37222078 | The temporomandibular joint in juvenile idiopathic arthritis: frequently used and frequently arthritic |
| Q70297970 | The temporomandibular joint in juvenile rheumatoid arthritis. Radiographic changes related to clinical and laboratory parameters in 100 children |
| Q72650802 | The temporomandibular joint in juvenile rheumatoid arthritis: I. Computed tomographic findings |
| Q53985374 | The temporomandibular joint in juvenile rheumatoid arthritis: Part II. Relationship between computed tomographic and clinical findings. |
| Q81045804 | The time has come to include assessment of radiographic progression in juvenile idiopathic arthritis clinical trials |
| Q56961956 | The time of DMARD start in Juvenile Idiopathic Arthritis determines the likelihood of a drug-free remission in young adulthood |
| Q67955126 | The timing of menarche in juvenile rheumatoid arthritis |
| Q70376152 | The toxicity of nonsteroidal antiinflammatory drugs in juvenile rheumatoid arthritis |
| Q55493570 | The transcription factor CREM drives an inflammatory phenotype of T cells in oligoarticular juvenile idiopathic arthritis. |
| Q45753634 | The transcription factor crem-αlpha regulates inflammatory T cell subsets in juvenile idiopathic arthritis. |
| Q49887118 | The transition of adolescents with juvenile idiopathic arthritis or epilepsy from paediatric health-care services to adult health-care services: A scoping review of the literature and a synthesis of the evidence. |
| Q40867570 | The triad of pneumonitis, pleuritis, and pericarditis in juvenile rheumatoid arthritis |
| Q57956154 | The turnover of synovial T cells is higher than in T cells in the peripheral blood in persistent oligoarticular juvenile idiopathic arthritis |
| Q57116603 | The type 1 diabetes susceptibility gene SUMO4 at IDDM5 is not associated with susceptibility to rheumatoid arthritis or juvenile idiopathic arthritis |
| Q40898268 | The unusual presentation of "juvenile" rheumatoid arthritis in an adult |
| Q92708104 | The use of S100 proteins testing in juvenile idiopathic arthritis and autoinflammatory diseases in a pediatric clinical setting: a retrospective analysis |
| Q38075649 | The use of biologic response modifiers in polyarticular-course juvenile idiopathic arthritis: a systematic review |
| Q67802724 | The use of interferon in the combined therapy of juvenile rheumatoid arthritis |
| Q51811550 | The use of lidocaine to reduce the pain of myochrysine injections for children with juvenile rheumatoid arthritis. |
| Q35273181 | The use of multidisciplinary assessment and scientific measurement in advanced juvenile idiopathic arthritis can categorise gait deviations to guide treatment |
| Q45902250 | The use of tocilizumab in a child with systemic onset juvenile idiopathic arthritis and ganglioneuroblastoma. |
| Q70996659 | The use of tolmetin sodium in systemic onset juvenile rheumatoid arthritis |
| Q38997077 | The uveitis and its relationship with disease activity and quality of life in Moroccan children with juvenile idiopathic arthritis. |
| Q73463834 | The validity and reliability of parental ratings of disease activity in juvenile rheumatoid arthritis |
| Q45745901 | The value of antibodies against mutated citrullinated vimentin in juvenile idiopathic arthritis |
| Q69584697 | The value of arthroscopy in the diagnosis and treatment of patients with juvenile rheumatoid arthritis |
| Q68860378 | The value of biopsy in patients with monarticular juvenile rheumatoid arthritis of recent onset |
| Q54393543 | The value of old drugs for juvenile idiopathic arthritis. |
| Q34208981 | The visual prognosis in juvenile rheumatoid arthritis |
| Q45878424 | The “Patellar Ratio” in Hemophilia and Juvenile Rheumatoid Arthritis |
| Q38648790 | Therapeutic Potential of Interferon-γ and Its Antagonists in Autoinflammation: Lessons from Murine Models of Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome |
| Q38224087 | Therapeutic advancements in juvenile idiopathic arthritis |
| Q92196418 | Therapeutic advances in juvenile idiopathic arthritis - associated uveitis |
| Q38684290 | Therapeutic approaches for ophthalmic problems in juvenile rheumatoid arthritis |
| Q45147356 | Therapeutic effects of the anti-tumor necrosis factor monoclonal antibody, infliximab, in four children with refractory juvenile idiopathic arthritis |
| Q81484758 | Therapeutic efficacy of humanized recombinant anti-interleukin-6 receptor antibody in children with systemic-onset juvenile idiopathic arthritis |
| Q73248407 | Therapeutic experience with infliximab in a patient with polyarticular juvenile idiopathic arthritis and uveitis |
| Q35551296 | Therapeutic use of etanercept in polyarticular course juvenile idiopathic arthritis over a two year period |
| Q69197739 | Therapy for systemic juvenile rheumatoid arthritis with gamma-interferon: a pilot study of nine patients |
| Q39947413 | Therapy of juvenile chronic polyarthritis |
| Q70650991 | Therapy of juvenile progressive chronic polyarthritis. Rheumatoid arthritis of childhood and adolescence |
| Q52264991 | Therapy of juvenile rheumatoid arthritis |
| Q41928745 | Therapy of juvenile rheumatoid arthritis. Personal experience |
| Q44949092 | Therapy-refractory systemic juvenile idiopathic arthritis successfully treated with statins |
| Q80106292 | Therapy-related membranous nephropathy in juvenile idiopathic arthritis with Turner syndrome |
| Q71438429 | Thermography in juvenile rheumatoid arthritis |
| Q82842048 | Thermography in juvenile rheumatoid arthritis |
| Q40057959 | Three cases with familial Mediterranean fever misdiagnosed as juvenile idiopathic arthritis |
| Q99637320 | Three-dimensional analysis of gait in children and adolescents with juvenile idiopathic arthritis |
| Q92552720 | Three-dimensional assessment of facial morphology in children and adolescents with juvenile idiopathic arthritis and moderate to severe TMJ involvement using 3D surface scans |
| Q85922476 | Three-dimensional morphological condylar and mandibular changes in a patient with juvenile idiopathic arthritis: interdisciplinary treatment |
| Q91279418 | Thrombocytopaenia in Systemic Juvenile Idiopathic Arthritis: Not Always Macrophage Activation Syndrome! |
| Q41772740 | Thrombocytosis in juvenile rheumatoid arthritis |
| Q44162946 | Thymic enlargement in a patient with juvenile idiopathic arthritis during etanercept therapy. |
| Q60061996 | Thymic function and immune senescence in juvenile idiopathic arthritis: Comment on the article by Prelog et al |
| Q37172799 | Thymic function in juvenile idiopathic arthritis |
| Q57927864 | Thyroid function, autoimmune thyroiditis and coeliac disease in juvenile idiopathic arthritis |
| Q70702676 | Time course of response to nonsteroidal antiinflammatory drugs in juvenile rheumatoid arthritis |
| Q45745988 | Time of onset of iridocyclitis (IC) in children with juvenile idiopathic arthritis (JIA). |
| Q35035966 | Time of onset of uveitis in children with juvenile rheumatoid arthritis |
| Q88136957 | Time to Reconsider Management of the Temporomandibular Joint in Juvenile Idiopathic Arthritis |
| Q37671203 | Time to diagnosis in juvenile idiopathic arthritis: a french perspective |
| Q57788650 | Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis |
| Q45745745 | Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis. |
| Q94586504 | Timing matters: real-world effectiveness of early combination of biologic and conventional synthetic disease-modifying antirheumatic drugs for treating newly diagnosed polyarticular course juvenile idiopathic arthritis |
| Q82359349 | Timing of uveitis onset in oligoarticular juvenile idiopathic arthritis (JIA) is the main predictor of severe course uveitis |
| Q77871144 | Tissue inhibitor of metalloproteinases-1 and matrix metalloproteinase-3 in Japanese healthy children and in Kawasaki disease and their clinical usefulness in juvenile rheumatoid arthritis |
| Q95606462 | Tocilizumab (Actemra, Intravenous): For the Treatment of Signs and Symptoms of Active Polyarticular Juvenile Idiopathic Arthritis in Patients Two Years of Age and Older Who Have Responded Inadequately to Previous Therapy With Disease-Modifying Antir |
| Q46380389 | Tocilizumab (TCZ) may be an effective treatment for poly-juvenile idiopathic arthritis (pJIA) as for rheumatoid arthritis (RA). |
| Q100456330 | Tocilizumab Employment in the Treatment of Resistant Juvenile Idiopathic Arthritis Associated Uveitis |
| Q90229848 | Tocilizumab for juvenile idiopathic arthritis: a single-center case series |
| Q91994276 | Tocilizumab for refractory uveitis associated with juvenile idiopathic arthritis: A report of two cases |
| Q57767909 | Tocilizumab for retinal vasoproliferative tumor secondary to juvenile idiopathic arthritis-associated uveitis: a case report |
| Q80932376 | Tocilizumab for rheumatoid and juvenile idiopathic arthritis |
| Q54386420 | Tocilizumab for severe chronic anterior uveitis associated with juvenile idiopathic arthritis in a pediatric patient. |
| Q86497096 | Tocilizumab for systemic juvenile idiopathic arthritis |
| Q38010425 | Tocilizumab for the treatment of juvenile idiopathic arthritis |
| Q38044757 | Tocilizumab for the treatment of systemic juvenile idiopathic arthritis |
| Q38723988 | Tocilizumab for treating juvenile idiopathic arthritis |
| Q91845987 | Tocilizumab in patients with anti-TNF refractory juvenile idiopathic arthritis-associated uveitis (APTITUDE): a multicentre, single-arm, phase 2 trial |
| Q92913278 | Tocilizumab in refractory juvenile idiopathic arthritis with associated uveitis: a case report |
| Q37235737 | Tocilizumab in systemic juvenile idiopathic arthritis in a real-world clinical setting: results from 1 year of postmarketing surveillance follow-up of 417 patients in Japan |
| Q38993284 | Tocilizumab in the treatment of systemic juvenile idiopathic arthritis |
| Q90037949 | Tocilizumab in the treatment of systemic-onset juvenile idiopathic arthritis - single-centre experience |
| Q83592010 | Tocilizumab masks the clinical symptoms of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome: the diagnostic significance of interleukin-18 and interleukin-6 |
| Q99348719 | Tocilizumab may slow radiographic progression in patients with systemic or polyarticular-course juvenile idiopathic arthritis: post hoc radiographic analysis from two randomized controlled trials |
| Q92559879 | Tocilizumab modifies clinical and laboratory features of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis |
| Q45908448 | Tocilizumab therapy in systemic juvenile idiopathic arthritis – lessons of real clinical practice. |
| Q92727822 | Tocilizumab treatment in juvenile idiopathic arthritis patients: A single center experience |
| Q55100193 | Tocilizumab-effects on growth impairment in systemic juvenile idiopathic arthritis. |
| Q90622281 | Tocilizumab-induced anaphylaxis in patients with adult-onset Still's disease and systemic juvenile idiopathic arthritis: a case-based review |
| Q37778738 | Tocilizumab: The evidence for its place in the treatment of juvenile idiopathic arthritis. |
| Q38155126 | Tocilizumab: a review of its use in the treatment of juvenile idiopathic arthritis |
| Q37786628 | Tocilizumab: molecular intervention therapy in children with systemic juvenile idiopathic arthritis |
| Q88813271 | Tofacitinib Response in Juvenile Idiopathic Arthritis (JIA) and Collagenous Colitis |
| Q92860457 | Tofacitinib Treatment of Refractory Systemic Juvenile Idiopathic Arthritis |
| Q41265995 | Tolerance of cyclosporine A in children with refractory juvenile rheumatoid arthritis |
| Q51970090 | Tolerogenic immune responses to novel T-cell epitopes from heat-shock protein 60 in juvenile idiopathic arthritis. |
| Q32128885 | Toll-like receptor 4 gene polymorphisms and susceptibility to juvenile idiopathic arthritis |
| Q40642438 | Torticollis as the sole initial presenting sign of systemic onset juvenile rheumatoid arthritis. |
| Q52734471 | Total Hip Replacement in Juvenile Chronic Polyarthritis and Ankylosing Spondylitis |
| Q39575877 | Total Hip Replacement in Juvenile Rheumatoid Arthritis:Analysis of 59 Hips |
| Q71405439 | Total and free salicylate concentrations in juvenile rheumatoid arthritis |
| Q74608652 | Total elbow arthroplasty in patients who have juvenile rheumatoid arthritis |
| Q39332273 | Total hip and knee arthroplasty for juvenile rheumatoid arthritis. |
| Q37956814 | Total hip and knee arthroplasty in juvenile rheumatoid arthritis |
| Q39556061 | Total hip and total knee arthroplasty in juvenile rheumatoid arthritis |
| Q70658266 | Total hip arthroplasty in juvenile rheumatoid arthritis |
| Q39854257 | Total hip arthroplasty in juvenile rheumatoid arthritis. Two to eleven-year results |
| Q73016581 | Total hip arthroplasty with cement for juvenile rheumatoid arthritis. Results at a minimum of ten years in patients less than thirty years old |
| Q39365086 | Total knee arthroplasty in juvenile rheumatoid arthritis |
| Q71070971 | Total knee arthroplasty in juvenile rheumatoid arthritis |
| Q69615820 | Total knee arthroplasty in juvenile rheumatoid arthritis. A seven-year follow-up study |
| Q37469025 | Total knee arthroplasty in patients with juvenile idiopathic arthritis |
| Q39394330 | Total knee arthroplasty in young patients with juvenile rheumatoid arthritis |
| Q36025491 | Total knee replacement in juvenile rheumatoid arthritis. |
| Q57956146 | Total pubertal growth in patients with juvenile idiopathic arthritis treated with growth hormone: Analysis of a single center |
| Q30849383 | Total-body bone mineral content in non-corticosteroid-treated postpubertal females with juvenile rheumatoid arthritis: frequency of osteopenia and contributing factors |
| Q91949988 | Toward Accelerated Authorization and Access to New Medicines for Juvenile Idiopathic Arthritis |
| Q90088663 | Toward Developing a Semiquantitative Whole Body-MRI Scoring for Juvenile Idiopathic Arthritis: Critical Appraisal of the State of the Art, Challenges, and Opportunities |
| Q57058404 | Toward New Classification Criteria for Juvenile Idiopathic Arthritis: First Steps, Pediatric Rheumatology International Trials Organization International Consensus |
| Q88239705 | Toward a Multibiomarker Panel to Optimize Outcome and Predict Response in Juvenile Idiopathic Arthritis |
| Q39535376 | Toward a treat-to-target approach in the management of juvenile idiopathic arthritis. |
| Q80090162 | Toward an understanding of the long-term outcome of juvenile idiopathic arthritis |
| Q50504285 | Towards Establishing a Standardized Magnetic Resonance Imaging Scoring System for Temporomandibular Joints in Juvenile Idiopathic Arthritis. |
| Q38059101 | Towards a role of ultrasound in children with juvenile idiopathic arthritis |
| Q92122055 | Towards therapeutic drug monitoring of TNF inhibitors for children with juvenile idiopathic arthritis: a scoping review |
| Q69636095 | Toxicity and serum levels of methotrexate in children with juvenile rheumatoid arthritis |
| Q47683190 | Trajectories of pain severity in juvenile idiopathic arthritis: results from the Research in Arthritis in Canadian Children Emphasizing Outcomes cohort |
| Q54945619 | Transcription factor motif enrichment in whole transcriptome analysis identifies STAT4 and BCL6 as the most prominent binding motif in systemic juvenile idiopathic arthritis. |
| Q92454945 | Transcriptomic and proteomic analysis of iris tissue and aqueous humor in juvenile idiopathic arthritis-associated uveitis |
| Q85651171 | Transfer from paediatric rheumatology to the adult rheumatology setting: experiences and expectations of young adults with juvenile idiopathic arthritis |
| Q57820617 | Transient natural killer cell dysfunction associated with interleukin-18 overproduction in systemic juvenile idiopathic arthritis |
| Q73511485 | Transient remission of intractable systemic-type of juvenile rheumatoid arthritis after chickenpox in a 2-year-old boy |
| Q70814459 | Transient remission of juvenile rheumatoid arthritis after measles |
| Q44202211 | Transient remission of systemic manifestations following intraarticular triamcinolone hexacetonide injection in a boy with systemic juvenile idiopathic arthritis. |
| Q70629474 | Transient scoliosis in a child with juvenile rheumatoid arthritis |
| Q33460376 | Transient thrombocytopenia in systemic onset juvenile rheumatoid arthritis |
| Q58574085 | Transition from child to adult care in an outpatient clinic for adolescents with juvenile idiopathic arthritis: An inductive qualitative study |
| Q38742401 | Transition to adult rheumatology care is necessary to maintain DMARD therapy in young people with juvenile idiopathic arthritis |
| Q80102944 | Transitional care for adolescents with juvenile idiopathic arthritis: a Delphi study |
| Q36761710 | Transitional care in clinical networks for young people with juvenile idiopathic arthritis: current situation and challenges. |
| Q92380991 | Transitional care of young people with juvenile idiopathic arthritis in Italy: results of a Delphi consensus survey |
| Q50865064 | Transmission disequilibrium as a test of linkage and association between HLA alleles and pauciarticular-onset juvenile rheumatoid arthritis. |
| Q48342772 | Transoral approach using the mandibular osteotomy for atlantoaxial vertical subluxation in juvenile rheumatoid arthritis associated with mandibular micrognathia. |
| Q33244184 | Transscleral diode laser cyclophotocoagulation as primary surgical treatment for secondary glaucoma in juvenile idiopathic arthritis: high failure rate after short term follow up |
| Q34480494 | Transscleral diode laser cyclophotocoagulation for refractory glaucoma secondary to juvenile idiopathic arthritis: a short term follow-up |
| Q57473979 | Treat to target (drug-free) inactive disease in DMARD-naive juvenile idiopathic arthritis: 24-month clinical outcomes of a three-armed randomised trial |
| Q46967065 | Treat to target: temporomandibular joint (TMJ) arthritis in children with juvenile idiopathic arthritis (JIA) – experience of Centro Hospitalar Do Porto |
| Q91996900 | Treat-to-target study for improved outcome in polyarticular juvenile idiopathic arthritis |
| Q72352815 | Treating growth and TMJ abnormalities in juvenile rheumatoid arthritis |
| Q91858168 | Treating juvenile idiopathic arthritis (JIA)-related uveitis beyond TNF-α inhibition: a narrative review |
| Q52593303 | Treating juvenile idiopathic arthritis to target: recommendations of an international task force. |
| Q91994562 | Treating juvenile idiopathic arthritis to target: what is the optimal target definition to reach all goals? |
| Q46864366 | Treating to target of minimal disease activity and normal function in polyarticular juvenile idiopathic arthritis with adalimumab: analysis from a phase 3 clinical trial |
| Q38664517 | Treatment Options for Juvenile Idiopathic Arthritis (JIA) Associated Uveitis |
| Q91408244 | Treatment Satisfaction with and Adherence to Disease-Modifying Antirheumatic Drugs in Adult Patients with Juvenile Idiopathic Arthritis |
| Q91049530 | Treatment Withdrawal Following Remission in Juvenile Idiopathic Arthritis: A Systematic Review of the Literature |
| Q33545002 | Treatment adherence in juvenile rheumatoid arthritis--a review. |
| Q38207061 | Treatment advances in systemic juvenile idiopathic arthritis |
| Q50933609 | Treatment choices of paediatric rheumatologists for juvenile idiopathic arthritis: etanercept or adalimumab? |
| Q38528889 | Treatment in juvenile rheumatoid arthritis and new treatment options. |
| Q38197746 | Treatment management of children with juvenile idiopathic arthritis with temporomandibular joint involvement: a systematic review. |
| Q28080084 | Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis |
| Q34708791 | Treatment of Juvenile Rheumatoid Arthritis with Diclofenac Sodium |
| Q38176004 | Treatment of Systemic Juvenile Idiopathic Arthritis with Tocilizumab - the Role of Anti-Interleukin-6 Therapy After a Decade of Treatment |
| Q68874171 | Treatment of children with juvenile rheumatoid arthritis |
| Q70545768 | Treatment of chronic juvenile rheumatoid arthritis |
| Q79449725 | Treatment of difficult cases of systemic-onset juvenile idiopathic arthritis with tacrolimus |
| Q70505697 | Treatment of hip damage in children with juvenile rheumatoid arthritis |
| Q45296086 | Treatment of juvenile chronic polyarthritis and of Still's syndrome using a new antirheumatic agent |
| Q46411926 | Treatment of juvenile idiopathic arthritis |
| Q46818804 | Treatment of juvenile idiopathic arthritis |
| Q38158594 | Treatment of juvenile idiopathic arthritis in the biologic age. |
| Q44202202 | Treatment of juvenile idiopathic arthritis with intra-articular triamcinolone hexacetonide: evaluation of clinical effectiveness correlated with circulating ANA and T gamma/delta + and B CD5+ lymphocyte populations of synovial fluid |
| Q37898988 | Treatment of juvenile idiopathic arthritis-associated uveitis: challenges and update |
| Q26849497 | Treatment of juvenile idiopathic arthritis: a revolution in care |
| Q92558691 | Treatment of juvenile idiopathic arthritis: what's new? |
| Q73073014 | Treatment of juvenile rheumatoid arthritis |
| Q83156534 | Treatment of juvenile rheumatoid arthritis |
| Q39327138 | Treatment of juvenile rheumatoid arthritis -- a world survey |
| Q41938558 | Treatment of juvenile rheumatoid arthritis by antimalarial drugs. Dosage in syrup and tablets |
| Q41936943 | Treatment of juvenile rheumatoid arthritis with chloroquine phosphate and hydroxychloroquine sulphate. Dosage of syrup and tablets with determinations of serum concentrations |
| Q74001238 | Treatment of juvenile rheumatoid arthritis with growth hormone |
| Q73092683 | Treatment of juvenile rheumatoid arthritis with oral type II collagen: comment on the article by Barnett et al |
| Q40490349 | Treatment of juvenile rheumatoid arthritis. |
| Q71699577 | Treatment of juvenile rheumatoid arthritis: approach to patients who fail standard therapy |
| Q73338473 | Treatment of leg length discrepancy with temporary epiphyseal stapling in children with juvenile idiopathic arthritis during 1957-99 |
| Q79979609 | Treatment of leg length discrepancy with temporary epiphyseal stapling in children with juvenile idiopathic arthritis during 1957-99 |
| Q46931949 | Treatment of pain in juvenile idiopathic arthritis: a survey of pediatric rheumatologists |
| Q36909288 | Treatment of patients with juvenile idiopathic arthritis (JIA) in a population-based cohort |
| Q44746230 | Treatment of patients with juvenile rheumatoid arthritis with combination of leflunomide and methotrexate |
| Q61816718 | Treatment of patients with systemic-onset juvenile idiopathic arthritis with tacrolimus |
| Q40432675 | Treatment of refractory autoimmune diseases with autologous stem cell transplantation: focus on juvenile idiopathic arthritis |
| Q73899258 | Treatment of refractory juvenile idiopathic arthritis |
| Q44550861 | Treatment of refractory juvenile idiopathic arthritis via pulse therapy using methylprednisolone and cyclophosphamide |
| Q87449868 | Treatment of refractory polyarticular juvenile idiopathic arthritis with tacrolimus |
| Q83540352 | Treatment of severe uveitis associated with juvenile idiopathic arthritis with anti-CD20 monoclonal antibody (rituximab) |
| Q38221012 | Treatment of uveitis associated with juvenile idiopathic arthritis |
| Q64893765 | Treatment patterns and economic outcomes in patients with juvenile idiopathic arthritis. |
| Q36614214 | Treatment preferences in juvenile idiopathic arthritis - a comparative analysis in two health care systems |
| Q59268639 | Treatment preferences in juvenile idiopathic arthritis – a comparative analysis in two health care systems |
| Q46862035 | Treatment prescribing patterns in a cohort of patients with juvenile idiopathic arthritis (JIA). Data from the childhood arthritis prospective study (CAPS). |
| Q37313894 | Treatment prescribing patterns in patients with juvenile idiopathic arthritis (JIA): Analysis from the UK Childhood Arthritis Prospective Study (CAPS). |
| Q38765960 | Treatment response to etanercept in methotrexate refractory juvenile idiopathic arthritis: an analysis of predictors and long-term outcomes. |
| Q37642763 | Treatment strategies for juvenile idiopathic arthritis |
| Q92219527 | Treatment to Target Using Recombinant Interleukin-1 Receptor Antagonist as First-Line Monotherapy in New-Onset Systemic Juvenile Idiopathic Arthritis: Results From a Five-Year Follow-Up Study |
| Q81353139 | Treatment with TNF inhibitors for uveitis associated with juvenile idiopathic arthritis |
| Q81601379 | Treatment with etanercept for patients with juvenile rheumatoid arthritis in Taiwan--a preliminary report |
| Q43475104 | Treatment with osmic acid for juvenile rheumatoid arthritis |
| Q88812033 | Trends in Population-Based Incidence and Prevalence of Juvenile Idiopathic Arthritis in Manitoba, Canada |
| Q85664682 | Trends in medication usage in juvenile idiopathic arthritis: prescribing trends or trends in prescribers? |
| Q37014830 | Trends in paediatric rheumatology referral times and disease activity indices over a ten-year period among children and young people with Juvenile Idiopathic Arthritis: results from the childhood arthritis prospective Study |
| Q46861687 | Trends in paediatric rheumatology referral times and disease activity indices over a ten-year period among children with juvenile idiopathic arthritis: results from the childhood arthritis prospective study. |
| Q43689633 | Trends in prescription of biological agents and outcomes of juvenile idiopathic arthritis: results of the Dutch national Arthritis and Biologics in Children Register |
| Q92191215 | Trends towards more active introduction of drug therapy, emphasizing methotrexate and biologic agents, for juvenile idiopathic arthritis |
| Q35870808 | Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis |
| Q73802382 | Trial of intravenous pulse cyclophosphamide and methylprednisolone in the treatment of severe systemic-onset juvenile rheumatoid arthritis |
| Q80427616 | Trials reveal promising options for treating juvenile rheumatoid arthritis |
| Q44977019 | Triamcinolone acetonide and hexacetonide intra-articular treatment of symmetrical joints in juvenile idiopathic arthritis: a double-blind trial |
| Q96130063 | Trochleitis presenting with double vision in a patient with juvenile idiopathic arthritis |
| Q79895455 | Trunk and center of mass movements during gait in children with juvenile idiopathic arthritis |
| Q33715426 | Tuberculin skin test and ELISPOT/T. SPOT.TB in children and adolescents with juvenile idiopathic arthritis |
| Q90430416 | Tuberculin skin test response in patients with juvenile idiopathic arthritis on anti-TNF therapy |
| Q55661346 | Tuberculosis in Juvenile Idiopathic arthritis under Anti-TNF therapy. |
| Q47943790 | Tuberculosis in a nine-year-old girl treated with infliximab for systemic juvenile idiopathic arthritis |
| Q41994818 | Tuberculosis occurred on an atlantoaxial synovial pannus during juvenile idiopathic arthritis treated with TNF inhibitors |
| Q92341212 | Tumefactive synovial thickening mimicking synovial chondromatosis in the setting of oligoarticular juvenile idiopathic arthritis in a toddler |
| Q37654068 | Tumor Necrosis Factor Alpha Blocker-Induced Erythrodermic Sarcoidosis in with Juvenile Rheumatoid Arthritis: A Case Report and Review of the Literature |
| Q82838486 | Tumor necrosis factor alpha promoter polymorphisms in patients with juvenile idiopathic arthritis |
| Q83429409 | Tumor necrosis factor inhibitors and cancer in juvenile idiopathic arthritis: disentangling the web |
| Q37804381 | Tumor necrosis factor inhibitors in the management of juvenile idiopathic arthritis: an evidence-based review |
| Q71098392 | Tumor necrosis factor receptor p75 correlates better than p55 with disease activity in juvenile rheumatoid arthritis: comment on the article by Mangge et al |
| Q40465907 | Tumor necrosis factor receptor-associated periodic syndrome mimicking systemic juvenile idiopathic arthritis. |
| Q45394763 | Tumor necrosis factor-alpha -308 genotypes influence inflammatory activity and TNF-alpha serum concentrations in children with juvenile idiopathic arthritis |
| Q53240768 | Tumor necrosis factor-alpha blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: results of a multinational survey. |
| Q47694591 | Tumor necrosis factor-alpha is a common genetic risk factor for asthma, juvenile rheumatoid arthritis, and systemic lupus erythematosus in a Mexican pediatric population |
| Q45745856 | Tumor necrosis factor-alpha polymorphism and susceptibility to juvenile idiopathic arthritis |
| Q50954037 | Tumor necrosis factor-α -308 A/G gene polymorphism in children with juvenile idiopathic arthritis: relation to disease activity, damage, and functional status. |
| Q93034671 | Tumor necrosis factor-α inhibitor-induced psoriasis in juvenile idiopathic arthritis patients |
| Q80210881 | Tumour necrosis factor alpha promoter polymorphisms and etanercept therapy in juvenile idiopathic arthritis |
| Q34124467 | Tumour necrosis factor receptor II polymorphism and juvenile idiopathic arthritis |
| Q57752753 | Tumour necrosis factor α G→A −238 and G→A −308 polymorphisms in juvenile idiopathic arthritis |
| Q44753104 | Tumour necrosis factor-blocking agents in persistent oligoarticular juvenile idiopathic arthritis: results from the Dutch Arthritis and Biologicals in Children Register |
| Q45850697 | Tumour necrosis factor-α levels are elevated in adolescent patients with juvenile idiopathic arthritis on etanercept therapy |
| Q54788930 | Turkish Pediatric Rheumatology Society consensus statements on systemic onset juvenile idiopathic arthritis in Turkey. |
| Q73202476 | Twins concordant for juvenile rheumatoid arthritis |
| Q46260442 | Two new DPB1 alleles identified in a study of the genetics of susceptibility to pauciarticular juvenile rheumatoid arthritis |
| Q33404895 | Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis |
| Q46378793 | Two year remission rates and functional outcomes in an inception cohort of Canadian children with juvenile idiopathic arthritis. |
| Q42284804 | Two-year outcome of juvenile idiopathic arthritis in current daily practice: what can we tell our patients? |
| Q42789869 | Type 1 diabetes associated with Hashimoto's thyroiditis and juvenile rheumatoid arthritis: a case report with clinical and genetic investigations |
| Q59268805 | Type 1 diabetes associated with Hashimoto’s thyroiditis and juvenile rheumatoid arthritis : a case report |
| Q94595996 | Type 1 interferonopathy presenting as juvenile idiopathic arthritis with interstitial lung disease: report of a new phenotype |
| Q73689952 | Type and extent of enamel defects in juvenile idiopathic arthritis (JIA) |
| Q74319776 | Type of onset of juvenile idiopathic arthritis in monozygotic twins can be phenotypically different |
| Q55047292 | UNIQUE MONOARTHRITIS PRESENTATIONS IN OLIGOARTICULAR JUVENILE IDIOPATHIC ARTHRITIS: A CASE SERIES. |
| Q40139720 | US Evaluation of Juvenile Idiopathic Arthritis and Osteoarticular Infection |
| Q45247787 | US trends in rates of arthroplasty for inflammatory arthritis including rheumatoid arthritis, juvenile idiopathic arthritis, and spondyloarthritis |
| Q49860921 | USG Doppler in Juvenile Idiopathic Arthritis Treatment Response Assessment: A Much Needed Objective Tool. |
| Q69389820 | Ulnar variance in children--standard measurements for evaluation of ulnar shortening in juvenile rheumatoid arthritis, hereditary multiple exostosis and other bone or joint disorders in childhood |
| Q44270535 | Ultrasonographic examination in juvenile idiopathic arthritis is better than clinical examination for identification of intraarticular disease |
| Q45746144 | Ultrasonography (US) in juvenile idiopathic arthritis (JIA): diagnosis, treatment and follow-up of ankle involvement |
| Q34587429 | Ultrasonography and color Doppler in juvenile idiopathic arthritis: diagnosis and follow-up of ultrasound-guided steroid injection in the ankle region. A descriptive interventional study. |
| Q35959315 | Ultrasonography and color Doppler in juvenile idiopathic arthritis: diagnosis and follow-up of ultrasound-guided steroid injection in the wrist region. A descriptive interventional study |
| Q35225836 | Ultrasonography and color Doppler of proximal gluteal enthesitis in juvenile idiopathic arthritis: a descriptive study. |
| Q59268808 | Ultrasonography and colour Doppler in juvenile idiopathic arthritis: Diagnosis and follow-up of ultrasound-guided steroid injection in the wrist |
| Q83396539 | Ultrasonography for detecting enthesitis in juvenile idiopathic arthritis |
| Q73687011 | Ultrasonography in the early diagnosis of hip joint involvement in juvenile rheumatoid arthritis |
| Q77805320 | Ultrasonography of the hip in the evaluation of children with seronegative juvenile rheumatoid arthritis |
| Q46624151 | Ultrasound and cartilage thickness in juvenile idiopathic arthritis: new findings, new questions. |
| Q49553203 | Ultrasound changes in synovial abnormalities induced by treatment in juvenile idiopathic arthritis. |
| Q92218580 | Ultrasound detected changes in joint cartilage thickness in juvenile idiopathic arthritis |
| Q83837085 | Ultrasound findings on patients with juvenile idiopathic arthritis in clinical remission |
| Q45746160 | Ultrasound guided joint fluid aspiration and corticosteroid injection in patients with juvenile idiopathic arthritis (JIA). |
| Q38188152 | Ultrasound imaging in juvenile idiopathic arthritis for the rheumatologist |
| Q88689149 | Ultrasound imaging of synovial inflammation in juvenile idiopathic arthritis |
| Q26745505 | Ultrasound in juvenile idiopathic arthritis |
| Q46902394 | Ultrasound versus MRI in the evaluation of juvenile idiopathic arthritis of the knee |
| Q38643401 | Ultrasound versus magnetic resonance imaging of the temporomandibular joint in juvenile idiopathic arthritis: a systematic review |
| Q57786184 | Ultrasound-detected synovial abnormalities are frequent in clinically inactive juvenile idiopathic arthritis, but do not predict a flare of synovitis |
| Q53612247 | Ultrasound-guided corticosteroid injection of the subtalar joint for treatment of juvenile idiopathic arthritis. |
| Q84916693 | Ultrasound-guided corticosteroid injection therapy for juvenile idiopathic arthritis: 12-year care experience |
| Q37747783 | Ultrasound-guided steroid tendon sheath injections in juvenile idiopathic arthritis: a 10-year single-center retrospective study. |
| Q44706033 | Unclassified hereditary connective tissue disorder or arrested juvenile rheumatoid arthritis in a 40 year old woman |
| Q46916993 | Uncommon case of tibial bone infarction associated with juvenile idiopathic arthritis |
| Q38909520 | Understanding inflammation in juvenile idiopathic arthritis: How immune biomarkers guide clinical strategies in the systemic onset subtype |
| Q37361905 | Understanding treatment decision making in juvenile idiopathic arthritis: a qualitative assessment |
| Q87381398 | Unfavorable prognosis in a patient with neglected juvenile idiopathic arthritis |
| Q80862927 | Unilateral destructive wrist synovitis in juvenile idiopathic arthritis |
| Q89105649 | Unraveling the Phenotypic Variability of Juvenile Idiopathic Arthritis across Races or Geographic Areas--Key to Understanding Etiology and Genetic Factors? |
| Q94448349 | Unstimulated Parotid Saliva Sampling in Juvenile Idiopathic Arthritis and Healthy Controls: A Proof-of-Concept Study on Biomarkers |
| Q33760034 | Unstimulated salivary flow, pH, proteins and oral health in patients with Juvenile Idiopathic Arthritis |
| Q83429716 | Up regulated complement and fc receptors in juvenile idiopathic arthritis and correlation with disease phenotype |
| Q80480316 | Up-regulated CD26 density on synovial fluid monocytes from patients with juvenile idiopathic arthritis |
| Q36278722 | Update in juvenile rheumatoid arthritis |
| Q90813588 | Update of the evidence based, interdisciplinary guideline for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis |
| Q50315315 | Update of the results of a multinational survey regarding diagnosis and treatment of the temporomandibulare joint involvement in juvenile idiopathic arthritis- reflection of the day to day practice. |
| Q38071693 | Update on biologicals for treatment of juvenile idiopathic arthritis |
| Q37242383 | Update on biologics in juvenile idiopathic arthritis. |
| Q88687475 | Update on imaging in juvenile idiopathic arthritis |
| Q40538496 | Update on malignancies in children with juvenile idiopathic arthritis in the German BIKER Registry |
| Q88719889 | Update on research and clinical translation on specific clinical areas from biology to bedside: Unpacking the mysteries of juvenile idiopathic arthritis pathogenesis |
| Q38224080 | Update on research and clinical translation on specific clinical areas: From bench to bedside: How insight in immune pathogenesis can lead to precision medicine of severe juvenile idiopathic arthritis |
| Q48293122 | Update on the Treatment of Uveitis in Patients with Juvenile Idiopathic Arthritis: A Review. |
| Q90346712 | Update on the epidemiology, risk factors and disease outcomes of Juvenile idiopathic arthritis |
| Q47150341 | Update on the management of systemic juvenile idiopathic arthritis and role of IL-1 and IL-6 inhibition |
| Q36648151 | Update on the medical treatment of juvenile idiopathic arthritis |
| Q38679840 | Update on the pathogenesis and treatment of juvenile idiopathic arthritis |
| Q36225797 | Update on the pathogenesis and treatment of systemic onset juvenile rheumatoid arthritis |
| Q37060351 | Update on the treatment of juvenile idiopathic arthritis |
| Q97546452 | Update on the treatment of nonsystemic juvenile idiopathic arthritis including treatment-to-target: is (drug-free) inactive disease already possible? |
| Q40081220 | Update upon efficacy and safety of etanercept for the treatment of spondyloarthritis and juvenile idiopathic arthritis |
| Q37262587 | Updates on the risk markers and outcomes of severe juvenile idiopathic arthritis-associated uveitis |
| Q73899388 | Upper airway obstruction due to cricoarytenoid arthritis in a case of systemic onset juvenile rheumatoid arthritis |
| Q41203201 | Ureaplasma septic arthritis in an immunosuppressed patient with juvenile idiopathic arthritis |
| Q34268714 | Urine Peptidomic and Targeted Plasma Protein Analyses in the Diagnosis and Monitoring of Systemic Juvenile Idiopathic Arthritis |
| Q69847912 | Urticaria associated with juvenile rheumatoid arthritis |
| Q103811417 | Usability of eHealth and Mobile Health Interventions by Young People Living With Juvenile Idiopathic Arthritis: Systematic Review |
| Q34206585 | Usability testing of an online self-management program for adolescents with juvenile idiopathic arthritis |
| Q81980679 | Usage of intra-articular corticosteroid injections for the treatment of juvenile idiopathic arthritis: a survey of pediatric rheumatologists in the United States and Canada |
| Q57794532 | Use and effectiveness of rituximab in children and young people with juvenile idiopathic arthritis in a cohort study in the United Kingdom |
| Q40282463 | Use and perceived relevance of health-related Internet sites and online contact with peers among young people with juvenile idiopathic arthritis |
| Q47707091 | Use of ELISA to measure antinuclear antibodies in children with juvenile rheumatoid arthritis. |
| Q38805990 | Use of Tumor Necrosis Factor-Alpha Inhibitors in Children and Young Adults With Juvenile Idiopathic Arthritis or Rheumatoid Arthritis |
| Q45082435 | Use of a polymorphic dinucleotide repeat DNA marker in a T-cell receptor V beta gene to identify a distinct subset of pauciarticular-onset juvenile rheumatoid arthritis patients |
| Q51750549 | Use of adalimumab in patients with juvenile idiopathic arthritis refractory to etanercept and/or infliximab. |
| Q39679712 | Use of autologous pregnancy plasma to treat a flare of juvenile rheumatoid arthritis: case report and literature review |
| Q40501459 | Use of infliximab in patients with systemic juvenile idiopathic arthritis refractory to etanercept. |
| Q35070936 | Use of methotrexate in juvenile idiopathic arthritis |
| Q30968455 | Use of quantitative ultrasound to assess bone status in children with juvenile idiopathic arthritis: a pilot study |
| Q70228045 | Use of the HEp-2 cell substrate in the detection of antinuclear antibodies in juvenile rheumatoid arthritis |
| Q79169611 | Use of the Sharp and Larsen scoring methods in the assessment of radiographic progression in juvenile idiopathic arthritis |
| Q83353458 | Use of the faces pain scale to evaluate pain of a pediatric patient with pauciarticular juvenile rheumatoid arthritis |
| Q87636756 | Use of tissue Doppler and its comparison with other pulse Doppler echocardiography in the evaluation of diastolic functions in patients with active juvenile idiopathic arthritis |
| Q37482393 | Usefulness of adalimumab in the treatment of refractory uveitis associated with juvenile idiopathic arthritis. |
| Q79815925 | User perspectives of transitional care for adolescents with juvenile idiopathic arthritis |
| Q60954857 | Using Chromatin Architecture to Understand the Genetics and Transcriptomics of Juvenile Idiopathic Arthritis |
| Q92092616 | Using Knee Acoustical Emissions for Sensing Joint Health in Patients with Juvenile Idiopathic Arthritis: A Pilot Study |
| Q36860571 | Using Patient-Reported Outcome Measures to Capture the Patient's Voice in Research and Care of Juvenile Idiopathic Arthritis |
| Q92780174 | Using an Artificial Intelligence-Based Argument Theory to Generate Automated Patient Education Dialogues for Families of Children with Juvenile Idiopathic Arthritis |
| Q38443735 | Using the attract method to identify core pathways in juvenile idiopathic arthritis |
| Q46778852 | Utility of corticosteroid injection for temporomandibular arthritis in children with juvenile idiopathic arthritis |
| Q39794133 | Utility of rheumatoid factor in the diagnosis of juvenile rheumatoid arthritis. |
| Q56835592 | Utilization of Tumor Necrosis Factor Alpha Inhibitors in Children and Young Adults with Juvenile Idiopathic Arthritis |
| Q42314425 | Uveitis Associated with Juvenile Idiopathic Arthritis, our Observations |
| Q35635172 | Uveitis Events During Adalimumab, Etanercept, and Methotrexate Therapy in Juvenile Idiopathic Arthritis: Data From the Biologics in Pediatric Rheumatology Registry |
| Q61831290 | Uveitis Related to Juvenile Idiopathic Arthritis: Familial Cases and Possible Genetic Implication in the Pathogenesis |
| Q34364655 | Uveitis and anti nuclear antibody positivity in children with juvenile idiopathic arthritis. |
| Q43102836 | Uveitis and juvenile idiopathic arthritis: A cohort study. |
| Q102331043 | Uveitis associated juvenile idiopathic arthritis - presentation of recently published international recommendations for diagnostic and therapeutic procedures |
| Q38396962 | Uveitis associated with juvenile idiopathic arthritis |
| Q34988555 | Uveitis associated with juvenile idiopathic arthritis: envisioning the future. |
| Q39759658 | Uveitis associated with juvenile rheumatoid arthritis |
| Q99634168 | Uveitis in Juvenile Idiopathic Arthritis: 18-year Outcome in the Population-based Nordic Cohort Study |
| Q28086972 | Uveitis in juvenile idiopathic arthritis |
| Q92830061 | Uveitis in juvenile idiopathic arthritis |
| Q26796509 | Uveitis in juvenile idiopathic arthritis: recent therapeutic advances |
| Q68344387 | Uveitis in juvenile rheumatoid arthritis--clinico-immunologic study |
| Q73635950 | Uveitis in sibling pairs with juvenile idiopathic arthritis |
| Q43049275 | Uveitis in young adults with juvenile idiopathic arthritis. |
| Q35555577 | Uveitis in young adults with juvenile idiopathic arthritis: a clinical evaluation of 123 patients |
| Q43556946 | Vaccination coverage in children with juvenile idiopathic arthritis followed at a paediatric tertiary care centre |
| Q84806498 | Vaccination leads to an aberrant FOXP3 T-cell response in non-remitting juvenile idiopathic arthritis |
| Q98649915 | Vaccinations Do Not Increase Arthritis Flares in Juvenile Idiopathic Arthritis: A Study of the Relationship between Routine Childhood Vaccinations on the Australian Immunisation Schedule and Arthritis Activity in Children with Juvenile Idiopathic Ar |
| Q102376670 | Vaccinology Education of Nurses and the Current Immunoprophylaxis Recommendations for Children with Juvenile Idiopathic Arthritis |
| Q35148537 | Valgus Knee Deformities in Children with Juvenile Chronic Polyarthritis Treated by Epiphysial Stapling |
| Q64927266 | Validating 10-joint juvenile arthritis disease activity score cut-offs for disease activity levels in non-systemic juvenile idiopathic arthritis. |
| Q91018338 | Validation and adaptation of a German screening tool to identify patients at risk of juvenile idiopathic arthritis |
| Q57913847 | Validation of Relapse Risk Biomarkers for Routine Use in Patients With Juvenile Idiopathic Arthritis |
| Q38787373 | Validation of administrative case ascertainment algorithms for chronic childhood arthritis in Manitoba, Canada |
| Q47383992 | Validation of classification criteria of macrophage activation syndrome in Japanese patients with systemic juvenile idiopathic arthritis |
| Q92666427 | Validation of prediction models of severe disease course and non-achievement of remission in juvenile idiopathic arthritis part 2: results of the Nordic model in the Canadian cohort |
| Q91729610 | Validation of prediction models of severe disease course and non-achievement of remission in juvenile idiopathic arthritis: part 1-results of the Canadian model in the Nordic cohort |
| Q30686042 | Validation of the Brazilian version of the Pediatric Outcomes Data Collection Instrument: a cross-sectional evaluation in children and adolescents with juvenile idiopathic arthritis |
| Q47415533 | Validation of the French version of the Childhood Health Assessment Questionnaire (CHAQ) in juvenile idiopathic arthritis |
| Q44572313 | Validation of the proposed ILAR classification criteria for juvenile idiopathic arthritis. International League of Associations for Rheumatology. |
| Q92488589 | Validity and feasibility of the self-report EQ-5D-Y as a generic Health-Related Quality of Life outcome measure in children and adolescents with Juvenile Idiopathic Arthritis in Western Cape, South Africa |
| Q37345902 | Validity of a three-variable Juvenile Arthritis Disease Activity Score in children with new-onset juvenile idiopathic arthritis |
| Q35290573 | Validity of juvenile idiopathic arthritis diagnoses using administrative health data |
| Q41212420 | Validity of reported pain as a measure of clinical state in juvenile rheumatoid arthritis |
| Q47818042 | Validity of the 6-minute walking test in juvenile idiopathic arthritis |
| Q80502312 | Validity of the childhood health assessment questionnaire is independent of age in juvenile idiopathic arthritis |
| Q34986236 | Value of monitoring plasma salicylate levels in treating juvenile rheumatoid arthritis. Observations in 42 cases |
| Q43553277 | Value of serum ferritin in measuring the activation and prognosis in systemic onset juvenile idiopathic arthritis |
| Q35966959 | Variants in CXCR4 associate with juvenile idiopathic arthritis susceptibility |
| Q35014339 | Variants in TNFAIP3, STAT4, and C12orf30 loci associated with multiple autoimmune diseases are also associated with juvenile idiopathic arthritis |
| Q53201077 | Variation in dentofacial morphology and occlusion in juvenile idiopathic arthritis subjects: a case-control study. |
| Q93513939 | Variation in the CD4/non-T cell autologous mixed lymphocyte reaction with disease activity and rheumatoid factor titer in patients with juvenile rheumatoid arthritis |
| Q81042729 | Variation in the initial treatment of knee monoarthritis in juvenile idiopathic arthritis: a survey of pediatric rheumatologists in the United States and Canada |
| Q82943098 | Variations in the Treatment for Juvenile Rheumatoid Arthritis: Is There a Place for Uncontrolled Observations in this Era of Controlled Clinical Trials? |
| Q46231014 | Varicella immunity and vaccine response in children with juvenile idiopathic arthritis treated with DMARD. |
| Q91947712 | Vertical Drop Jump Performance in Youth with Juvenile Idiopathic Arthritis |
| Q53457194 | VibroCV: a computer vision-based vibroarthrography platform with possible application to Juvenile Idiopathic Arthritis. |
| Q69354059 | Viral antibody titers to rubella and rubeola in juvenile rheumatoid arthritis |
| Q39786431 | Visiting consultant clinics to study prevalence rates of juvenile rheumatoid arthritis and childhood systemic lupus erythematosus across dispersed geographic areas |
| Q91366919 | Visual Function And Quality Of Life In A Cohort Of Swedish Children With Juvenile Idiopathic Arthritis |
| Q36563352 | Visual outcome in children with juvenile idiopathic arthritis related uveitis |
| Q81604265 | Visual outcome of juvenile rheumatoid arthritis-associated uveitis in adults |
| Q51792606 | Visual outcomes in children with juvenile idiopathic arthritis-associated uveitis. |
| Q50970871 | Visual outcomes prognosticators in juvenile rheumatoid arthritis-associated uveitis. |
| Q96161607 | Vitamin D Profile in Juvenile Idiopathic Arthritis Patients in a Tertiary Care Hospital in Bangladesh |
| Q35136974 | Vitamin D concentrations and disease activity in Moroccan children with juvenile idiopathic arthritis |
| Q60044822 | Vitamin D deficiency is associated with higher disease activity and the risk for uveitis in juvenile idiopathic arthritis - data from a German inception cohort |
| Q40921585 | Vitamin D levels in juvenile idiopathic arthritis from an equatorial region |
| Q46295342 | Vitamin D metabolism and bone mineralization in children with juvenile rheumatoid arthritis |
| Q91056050 | Vitamin D receptor gene polymorphism influences lipid profile in patients with juvenile idiopathic arthritis |
| Q71688174 | Vitamin E, thiobarbituric acid reactive substance concentrations and superoxide dismutase activity in the blood of children with juvenile rheumatoid arthritis |
| Q47279634 | Weight bearing as a treatment for damaged hips in juvenile rheumatoid arthritis |
| Q81370183 | Weighting improves the information provided by joint counts on the severity of arthritis and its impact on patients' well-being in juvenile idiopathic arthritis |
| Q37975164 | What do cytokine profiles tell us about subsets of juvenile idiopathic arthritis? |
| Q38072347 | What do we know about juvenile idiopathic arthritis and vitamin D? A systematic literature review and meta-analysis of current evidence. |
| Q40436190 | What does "active disease" mean? patient and parent perceptions of disease activity in the systemic arthritis form of juvenile idiopathic arthritis (SO-JIA). |
| Q26995394 | What does an adult rheumatologist need to know about juvenile idiopathic arthritis? |
| Q39883899 | What does it mean to grow up with juvenile idiopathic arthritis? A qualitative study on the perspectives of patients. |
| Q47644621 | What is low-dose corticosteroid therapy in juvenile idiopathic arthritis? A worldwide, questionnaire-based survey |
| Q89721693 | What is the real role of ultrasound in the management of juvenile idiopathic arthritis? |
| Q48065384 | What matters most for patients, parents, and clinicians in the course of juvenile idiopathic arthritis? A qualitative study |
| Q50547713 | What we can learn from existing evidence about physical activity for juvenile idiopathic arthritis? |
| Q74059922 | What's new in the diagnosis and treatment of juvenile rheumatoid arthritis |
| Q33651558 | When a patient suspected with juvenile idiopathic arthritis turns out to be diagnosed with an infectious disease - a review of Lyme arthritis in children |
| Q45745701 | When and how to stop etanercept after successful treatment of patients with juvenile idiopathic arthritis |
| Q84068284 | When and how to stop etanercept after successful treatment of patients with juvenile idiopathic arthritis |
| Q51115098 | When should intraocular lenses be implanted in patients with juvenile idiopathic arthritis-associated iridocyclitis? |
| Q38575468 | Which patients with rheumatoid arthritis, spondyloarthritis, or juvenile idiopathic arthritis receive TNF-α antagonists in France? The CORPUS cohort study. |
| Q37073220 | Whole blood expression profiling from the TREAT trial: insights for the pathogenesis of polyarticular juvenile idiopathic arthritis |
| Q33828973 | Whole blood gene expression profiling predicts therapeutic response at six months in patients with polyarticular juvenile idiopathic arthritis |
| Q57073315 | Whole exome sequencing in systemic juvenile idiopathic arthritis |
| Q55124592 | Whole exome sequencing in systemic juvenile idiopathic arthritis. |
| Q35064189 | Whole-exome sequencing reveals overlap between macrophage activation syndrome in systemic juvenile idiopathic arthritis and familial hemophagocytic lymphohistiocytosis |
| Q81505201 | Why can we no longer find juvenile idiopathic arthritis-associated amyloidosis in childhood or in adolescence in Finland? |
| Q93191233 | Why is the frequency of uveitis low in Turkish children with juvenile idiopathic arthritis? |
| Q39746571 | Why we need a process on breaking news of Juvenile Idiopathic Arthritis: a mixed methods study |
| Q103828541 | Widefield Fundus Fluorescein Angiography Features of Uveitis Associated with Juvenile Idiopathic Arthritis |
| Q98395377 | Wilson's Disease Masquerading as Juvenile Idiopathic Arthritis in an Adolescent |
| Q57322720 | Wnt-1-inducible signaling pathway protein 3 and susceptibility to juvenile idiopathic arthritis |
| Q89159800 | Wrist Arthroscopy in Juvenile Idiopathic Arthritis |
| Q57178610 | Wrist Arthroscopy in Juvenile Idiopathic Arthritis: A Review of Current Literature and Future Implications |
| Q71262172 | Wrist and Finger Deformities in Juvenile Rheumatoid Arthritis |
| Q51166772 | Wrist and ankle MRI of patients with juvenile idiopathic arthritis: identification of unsuspected multicompartmental tenosynovitis and arthritis. |
| Q71659510 | Wrist subluxation in juvenile rheumatoid arthritis: pathophysiology and management |
| Q38190909 | X-linked agammaglobulinemia combined with juvenile idiopathic arthritis and invasive Klebsiella pneumoniae polyarticular septic arthritis |
| Q55065949 | X-linked agammaglobulinemia in two siblings with a novel mutation in the BTK gene who presented with polyarticular juvenile idiopathic arthritis. |
| Q70746727 | X-ray changes in the joints in patients with juvenile rheumatoid arthritis |
| Q69386424 | X-ray findings in the hand skeleton in the juvenile rheumatoid arthritis |
| Q46974946 | YIM-O13. Development of novel protein biomarkers for the prediction of response to treatment in juvenile idiopathic arthritis |
| Q48500129 | Yoga Intervention for an Adolescent With Juvenile Idiopathic Arthritis: A Case Study. |
| Q95649215 | Yoga and Aerobic Dance for Pain Management in Juvenile Idiopathic Arthritis: Protocol for a Pilot Randomized Controlled Trial |
| Q41407128 | You are what you eat: healthy food choices, nutrition, and the child with juvenile rheumatoid arthritis. |
| Q37231137 | Young people first, juvenile idiopathic arthritis second: transitional care in rheumatology |
| Q70745700 | [A case of adult onset juvenile rheumatoid arthritis] |
| Q85026036 | [A case of cricoarytenoid ankylosis in juvenile idiopathic arthritis] |
| Q79496481 | [A case of juvenile rheumatoid arthritis associated with valvulopathies] |
| Q68074026 | [A case of juvenile rheumatoid arthritis recurred in adulthood with remarkably high level of serum ferritin] |
| Q69513074 | [A case of juvenile rheumatoid arthritis treated with thymopentin] |
| Q74493255 | [A case of juvenile rheumatoid arthritis with MPO-ANCA associated nephritis] |
| Q70946983 | [A case of mixed connective tissue disease in childhood with symptoms of juvenile rheumatoid arthritis (author's transl)] |
| Q80204229 | [A case report of macrophage activation syndrome complicated by systemic onset juvenile idiopathic arthritis] |
| Q95553089 | [A case report of plasmapheresis successfully treated macrophage activation syndrome in juvenile idiopathic arthritis] |
| Q69468736 | [A clinical assessment of whole blood chemoluminescence in juvenile rheumatoid arthritis] |
| Q73480516 | [A girl with systemic onset juvenile rheumatoid arthritis suspected to be due to human parvovirus B19 infection] |
| Q70306877 | [A model and 3 examples for understanding HLA and diseases: cis and trans complementation of MHC class II in juvenile insulin-dependent diabetes, juvenile rheumatoid arthritis and celiac disease] |
| Q56892828 | [A new computerized file of juvenile rheumatoid arthritis] |
| Q69860352 | [A study of HLA in Japanese patients with juvenile rheumatoid arthritis] |
| Q81224701 | [Abbott proposes in Europe and the U.S.A. the approval of Humira (adalimumab) for therapy of juvenile idiopathic arthritis. Pediatric clinical trial shows very promising results in juvenile rheumatoid arthritis] |
| Q85255255 | [Ability of the Childhood Health Assessment Questionnaire in predicting outcome of patients with juvenile idiopathic arthritis] |
| Q69812256 | [Administration of massive dosages of immunoglobulin for the treatment of juvenile rheumatoid arthritis] |
| Q103790720 | [Advances and suggestions for option in imaging for juvenile idiopathic arthritis] |
| Q71189866 | [Age-related characteristics of the pauciarticular variant of an articular form of juvenile rheumatoid arthritis] |
| Q50108868 | [An atypical case of systemic juvenile idiopathic arthritis]. |
| Q77895742 | [Analysis of 56 cases of generalized juvenile rheumatoid arthritis] |
| Q72562290 | [Anemia in juvenile rheumatoid arthritis] |
| Q79187942 | [Anterior uveitis and juvenile idiopathic arthritis] |
| Q75828484 | [Anti-chromatin antibodies in juvenile rheumatoid arthritis] |
| Q95553083 | [Antibodies to mutated citrullinated vimentin and some associated autoantibodies in juvenile idiopathic arthritis] |
| Q71633823 | [Antinuclear antibodies and juvenile chronic rheumatoid arthritis] |
| Q69742296 | [Aortic insufficiency and rapidly constrictive pericarditis in juvenile onset rheumatoid arthritis. Apropos of a case and review of the literature] |
| Q82558342 | [Application of etanercept in treatment of juvenile idiopathic arthritis and adult onset still disease] |
| Q69522026 | [Application of thermography in the diagnosis and follow-up of juvenile rheumatoid arthritis] |
| Q73175438 | [Arsenal against juvenile rheumatoid arthritis. Preventing permanent damage] |
| Q54195667 | [Assessment of activity of juvenile rheumatoid arthritis] |
| Q83832198 | [Assessment of left ventricular functions with tissue Doppler, strain and strain rate echocardiography in children with juvenile idiopathic arthritis: An observational study] |
| Q80208391 | [Assessment of the ocular changes in children with juvenile idiopathic arthritis] |
| Q90898798 | [Association between autophagy and systemic juvenile idiopathic arthritis and related mechanism: a preliminary study] |
| Q68165843 | [Association of juvenile rheumatoid arthritis with hepatitis B] |
| Q95363022 | [Association of vitamin D concentrations with juvenile idiopathic arthritis] |
| Q69674705 | [Autoantibodies in juvenile rheumatoid arthritis. Clinical and serologic study] |
| Q69923328 | [Autoantibodies in juvenile rheumatoid arthritis] |
| Q50088385 | [BIOLOGIC THERAPY FOR JUVENILE IDIOPATHIC ARTHRITIS]. |
| Q79381563 | [Band-shaped keratitis with juvenile rheumatoid arthritis.] |
| Q80197419 | [Biologic agents in juvenile idiopathic arthritis] |
| Q81483227 | [Biological therapy treatment of juvenile idiopathic arthritis] |
| Q82056256 | [Biologics for treatment of juvenile idiopathic arthritis. Consensus statement of the 7th Wörlitzer Expertengespräche 2004 for the German Arbeitsgemeinschaft Kinder- und Jugendrheumatologie] |
| Q92006121 | [Biologics in the treatment of juvenile idiopathic arthritis : A comparison of mono- and combination therapy with synthetic DMARDs] |
| Q92018935 | [CONDITION OF HEPATOBILIARY SYSTEM IN JUVENILE RHEUMATOID ARTHRITIS] |
| Q68007158 | [Calcaneal enthesopathy in juvenile rheumatoid arthritis with oligoarticular onset] |
| Q68048050 | [Cardiac involvement in juvenile rheumatoid arthritis] |
| Q70377794 | [Catecholamine excretion in children with juvenile rheumatoid arthritis] |
| Q95437144 | [Cervical spine involvement in juvenile idiopathic arthritis] |
| Q104746753 | [Change of diagnosis and diagnostic category in patients with juvenile idiopathic arthritis within 7 years of follow-up] |
| Q68021058 | [Changes in the hepatobiliary system in juvenile rheumatoid arthritis] |
| Q71189861 | [Characteristics of secondary amyloidosis in juvenile rheumatoid arthritis] |
| Q91722157 | [Characteristics of synovial fluid in patients with juvenile idiopathic arthritis] |
| Q74204299 | [Characteristics of the cytokine response in patients with various forms of juvenile idiopathic arthritis] |
| Q81069839 | [Chronic juvenile rheumatoid arthritis in the hospital. IV. Psychological study of affected children] |
| Q81069831 | [Chronic juvenile rheumatoid arthritis in the hospital. Psychosociological study. II.--Hospitalization] |
| Q81069835 | [Chronic juvenile rheumatoid arthritis in the hospital. Psychosociological study. III--Interviews with the parents] |
| Q81069844 | [Chronic juvenile rheumatoid arthritis in the hospital. V.-- Schooling, social and family life] |
| Q81325040 | [Chronic juvenile rheumatoid arthritis: introduction] |
| Q68550505 | [Chronic meningococcal meningitis simulating systemic juvenile rheumatoid arthritis] |
| Q86605406 | [Chronic tonsillitis complicated by juvenile rheumatoid arthritis] |
| Q71344718 | [Circulating immune complexes in juvenile rheumatoid arthritis. The relationship to involvement of the visceral organs in the process] |
| Q52978325 | [Classic pachydermodactyly. A simulator of juvenile idiopathic arthritis]. |
| Q48732998 | [Classification criteria and clinical picture of juvenile idiopathic arthritis]. |
| Q77726647 | [Classification of juvenile rheumatoid arthritis becoming more precise] |
| Q67385281 | [Classification of juvenile rheumatoid arthritis] |
| Q70996843 | [Classification of juvenile rheumatoid arthritis] |
| Q64932190 | [Clinical analysis of 25 cases of enthesitis related juvenile idiopathic arthritis]. |
| Q81069938 | [Clinical and biological study of the very early forms of juvenile rheumatoid arthritis] |
| Q83743756 | [Clinical and immunological features of oral health in children with juvenile rheumatoid arthritis] |
| Q70434183 | [Clinical and serological diagnosis of juvenile rheumatoid arthritis] |
| Q104489911 | [Clinical characteristics and biological treatment of adult patient with juvenile idiopathic arthritis] |
| Q72359142 | [Clinical features of infantile patient with juvenile rheumatoid arthritis] |
| Q71736023 | [Clinical picture and course of juvenile rheumatoid arthritis and Still's syndrome] |
| Q67846827 | [Clinical studies on severe growth retardation in juvenile rheumatoid arthritis and Still's syndrome (proceedings)] |
| Q67873947 | [Clinical study on severe growth retardation in juvenile rheumatoid arthritis and Still's syndrome] |
| Q52260036 | [Clinico-developmental aspects of juvenile rheumatoid arthritis] |
| Q67289685 | [Clinico-morphological comparison of juvenile rheumatoid arthritis (mostly in torpid mono- and oligoarthritides] |
| Q80244831 | [Coincidence of juvenile idiopathic arthritis and multiple sclerosis: case report] |
| Q77775937 | [Combined ultrasound and sinusoidal modulated currents in treating children with juvenile rheumatoid arthritis] |
| Q69125101 | [Comparative evaluation of the effectiveness of intra-articular therapy with contrical and hydrocortisone of patients with juvenile rheumatoid arthritis] |
| Q70689520 | [Comparison of clinical symptoms and immunological findings between two groups of patients with complete remission and persisting course of juvenile rheumatoid arthritis] |
| Q45937442 | [Comparison of magnetic resonance imaging signs and clinical findings in follow-up examinations in children and juveniles with temporomandibular joint involvement in juvenile idiopathic arthritis]. |
| Q86092900 | [Comparison of the Disease Activity Score-28 and Juvenile Arthritis Disease Activity Score in the juvenile idiopathic arthritis] |
| Q81437650 | [Complex functional test in juvenile rheumatoid arthritis] |
| Q53561887 | [Composition of linoleic and arachidonic acids in phosphatidylcholine of erythrocytes membrane and IL-6 and TNF-alpha in serum and C-reactive protein concentration in children with juvenile idiopathic arthritis]. |
| Q68765975 | [Compromise of the maxillo-facial complex in juvenile rheumatoid arthritis] |
| Q69472600 | [Compromised function of the masticatory apparatus in juvenile rheumatoid arthritis] |
| Q69518870 | [Computer-assisted evaluation of the symptoms of juvenile rheumatoid arthritis] |
| Q80795403 | [Concepts on the pathogenesis of juvenile idiopathic arthritis] |
| Q81300141 | [Condition of organ of vision in children and adolescence with juvenile idiopathic arthritis] |
| Q87008355 | [Contribution of non-HLA genes to juvenile idiopathic arthritis susceptibility] |
| Q82545079 | [Correlation between intima-media thickness in carotid artery and markers of epithelial cell dysfunction in patients with juvenile idiopathic arthritis] |
| Q81325050 | [Course and prognosis of systemic forms of chronic juvenile rheumatoid arthritis] |
| Q68850590 | [Criteria for the classification of juvenile rheumatoid arthritis] |
| Q83489399 | [Current application of glucocoriticoid in juvenile idiopathic arthritis] |
| Q69924100 | [Current problems in juvenile rheumatoid arthritis] |
| Q89032544 | [Current therapy of polyarticular forms of juvenile idiopathic arthritis] |
| Q68592918 | [Current treatment of juvenile rheumatoid arthritis (juvenile chronic polyarthritis) and Still's syndrome] |
| Q81220059 | [Cytokine levels in serum of patients with juvenile idiopathic arthritis depending on subtype and disease activity] |
| Q50802438 | [Cytokine profile changes in children with juvenile idiopathic arthritis-associated uveitis]. |
| Q69949674 | [Cytologic and cytochemical examinations of joint effusions in juvenile rheumatoid arthritis] |
| Q70025450 | [Cytomorphologic findings in juvenile rheumatoid arthritis] |
| Q69961523 | [Cytomorphological and biochemical aspects of juvenile rheumatoid arthritis] |
| Q69794299 | [Decimetric waves and radon baths in the treatment of juvenile rheumatoid arthritis] |
| Q95809383 | [Definition of criteria for high disease activity using the Juvenile Rheumatoid Arthritis Disease Activity Score] |
| Q71344743 | [Design of a juvenile rheumatoid arthritis classification] |
| Q67854284 | [Destructive changes in the joints in juvenile rheumatoid arthritis] |
| Q69936429 | [Detection of antinuclear antibodies using chicken erythrocytes in lupus erythematosus, scleroderma, rheumatoid arthritis and juvenile chronic arthritis] |
| Q50095724 | [Determination of 25(OH)D serum levels in children with systemic lupus erythematosus and juvenile idiopathic arthritis]. |
| Q75408432 | [Diagnosis and prognosis of systemic juvenile rheumatoid arthritis] |
| Q95416634 | [Diagnosis and treatment of juvenile idiopathic arthritis (JIA)] |
| Q71882666 | [Diagnosis of active inflammatory process in juvenile rheumatoid arthritis] |
| Q52925889 | [Diagnosis, prophylaxis and therapy of osteoporosis in juvenile idiopathic arthritis: consensus statement of the German Association for Pediatric Rheumatology]. |
| Q69794278 | [Diagnostic criteria for juvenile rheumatoid arthritis] |
| Q71227422 | [Diagnostic criteria of juvenile rheumatoid arthritis (discussion apropos the article by A. V. Dolgopolova et al.)] |
| Q68147049 | [Diagnostic value of various hematological indicators in juvenile rheumatoid arthritis] |
| Q73720849 | [Dietetic and anthropometric assessment in juvenile rheumatoid arthritis patients] |
| Q83442847 | [Disorders of growth and development of maxillofacial area in children with juvenile rheumatoid arthritis] |
| Q71173315 | [Drug therapy of juvenile rheumatoid arthritis] |
| Q80757832 | [Early atherosclerosis changes in children with juvenile idiopathic arthritis] |
| Q71500319 | [Early bilateral coxitis in a case of juvenile rheumatoid arthritis] |
| Q68855192 | [Effect of juvenile rheumatoid arthritis on the growth of facial skeleton] |
| Q79828087 | [Effective application of anti-IL-6-monoclonal antibody for children with systemic-onset juvenile idiopathic arthritis] |
| Q92173852 | [Effectiveness of Watsu therapy in patients with juvenile idiopathic arthritis. A parallel, randomized, controlled and single-blind clinical trial] |
| Q69430870 | [Effectiveness of intra-articular dimexide in combination with hydrocortisone and hydrocortisone in patients with juvenile rheumatoid arthritis] |
| Q68897469 | [Effectiveness of the treatment of juvenile rheumatoid arthritis with dimethyl sulfoxide gel] |
| Q54299102 | [Efficacy and safety of humanized interleukin-6 receptor antibody in treatment of systemic juvenile idiopathic arthritis]. |
| Q83565577 | [Efficacy of etanercept in the treatment of juvenile idiopathic arthritis] |
| Q84782202 | [Efficacy of thalidomide for treatment of juvenile idiopathic arthritis] |
| Q95567549 | [Efficiency and safety of human monoclonal antibodies to TNF-alpha in children with juvenile idiopathic arthritis in primary and secondary ineffectiveness of other biologicals] |
| Q67842935 | [Electromyographic and electrognathographic analysis of patients with juvenile rheumatoid arthritis] |
| Q36513302 | [Electron microscope studies of synovial tissue in juvenile rheumatoid arthritis] |
| Q70384490 | [Endocrinological studies on growth retardation in children with juvenile rheumatoid arthritis (author's transl)] |
| Q81325044 | [Enquiry concerning the incidence of chronic juvenile rheumatoid arthritis in France in 1972] |
| Q68870249 | [Errors in the diagnosis of juvenile rheumatoid arthritis] |
| Q64382843 | [Etiological connection between juvenile rheumatoid arthritis and the chronic form of coxsackie virus infection] |
| Q71467446 | [Evaluation of some inflammatory and immune parameters in juvenile rheumatoid arthritis during the acute phase and in remission] |
| Q82105204 | [Evidence and consensus based treatment guidelines 2010 for juvenile idiopathic arthritis by the German Society of Paediatric Rheumatology] |
| Q78292875 | [Experimental studies on elephantiasis developed in juvenile rheumatoid arthritis.] |
| Q70603135 | [Features of the pre- and postoperative management of patients with eye lesions in juvenile rheumatoid arthritis] |
| Q81069826 | [For "psychological management" in juvenile rheumatoid arthritis] |
| Q68021054 | [Functional state of the endocrine glands and the immune system in patients with juvenile rheumatoid arthritis] |
| Q93674770 | [Genetic aspects of Behçet's disease and juvenile rheumatoid arthritis] |
| Q69842420 | [Genetic study of properdin factor B in juvenile rheumatoid arthritis] |
| Q73960974 | [Growth disturbances in children with juvenile rheumatoid arthritis] |
| Q73466438 | [Growth in children with juvenile idiopathic arthritis] |
| Q56966533 | [Guidelines for prescribing and monitoring biologic therapies in juvenile idiopathic arthritis] |
| Q85633601 | [Guidelines on biologic drugs for the treatment of children with juvenile idiopathic arthritis (JIA)] |
| Q69157102 | [HLA antigens and juvenile rheumatoid arthritis] |
| Q84290216 | [HLA-DRB1 allelic polymorphism in children with juvenile idiopathic arthritis] |
| Q82967859 | [Hand deformity in adult rheumatoid arthritis and juvenile chronic arthritis] |
| Q73940102 | [Health related quality of life survey about children and adolescents with juvenile idiopathic arthritis] |
| Q69833018 | [Hepatitis caused by cytomegalovirus. Apropos of a patient with complicated juvenile rheumatoid arthritis] |
| Q72461289 | [Hip joint surgery in juvenile rheumatoid arthritis] |
| Q77735386 | [Humoral immunological aspects of the pathogenesis of rheumatism, nonrheumatic carditis and juvenile rheumatoid arthritis in children] |
| Q71189900 | [Hyperbaric oxygenation in the complex treatment of juvenile rheumatoid arthritis] |
| Q68546956 | [Immune cell alterations in juvenile rheumatoid arthritis] |
| Q68207900 | [Immunocorrection with T-activin in the combined treatment of juvenile rheumatoid arthritis] |
| Q71328031 | [Immunogenetic aspects and possibilities of classification of juvenile rheumatoid arthritis] |
| Q68357357 | [Immunoglobulins and complement in systemic lupus erythematosus, rheumatoid arthritis and juvenile rheumatoid arthritis] |
| Q54384111 | [Immunologic reactivity in juvenile rheumatoid arthritis] |
| Q70732043 | [Immunomodulating therapy of systemic juvenile rheumatoid arthritis: administration of high-dose intravenous gamma globulin] |
| Q81868189 | [Importance of the new biologicals and cytokine antagonists in the treatment of juvenile idiopathic arthritis (JIA)] |
| Q71201036 | [Indication of synovectomy of the knee joint in juvenile rheumatoid arthritis (author's transl)] |
| Q79699363 | [Interdisciplinary and evidence-based treatment guideline for juvenile idiopathic arthritis] |
| Q82672546 | [Interdisciplinary treatment of temporomandibular inflammation in children with juvenile idiopathic arthritis] |
| Q83760468 | [Interpretation of the evidence-based recommendations for the diagnosis and management of juvenile idiopathic arthritis (oligoarticular and polyarticular)] |
| Q82336755 | [Intra-articular corticosteroid injections in the management of juvenile idiopathic arthritis] |
| Q70406096 | [Intra-articular drug therapy of juvenile rheumatoid arthritis (a review of the literature)] |
| Q78166389 | [Intravenous immunoglobulin in combined therapy for children with juvenile rheumatoid arthritis (evaluation of therapeutical efficiency and factors that influence them)] |
| Q68229258 | [Iridocyclitis and juvenile rheumatoid arthritis] |
| Q70458701 | [Iridocyclitis with juvenile rheumatoid arthritis] |
| Q92914085 | [It is time to reconcile systemic juvenile idiopathic arthritis and adult-onset Still's disease] |
| Q67580500 | [JRA (juvenile rheumatoid arthritis) and benign juvenile polyarthritis] |
| Q93495704 | [JRA (juvenile rheumatoid arthritis) and benign juvenile polyarthritis] |
| Q76911599 | [JUVENILE RHEUMATOID ARTHRITIS] |
| Q89712728 | [Juvenile idiopathic arthritis and Turner's syndrome] |
| Q84700382 | [Juvenile idiopathic arthritis with dry synovitis: clinical case and review of literature] |
| Q52920068 | [Juvenile idiopathic arthritis--clinical subgroups and classification]. |
| Q61831314 | [Juvenile idiopathic arthritis. (I) Clinical aspects] |
| Q61831316 | [Juvenile idiopathic arthritis. II. Treatment and prognosis] |
| Q87443781 | [Juvenile idiopathic arthritis: Definition and classification] |
| Q82397438 | [Juvenile idiopathic arthritis: Part 2. Prognosis and current therapeutic approach] |
| Q95457794 | [Juvenile idiopathic arthritis: from biomarker to treatment] |
| Q53312431 | [Juvenile idiopathic arthritis: the silent killer of pediatric temporomandibular joints]. |
| Q73161363 | [Juvenile idiopathic arthritis] |
| Q83560926 | [Juvenile idiopathic arthritis] |
| Q87149030 | [Juvenile idiopathic arthritis] |
| Q93083378 | [Juvenile idiopathic arthritis] |
| Q70639014 | [Juvenile rheumatoid arthritis (juvenile chronic arthritis--Still's disease)] |
| Q71189852 | [Juvenile rheumatoid arthritis - an articular-visceral form] |
| Q71210532 | [Juvenile rheumatoid arthritis and constrictive pericarditis with effusion] |
| Q70001253 | [Juvenile rheumatoid arthritis and lupus erythematosus. Apropos of 2 cases] |
| Q72840482 | [Juvenile rheumatoid arthritis and uveitis] |
| Q77538779 | [Juvenile rheumatoid arthritis associated with aortitis syndrome] |
| Q71208055 | [Juvenile rheumatoid arthritis with adult onset. Report of 5 cases] |
| Q51034600 | [Juvenile rheumatoid arthritis, incidence and most frequent symptoms (author's transl)] |
| Q72037740 | [Juvenile rheumatoid arthritis--a clinical study of 52 cases (author's transl)] |
| Q73657012 | [Juvenile rheumatoid arthritis-associated uveitis] |
| Q80127883 | [Juvenile rheumatoid arthritis. 1928] |
| Q54477939 | [Juvenile rheumatoid arthritis. A follow-up study of 93 patients] |
| Q70810760 | [Juvenile rheumatoid arthritis. Clinical and immunological study in JRA] |
| Q70810768 | [Juvenile rheumatoid arthritis. Comparative clinical studies between juvenile and adult onset RA] |
| Q70810752 | [Juvenile rheumatoid arthritis. Epidemiology and pathogenesis] |
| Q70810765 | [Juvenile rheumatoid arthritis. Management and prognosis of JRA] |
| Q70810775 | [Juvenile rheumatoid arthritis. Pathology of JRA in Japan--Survey of autopsied as well as biopsied cases] |
| Q70810756 | [Juvenile rheumatoid arthritis. Problems in the diagnosis of JRA] |
| Q70810771 | [Juvenile rheumatoid arthritis. Prognostic study from the standpoint of orthopedics of the patients with JRA] |
| Q78822670 | [Juvenile rheumatoid arthritis. Still's disease.] |
| Q81389242 | [Juvenile rheumatoid arthritis. What is the optimal treatment?] |
| Q79381564 | [Juvenile rheumatoid arthritis.] |
| Q69522021 | [Juvenile rheumatoid arthritis: a proposal for its follow-up] |
| Q71287626 | [Juvenile rheumatoid arthritis: consideration on its clinical course and diagnosis] |
| Q70244187 | [Juvenile rheumatoid arthritis: the role of the TMJ and stomatognathic system] |
| Q67294044 | [Juvenile rheumatoid arthritis] |
| Q69473801 | [Juvenile rheumatoid arthritis] |
| Q69727914 | [Juvenile rheumatoid arthritis] |
| Q69793727 | [Juvenile rheumatoid arthritis] |
| Q70770276 | [Juvenile rheumatoid arthritis] |
| Q73673338 | [Juvenile rheumatoid arthritis] |
| Q81846088 | [Juvenile rheumatoid arthritis] |
| Q94034908 | [Juvenile rheumatoid arthritis] |
| Q73002086 | [Knee joint synovectomy in treatment of juvenile idiopathic arthritis] |
| Q52267383 | [Learning through contact with children--an experience with medication training of a child with juvenile rheumatoid arthritis] |
| Q70240579 | [Lesions of the large joints in systemic forms of juvenile rheumatoid arthritis] |
| Q82753832 | [Levels of serum interleukin-15 and the expression of T-helper lymphocyte subsets in peripheral blood of children with juvenile rheumatoid arthritis] |
| Q80161775 | [Long-term evaluation of infliximab in the treatment of persistently active juvenile idiopathic arthritis refractory to conventional therapy] |
| Q67940385 | [Long-term remission induced by measles infection and followed by immunosuppressive therapy in a case of refractory juvenile rheumatoid arthritis] |
| Q54065548 | [Low bone mineral density in juvenile idiopathic arthritis: Prevalence and related factors]. |
| Q69871265 | [Lymphoplasmapheresis in the treatment of juvenile rheumatoid arthritis] |
| Q85482618 | [MEDICAL AND SOCIAL INSPECTION AS A PART OF THE REHABILITATION OF CHILDREN WITH JUVENILE RHEUMATOID ARTHRITIS] |
| Q91839598 | [MTX intolerance in children and adolescents with juvenile idiopathic arthritis] |
| Q82629607 | [Macrophage activation syndrome and systemic onset of juvenile idiopathic arthritis] |
| Q40458588 | [Macrophage activation syndrome in Chinese children with systemic onset juvenile idiopathic arthritis]. |
| Q53805150 | [Macrophage activation syndrome in a patient with systemic type juvenile idiopathic arthritis]. |
| Q40458581 | [Macrophage activation syndrome in children with systemic onset juvenile idiopathic arthritis: analysis of 13 patients]. |
| Q85931848 | [Magnetic resonance imaging in juvenile idiopathic arthritis: peculiarities of imaging children] |
| Q69572348 | [Measurement and comparison of the rheumatoid factors class IgG, IgM and IgA in chronic juvenile rheumatoid arthritis] |
| Q84996885 | [Medical clowns--dream doctors as important team members in the treatment of young children with juvenile idiopathic arthritis] |
| Q83836447 | [Medical treatment of juvenile idiopathic arthritis] |
| Q46334863 | [Medical treatment of juvenile idiopathic arthritis]. |
| Q91171685 | [Methotrexate in juvenile idiopathic arthritis. Adverse effects and associated factors] |
| Q74056316 | [Methotrexate treatment in refractory juvenile rheumatoid arthritis] |
| Q80259453 | [Migraine, juvenile rheumatoid arthritis, prevention of cancer. Potential of coxibs has not been exhausted] |
| Q81924994 | [Modern approach to treatment of juvenile rheumatoid arthritis] |
| Q70041369 | [Myocarditis in juvenile rheumatoid arthritis] |
| Q84432422 | [Nailfold videocapillaroscopy - a useful tool for screening patients with juvenile idiopathic arthritis at the risk of development of premature atherosclerosis] |
| Q75353168 | [National investigation program of systemic onset juvenile idiopathic arthritis in diagnosis, therapy and prognosis] |
| Q54698168 | [Neurologic involvement in juvenile rheumatoid arthritis] |
| Q92099791 | [New drugs for treatment of juvenile idiopathic arthritis] |
| Q92283836 | [New therapy approaches, better outcomes? : Results from inception cohorts for patients with juvenile idiopathic arthritis] |
| Q93585331 | [Non-steroidal anti-inflammatory agents in juvenile rheumatoid arthritis] |
| Q71892003 | [Nonconventional therapy in a case of systemic juvenile rheumatoid arthritis] |
| Q81437427 | [Nursing in juvenile idiopathic arthritis: not making the illness the center of care] |
| Q70650002 | [Ocular pathology and juvenile rheumatoid arthritis (IRA). Personal cases] |
| Q72830739 | [On juvenile rheumatoid arthritis] |
| Q86089501 | [Optic neuritis in juvenile idiopathic arthritis patient] |
| Q57225818 | [Oral zinc therapy in juvenile rheumatoid arthritis] |
| Q52310630 | [Orthopedic-surgical therapy of juvenile rheumatoid arthritis]. |
| Q80533993 | [Other rheumatic diseases with uveitis besides juvenile idiopathic arthritis] |
| Q51961241 | [Pain and coping strategies in juvenile idiopathic arthritis]. |
| Q69430011 | [Painful abdominal manifestations in juvenile rheumatoid arthritis] |
| Q72461458 | [Pathologic-anatomical aspects of juvenile chronic polyarthritis] |
| Q93089484 | [Pediatric and adolescent rheumatology-A rapidly developing field in pediatrics : Current status of juvenile idiopathic arthritis and juvenile dermatomyositis] |
| Q79610189 | [Physical development in children with juvenile idiopathic arthritis] |
| Q68198846 | [Physical working capacity in juvenile rheumatoid arthritis] |
| Q54746495 | [Polymorphism of human HLA-DRB1 leukocyte antigen alleles and its association to juvenile rheumatoid arthritis in a sample of Colombian mestizo children]. |
| Q69792249 | [Positive Kveim test and amyloidosis in a case of juvenile form of rheumatoid arthritis with an atypical course] |
| Q79956318 | [Post-academic dental specialties 7. Masticatory function of patients with juvenile idiopathic arthritis] |
| Q95784081 | [Presence of riziform bodies in a patient with juvenile idiopathic arthritis: case report and literature review.] |
| Q68106971 | [Present possibilities and value of surgical treatment of the hip joint in juvenile rheumatoid arthritis] |
| Q40472614 | [Presentation of a clinical case of systemic juvenile rheumatoid arthritis]. |
| Q82528211 | [Progress in treatment of juvenile idiopathic arthritis with biologic agents] |
| Q73091008 | [Prolonged treatment of the juvenile rheumatoid arthritis with ACTH and cortisone] |
| Q56966537 | [Protocol for clinical monitoring of juvenile idiopathic arthritis] |
| Q71015811 | [Psychological aspects of juvenile rheumatoid arthritis] |
| Q67846891 | [Radiographic morphology of juvenile rheumatoid arthritis in adulthood (using the hands as an example) (proceedings)] |
| Q68807800 | [Radiological changes in cervical occipital joints during a course of juvenile rheumatoid arthritis] |
| Q70219665 | [Recognition and diagnosis of juvenile ankylosing spondylitis: clinical analysis and comparative study of juvenile rheumatoid arthritis] |
| Q88004689 | [Recognition of systemic-onset juvenile idiopathic arthritis at the genetic level] |
| Q70493196 | [Recurring tamponade in juvenile rheumatoid arthritis treated with pericardotomy and corticoids] |
| Q85872359 | [Report of a child with Ewing's sarcoma who was misdiagnosed as juvenile idiopathic arthritis] |
| Q57189613 | [Research progress in the risk factors of juvenile idiopathic arthritis-associated uveitis and its severe visual outcome] |
| Q75282505 | [Responses of gamma-interferon and interleukin-4 in children with juvenile rheumatoid arthritis] |
| Q72266921 | [Results of electroencephalographic examination in cases with juvenile form of rheumatoid arthritis] |
| Q72891121 | [Results of electromyographic examinations of juvenile form of rheumatoid arthritis] |
| Q73105472 | [Rheumatoid arthritis and juvenile rheumatoid arthritis] |
| Q70184296 | [Rheumatoid disease in children (juvenile rheumatoid arthritis)] |
| Q68976201 | [Rheumatoid factor isotypes and immune complex isotypes in juvenile rheumatoid arthritis] |
| Q95492594 | [Risk factors for pleural lung disease in children with juvenile idiopathic arthritis] |
| Q69520746 | [Roentgenologic staging of juvenile rheumatoid arthritis] |
| Q70780879 | [Role and aspects of lymphography in juvenile chronic polyarthritis] |
| Q70508482 | [Role of D-penicillamine in the complex treatment of juvenile rheumatoid arthritis] |
| Q79333785 | [Role of oxidative stress in the maintenance of inflamation in patients with juvenile rheumatoid arthritis] |
| Q54325522 | [Role of ultrasonography of the knee in the follow-up of juvenile rheumatoid arthritis] |
| Q83760465 | [SGI-PS-CMA evidence-based recommendations for the diagnosis and management of juvenile idiopathic arthritis (oligoarticular and polyarticular)] |
| Q77980418 | [Sandimmun-Neoral--a new quality of life for patients with severe systemic juvenile rheumatoid arthritis] |
| Q70441177 | [Selection of the best method for treating juvenile rheumatoid arthritis by using a chart] |
| Q70087279 | [Serological aspects of the juvenile forms of rheumatoid arthritis] |
| Q95534642 | [Serum levels of Th1/Th2 cytokines in children with non-systemic juvenile idiopathic arthritis] |
| Q92820459 | [Serum lipid profile in children with different subtypes of juvenile idiopathic arthritis] |
| Q70789530 | [Social adaptation of children with juvenile rheumatoid arthritis] |
| Q73045809 | [Still's syndrome; atypical juvenile rheumatoid arthritis] |
| Q70745688 | [Studies on cytotoxicity against synovial cells in juvenile rheumatoid arthritis. 1. Cytotoxicity of patients' sera with normal lymphocytes to cultured synovial cells of rats] |
| Q81805075 | [Successive connections: juvenile idiopathic arthritis and systemic lupus erythematosus] |
| Q81019075 | [Superoxide dismutase in children with juvenile idiopathic arthritis] |
| Q69522029 | [Support therapy with 25-OH-D3 for osteoporosis in juvenile rheumatoid arthritis] |
| Q54103601 | [Symposium I. 2. Treatment in the field of internal medicine and prognosis of juvenile rheumatoid arthritis] |
| Q80432719 | [Systemic juvenile rheumatoid arthritis] |
| Q78140990 | [T lymphocyte immunological response to different antigenic fractions of Mycobacterium bovis in juvenile chronic polyarthritis] |
| Q67942388 | [TMJ in subjects with juvenile rheumatoid arthritis: functional and cephalometric analysis] |
| Q81420069 | [Temporomandibular joint involvement in juvenile idiopathic arthritis: treatment with an orthodontic appliance] |
| Q73223630 | [The EHF therapy of children with juvenile rheumatoid arthritis] |
| Q68909938 | [The characteristics of medical rehabilitation in juvenile rheumatoid arthritis] |
| Q88018677 | [The clinical application of biologicals in juvenile idiopathic arthritis] |
| Q73954425 | [The clinical course of juvenile rheumatoid arthritis] |
| Q84138845 | [The occurrence of anticardiolipin antibodies bound in circulating immunological complexes in sera of patients suffering from juvenile lupus erythematosus and juvenile idiopathic arthritis] |
| Q81573978 | [The prevalence of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis.] |
| Q68543512 | [The problem of faulty central regulation of immune mechanisms in juvenile rheumatoid arthritis] |
| Q72314101 | [The rheumatoid factor in patients with juvenile rheumatoid arthritis and with Still's disease] |
| Q86293822 | [The significance of innate immunity in juvenile idiopathic arthritis] |
| Q69713644 | [The state of humoral immunity to enterobacterial antigens in juvenile rheumatoid arthritis and reactive arthritis in children] |
| Q87802464 | [The temporomandibular joint in juvenile idiopathic arthritis: what radiologists need to look for on magnetic resonance imaging] |
| Q57022843 | [Therapeutic options in juvenile idiopathic arthritis : Part 1: Nonsurgical treatment] |
| Q52874762 | [Therapy of juvenile idiopathic arthritis in early adulthood with biologics: transition from pediatric to adult care]. |
| Q69956137 | [Therapy of juvenile rheumatoid arthritis: presentation of 3 protocols] |
| Q69431520 | [Therapy with plasmapheresis and lymphoplasmapheresis combined with immunosuppressive agents in 2 cases of intractable juvenile rheumatoid arthritis] |
| Q71269172 | [Three cases with juvenile rheumatoid arthritis who showed hypocomplementemia related to disease activity] |
| Q49993751 | [Tocilizumab for refractory systemic juvenile idiopathic arthritis]. |
| Q87262201 | [Trabeculectomy in uveitis associated with juvenile idiopathic arthritis: long-term results in pediatric secondary glaucoma] |
| Q71027783 | [Treatment of juvenile rheumatoid arthritis (author's transl)] |
| Q72998187 | [Treatment of juvenile rheumatoid arthritis with ACTH] |
| Q69237924 | [Treatment of juvenile rheumatoid arthritis with gold salts. Follow-up after 2 years of treatment] |
| Q68212049 | [Treatment of juvenile rheumatoid arthritis] |
| Q70102274 | [Treatment of juvenile rheumatoid arthritis] |
| Q57022844 | [Treatment options in juvenile idiopathic arthritis : Part 2: Orthopedics und surgery] |
| Q84589749 | [Trends in imaging of juvenile idiopathic arthritis] |
| Q86484116 | [Two pairs of brothers with juvenile idiopathic arthritis (JIA): case reports] |
| Q88900384 | [Unilateral amaurosis as an initial symptom of juvenile idiopathic arthritis] |
| Q87453028 | [Unusual presentation of juvenile idiopathic arthritis and autoimmune hepatitis] |
| Q71764302 | [Update drug therapy of juvenile rheumatoid arthritis] |
| Q68533835 | [Use of chlorbutin in the complex treatment of systemic forms of juvenile rheumatoid arthritis] |
| Q53885725 | [Uveitis and juvenile idiopathic arthritis] |
| Q89362075 | [Uveitis associated with juvenile idiopathic arthritis : Optimization of immunomodulatory therapy] |
| Q79334038 | [Uveitis in juvenile idiopathic arthritis] |
| Q84373475 | [Uveitis in juvenile idiopathic arthritis] |
| Q88784063 | [Uveitis in juvenile idiopathic arthritis] |
| Q69431285 | [Value of studying circulating immune complexes (CIC-PEG 280) in juvenile rheumatoid arthritis] |
| Q84843879 | [Vascular malformation of the knee simulating juvenile idiopathic arthritis] |
| Q69739882 | [Von Willebrand factor in juvenile rheumatoid arthritis] |
| Q69765255 | [X-ray characterization of changes of the lungs in juvenile rheumatoid arthritis] |
| Q41921778 | Τhe genetics of juvenile idiopathic arthritis: Searching for new susceptibility loci. |
| Q24812856 | Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolong |
Search more.